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In vertebrates, immunoglobulins have long been considered the primary means for recognition 
of potential pathogens since they are the product of an adaptive immune system capable of 
generating and selecting for the most efficient antibody when adequately primed.  However, 
initiating a naive system requires signals from cells that employ invariant receptors rather than 
antibodies.  These innate receptors appear to recognize repetitive polymers commonly found 
only in microbes.  Frequently, these receptors are lectins specific for polysaccharides 
ubiquitous of the microbial surface.  Lectins in the blood or lymph are widespread among 
metazoans while antibodies are a vertebrate innovation suggesting that lectins may be 
evolutionarily their functional precursors.  Even in primitive jawed vertebrates, there is a 
complete adaptive immune system, but it is relatively inefficient in comparison to mammals.  
Therefore, lectins might have a prominent immune function in lower vertebrates comparable 
 
to antibodies.  To test this, a teleost was surveyed for humoral and hepatic lectins.  A fucose-
specific lectin of 32 kDa (FBP32) was initially purified from the palmetto bass and upon 
sequencing indicated it was unlike other reported lectins.  The primary structure is 
characterized by a tandem polypeptide motif (FBPL) with partial homology to a long pentraxin 
from a frog.  An inflammatory challenge of bass to test if FBP32 behaved like a mammalian 
pentraxin indicated that the FBP32 transcript level increases, but protein levels appear 
constitutive.  An extensive search using both molecular cloning and gene database queries 
revealed that FBP32 is a member of a diverse protein family reflecting varying concatenations 
of the FBPL and even present in a cell surface receptor, but of sporadic phylogenetic 
distribution most notably being absent in mammals.  Analysis of FBP32s genic structure 
reveals that it is flanked by phase 1 introns, which may explain the domains ability to 
concatenate and shuffle to form mosaic proteins.  In collaboration with experts, the tertiary 
structure of an FBPL including its fucose-binding site was elucidated revealing a novel lectin 
fold, the F-type lectin fold (FTL), that is shared by unrelated proteins.  Characterization of 
FBPLs demonstrates that the study of mammals alone may not reveal the full extent of 
immune system innovation. 
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CHAPTER 1.  INTRODUCTION 
A synopsis of adaptive immunity 
It is believed that the establishment of molecular mechanisms for self recognition (i.e. 
intercellular adhesion and communication) was crucial for the evolutionary emergence of 
multicellular organisms [1], but their evolutionary success would also appear intimately linked 
to their capacity for non-self recognition.   Another significant evolutionary transition, from 
jawless- to jawed-vertebrates, marks the appearance of a substantially more complex immune 
system, specifically an adaptive immune system [2].  A unique feature of the immune response 
in vertebrate, as derived mostly from the study of mammals and birds, is that if an individual 
survives the initial infection, the system adapts and remains prepared, typically for the rest the 
animal’s life, to rapidly clear any subsequent infection.  Several evolutionary innovations 
contributed to establishing this immunological “memory” [3].  Firstly, the somatic 
recombination of receptor genes, which occurs independently in each lymphocyte as it 
matures, permits generating an exorbitant number of unique receptors to select from without 
needing to encode them individually in the genome.  Secondly, the development of 
mechanisms for sorting through these cells in order to select those which are specific to 
infectious agents and eliminate those that are specific for self.  Following is a brief review of 
the elements that define the adaptive immune response. 
The appearance of an adaptive response [2] is correlated with the simultaneous appearance of 
three genes central to immune recognition: rearrangement-associated genes (RAG), the 
variable (V) domain of the Ig superfamily (Igsf), and class I and class II major 
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histocompatibility complex receptors (MHC).  The V(D)J recombination that produces the V 
domain, which mediates recognition by immunoglobulins (Ig) and T-cell receptors (TCR), can 
occur only through the action of the RAG protein.  Afterwards, the selection and proliferation 
of lymphocytes expressing the recombined V domain of high affinity to non-self requires 
interaction with the MHC presented on the cell surface.  Through this recombination and 
selection process, clonal lymphocyte populations emerge that can efficiently detect pathogens 
present intracellularly (i.e. viruses and intracellular bacteria) or encountered in the interstices of 
the body.  For intracellular pathogens, a subset of naïve T-cells, which have never encountered 
antigen, are activated into cytotoxic cells when the TCR recognizes MHC I loaded with 
peptides produced during degradation in the cytoplasm.  A different subset of naïve T-cells are 
activated into effector helper cells through MHC II loaded with peptides produced during 
phagosomal degradation.  The subsequent interactions of these activated T-cells compose 
cellular immunity.  However, these effector helper T-cells are also responsible for initiating a 
humoral response through activation of mature B-cells, which will eventually mature into 
antibody-secreting plasma cells.  Therefore, the resulting contribution of RAG, V domain 
recombination, and MHC selection is the development of humoral and cellular mechanisms 
for rapidly detecting and eliminating pathogens. 
The best inducers of immunity are T-dependent antigens (TD) presented by MHC (i.e. 
proteins), however other macromolecules present in pathogens such as polysaccharides, 
nucleic acids and lipids can also serve as antigens.  Since MHC does not present these 
molecules, they are referred to as T-lymphocyte-independent (TI) antigens.  However, TI 
antigens are poor immunogens because they do not activate cellular immunity.  Characteristic 
of the immune response to TI antigens is the prevalence of low affinity IgM and the lack of 
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establishment of lymphocyte memory so important for immunity.  This difference in 
immunogenicity between TD and TI antigens is particularly important for vaccine 
development since bacterial and fungal cell surfaces are covered predominantly with 
polysaccharides (e.g. capsules, peptidoglycan, lipopolysaccharide, β-glucan, and mannan) 
serving as prominent epitopes available for immune recognition [4].  Moreover, children 
younger than 2 years old and the elderly appear unresponsive to polysaccharide immunizations 
making it difficult to protect them from infections, which is especially of concern due to the 
current rise in antibiotic-resistant infections.  Evidently, the adaptive immune system is geared 
toward the recognition of peptide antigens rather than saccharides.  This can sometimes be 
overcome by conjugating saccharides to a carrier protein to induce the presentation of 
glycosylated peptides by the MHC.  However, this does not likely reflect the events during a 
natural encounter with a pathogen.  What is emerging is that for recognition of TI antigens, 
the adaptive immune system is dependent on  non-immunoglobulin receptors for initiating an 
immune response. 
The immunoglobulin fold 
The Ig fold [5] is the most frequently detected protein domain in receptors associated with the 
adaptive immune system.  Currently, Ig domains can be classified based on sequence similarity 
into V, C and H domain families, which together form the Igsf, however it is the presence of 
hypermutable regions in the V domain that make it an extremely good receptor domain.  The 
Ig fold is topologically described as a sandwich formed by two β-sheets consisting of 3 to 5 
antiparallel β-strands connected by loops of various lengths.  An intrachain disulfide bridge is 
commonly present serving to stabilize the fold.  Substantiated by the diversity represented by 
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the Igsf, the Ig fold is highly mutable in positions that do not disrupt the fold, especially the 
loops.  It is three of these loops, named complementarity-determining regions (CDR1, 2 and 
3), from the distal V domain on the immunoglobulin that form the binding site.  An important 
property of the Ig fold is its tendency to associate to itself as is found in immunoglobulins.  An 
immunoglobulin basically consists of two light (2L) and two heavy polypeptide chains (2H) 
each possessing one variable (VL and VH) and several constant (CL and CH) Ig domains.  
Association of L and H chains involves interactions between their C domains, but association 
between V domains actually results in creation of the antibodies binding site by bringing 
together both domains’ CDRs.  In other words, the binding-site of immunoglobulins is not 
encoded within a single polypeptide, but instead relies on the integration of CDRs from 
heterologous domains.  Arguably, this structural feature has made the immunoglobulin fold 
the predominant domain of adaptive immune receptors.  
A synopsis of innate immunity 
An inherent deficiency of the process of acquiring immunity is the initial lag (i.e. days) required 
for activating lymphocytes that will eventually establish a specific response that can quickly 
eliminate a pathogen.  During this naïve stage, the immune system depends on the general 
activation of humoral and cellular effector mechanisms that will typically eliminate the 
offending pathogen.  Since the receptors involved in recognition of the pathogen are not 
recombined, like immunoglobulin genes, they are referred to as innate or germline-encoded.  
Macrophages, neutrophils and natural-killer cells, not lymphocytes, are the principal effector 
cells that respond to microbial invasion as part of the innate response.  The complement 
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system, coagulation factors, collectin and pentraxins are examples of humoral effectors of 
innate immunity. 
As mentioned, innate immunity has emerged as an important contributor during initiation of 
an adaptive response by recognizing TI antigens and supplying secondary signals required for 
activation of lymphocytes [6].  It has long been observed that an adjuvant is required to initiate 
an immune response toward protein antigens that are poorly immunogenic.  An explanation 
resides in that the uptake of microbial products commonly contained in adjuvant induces the 
expression of accessory receptors, such as B7 receptors [7], on the surface of long lived 
phagocytes (i.e. dendritic cells and macrophages) during antigen presentation.  T-lymphocytes 
are activated only if they receive this secondary signal.  Similarly, B-cells also are activated 
through a secondary signal provided by a component of innate immunity.  Circulating antigens 
fixed with complement component C3d are able to bind both mIg and complement receptor 2 
present on the lymphocyte surface which initiates proliferation [8].  Therefore, innate 
recognition translates into positive signals for activation of both humoral and cellular 
mechanisms of the adaptive immune response. 
Innate immune receptors are typically considered non-specific in comparison to antibodies 
because their affinities are typically lower.  Nevertheless, innate receptors do specifically bind 
to moieties, or molecular patterns, typically present on the surface of microbes, but absent 
from the metazoan host.  These have been referred to as pathogen-associated molecular 
patterns (PAMP) [9].  Examples of likely PAMPs are lipopolysaccharide (LPS), capsular 
polysaccharides (CPS), peptidoglycan (PG), teichoic acid (TA), lipoarabinomannan, N-
formylmethionyl peptides, and unmethylated CpG dinucleotide-rich DNA from bacteria, 
mannose-rich cell wall polysaccharides from fungi (i.e. zymosan), and double-stranded RNA 
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from retroviruses.  Most of these molecules appear indispensable for survival and consist of 
conserved repeating structures.  Consequentially, the repertoire of receptors needed to 
recognize these structures does not probably need to reach the diversity attainable by somatic 
recombination of antibodies.  Interestingly, most PAMPs are not polypeptides, so like most TI 
antigens they are not expected to be good immunogens.  In the following section, a brief 
overview of innate receptors is given to illustrate the diversity of protein domains that are 
involved in recognizing PAMPs.  It is noteworthy that none of the receptors currently 
reported possess an immunoglobulin domain. 
Cellular innate receptors 
Phagocytes are endowed with an array of receptors involved in the recognition of PAMPs [10].  
Dendritic cells (DCs) are especially efficient at antigen uptake as they are capable of engulfing 
fluids (i.e. macropinocytosis), ingesting particulates (i.e. phagocytosis), and receptor-mediated 
endocytosis through diverse PAMP receptors such as C-type lectins and Toll-like receptors 
[11].  Most of the C-type lectin receptors described consist of a single lectin domain, but the 
macrophage receptor [12], also expressed by most myeloid cells, consists of 8 concatenated 
lectin domains.  A more detailed discussion of the C-type and other lectin families is presented 
below. 
Presently, much attention is directed at the Toll-like receptors (TLR) of mammals, which were 
initially linked to innate immunity from studies of the antimicrobial response in the fruit fly 
(Drosophila melanogaster) [13, 14].  TLRs consist of a leucine-rich repeat (LRR) ectodomain and a 
cytoplasmic IL-1 receptor-like domain (TIR) [15] which activate signal transduction through 
the NF-κB pathway [16].  Unlike the fruit fly [17, 18], many of the mammalian TLRs appear to 
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directly bind, through their LRR, diverse and unrelated PAMPs [19].  However, the structural 
mechanism for recognition of such diversity of PAMPs remains unknown at present.  
Although TLRs are not endocytic receptors, their activation initiates the adaptive response (i.e. 
TH1) that is crucial for eliminating microbial infections [20] demonstrating that they also help 
instruct the adaptive immune response.  
Acute phase proteins 
Inflammation frequently accompanies the activation of an innate response.  It is principally 
characterized by an increased blood flow to the area of injury, increased blood vessel 
permeability allowing plasma proteins to infiltrate, the arrival of neutrophils in great numbers 
to the site, and a rise in body temperature [21].  Cytokine signals that originate at the site of 
injury spread to the rest of the body and in the liver they induce what is referred to as an acute 
phase response.  The liver responds to these inflammatory signals by rapidly upregulating 
synthesis of acute phase proteins (APP) many which are innate receptors such as pentraxins, 
complement proteins, and collectins.  Of these APPs, pentraxins exhibit the most dramatic 
response by increasing as much as three orders of magnitude from their normal levels [22].  C-
reactive protein (CRP), the first pentraxin identified, specifically binds to the unusual 
phosphorylcholine modification of teichoic acid from the pneumococcal cell wall [23].  CRP 
also binds lipophosphoglycan present on Leishmania, a protozoan parasite [24] so it appear to 
have broad recognition capabilities.  The principal effector functions initiated by binding of 
CRP are phagocytosis and activation of the classical complement pathway [25].   
Another acute phase protein that functions as a PAMP-receptor is the lipopolysaccharide -
binding protein (LBP) [26].  As the name implies, LPB binds LPS released from Gram-
negative bacteria and transfers it to CD14 [27], a GPI-anchored receptor that associates with 
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TLR4 [28].  Surprisingly, LBP [29] and CD14 [30] are also capable of binding to bacterial PG.  
Although the structure of LPB with ligand has not been determined, it is proposed that the 
determinants recognized by LBP are the repeating array of anionic groups (i.e. carboxyls) 
attached to the disaccharide repeats that form the backbone of PG.  Unlike LPS, PG is present 
in the cell walls of all bacteria, which suggests that LBP is a sensor for bacteria in general and 
not only of those that are Gram-negative.  It remains to be seen if upon binding PG, LBP and 
CD14 induce TLR4 signaling. 
Lectins 
Lectin generally refers to any protein, excluding recombined immunoglobulins, that binds 
carbohydrate, but does not exert enzymatic activity (e.g. hydrolases).  Lectins were initially 
grouped in families that shared unique characteristics such as calcium dependence, ligand 
specificity, or source.  With the advent of techniques for recombinant cloning of DNA, these 
initial representatives provided the corresponding sequence motif with which to identify 
homologues.  The currently described lectin families are calcium-dependent C-type, galactose-
binding galectins [31], immunoglobulin-like I-type [32], P-type mannose-6-phospate 
receptors[33], and pentraxins [34] from animals, and legume [35] and cereal [36] lectins from 
plants.  Presently, for each of these families a representative topological structure has been 
determined including placement of their binding sites as demonstrated by the co-crystallized 
ligand [37-42].  The diversity of animal lectins is not restricted to just these families as many 
other unique saccharide-binding topologies, sometimes of unclear ancestry, have been 
discovered [43, 44].  The functional mechanisms of some formerly well-studied proteins are 
being reevaluated since discovering they additionally possess lectin activity.  For example, 
calreticulin and calnexin, named for their involvement in intracellular Ca2+ homeostasis, also 
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are involved in quality control of protein-folding within the endoplasmic reticulum, which is 
achieved through recognition of the polypeptide’s glucosylation state [45].  Likewise, the lectin 
activity of certain cytokines maps to a site unique from the known peptide receptor-binding 
site, which led to postulating a new model for cell signal activation [46].  As direct products of 
genes that can be manipulated in vitro, protein-protein interactions have received much 
attention, but technological inroads [47] should facilitate understanding the contribution of less 
malleable post-translational modifications, such as glycosylation, to protein interactions [48].  
Surely, continued interest on the role of glycoconjugates will likely reveal that lectin activity is 
more widespread than previously appreciated. 
The diversity of lectin families suggests great divergence between them, but detailed 
topological comparison demonstrates they share many similarities.  Some of the lectin families 
share similar topology, such as legume lectins, galectins and pentraxins [49], despite lacking any 
sequence similarity or location of binding site, suggesting a parallel evolution of saccharide-
binding activity by analogous folds.  Moreover, distinct topologies also appear to share similar 
interactions for achieving specificity towards ligand [50].  The binding sites of lectins are 
typically a shallow indentation where polypeptide residues extend to mediate hydrogen bonds 
with saccharide hydroxyls and the ring oxygen.  The hydroxyls of saccharides can form 
cooperative hydrogen bonds by serving as both acceptor of two bonds and donor of one 
bond.  In addition, van der Waal packing through aromatic residues that stack against the 
aromatic face of the monosaccharide ring plays a part in binding [51].  In the case of the C-
type family of lectins [52], binding is mediated directly by the lectin-coordinated Ca2+ that 
forms coordination bonds with the hydroxyl oxygen of the saccharide.  Abrogation of binding 
activity upon removal of the cation emphasizes the importance of this interaction.  Water, as 
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both donor and acceptor, also plays an important role in forming hydrogen bridges especially 
if residues are out of reach of the saccharide hydroxyls.  The most common monosaccharides 
present in natural glycoconjugates are mannose (Man), galactose (Gal), glucose (Glc) and their 
amidated derivatives (i.e. GalNAc and GlcNAc), fucose (Fuc) and sialic acid (NeuNAc).  One 
of the key characteristic used by lectins to distinguish these saccharides is the disposition of the 
C-4 hydroxyl.  Gal has an axial 4-OH while in mannose and glucose this moiety has an 
equatorial disposition.  Oligosaccharides and polysaccharides, not monosaccharides are most 
likely the naturally relevant ligands for most lectins, so additional interactions are formed, but 
usually with no more than with three saccharides.  An important difference between lectins 
and immunoglobulins is that lectins typically exhibit much lower binding affinity; nevertheless, 
this is typically compensated through association of many units to create a multivalent protein.  
Much has been gained in the understanding of the mechanisms of lectin binding, but 
addressing the physiological function of lectins remains a challenge, especially in light of the 
multiplicity of paralogues present in most organisms. 
Many cell-surface lectins, especially those of the C-type family, have evolved to function in 
cellular immunity [53]; additionally, there is growing evidence that mammalian serum lectins 
are relics of an ancient humoral immune system.  The ubiquity and diversity of humoral 
lectins, especially in taxonomic lineages, which emerged prior to the innovation of somatic 
recombination and clonal selection, supports the hypothesis that lectins evolutionarily 
preceded immunoglobulins in the role of antibodies [54].  Humoral or hemocyte-associated 
lectins have been detected in diverse mollusks [55, 56], arthropods [54, 57-70], non-chordate 
deuterostomes [71-74] and lower chordates [75] demonstrating their widespread presence [76, 
77].  Study of the horseshoe crab (Tachypleus tridentatus and Limulus polyphemus), exploited for the 
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sensitivity of its blood coagulation system [78] to LPS [79], has provided the best description in 
arthropods of direct induction by a microbial product of hemocyte degranulation resulting in 
the release of lectins and diverse antibacterial proteins [80].  The release of whole genome 
sequences of the nematode (Caenorhabditis elegans) [81], the fruit fly [82], and the ascidian (Ciona 
intestinalis) allows the complete enumeration of the lectin gene repertoire from diverse 
invertebrate lineages.  Evidently, multiple members of the C-type family [83-85] are present in 
each of these taxa, which is interesting since this domain is well known for its involvement in 
vertebrate immunity [86].  The role of these lectins remains to be determined, but their 
predominance is suggestive of their importance to invertebrate defense. 
Undoubtedly, arthropods have been useful in the discovery of novel recognition mechanisms 
of innate immunity [87], but the lack of correspondence of invertebrate lectin genes to those in 
vertebrates leaves any statement of homology questionable.  However, the fact that 
components of the lectin-activated complement pathway [88] are conserved throughout 
chordates [89] provides strong evidence that lectins preceded immunoglobulins as antibodies.  
Initial evidence of activation of a complement cascade by a lectin was observed with the rabbit 
mannose-binding lectin (MBL) [90], which is very similar to the prototype described from rat 
[91].  MBL is one of several collectins [92] sharing a common structure consisting of a 
filamentous collagen-like tail, a neck region, and terminated with a C-type lectin globular head.  
The collagenous tail assembles into an alpha-helical coiled-coil producing a trimer of lectin 
domains at one end [93].  In the case of MBL, these trimeric protomers further assemble into 
larger oligomers, which is necessary for complement activation [94, 95].  Ficolins, whose 
globular head is an N-acetyl amino saccharide-specific fibrinogen-like domain [96], and 
collectins both share the collagen-like tail of C1q [97], which is implicated in the association to 
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C1s and C1r serine proteases in order to form the C1 complex.  This implied that like C1q, 
MBL and ficolins also associate with serine proteases.  Subsequently, classical complement 
pathway activation by MBL was demonstrated to require homologous proteases, known as 
MBL-associated serine proteases (MASP), which were co-eluted throughout the purification of 
MBL [98].  Unlike C1q, MBL and ficolin bind directly to the target bacterial surfaces rather 
than through an Ig so they are able to initiate complement fixation directly.  A survey of 
immune-related genes in the recently released ascidian genome [85] conclusively demonstrates 
that a vertebrate-like complement system was established prior to the emergence of adaptive 
immunity.  Candidate genes for all three receptors including components of both the classical 
and alternative complement pathways were detected, which contrasts to the lack of any of the 
genes representative of adaptive immunity.  This evidence suggests that C1q bound an 
alternative ligand, likely a pentraxin [99], prior to the appearance of Ig.  Hence, lectin-activation 
appears to be the original mechanism for endowing specificity to complement fixation 
illustrating a link between ancient humoral recognition and effector mechanisms.  
Immunity in ancient vertebrates 
The existence of an adaptive immune response can be found throughout vertebrates except in 
their most primitive class, the agnathans.  There is no evidence of the presence of RAG, MHC 
or immunoglobulin gene clusters in invertebrates though the Ig domain is employed for 
immune recognition [100, 101].  The relatively sudden appearance [102] of an adaptive 
immune response would appear an unlikely event that has been explained [103, 104] to be due 
to large scale chromosomal duplications, which subsequently allowed the diversification of 
multiple immune receptor genes.  Gene duplication has been long proposed as the principal 
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mechanism [105] for expanding the protein repertoire [106].  It is commonly observed that for 
every gene from an invertebrate there are typically four homologues present in vertebrates 
[107].  Surprisingly, this was not just the result of small scale gene duplications, but of two 
virtually consecutive whole genome duplications that occurred during the transition from 
cephalochordates to jawed fish (600 mya) [108].  Additionally, a third duplication occurred 
during the radiation of modern ray-finned fish lineages (320 mya) after they diverged from the 
lobe-finned fish [109, 110] leading to even more gene copies than in tetrapods, although many 
appeared to have been subsequently lost.   
Teleosts possess many of the basic features of the mammalian immune system though they do 
present important differences that suggest their system may be less efficient.  This conclusion 
is principally based on comparative analysis of immunoglobulin gene structure [111] and their 
serum repertoire upon immunization.  Firstly, affinity maturation, the phenomenon where 
antibody affinity increases as the immune response progresses, appears to be absent in teleosts.  
Secondly, electrophoretic analysis of circulating antibodies from fish reveals fewer isoforms 
than those detected in mammals demonstrating that their diversity is lower.  In addition, fewer 
immunoglobulin isotypes are present in fish as only IgM-like and IgD-like isotypes have been 
detected in contrast with the diverse isotypes (i.e. IgM, IgG, IgA, IgE and IgD) present in 
mammals, which are dedicated to specific effector functions.  The genetic capacity for 
generating diversity by means of somatic recombination and hypermutation is present in 
teleosts, so it may be that the deficiency lies in the selection of B-cells expressing high-affinity 
mIg receptors.  Indeed, secondary lymphoid structures and cells associated with affinity 
maturation (i.e. germinal centers and follicular dentritic cells) first appeared in mammals [112].  
Regardless of their lack of antibody affinity maturation, so crucial in maximizing the humoral 
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immune response, teleosts or ectotherms in general thrive in aquatic environments where they 
are continuously exposed to potential microbial pathogens.  Therefore, innate receptors may 
have an even greater role than immunoglobulins as sensors of invasion by any microbes.  This 
is supported by the observation that a zebrafish (Danio rerio) mutant deficient in 
immunoglobulin gene recombination (i.e. rag1) does not appear to be immuno-compromised 
[113]. 
By definition, innate receptors do not somatically recombine like immunoglobulins in 
vertebrates, so it is unclear then how they can express the diversity of specificities in lieu of the 
inefficiency of acquired immunity in teleosts.  Evidence is being provided showing that teleosts 
possess many more members of innate receptor families in comparison to mammals.  For 
example, the repertoire of TLRs detected in teleosts is more numerous [114-116] than that of 
mammals [19].  This implies that in teleosts the repertoire of TLR microbial ligands may be 
even more diverse than presently described in mammals.  Humoral receptors also appear to be 
more diversified in teleosts.  A single C3 is the central component of the non-specific 
alternative complement pathway in mammals, but in fish several isoforms are present that are 
specific towards diverse surfaces [117].  These examples clearly illustrate that innate receptors 
are diversified in teleosts potentially fulfilling functions analogous to that of antibodies.  Like 
mammals, fish possess many of the same innate humoral receptors implicated in pathogen 
recognition, such as collectins [118], pentraxins [119-122], and LPS-binding protein [123].  
However, unlike TLRs, it does not appear that these receptors are more diversified than their 
mammalian homologues. 
Components of the lectin-activated complement pathway have been identified in teleosts [124, 
125], but the additional presence of diverse humoral lectins [126-129] suggests that lectins may 
 
 15 
have a more prominent role in humoral immunity of teleosts than in mammals.  Like 
collectins, these lectins may participate in complement activation, but likely perform as 
immune effectors through agglutination, neutralization or opsonization. 
Fish as models of immunity  
Significant advances have been made to develop teleostean models for the study of immunity 
especially the establishment of the tools comparable to those that are available for mice and 
humans.  Immortalized lymphocyte and macrophage cell lines finally have been established 
[130, 131], which are crucial for studying cellular immunity.  The number of cytokines 
identified and characterized is increasing [132] which should provide useful reagents for 
modulating the immune response.  As previously mentioned, teleosts have undergone a 
genome duplication that may have allowed their protein repertoire to expand extensively.  The 
diversity of the C3 complement components may have resulted from this event.  There have 
even been advances in developing zebrafish, a popular development model, as a model for 
immunology [133].  Surely, teleost are increasingly contributing insights into both ancient and 
derived features of vertebrate immunity. 
Project Goal and Significance 
The goal of this dissertation project is the identification and characterization of humoral lectins 
from a ray-finned fish and to describe the role they may serve as innate PAMP receptors. 
Insight into conserved mechanisms of innate immunity may be gained from the study of 
organisms not conventionally perceived as models for the study of human immunology.  
Specifically, ray-finned fish represent a transitional stage towards the development of the 
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mammalian adaptive immune system since they exhibit lower capacity for generating diversity 
of recombined immunoglobulin-receptors.  Therefore, ray-finned fish potentially rely 
substantially on humoral innate receptors, such as lectins, for immediate recognition and 
elimination of potential pathogens thereby compensating for their underdeveloped antibody 
repertoire.  In this immunological context, the contribution of lectins in defense may be more 
readily parsed whereas in mammals efficient development of immunological memory may 
occlude elucidating their function.  A basic understanding of innate immunity in teleosts is not 
only potentially valuable from a comparative standpoint, but can also contribute to successful 




CHAPTER 2.  IDENTIFICATION OF A UNIQUE BASS LECTIN 
Moronid bass are commonly found inhabiting fresh and saline waters of the North Temperate 
Zone.  The four North American species currently described are striped bass (M. saxatilis), 
white bass (M. chrysops), white perch (M. americana) and yellow bass (M. mississippiensis).  Species 
phylogeny based on morphological and molecular characters suggests these species group into 
two sister clades: white perch: yellow bass and striped bass: white bass, the former being the 
most closely related [135].  The anadromous life style of the striped bass is unique from the 
other species, which exclusively inhabit fresh water.  Rockfish, as striped bass is also known, 
are the largest growing within the genus and due to this, meat quality, and angling 
characteristics they have been historically of commercial importance [136].  Until the mid 
1800s, the striped bass' grounds stretched only from the Gulf of Mexico to the Maine coast.  
Populations present along the Pacific coastline appeared later on due to introduction from 
humans.  In the 1960s, a successful hybridization of the striped bass (♀) to the white bass (♂) 
created the hybrid palmetto bass [137].  The motive behind creating hybrid crosses was to 
combine the size, longevity, food habits, and angling qualities of the striped bass with the 
adaptability to exotic environments of the white bass.  Indeed, the palmetto bass exhibits 
heterosis showing improved survivability, superior early growth rates, greater disease resistance 
[138, 139], and general hardiness [140] compared to striped bass.  These features have been 
exploited for aquaculture by allowing hybrids to be raised at higher population densities 
required to maintain efficient production.  The indoor culture of palmetto bass in the mid-
atlantic region presently allows substantial numbers of large fish to be readily obtained, which 
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was especially advantageous for obtaining the biological materials required for this research 
project. 
At the onset of this project, a choice was made between following a molecular or a 
biochemical approach.  Identification of lectins through use of PCR primers based on protein 
family profiles can be an uncertain proposition [141] due to the extensive divergence observed 
in their polypeptide sequence.  Therefore, a purification protocol exploiting lectin activity and 
documented dependability of sugar-affinity chromatography was chosen.  In addition, 
carbohydrate-affinity purification targets the defining activity of lectins rather than focusing on 
any single lectin sequence family.  From the apparent ubiquity of MPB-like proteins in 
vertebrates, one lectin purification protocol was designed based on the successful 
methodology implemented for isolation of collectins from the liver.  As a first step in 
identifying a collectin-like lectin from the palmetto bass liver, a protein purification protocol 
was compiled based on the published methods for the rabbit [142], rat [143], alligator [144], 
and human [145] liver collectins.  These protocols center on the use of mannan-affinity 
chromatography to selectively exploit the carbohydrate-binding activity commonly exhibited 
by collectins.  However, to cover the possibility that the bass possesses lectins of alternate 
specificity, other ligands (i.e. Fuc, Gal, GlcNAc, Glc, and Lac) were also conjugated to agarose 
for affinity chromatography.  Following the published methods, the initial step in purification 
involves extracting the liver lectin under high salt and in the presence of detergent to help 
dissociate the protein from a liver acetone cake.  The extract is subsequently screened on each 
of the monosaccharide columns, which are eluted with the corresponding free 
monosaccharide.  One drawback brought about by the use of high salt concentrations and 
detergent is that they are not compatible with the hemagglutination assay commonly used for 
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detecting lectin activity leaving no other facile means of testing for a lectin in the liver.  
Therefore, an alternative protocol adapted from [146] based on aqueous extraction at 
physiological salinity and without detergent was implemented.  Based on the common 
presence of soluble lectins in circulation among both protostome, deuterostome invertebrates 
and vertebrates, as previously mentioned, blood from bass was also assayed for lectin activity.  
Serum was used instead of plasma since by being difribinated it is more stable under storage 
and handling.  This chapter describes the purification, characterization, and cloning of a 
fucose-binding lectin present in the liver and blood of the palmetto bass and striped bass. 
Materials and Methods 
Reagents 
Monosaccharides, oligosaccharides, glycoproteins, divinyl sulfone, and Sepharose 6B were 
purchased from Sigma (St. Louis, MO, USA).  Enzymes used for molecular biology were 
purchased from New England Biolabs (Beverly, MA, USA).  Red blood cells were obtained as 
expired lots from the University of Maryland at Baltimore Hospital Blood Bank, or as washed 
Immucor Referencells (Norcross, GA, USA).  EnzyOne 2000 DNA polymerase and dNTPs 
used in PCR were purchased from ID Labs (London, Ontario, Canada).  TaKaRa ExTaq high 
fidelity DNA polymerase was purchased from PanVera (Madison, WI, USA). 
Animals 
Striped and palmetto bass of >1 kg housed at the COMB Aquaculture Research Center (ARC) 
were used for extraction of blood and liver.  Animals for the challenge experiments (Sixteen-
month-old palmetto bass; 300-400 g each) were purchased from Integrated Food 
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Technologies (Emmaus, PA, USA), transported to the ARC, and acclimated (10 ppt at 18 °C).  
Fish were held in 6 ft and 12 ft circular tanks within a recirculating water system, with stocking 
densities not exceeding 38 kg/m3.  Feed was pelleted fish feed (Purina Mills; Richmond, IN, 
USA).  Before venipuncture or challenge injections, all animals were anesthetized in 250 ppm 
2-phenoxyethanol (J. T. Baker; Phillipsburg, NJ, USA).  Killing of fish prior to dissection was 
accomplished by anaesthetic overdose (1000 ppm).  The Institutional Animal Care and Use 
Committee of the University of Maryland Biotechnology Institute approved the procedures 
described below.  
Extraction of blood and separation of serum 
Peripheral blood (approx. 10 ml/kg) was collected from the caudal vein using  20 ml syringe 
fitted with an 18-gauge hypodermic needle (BD Biosciences; Bedford, MA, USA).  After 
removing the needle from the syringe, the blood was transferred to 50 ml polypropylene 
conical tubes (Sarsted; Newton, NC, USA) and the clot allowed to retract overnight at 4 °C.  
Serum was separated from the clot by centrifugation at 3,000 x g for 30 min in a swinging-
bucket Beckman Model J centrifuge at 4 °C, and stored at -80 °C. 
Dissection and collection of livers 
Whole livers (approximately 200 g each) were collected and snap frozen in liquid nitrogen.  
Livers were subsequently stored at -20 °C (for protein purification) and at -80 °C (for RNA 
extraction) until further use.  
Preparation of liver extracts 
Livers were first allowed to thaw overnight at 4 °C and then minced with scissors in a tray on 
wet ice.  For extraction from acetone cake preparations, approximately 150 g minced liver was 
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homogenized in cold acetone (-20 °C; 2 ml acetone/g liver) for 1 min with a Waring blender 
to produce a fine slurry.  The homogenate was filtered through Whatman No. 1 paper on a 
Büchner funnel and the retentate was extracted again by pouring cold acetone over the powder 
remaining on the filter.  The resulting acetone cake was dried overnight in a vacuum chamber 
at 4 °C.  Aqueous extraction of the delipidated liver tissue was a modification of the procedure 
established for purifying the alligator hepatic binding protein [144].  The acetone cake was 
rehydrated by suspending the powder in 500 ml (3.5 vol) of ice chilled 0.2 M NaCl, and stirring 
the slurry for 30 min at 4 °C.  The rehydrated acetone powder was centrifuged at 12,000 x g for 
15 min at 4 °C in a Beckman Model JR-21 centrifuge with a Beckman J-10 rotor.  The 
resulting pellet was resuspended in 400 ml (2.5 vol.) extraction buffer (10 mM Tris-HCl (pH 
7.8, 4 °C), 0.4 M KCl, 2% (v/v) Triton X-100, 0.1 mM PMSF, 5 mM iodoacetamide) and 
stirred for 30 min at 4 °C.  The resulting extract was clarified by centrifugation at 12,000x g for 
15 min at 4 °C and the supernatatant was set aside.  The remaining pellet was extracted three 
more times, supernatants pooled (1.2 liters), and the final pellet discarded.  Finally, the pooled 
extract was adjusted to 20 mM Ca2+ by adding solid CaCl2 . 
For preparation of aqueous liver extracts, minced bass liver was mixed with 200 ml of chilled 
extraction buffer (10 mM Tris-HCl (pH 7.8, 4 °C), 100 mM lactose, 25 mM KCl, 0.1 mM 
PMSF, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin), and liquefied in a chilled 
Waring blender for 1 min.  The smooth homogenate was centrifuged at 12,000 x g, 15 min at 4 
°C.  The supernatant was filtered through cheesecloth, and stored on wet ice.  A second 
extraction of the pellet with 200 ml chilled extraction buffer was perfomed twice, and the 
supernatants pooled with the first supernatant.  To allow lipids to separate, the homogenate 
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was kept on wet ice for 1 h, and the floating lipid layer removed with a pipet.  The 
homogenate was clarified by a second centrifugation at 14,000 x g for 1 h at 4 °C. 
Protein concentration estimation 
Protein concentrations were estimated using the Protein Assay kit I (BioRad; Hercules, CA, 
USA), based on Coomassie dye binding [147] and crystalline bovine serum albumin as 
standard.  The microassay format in 96-well flat bottom plates was performed as described by 
the manufacturer.  Five minutes after combining protein and dye, the reactions were read at 
595 nm on a SpectraMax 340 plate reader (Molecular Devices; Sunnyvale, CA, USA) 
controlled by SoftmaxPro software v.1 (PC version). 
Protein purification and storage 
A. Preparation of affinity chromatography gel 
Sugars were covalently bound to the chromatography resin by the divinylsulfone method [148], 
which has the advantage of producing 40-50 µmol active groups per ml of gel and therefore 
produces a highly substituted matrix.  This method involves the reaction of the sulfone-
bridged divinyl group to the hydroxyl-rich chromatography gel and subsequently forming a 
glycosidic linkage to the free saccharide.  The protocol is as follows: 100 ml settled volume of 
Sepharose 6B-CL (Sigma, St. Louis, MO, USA) was washed with 1 l water in a medium 
porosity sintered glass funnel, suction-dried to a wet cake, and transfered to a 500 ml glass 
beaker.  The gel was suspended in 100 ml 0.5 M sodium carbonate and mixed with magnetic 
stirrer.  In a flow hood, a volume of 10 ml divinylsulfone (DVS) (Fluka; Milwaukee, WI, USA) 
was added drop-wise with constant stirring over a 15 min period after which the suspension 
was continually stirred for 1 hr at room temperature.  After this activation step, the gel was 
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washed with 2 l of water in the sintered funnel until the filtrate was no longer alkaline.  To 
couple the carbohydrate ligands, the activated gel was washed with 0.5 M sodium carbonate (5 
vol.) on the sintered funnel and suspended in an equal volume of a 20% solution of desired 
saccharide dissolved in 0.5 M sodium carbonate. Man, GlcNAc, Fuc, Lac and Glc were 
conjugated in separate batches.  During coupling the gel was mixed end-over-end at room 
temperature for 24 hr.  After the coupling period the gel was washed successively with 2 l of 
water and 2 l of  0.5 M sodium bicarbonate on the sintered funnel.  To block any unreacted 
vinyl groups present, the conjugated gel was suspended in 100 ml 0.5 M sodium bicarbonate 
containing 5 ml 2-β-mercaptoethanol (2-ME)(BioRad; Hercules, CA, USA), and stirred for 2 
hr at room temperature.  Finally, the gel was washed with 2 l of distilled water and stored in 
the presence of 0.02% (w/v) sodium azide at 4 °C to inhibit bacterial growth. 
B. Affinity chromatography of liver acetone extracts 
Liver extracts were applied (0.9 ml/h flow rate) to a 60 ml bed volume of sugar-conjugated 
Sepharose 6B-CL pre-equilibrated with equilibration buffer (10 mM Tris-HCl, pH 7.8, 4 °C; 20 
mM CaCl2; 1.25 M NaCl; 0.5% (v/v) Triton X-100) in a 2.5 cm i.d. Kontes Flexcolumn 
(Vineland, NJ, USA).  The low pressure chromatography system consisted of a Rainin Rabbit 
Peristaltic Pump (Woburn, MA, USA), a LKB 2112 Redirac Fraction collector (Upsala, 
Sweden) and a LKB Uvicord S ultraviolet detector placed in a walk-in refrigerator.  All affinity 
chromatography steps were performed at 4 °C.  After washing the column to baseline 
absorbance as monitored at 280 nm, the potentially-bound fraction was eluted from the 
column with 200 mM of the corresponding sugar ligand dissolved in equilibration buffer or 
eluted with EDTA elution buffer (20 mM Tris-HCl, pH 7.8, 4 °C; 1.25 M NaCl; 20 mM 
EDTA; 0.5% (v/v) Triton X-100).  The eluate was dialyzed using a SpectraPor 1 membrane 
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(Spectrum Medical Supplier; Carson, CA, USA) against 0.05% (v/v) Triton X-100, and the 
detergent removed by protein precipitation in cold ethanol [149].  An equal volume of cold 
ethanol (-80 °C) was added and the mixture left standing for 10 min in ice water.  The 
precipitated protein was pelleted by centrifuging at 20,000 x g for 10 min, at 4 °C in a Beckman 
J-20 rotor.  Finally, the pellet was washed in 50% (v/v) ethanol and resuspended in deionized 
water or buffer.   
C. Anion exchange batch chromatography (AEX) of aqueous liver extract 
To address the possibility that lectin-bound endogenous ligands may interfere with the affinity 
chromatography isolation, batch anion-exchange chromatography was perfomed prior to the 
affinity step.  The pH of the aqueous liver extract prepared in the previous step was adjusted 
to 8.5 with 1 M Tris and combined with pre-equilibrated 100 ml packed DEAE-Sepharose-4B 
(Sigma) by mixing on an orbital shaker for 2 h at 4 °C.  The chromatography gel was washed 
on a sintered glass funnel with 10 volumes of AEX buffer (10 mM Tris-HCl, pH 8; 25 mM 
KCl; 0.1 mM PMSF) to remove any putative endogenous ligand of the lectin.  Protein was 
eluted by step elution in 0.25 M, 0.5 M and 1 M NaCl in 10 mM Tris-HCl, pH 7.8, 4 °C; 0.1 
mM PMSF.  
D. Affinity chromatography of aqueous liver extracts 
The subsequent step after AEX was affinity chromatography on Glc, Man, GlcNAc, Lac or 
Fuc-conjugated Sepharose 6B-CL packed in a 1.5 cm i.d. Kontes Flexcolumn.  The packed 
column was preequilibrated in 10 mM Tris-HCl, pH 7.8, 4 °C; 20 mM CaCl2; 0.5 M NaCl;  0.1 
mM PMSF.  After adjusting to 20 mM Ca2+ with solid CaCl2, the lysate was passed at 0.9 ml/h 
and the flow monitored at 280 nm.  The column was washed to baseline absorbance with 
equilibration buffer, and the lectin(s) bound in each column eluted with 200 mM of the 
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corresponding ligand sugar in equilibration buffer.  The eluates were dialyzed against 50 mM 
Tris-HCl, pH 7.5, 4 °C; 100 mM NaCl; 20 mM CaCl2 to remove the eluting sugar, and stored 
at 4 °C.   
E. Affinity chromatography of serum 
Typically, serum samples from four specimens were pooled (40 ml), dialyzed against 2 l of 
TBS-Ca (50 mM Tris-HCl, pH 7.5, 4 °C; 100 mM NaCl; 20 mM CaCl2) with four changes in a 
24 h period.  The dialyzed serum was diluted 1:1 in TBS-Ca and passed over a 10 ml bed 
volume of saccharide-linked gel (2.5 cm i.d. Kontes Flexcolumn) at 0.9 ml/h and monitored at 
280 nm.  The column was washed to baseline with TBS-Ca, eluted with 30 mM EDTA in TBS 
(no CaCl2), washed to baseline again, and finally, eluted with 200 mM Fuc in TBS-Ca.  
Fractions (0.5 ml) containing protein peaks were pooled and concentrated by ultrafiltration on 
a Centricon 10 (Millipore; Bedford, MA, USA) to a final concentration of approximately 10 
mg/ml.  An opportunity for purifying of gram quantities of protein presented itself when 
significant amounts of blood (~100 ml/fish) became available due to the need for euthanizing 
diseased large striped bass (>3 kg). 
F. Size exclusion chromatography 
The concentrated Fuc-binding fraction from the affinity step was polished by size exclusion 
chromatography (SEC) on a Superose 12 10/30 HR column (Amersham Biosciences; 
Piscataway, NJ, USA) pre-equilibrated with 0.45 µm-filtered running buffer (TBS-Ca, 10 mM 
lactose, 0.02% sodium azide).  This was performed using a Beckman Gold 126/166 HPLC 
system (Fullerton, CA, USA) at a flow rate of 0.4 ml/min, at room temperature, and the 
elution monitored at 280 nm through a 1 cm path-length cell.  Fractions were collected by 
hand into polypropylene Eppendorf microtubes. 
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G. Storage of purified bass lectin 
For short term storage, usually no more than 1 month, 1 mg of purified protein was stored at 4 
°C in the presence of 0.02% (w/v) sodium azide and the rest frozen at -20 °C for long term 
storage. 
Analytical procedures 
A. Electrophoresis and isoelectric focusing 
Polyacrylamide gel electrophoresis in the presence of dodecyl sodium sulfate (SDS-PAGE) 
[150] was performed on 5-20%T gradient mini-gels (8x10 cm) using a Hoefer SE250 system 
(Amersham Biosciences) cooled at 15 °C.  The gels were prepared with reagents purchased 
from BioRad (Hercules, CA, USA), using the Hoefer casting mold and the Hoefer gradient 
maker, following the manufacturer’s protocol.  Gels were stained for ≥2 hours in a Coomassie 
stain (0.25% (w/v) Coomassie R-250 in 50% methanol, 10% (v/v) acetic acid) and destained 
overnight in 10% (v/v) methanol, 7.5% (v/v) acetic acid with a crumpled Kimwipe to adsorb 
the dye.  Silver staining was performed using the Silver Stain Kit (Pierce; Rockford, IL, USA) 
following the manufacturer’s protocol.  Two-dimensional gel electrophoresis was performed 
according to the manufacturer using the same Hoefer SE250 mini-format system equipped 
with a Hoefer Mighty Small™ tube gel adapter for the 1D (IEF) separation step.  Urea vertical 
slab isoelectric focusing was performed as described in [151] using a Hoefer SE600 device. 
B. Glycosylation analysis 
Glycosylation was analyzed with the Glycan Detection Kit (Roche Molecular Biochemicals; 
Indianapolis, IN, USA), which employs an immunoblot format.  Briefly, the bass lectin was 
resolved by SDS-PAGE and electrotransferred for 1 h at 0.4 mA in Towbin buffer (25 mM 
Tris, 192 mM glycine, 10% methanol) onto an Immobilon-P membrane (Millipore; Bedford, 
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MA, USA) using a Hoefer TE22 tank transfer unit refrigerated to 10 °C.  After blocking with 
the solution provided by the kit, the membrane was treated with 10 mM sodium 
metaperiodate.  This treatment cleaves vicinal hydroxyls on sugar rings, which can react with 
digoxigenin-succinyl-[ε]-aminocaproic acid hydrazide, an epitope tag.  The labeled-lectin was 
incubated with a 1:1000 dilution of goat anti-digoxigenin antibody labeled with alkaline 
phosphatase.  The bound antibody was detected by developing the membrane in the 
colorimetric substrate, nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate 
(NBT/BCIP).  Transferrin and creatinase served as positive and negative controls, 
respectively. 
C. Electron spray ionization-mass spectrometry (ESI-MS) 
Mass spectrometry was performed at Emory University’s Winship Cancer Center 
Microchemical Facility.  Bass serum lectin (1 nmoles) was desalted by binding to a Millipore C-
18 ZipTip followed by elution with 2 µl of 50% acetonitrile: 0.1% trifluroroacetic acid.  
Isopropanol:water (50:50; 5 µl) mixture was added to the eluate, and 5 µl taken for flow 
injection analysis (FIA) on a Applied Biosystems PE-SCIEX API 3000 triple quadrupole mass 
spectrometer (Foster City, CA, USA).  A Q1 scan was performed with a scan range of 400 to 
2000 m/z, step size of 0.2 amu, and a dwell time of 0.8 ms. 
D. Size exclusion chromatography 
To determine the native molecular size of the Fuc-binding lectin in solution, the Superose 12 
10/30 HR column used above for final purification was calibrated with low-molecular size 
SEC standards of known hydrodynamic radius (Amersham Biosciences) following the 
procedure in [151] while using the same HPLC system.  These calibrations markers were: 
bovine serum albumin (BSA; 35.5 Å, 67 kDa), ovalbumin (30.5 Å, 43 kDa), chymotrypsinogen 
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A (20.9 Å, 25 kDa), and RNase A (16.4 Å, 13.7 kDa).  Two sets of calibration protein mixes 
were prepared in water at empirically determined concentrations to yield peaks of similar 
absorbance at 280 nm.  Calibration marker set I consisted of BSA (7 mg/ml) and 
chymotrypsinogen A (3 mg/ml).  Calibration marker set II consisted of ovalbumin (7 mg/ml) 
and RNase A (10 mg/ml).  Injecting 200 µl of each set separately allowed complete peak 
separation for each of the marker proteins using this specific column.  The column void 
volume (V0) and total liquid column volume (Vt) was determined by injecting 200 µl of dextran 
blue 2000 (2 mg/ml) (Amersham Biosciences) dissolved in a solution of 5 mg/ml 
chromatography-grade acetone (0.792 g/cm3) (Fisher Scientific) in water.  For the purpose of 
normalizing the procedure irrespective of chromatography system, a distribution coefficient 
(KD) was calculated as follows: KD= (Vr-V0)/(Vt-V0), where Vr is the elution volume of a peak.  
A plot of KD vs log10MW was prepared and a third order polynomial curve fit was made 
(DeltaGraph v.4.1, SPSS; Chicago, IL, USA) to allow the interpolation of molecular weight for 
the experimental sample.  The estimate of molecular weight assumes that the experimental 
protein is globular and behaves hydrodynamically similar to the calibration markers. 
E. Chemical crosslinking 
MsaFBP32 was first dialyzed against 2 l of 100 mM sodium HEPES (pH 7.5), 150 mM NaCl, 
10 mM CaCl2.  Concentration of working solution was adjusted to 35 µM (1.13 g/L based on 
MW 32,388 Da) and 5 µl aliquots were combined with 5 µl (0, 35, 70, 140, 350, 700, 1,400 
µM) bis(sulfosuccinimidyl) suberate (BS3, Pierce Chemicals) (10 mM stock and serial dilutions 
were prepared in fresh dialysis buffer) to achieve up to a 20-molar excess.  The reactions were 
incubated for 60 min at room temperature and finallly diluted 1:1 with double-strength SDS-
PAGE (DTT) sample buffer, heated to 100 ºC for 5 min to denature, and the full reaction (20 
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µl) loaded on a 10% SDS-polyacrylamide mini-format gel (1.5 mm thick) (Hoefer SE250).  
Molecular weight calibration markers were obtained from BioRad (Broad SDS-PAGE). 
Carbohydrate-binding properties 
A. Hemagglutination assay 
Erythrocytes (red blood cells, RBCs) were used in an agglutination tests after Pronase 
treatment (Pr-RBC) using 96-well Terasaki plates (Robbins Scientific; Mountain View, CA, 
USA) as reported earlier [152].  Plates were blocked overnight at 4 °C in 1% (w/v) BSA 
(Sigma) in physiological saline (0.85% NaCl, 0.2% sodium azide).  Dilution plates (96-well, 
Corning; Acton, MA, USA) were blocked to avoid loss of lectin during dilution.  The RBCs 
were washed 4 times at 800 x g for 2 min in physiological saline, and 50 µl of packed RBCs 
were resuspended in 50 µl of 0.1% Pronase (Calbiochem-Novabiochem; La Jolla, CA, USA) in 
physiological saline for 20 min at 37 °C.  Subsequently, cells were washed 4 times with 
physiological saline, and once with TBS-Ca (50 mM Tris-HCl (pH 7.6), 100 mM NaCl, 10 mM 
CaCl2).  The Pr-RBC were resuspended in assay buffer, counted with a hemocytometer, and 
resuspended at 5x106 cells/ml in assay buffer.  An equal volume of a Pr-RBC suspension was 
added to 5 µl of two-fold dilutions of bass lectin in TBS-Ca.  Negative controls were set up 
using TBS-Ca instead of lectin.  The plates were gently vortex-mixed for 10 sec and incubated 
at room temperature for 1 h.  Finally, agglutination was assessed under a microscope and 
scored from 0 (negative) to +4 (full agglutination).  The reciprocal of the highest dilution of 
lectin showing an agglutination score of +1/2 was recorded as the titer.  Total agglutination 
units (AU) is defined as the product of the total volume of the solution assayed for 
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agglutinating activity and its titer.  The lectin specific activity (SA) is defined as the ratio of AU 
per the total protein in the assayed solution.  
B. Hemagglutination inhibition   
The carbohydrate ligand specificity was examined by the microhemagglutination assay 
described above.  A lectin solution with a titer of 2 AU was prepared in TBS-Ca.  Mucins were 
desialylated by mild hydrolysis in 0.1 N H2SO4 at 80 °C for 1 h.  All carbohydrates to be tested 
as inhibitors were dissolved in TBS at concentrations up to 100 mM for mono- and 
oligosaccharides and 10 mg/ml for polysaccharides and glycoproteins, and adjusted to pH 7.6 
with concentrated NaOH.  Serial two-fold dilutions were made of the inhibitors in the same 
buffer.  Inhibition by mono- and oligosaccharides was tested at concentrations from 0.1 mM 
up to 200 mM. Inhibition by glycoproteins, asialoglycoproteins, and polysaccharides was tested 
at concentrations up to 10 mg/ml.  A volume of 5 µl of ligand dilution was added to 5 µl of 
lectin in the wells of 96-well Terasaki plates.  The mixture was incubated for 45 min and 2 µl 
of the Pr-RBC suspension (107 Pr-RBC/ml) was added to each well.  Controls are the 
substitutions of the inhibitor solution by TBS-Ca and substitution of purified lectins by TBS-
Ca.  Ligand concentrations that produced 50% inhibition (IC50) were interpolated by 
polynomial curve fit from plots of percent inhibition versus inhibitor concentration. 
C. Cation requirements   
To test cation requirements for lectin binding to ligand, the bass lectin (200 µl) was dialyzed 
overnight against 1 l of 100 mM citrate (pH 6); 10 mM EDTA using three buffer changes.  
The sample was then dialyzed against TBS-HCl (pH 7.5, 4 °C) to restore neutral pH.  A 
control sample was dialyzed against TBS-HCl (pH 7.5, 4 °C); 1mM CaCl2 in parallel with the 
experimental.  To test if calcium concentration has an enhancing effect on hemagglutinating 
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activity, 5 µl samples of bass lectin serially diluted in TBS (No Ca 2+) were incubated with 5 µl 
of 200, 20, 2, 0.2 and 0.02 CaCl2 or 200 mM EDTA (pH 8) in Terasaki plates.  After 30 min 
equilibration, 2 µl of Pr-RBC suspension (107 cells/ml) were added to the wells and vortex 
mixed gently for 10 sec.  Agglutination was read as described above. 
Peptide and nucleic acid sequence 
A. Edman sequence analysis 
Peptide sequencing was performed at Winship Cancer Center’s Microchemical Facility of 
Emory University.  Bass lectin (50 µg) was digested with trypsin and lysyl endopeptidase in 
0.05 M Tris-HCl (pH 8.5), 1 M guanidine hydrochloride (E/S=1:50, w/w, at 30 °C, 10-20 h).  
The digests were acidified to pH~2 using 10% TFA, and the fragments were purified by 
HPLC.  The peptides were separated on a microbore RP-HPLC system consisting of Applied 
Biosystems model 140A pumps and model 1000S diode-array detector (2.3 ml flow cell, 0.0025 
inch i.d. tubing) (Foster City, CA, USA).  Fractionation of the peptides was performed either 
on a Zorbax-SB C-18 silica column (0.1x15 cm, dp~5 mm, 300 Å pore size; Microtech 
Scientific; Saratoga, CA, USA), or on an Applied Biosystems Aquapore ODS-300 C-18 silica 
column (0.1 x 25 cm, dp~7 mm, 300 Å pore size) equilibrated at room temperature in 0.1% 
aqueous TFA, and eluted at flow rates of 50-80 µl/min using linear gradients of 
acetonitrile/water/TFA (80:20:0.1, v/v).  The column effluent was monitored at 215 nm, the 
UV absorption spectra of the absorbing material was determined, and the eluate was manually 
collected and stored at -20 oC prior to further analysis.  Rechromatography of some fractions 
in the second RP-HPLC elution solvent system consisting of 2-
propanol/acetonitrile/water/TFA (70:20:10:0.1, v/v) was required prior to sequencing.  
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Automated Edman degradation of the peptides [153] was performed on an Applied 
Biosystems model 477A/120A pulsed-liquid sequencing system (Foster City, CA, USA).  The 
PTH-amino acids are separated and identified as described in [154].  
NH2-terminus sequencing of 10 µg of palmetto bass serum lectin was performed at the 
Bioanalyitical laboratory of the Center of Marine Biotechnology, Baltimore, Maryland by Dr. 
Michael S. Quesenberry.  A Beckman LG3000 gas-phase sequencer was used for this 
procedure.  Seven cycles were completed successfully providing sequence of seven residues. 
B. Isolation of total RNA from bass liver 
Total RNA from liver was purified by the acid phenol/guanidinium isothiocyanate method 
[155] with modifications.  One gram of liver tissue, stored at -80 °C, was placed in a mortar 
pre-chilled on dry ice and filled with liquid N2.  The tissue was ground with the pestle to a fine 
powder under liquid N2, was and placed in a 50 ml polypropylene conical tube prechilled with 
liquid N2.  The nitrogen was allowed to evaporate and 10 ml of lysis solution (4 M guanidinium 
thiocyanate; 25 mM sodium citrate; 0.5% sarkosyl, 100 mM 2-ME) were added.  The 
suspension was quickly processed with a homogenizer (Pro Scientific; Oxford, CT, USA) until 
complete dissolution of the tissue.  The lysate was transferred to a polypropylene 30 ml Oak 
Ridge centrifuge tube, 1 ml of 2 M sodium acetate (pH 4) was added, and the contents mixed 
by vortexing.  To extract DNA and protein, 10 ml of water-saturated phenol was added and 
mixed by vortex.  A volume of 2 ml of chloroform/isoamyl alcohol (49:1) was finally added, 
mixed, and left on ice for 15 min.  Separation of phases was accomplished by centrifugation 
12,000 x g (4 °C) for 10 min in a fixed-angle rotor.  To remove unwanted polysaccharides [156] 
from the aqueouse phase collected, 5 ml of high-salt precipitation solution (1.2 M NaCl; 0.8 M 
sodium citrate) was added, mixed, and RNA precipitated by addition of 5 ml of isopropanol 
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and mixing.  The precipitated RNA was collected by centrifugation at 12,000 x g (4 °C) for 20 
min.  After washing the pellet in 70% (v/v) ethanol, the pellet was dissolved in 5 ml of Tris-
HCl (pH 7.5), 1 mM EDTA, 0.5% (w/v) SDS.  The SDS was extracted with 5 ml of 
chloroform, followed by centrifugation.  The RNA was precipitated by addition of 0.5 ml 3 M 
sodium acetate (pH 5.2) and 5 ml isopropanol, mixing between additions.  To increase 
recoveries, the RNA was placed at -80 °C for 1 h.  RNA was finally pelleted by centrifugation 
at 12,000 x g (4 °C) for 30 min.  The pellet was washed with 70% (v/v) ethanol, air-dried until 
transparent, and dissolved in 1 mM sodium citrate (pH 6.4).  RNA was quantified by 
photospectrometry at 260 nm (1 O. D. =40 µg/ml), and the purity assessed by the ratio of 260 
nm/280 nm of >1.8 O.D [157].  The integrity of the RNA was revealed by sharp bands at 2 
and 5 kb (i.e. nuclear ribosomal RNA) after electrophoresis in a 1% (w/v) agarose submarine 
gel. 
The purification of poly(A)+ RNA followed a conventional method based on oligo(dT)-
cellulose affinity chromatrography [158].  Briefly, the total RNA was denatured by heating 65 
°C for 5 min, cooled, on ice, mixed with 1 volume of 2X column-loading buffer (40 mM Tris-
HCl, pH 7.6; 1 M NaCl; 2 mM EDTA; 0.2% (w/v) sarkosyl), and applied to a column packed 
with oligo(dT)-cellulose.  The column was washed with 10 column volumes of 1X column-
loading buffer , and the poly(A)+ RNA eluted with 3 column volumes of elution buffer (10 
mM Tris-HCl (pH 7.6), 1 mM EDTA, 0.05% SDS), with fractions of 1/3 to 1/2 of the 
column volume collected.  A second round of purification to remove the remaining ribosomal 
RNA was carried out as follows: the RNA-containing fractions from the first round of 
purification were adjusted to 0.5 M NaCl from a 5 M stock, heat-denatured, and 
chromatographed as before.  The re-purified poly(A)+ RNA was precipitated by addition 
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1/10th the eluted volume of 3 M sodium acetate (pH 5.2), followed by addition of 2.5 volumes 
of ice-cold ethanol, and storage overnight at -20 °C.  The precipitated poly(A)+ RNA was 
pelleted by centrifugation at 10,000 x g for 15 minutes at 4 °C, washed with 70% (v/v) ethanol, 
to remove salts, and centrifuged.  After air-drying, the pellet was dissolved in 1 mM sodium 
citrate (pH 6.4).  For long term storage, the poly(A)+ RNA was ethanol-precipitated as above, 
and stored at -80 °C under ethanol. 
C. Synthesis of first strand cDNA 
Reverse transcription of liver total RNA was performed using the SUPERSCRIPT First-
Strand Synthesis System (Invitrogen; Carlsbad, CA, USA) according to the manufacturer’s 
instructions.  Five µg of total RNA was suspended in 10 µl DEPC-treated water and 1 µl (0.5 
µg) of oligo dT17 was added along with 1 µl of 10 mM dNTPs in an RNase-free 0.5 ml 
Eppendorf tube.  To disrupt any RNA secondary structure, the sample was heated at 65 °C for 
5 min on a dry heating block, and immediately cooled on wet ice for 1 min.  After 
centrifugation at 14,000 x g for 5 s, 4 µl of RT buffer (5X), 1 µl RNaseOUT inhibitor (40 
U/µl), and 2 µl 0.1M DTT were added to the sample kept on ice, and mixed by pipetting.  
Superscript II reverse transcriptase (1 µl of 50 U/µl) was added to the sample and was mixed 
by pipeting.  The reaction was catalyzed at 42 °C for 50 min in an air incubator to avoid 
evaporation and changes in volume due to condensation on the cap.  To stop the reaction it 
was heated at 70 °C for 15 min to denature the enzyme.  Treatment with RNase H was 
recommended to remove the remaining RNA.  After cooling the sample on ice, 1 µl of RNase 
H (2 U/µl) was added and the first-strand cDNA heated at 37 °C for 20 min.  Finally, the 
cDNA was stored at -20 °C until needed. 
 
 35 
D. cDNA cloning  
The lectin cDNA was amplified by PCR by using mixed oligonucleotide amplification of 
cDNA (MOPAC) [159].  Degenerate primers, with 5’ adapter extension ends for ease of 
cloning, were designed based on the NH2-terminal and internal peptide sequence of hybrid 
bass liver lectin accounting for codon frequencies of striped bass.  Degenerate primers 
FntermD (5’-CAA AGC TTT AYA ACT AYA ARA ACG TNG C-3’), RV3083D (5’-TCG 
AAT TCG TNA CGA TRT ANG GCT C-3’), RV437BD (5’-TCG AAT TCA CCT CAN 
CCT CRC A-3’) and R3083D (5’-TCG AAT TCG TNA CGA TRT ANG GCT C -3’) are 
used in RT-PCR amplification of liver cDNA.  The amplification reaction consisted of 1 µl 
first strand cDNA, 1 µM each primer, 0.2 mM dNTPs, 1X Taq polymerase buffer, and 0.625 
U of Taq polymerase (5U/µl) (Fisher Scientific) in a final volume of 25 µl held in 0.2 ml thin-
walled tubes (Marsh Bio Products , Rochester, NY, USA).  Thermal cycling was performed in 
a MJ Research DNA engine PTC-200 (Waltham, MA, USA).  For MOPAC, the following 
parameters were used: (1) 72 °C for 20 s; (2) ramp 0.3 °C/s to 94 °C and hold 1 min; (3)1.5 
°C/s to 37 °C and hold for 1; (4) 0.2 °C/s to 72 °C and hold 1 min, repeat steps 2-4 five times; 
(5) 0.3 °C/s to 94 °C and hold for 1 min; (6) 0.7 °C/s to 50 °C and hold for 1 min+2s/cycle; 
(7) 0.7 °C/s to 72 °C and hold 1 min+4s/cycle, repeat steps 5 through 7 thirty nine times; fill-
in at 72 °C for 10 min as described in [160].  As control for verifying the completion of the 
reverse transcription reaction, β-actin was amplified with ACTA.F (5’-TCA CCA ACT GGG 
ATG ACA TGG-3’) and ACTB.R (5’-GAT GTC GAC GTC ACA CTT CAT-3’).  Amplified 
fragments were  extracted from the gel using a QIAquik gel extraction kit (Qiagen; Valencia, 
CA, USA) and TA-cloned into the pGEM-T easy vector (Promega; Madison, WI, USA).  
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Transformed bacteria were plated on Luria-Bertani agar prepared with 0.1 mM IPTG; 20 
µg/ml X-gal; 100 µg/ml ampicillin and grown overnight at 37 °C. 
Clones that contained the desired insert were identified by colony PCR [161].  Individual 
colonies were picked with automatic pipet tips and suspended in 50 µl of PCR grade-water.  
The bacteria were lysed by heating in boiling water for 10 min.  For amplification, 1 µl of the 
boiled bacteria was mixed in 20 µl of PCR reaction mix previously prepared [0.4 µM each 
primer, 0.2 mM dNTPs, 1X Taq polymerase buffer, and 0.5 U of Taq polymerase (5 U/µl)] 
(Fisher Scientific).  PCR amplification was extended for 35 cycles. 
E. Completion of full length cDNA   
The hybrid bass lectin cDNA sequence was completed by rapid amplification of cDNA ends 
(RACE) using the Marathon cDNA amplification kit (Clontech Laboratories; Palo Alto, CA, 
USA).  One µg of poly(A)+ RNA was reverse transcribed using the kit’s anchored oligo(dT) 
primer.  After second strand synthesis, an adaptor was ligated to the ends of the double 
stranded cDNA.  Five µl of a 1/50 dilution of the adaptor-ligated cDNA was used as template 
for PCR amplification.  The adaptor serves as an anchor site for the AP1 primer provided by 
the kit.  The gene-specific primers used were 3083anti (5’-GAT GGA GGT GAC GAT GTA 
GGG CTC-3’) for the 5’ end and 3083sense (5’-AGC CCT ACA TCG TCA CCT CCA TC- 
3’) for the 3’end.  The reaction mix had the following composition 0.2 µM each primer, 0.2 
mM dNTPs, 1X Taq polymerase buffer, and 1.25 U of Taq polymerase (Fisher Scientific) in a 
final volume of 50 µl.  The cycling parameters were: (1) 94 °C for 1 min; (2) 94 °C , 30 sec; (3) 
60 °C, 30 sec; (4) 72 °C , 2 min (repeat steps 2 through 4 30 times); fill-in at 72 °C for 10 min.  
PCR amplicons were cloned as described above. 
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F. DNA sequencing 
Sequencing was performed in the Bioanalytical Services laboratory of the Center of Marine 
Biotechnology using an Applied Biosystems ABI 373 Stretch sequencer.  Plasmids from clones 
chosen for sequencing were prepared by conventional alkaline lysis using the Wizard SV 
Plasmid Prep kit (Promega) following the manufacturers instructions.  Each plasmid was 
sequenced from both ends of the cloning site using cycle sequencing with plasmid primers and 
Big-dye termination chemistry (Applied Biosystems).  Contig assembly was accomplished 
using Sequencher v.3.1 software (Gene Codes; Ann Arbor, MI, USA).  
G. Bioinformatics 
Sequence manipulations were performed with Accelrys GCG Wisconsin Package v.8 (San 
Diego, CA, USA) operating on a Silicon Graphics IRIX workstation (Mountain View, CA, 
USA).  Calculations of theoretical protein characteristics from the deduced peptide sequence 
were performed with ProtParam (www.expasy.ch).  The signal sequence cleavage site was 
predicted [162] with the SignalP algorithm (www.cbs.dtu.dk/services/SignalP/). 
Immune challenges 
Fish (approximately 500 g) were injected over several postdorsal sites above the midline with 1 
ml total volume of turpentine, and maintained in a 6 ft tank under the conditions described 
above.  Control (uninjected) fish were only anaesthetized, and maintained under the same 
conditions as the injected fish.  Fish were killed at 1, 3, 6, 12, 24, 48, 72, 96, and 120 h after 
injection, dissected, and the livers flash-frozen in liquid N2.  
A. Northern analysis 
 Ten µg of liver total RNA and 1 µg of poly(A)+ RNA, isolated as described above, were 
resolved by denaturing agarose formaldehyde gel electrophoresis [157, 161].  The RNA 
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samples were prepared by mixing 5 µl of the sample with 15 µl of Ambion Formaldehyde 
Load Dye (Austin, TX, USA) and incubated at 65 °C for 15 min and chilled on wet ice.  To 
visualize the separation of the RNA in the gel, 1 µl 200 µg/ml ethidium bromide was added to 
the sample.  The samples were loaded on a 1% agarose gel and separated at 3 V/cm electrode 
distance.  Downward, passive capillary transfer following Ambion’s bulletin 169 was used to 
transfer the resolved RNA to a membrane (www.ambion.com/techlib/tb/tb_169.html).  The 
gel was placed on top of a charged nylon membrane, Zeta Probe GT (BioRad), which in turn 
rested on a stack of blotting paper (VWR Scientific; West Chester, PA, USA).  A salt bridge 
was built with a strip of Whatman 3MM paper (Fisher Scientific) connecting a reservoir of 
transfer solution (3 M NaCl/10 mM NaOH) to the top of the transfer stack.  The transfer was 
allowed to progress for 2 h after which the membrane was washed in 2X SSC (20X SSC: 300 
mM sodium citrate (pH 7), 3 M NaCl).  For storage, the membrane was air-dried and stored at 
room temperature sandwiched between blotting paper.  
The synthesis of the radioactive probe used in membrane hybridization was perfomed by 
random hexamer-primed extension using template DNA prepared by PCR amplification from 
pFBP5 cDNA clone.  The amplicon was gel-purified by agarose slab electrophoresis, and 
extracted with Qiagen’s QIAquick kit.  The double-stranded probe was produced in the 
presence of Amersham Redivue α[32P]-dCTP with the Amersham RediPrime II kit, following 
the manufacturer’s instructions.  To remove the unincorporated nucleotide, the labeling 
reaction was loaded onto an Amersham ProbeQuant G-50 spin-column and processed as 
instructed by the manufacturer.  To measure activity, 2 µl of the purified probe was added to 3 
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ml of scintillation cocktail (National Diagnostics; Atlanta, GA, USA) and measured with the 
high energy channel of a Beckman LS 1801 scintillation counter. 
Hybridization was performed in a forced-air oven/shaker (Amersham Biosciences) in rotating 
glass hybridization bottles.  The dry transfer membrane was briefly wetted in 5X SSC and pre-
hybridized in Ambion ULTRAhyb™ at 42 °C for 30 min, which contains 50% formamide.  
The DNA probe was denatured by heating at 100 °C for 10 min, followed by placing in wet 
ice.  The probe was added to the pre-heated (42 °C) hybridization solution (70 µl/cm2 
membrane area), and mixed to achieve a probe concentration of at least 106 cpm/ml.  After 
hybridization overnight at 42 °C, the membrane was washed twice successively for 15 min at 
65 °C in 2X SSC/0.1% SDS, 1X SSC/0.1%, and 0.5X SSC/0.1% SDS pre-heated at 65 °C, 
while monitoring the radioactivity remaining on the membrane with a handheld Ludlum 
Measurements Model 3 Geiger monitor (Sweetwater, TX, USA).  The radioactive signal 
annealed to the membranes was imaged by autoradiography.  First the washed membrane was 
blotted to remove excess liquid and wrapped in Fisherbrand® all-purpose laboratory wrap 
(Fisher Scientific).  The membrane was sandwiched between a XAR film (Eastman Kodak; 
Rochester, NY, USA) and an intensifying screen, and exposure was carried out overnight at     
-80 °C.  Development of the film was performed in an XOMAT automated developer 
(Eastman Kodak).   
B. Western analysis 
Serum samples (1/20) for SDS-PAGE were prepared with 2X reducing sample buffer.  
Electrophoresis was performed with 10% acrylamide, 0.8% bis-acrylamide mini-format gels of 
0.75 mm thickness.  Resolved samples were transferred to PVDF (Millipore) in Towbin’s 
buffer, 0.1% SDS as described above.  Antiserum against liver lectin was produced in rabbits 
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by Duncroft (Lovettsville, VA, USA).  Briefly, 100 µg lectin prepared in complete Freund’s 
adjuvant was injected intramuscularly.  On day 14 and day 28 a boost of 50 µg in incomplete 
Freund’s adjuvant was injected subcutaneously.  On day 56 the rabbits were bled, and antibody 
titers were tested by Western blot.  A 1/6000 dilution of antiserum was prepared for Western 
blot in T-TBS/gelatin (0.1% Tween-20; 50 mM Tris-HCl, pH 7.5; 100 mM NaCl; 3% fish 
gelatin).  Antibodies were detected with goat anti-rabbit antibodies conjugated to horseradish 
peroxidase (HRPO) (BioRad).  Blots were developed with SuperSignal West Pico (Pierce 




Results and Discussion 
Purification of a fucose-binding lectin 
To screen for the presence of putative lectins in striped bass’ liver a set of divinyl sulfone-
conjugated carbohydrate affinity matrices were produced.  Because lectins of various types may 
bind selectively to different sugars, Man, GlcNAc, Fuc, Glc and Lac were selected as potential 
ligands for the screening [163].  Most work [143, 164, 165] describing purification protocols 
for isolating hepatic lectins refer to earlier work on the purification of the asialoglycoprotein 
receptor from rabbit liver [142].  Their methodology describes using liver acetone extracts, 
which although a seemingly harsh treatment, facilitates protein purification from lipid-rich 
tissues (i.e. liver) by crudely precipitating the protein fraction.  Thus, these methods were 
adapted for the purification of lectin(s) from fish livers.  In the initial attempts, in spite of 
clarifying the sample by centrifugation, the chromatography columns clogged by a deposit left 
on the surface of the affinity matrix.  These technical problems with slow or interrupted flow 
of the affinity columns led to attempts at batch affinity purification.  However, no proteins 
could be eluted from the affinity matrices.  Suspecting that acetone precipitation or the 
presence of detergents may have denatured the putative lectins, aqueous liver extracts prepared 
in the absence of detergent were tested for the purification procedures.  Further, in an attempt 
to enrich the extract for lectin activity prior to the affinity purification, the crude homogenate 
was subjected to batch anion-exchange chromatography (AEX).  Each of the fractions eluted 
(250 mM, 500 mM, 1 M NaCl) was loaded on the diverse affinity columns described above.  
From the Fuc-conjugated gel, a large peak absorbing at 280 nm appeared during elution.  
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From this initial purification a yield of 420 µg of lectin was isolated, which exhibited a single 
band of about 32 kDa (fig. 1) by SDS-PAGE in the presence of 2-ME.  The absence of 
reducing agent resulted in a smaller band of 29 kDa suggesting that the lectin contained intra-
chain disulfide bridges that upon reduction allow linearization of the polypeptide.  The 
mobility of the bass lectin under reducing conditions corresponded to the size expected for a 
collectin subunit but the non-reduced size is unlike the characteristic trimer resulting from the 
covalent linking of their collagenous tail.  To test if the bass lectin shared sequence similarity 
with collectins, the NH2-terminus was sequenced [YNYKNVAL(R)GKATQXA(R)Y 
LX(T)(S)] and cmpared to the NCBI protein database, but no matches appeared. 
Attempts to reproduce the purification from liver tissues from other individuals failed to yield 
a comparable protein.  As for many proteins produced by the liver, particularly as acute phase 
reactants during innate immune responses, it was assumed that the bass lectin was likely 
synthesized as a humoral component, destined for circulation in blood.  Therefore, an attempt 
was made to isolate the lectin from serum collected from the hybrid bass.  Using fresh batches 
of affinity matrix, diluted and dialyzed bass serum was directly processed by affinity 
chromatography.  A protein eluting from the Fuc-conjugated column demonstrated the same 
 
Figure 1. SDS-PAGE analysis of the hybrid bass hepatic lectin. 
 Lanes are presence (+) and absence (-) of 2-ME.  Calibration markers are displayed on the left. 
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size as that isolated from the liver although other bands appeared also co-eluted.  Thus, a 
second purification step using size exclusion chromatography was performed (fig. 2). 
A larger retarded peak followed a small peak (10% total peak volume) eluting at the void 
volume of the column.  This second chromatography step was enough to purify the lectin to 
homogeneity as judged by silver staining (fig. 3) and is referred hereon as Fuc-binding 
protein 32 kDa (FBP32). 
 
Several characteristics of the protein eluted in the void peak suggest that it is immunoglobulin 
µ (IgM), which is the main antibody isotype produced by fish.  Dissociation of IgM in the 
presence of 2-ME produces a heavy chain (70 kDa) and light chains (25 kDa) [166] 
 Figure 2. SEC polishing of Fuc affinity-purified serum lectin. 
 
Figure 3. SDS-PAGE analysis of the purification steps for the bass serum lectin. 
All samples where treated with 2-ME.  Coomassie stain reflects relative band intensities while silver stain is 
for maximum sensitivity.  Lanes are labeled according to the purification steps. 
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corresponding to the bands co-eluted with the lectin.  In addition, the exclusion limit of the 
column (500 kDa) is below the native size of IgM (>500 kDa).  Interestingly, the presence of 
Fuc-specific IgM in serum suggests that the immune system recognizes this sugar as antigen.  
A faint band of approximately 50 kDa present in the affinity-purified fraction (fig. 3) was not 
identified in the SEC eluates.  No further characterization of the IgM or of this minor band 
was performed; however, the detection of antibodies with identical specificity to the lectin in 
presumably unchallenged fish is indicative that the adaptive immune systems should be 
capable of responding to the same epitope.  Future studies should address if these antibodies 
represent a natural subset, a phenomenon observed first in mammals but also present in 
ectotherms [167], or actually reflect a prior infection event that was effectively cleared.  
SDS-PAGE analysis of the serum lectin produced similar results as for the hepatically isolated 
lectin (fig. 4).  Although the bass serum lectin exhibits similar binding to the L-fuc affinity 
matrix and electrophoretic mobility as the hepatic lectin, their identification as the same 
protein required further confirmation by sequence from the NH2-terminus of the serum lectin.  
The seven amino acids identified, Y-N-Y-K-N-V-A, matched those presented above from the 
 
Figure 4. SDS-PAGE analysis of the serum form of the Fuc bass lectin. 




hepatic lectin, providing more evidence to support the hypothesis that the serum lectin is 
synthesized by the liver and secreted to the blood stream.  Accordingly, all of the following 
biochemical work was performed on the serum-purified lectin.  Small-scale purification from 
striped bass produced a lectin identical to the palmetto bass, as judged by SDS-PAGE.  
Henceforth, the hybrid bass serum lectin will be referred to as MsxMcFBP32 and MsaFBP32 
for the striped bass. 
A more accurate mass estimation of the lectin was obtained by electron spray ionization-mass 
spectrometry (ESI-MS).  The ESI-MS determined mass was 32.388 kDa (fig. 5) which matches 
closely the estimate calculated from SDS-PAGE.  
 
Figure 5. Determination of MsaFBP32 mass by ESI-MS. 
The lower panel is an expanded view of the most prominent peak (32388 kDa)  in the upper panel. 
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Preliminary information on the hemagglutinating activity of the serum lectin was obtained by 
screening human red blood cells for potential ABO blood group specificity.  All of the human 
ABO groups were agglutinated by the bass lectin with marked enhancement when treated with 
proteinase, which is in agreement with the presence of terminal Fuc α1-2 on all types from this 
blood group system.  Thus, human RBCs of blood group A were selected for preparing a 
purification table.  After two purification steps, affinity and SEC, the bass serum lectin was 
purified 400-fold with a 97% recovery of total serum hemagglutinating activity (Table 1).  
From the purification table it is estimated that the lectin is present at ~110 µg/ml in serum 
and makes up approximately 0.23% of total serum protein.  Several subsequent purification 































































































































































































































































Characterization of the native FBP32 
Results from SDS-PAGE and ESI-MS indicate that FBP32 consists of a single polypeptide but 
they do not provide information regarding the quaternary structure of the lectin in conditions 
closer to physiological state.  To address this question, the size of the serum lectin in its native 
form was estimated by SEC using a calibrated column equilibrated in buffered saline.  The 
elution position of the MsaFBP32 (fig. 6) under the chromatography conditions selected 
suggests an apparent molecular weight of 35.5 kDa, which is similar to the size determined 
under previous denaturing conditions.  
Similar results were obtained from cross-linking the purified lectin with a water-soluble, 
homobifunctional cross-linker that is not cleaved by 2-ME (fig. 7).  Stoichiometrically 
 Figure 6. Size estimation of MsaFBP32 by SEC. 
Overlay of independent chromatographic traces for calibration markers (dashed line) and for MsaFBP32 
(solid line).  Numbers indicate molecular weight in kilodaltons.  Inset. Calibration curve of markers 
indicating position of elution of lectin. 
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increasing amounts of BS3 produce an ever increasing number of larger molecular species 
which are separated by intervals corresponding to the monomers weight.  This incremental 
pattern most likely reflects artifactual polymerization of the lectin rather than a natural 
association between subunits.   
The consensus from these independent size determinations is that FBP32 naturally occurs as a 
32 kDa monomer possessing internal disulfide bridges that likely contribute to its structural 
stability in circulation.  This contrasts with the other reported fish serum lectins, which either 
associate into dimeric [126] or multimeric molecules [127, 168, 169]. 
Isoelectric focusing analysis 
Although electrophoresis and chromatography indicate that FBP32 is pure, the 
heterodispersity of peaks observed in ESI-MS suggest that isoforms may be present.  To 
investigate this possibility and further characterize the lectin’s biochemical features, isoelectric 
focusing (IEF) was performed in the presence of urea as a denaturant.  The IEF-resolved 
MsaFBP32 revealed limited heterodispersity (fig. 8) with one strongly stained band (pI 4.97) 
and four weaker bands (pI 5.09, 4.91, 4.87, and 4.86) all exhibiting the same electrophoretic 
 Figure 7. SDS-PAGE of MsaFBP32 cross-linked with BS3. 
The final concentration of cross-linking reagent in each reaction is indicated at the top of each lane.  The gel 
used was 10% T and was stained with Coomassie blue R-250.  Migration of molecular weight calibration 
markers is indicated at left.  
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mobility when analyzed by 2D-PAGE (fig. 9).  Analysis on native IEF revealed higher pI than 
the denatured protein (data not shown).  An assay for detection of glycosylation did not detect 
any carbohydrate modifications on MsaFBP32 (data not shown) excluding any possibility that 
microheterogeneity of glycans is the cause of the observed heterodispersity.  Presence of 
isolectric point heterodispersity has been reported for other lectins [146] and it is plausible that 
these represent sequence isoforms or post-translational modifications.  The reproducibility of 
the band pattern has not been tested, but is possible that these minor bands actually represent 
artifacts due to the deamidation of basic residues or carbamylation from the urea present 
during electrophoresis.  
 
Carbohydrate specificity 
From the screening with affinity columns, it became evident that MsaFBP32 recognizes Fuc 
(i.e. 6-deoxy-L-galactose) preferably over Man, Glc, GlcNAc or Lac.  However, in circulation 
 
Figure 8. Denaturing isoelectric focusing of MsaFBP32 
 
Figure 9. 2-D PAGE analysis of SEC-grade MsaFBP32. 
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Fuc is mostly protein-bound [170] suggesting that the lectin unlikely encounters significant 
amounts of monosaccharide.  To determine the configurational constraints required for lectin 
binding to carbohydrate ligands, diverse carbohydrates were tested for their inhibitory activity 
on agglutination (fig. 10).  Among these were included glycans and glycoconjugates possessing 
Fuc that may represent biologically relevant ligands.  As expected, Fuc, fucosyl-
oligosaccharides and glycoproteins rich in Fuc are the preferred ligands for MsaFBP32 (table 
2).  In contrast to most other natural hexopyranoses, fucose is predominantly in the L- 
configuration and is a 6-deoxy sugar [171].  The relatively lower inhibitory capacity of D-Fuc 
(4C1) and the even weaker effects of other D-hexopyranose isomers illustrate the importance of 
the 1C4 conformation adopted by Fuc to binding MsaFBP32.  Comparison of methyl 
glycosides of Fuc indicates a preference for the α anomeric configuration over β.  The 
difference is further enhanced when a large bulky substituent (i.e. p-nitrophenyl) is the 
aglycone.  Because L-sugars are enantiomers to D-sugars the anomeric configurations are 
reversed, which means α is above the plane of the Fuc ring when viewed in standard 
orientation.  The importance of the absence of hydroxyl group on C6 in Fuc is demonstrated 
by the relatively weaker inhibitory activity of L-Gal.  Further, the increased hydrophobicity of 
deoxy C6 apparently contributes to the binding of Fuc.  Competition with fucosylamine, which 
has an amino modification on C2, showed comparable levels of inhibition to L-Gal suggesting 
that loss of C2 hydroxyl is important but does not abrogate binding.  The effect of 
modifications on C3 and C4 of Fuc on binding was not tested but weak inhibition observed by 
Man may provide a clue to their role in specificity.  Structural studies in C-type lectins 
described [172] how the hydroxyls on C2 and C3 of Man, which adopt the same configuration 
as hydroxyls on C4 and C3 of Fuc, are able to bind albeit in a different orientation.  It is likely 
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that weak inhibition of MsaFBP32 by Man reflects a similar phenomenon supporting the 
importance of a (+) syn-clinal configuration in the C3-C4 bond as present in Fuc. 
In oligosaccharide chains of glycoconjugates, such as human blood group substances, Fuc is 
commonly found as the terminal residue linked to C2, C3 or C6 of the subterminal sugar.  To 
test if MsaFBP32 bound Fuc in the different linkages present in these natural glycans, 
inhibition was performed with oligosaccharides present in ABO group (H-antigen), Lewis 
group (2’-fucosyllactose and 3-fucosyllactose) and the N-glycan core modification, fucosyl(1-
6)N-acetylglucosamine.  Similarly, glycoproteins described to contain fucosylated glycans such 
as gastric mucins [173, 174] were tested as inhibitors.  All four fucosylated oligosaccharides 
inhibited agglutination, indicating that its terminal position is sufficient for binding.  The 
presence of a subterminal GlcNAc appeared to enhance inhibition in spite of this 
monosaccharide not exhibiting significant inhibition by itself.  As expected, the fucosylated 
glycoproteins were effective inhibitors despite removal of terminal sialic acids.  Interestingly, 
no inhibition of agglutination was observed with algal fucoidan in spite of being a fucose 
polymer.  Chemical analysis of fucoidan reveals it consists of 1-3 linked Fuc core substituted at 
C4 by sulphate or branching fucose residues on some of the residues [175].  Hence, the 
presence of unsubstituted hydroxyls at C3 and C4 of Fuc appear necessary for the lectin to 
bind.  In summary, the 1C4 chair conformation placing free hydroxyls axial at C-4 and 
equatorial at C-3, the axial C1 in the α anomer, the deoxy C-6 of Fuc, all appear to contribute 
to the preference for this ligand.  
The affinity of MsaFBP32 for Fuc is shared with lectins described in bacteria, plants, and 
animals.  However, structures resolved from bacterial lectins [176, 177], a plant lectin [178], 
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and a fungal lectin [179, 180] clearly indicate that binding to Fuc can be achieved through 
topologically unrelated folds.  Plant and animal lectins appear to have emerged independently 
during evolution.  Thus, considering the source of MsaFBP32 its ancestry probably lays with 
the latter.  Two families of animal lectins that bind Fuc have been described: C-type lectins and 
homologous lectins from the Japanese horseshoe crab [181], and a fucolectin from eel serum 
[182, 183].  Nevertheless, in C-type lectins that bind Fuc, Man and GlcNAc are also bound 
equally well since all three monosaccharides share a (+)syn-clinal hydroxyl configuration.  In 
contrast, the specificity of the eel and horseshoe crab lectins is restricted only to Fuc.  Several 
other Fuc-specific lectins from fish serum have been reported [184], but their primary 
sequence was not determined so their ancestry remains unknown.  Structural models of C-type 
lectins [39] explain the interchangeability of ligands in the binding site but no such detail is 
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Table 2. Hemagglutination inhibition profile of hybrid bass FBP32 by 
monosaccharides, oligosaccharides, and glycoproteins* 
Inhibitor 50 % Inhibition Concentration 1 Specificity Factor2 
 (mM)  
Fuc α(1-6) GlcNAc  0.5  2.60 
Methyl α-L-Fuc  0.7  1.86 
L-Fuc  1.3  1.00 
2’-fucosyllactose  2.5  0.52 
3-fucosyllactose  3  0.43 
H-dissacharide  3.6  0.36 
p-nitrophenyl α-L-Fuc  3.6  0.36 
L-Gal  4  0.33 
fucosylamine  4  0.33 
D-Fuc  5  0.26 
p-nitrophenyl β-L-Fuc  8  0.16 
Methyl β-L-Fuc  9  0.14 
p-nitrophenyl-β-D-Fuc  16  0.08 
D-Man  20  0.07 
D-Gal  25  0.05 
mannosamine HCl  35  0.04 
glucosamine  100  0.01 
 (µg/ml)  
Porcine gastric mucin (PGM)  0.08  1 
asialo-PGM  0.08  1 
Bovine submaxillary mucin (BSM)  40  0.0020 
asialo-BSM  10  0.0080 
Bovine lung galactan  55  0.0015 
Hyaluronic acid  160  0.0005 
Helix pomatia galactan  400  0.0002 
*Mono- and oligosaccharides not inhibitory at 200 mM:  D-Glc, D-glucosamine, GlcNAc, N-acetyl 
glutamine, N-acetyl galactosamine, N-acetyl mannosamine, N-acetyl muramic acid, N-acetyl 
glutamic acid, and L-Man.  Glycoproteins and polysaccharides not inhibitory at 1 mg/ml: fetuin, 
asialo-fetuin, heparin and chondroitin sulfate and fucoidan. 
1Concentration of carbohydrates and glycoproteins required to inhibit 50% of the agglutinating 
activity (IC50) as scored in assay. Pronase-treated human A RBC were used as test cells.  
2Calculated in relation to Fuc and PSM, respectively. 
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Cation requirements  
The role of the presence of metals in lectins ranges from principally structural [185] to 
mediating directly interaction between protein and the saccharide ligand [39].  Calcium directly 
binds to the saccharide ring hydroxyls in C-type lectins [39] and P. aeruginosa lectin [176, 177], 
and therefore  it is essential for maintaining their activity.  However, in no other animal lectin 
families does calcium directly interact with simple monosaccharides, although lectin activity is 
dependent on the presence of calcium in pentraxins [40] and fucolectins [181, 182].  Addition 
of 30 mM EDTA to MsaFBP32 bound to a Fuc affinity column did not elute the lectin 
suggesting its activity was not dependent on cations (data not shown).  More extensive 
treatment of the lectin with EDTA under acidic conditions failed to affect its hemagglutination 
activity.  Neither did the addition of increasing concentrations of Ca2+ to the assay improve 
agglutination titers.  Thus, the lectin activity of bass FBP32 does not appear to require divalent 
cations.  The lack of strong affinity for the typical ligands (i.e. GlcNAc and Man) of the Fuc-
binding C-type lectins and the apparent lack a cation requirement for binding strongly suggest 
that the bass Fuc-binding lectin does not belong to this family.  However, to identify with 
certainty if the bass lectin belongs to any of the characterized lectin families or is unique will 
require deducing its peptide sequence.  
Cloning of the hybrid bass lectin  
To determine the nucleotide sequence of the bass lectin transcript, the MOPAC procedure 
[159] was employed to obtain an initial PCR amplicon, which could be later extended to 
complete the transcript.  The initial step was to obtain peptide sequence of the NH2-terminus 
and several internal peptides, on which the degenerate primers needed for amplification could 
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be designed (Table 3).  Because the relative positions of the internal peptides in the 
polypeptide sequence were unknown, a forward primer was designed from the N-terminal 
peptide sequence and reverse primers on the internal peptides, all selected with the lowest 
codon degeneracy possible. 
Table 3. Edman sequencing of bass hepatic lectin 
Peptide name Digestion 
enzyme 
Peptide sequence 
NH2-terminal - YNYKNVAL(R)GKATQXA(R)YLX(T)(S) 
3081 Trypsin NSDFEAGSCTHTIEQTNPX(S) 
3082 Trypsin YVTVLLPGTNK 
3083 Trypsin VDLLEPYITSITIT(N)(R) 
V437 Trypsin YVNIVIPGREEYLTLCEVEVYGSVL(L) 
V438 Trypsin ATQSSLFESGIAYNAIDGNQAN(NNWEMASETH) 
 Lys-C (K)NTMNP 
Residues in parenthesis are tentatively assigned 
After using several combinations of primers, the longest PCR amplicon (861 bp) was obtained 
with primers FNTERMD and RV437BD (fig. 11).  Upon sequencing this amplicon, the 
deduced peptide sequence was found to contain all of the other sequenced peptides (i.e. 3081, 
3082, 3083, v438 and Lys-C).   
Although the sequence obtained by MOPAC accounted for all of the sequenced peptides, the 
full open reading frame (ORF) was not complete.  The complete ORF was obtained by RACE 
in both directions.  With forward primer 3083sense.F, a 917 bp amplicon (fig. 12, lane 2) was 
obtained for the 3’ end RACE reaction.  For the 5’ end the cDNA, the 3083anti.R reverse 
primer produced a 340 bp amplicon (fig. 12, lane 3).  The assembly of all three amplicons 
resulted in a contig of 1,099 bp (fig. 13).  The ORF deduced from this contig was judged to be 
complete since a stop codon was present upstream of the putative start methionine codon.  






Figure 11. PCR amplification of MsxMcFBP32 transcript by MOPAC. 
Lanes: 1) 123 bp marker, 2) FNTERM/Rv438DB primers, 3) FNTERMD/Rv437DB primers, 4) 
FNTERMD /R3083D primers, 5) FNTERMD/R3082D primers, 6) ACTA.F/ACTB.R positive control 
primers.  Gel: 1.5%, 1X TAE 
 
Figure 12. 5’ and 3’ RACE of MsxMcFBP32 cDNA. 
Lanes: 1) 100 bp marker, 2) 3083sense/AP1, 3) AP1/3083anti.  Gel: 1.5%, 1X TAE 
 
Figure 13. Sequencing contig scheme of the full-length MsxMcFBP32 cDNA. 
Clones pFBP2 and pFBP1 represent the amplicons obtained by MOPAC using degenerate primers based 
on the peptides sequenced by Edman’s degradation (short arrows).  The clones pFBP6 and pFBP5 are the 
3’ and 5’ RACE amplicons, respectively. Rectangles below represent the three forward reading frames of 




The ORF encoded a 311 residue polypeptide, of which the first 18 amino acid residues 
corresponded to a signal peptide accurately predicted by the SignalP algorithm [162] as 
confirmed by the NH2-terminal peptide sequence (fig. 14).  In retrospect, 37% of the bass 
hepatic lectin had been completed by Edman sequencing.  The calculated mass (ProtParam) 
for the 293 resdidue mature polypeptide was 32,449.2 Da, in good agreement with the 
biochemical estimates.  The 61 Da mass discrepancies between the calculated mass and the 
mass determined  by spectrometry (32,388 Da) may reflect unknown polymorphism(s) or 
secondary modifications.  Flanking the ORF, the cDNA contained a 47 bp 5’ untranslated 
region (UTR) and a 110 bp 3’ UTR ending in a canonical polyadenylation signal.  Interestingly, 
a pairwise comparison (fig 15, Panel A)) of the deduced polypeptide revealed internal sequence 
duplication.  This is not unusual among lectins since other tandemly arranged domains have 
been described in unrelated lectin families such as: macrophage mannose receptor [186], 
galectin-4 [187] and galectin-8 [188], and in less described groups: tachylectin-1 and 2 [189, 
190], a tunicate lectin [191] and the steelhead trout egg lectin [192].  Notably, the deduced 
polypeptide of FBP32 did not show any similarity to the CRDs of any known lectin families to 
date [31-33, 193] or to the collagen tails characteristic of collectins. However, a gene encoding 
an MBL-like protein was previously cloned from the zebrafish and common carp [125], 
demonstrating that teleosts do possess collectins.  Unlike the mammalian MBPs, however, 
based on its CRD motif the cyprinid homologue is predicted to bind Gal rather than Man and 
is expressed in spleen and not liver.  It is of note then, assuming this protein is broadly 
distributed among fish taxa, that during the affinity screen of bass humoral lectins no lactose 
binding-protein matching the size of the cyprinid MBL was encountered.  Therefore, it is 
unclear if this protein is present in the serum of the striped bass or of cyprinids.  
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Each duplicated motifs is approximately 140 residues long (fig. 15, Panel B).  The duplicated 
domains of bass lectin ranged from Asn5 to Gly145 (N-domain) and from Asn153 to Gly289 
(COOH-domain) covering most of the mature protein.  A 7 residue spacer links the two 
putative domains.  Pairwise comparison using the Blosum 62 matrix indicates the domains 
share 50% identity and 67% similarity.   The considerable length of these motifs suggest they 
encode a structural fold or domain which mediates carbohydrate binding.  The distribution of 
cysteine residues within each motif is noteworthy (fig. 15, Panel B), especially the unusual 
contiguous cyteines in the N-domain.  Due to the closeness of these residues in the 
polypeptide chain they most likely form a disulfide bridge between them, though it remains to 
be demonstrated biochemically.  The presence of solely intrachain disulfide bridges, as 
deduced from SDS-PAGE, is supported by the presence of an even number of cysteine 
residues within each motif.   In lepidopterans [68, 194] and an ascidian [191], a humoral lectin 
with distinct tandem CTLDs has been identified which are implicated in immunity.  No 
tandem CTLDs have been identified in vertebrates, so the distinct lectin domains of FBP32 




1    CTGGACTCCAGGGATAAAAGATCTGTTCTAACCAGGAAGCAGGAATAATGAGGCACAGTGTGGTATTTCT  
                                                     m  r  h  s  v  v  f  l -11 
 
71   GTTGCTGCTCCTCTTAGGGGCGTGTTCAGCTTACAACTATAAAAATGTGGCCTTGCGTGGAAAAGCGACT  
       l  l  l  l  l  g  a  c  s  a  Y  N  Y  K  N  V  A  L  R  G  K  A  T   13 
                                     NH2-terminal 
141  CAGTCGGCACGTTATTTGCACACACATGGAGCCGCCTACAACGCCATTGATGGAAACCGTAACTCTGACT  
      Q  S  A  R  Y  L  H  T  H  G  A  A  Y  N  A  I  D  G  N  R  N  S  D    36 
                                                                  3081 
211  TCGAAGCTGGATCGTGCACCCACACTATTGAACAGACCAACCCCTGGTGGAGAGTGGACCTACTGGAGCC  
     F  E  A  G  S  C  T  H  T  I  E  Q  T  N  P  W  W  R  V  D  L  L  E  P  60 
                                                           3083 
281  CTACATCGTCACCTCCATCACCATCACCAACAGAGGAGACTGCTGTCCAGAAAGGCTCAACGGGGTGGAG  
       Y  I  V  T  S  I  T  I  T  N  R  G  D  C  C  P  E  R  L  N  G  V  E   83 
 
351  ATTCACATCGGCAACTCTATACAAGAAAATGGTGTTGCAAACCCAAGGGTTGGTGTAATTTCTCATATCC  
      I  H  I  G  N  S  I  Q  E  N  G  V  A  N  P  R  V  G  V  I  S  H  I    106 
 
421  CTGCAGGGATCTCACATACTATCAGTTTCACTGAACGTGTGGAGGGACGTTACGTGACTGTGCTTCTACC  
     P  A  G  I  S  H  T  I  S  F  T  E  R  V  E  G  R  Y  V  T  V  L  L  P  130  
                                                        3082 
491  TGGTACAAACAAGGTTCTTACACTCTGTGAAGTGGAGGTTCATGGGTACCGAGCCCCAACTGGAGAGAAC  
       G  T  N  K  V  L  T  L  C  E  V  E  V  H  G  Y  R  A  P  T  G  E  N   153 
 
561  CTGGCCCTCCGAGGAAAAGCCACACAGTCTTCATTGTTTGAATCTGGTATTGCATATAATGCCATTGATG  
      L  A  L  R  G  K  A  T  Q  S  S  L  F  E  S  G  I  A  Y  N  A  I  D    176   
                        V438 
631  GGAATCAAGCCAACAATTGGGAAATGGCCTCCTGCACTCACACAAAAAACACAATGAACCCCTGGTGGCG  
     G  N  Q  A  N  N  W  E  M  A  S  C  T  H  T  K  N  T  M  N  P  W  W  R  200 
                                                  Lys-C 
701  AATGGATCTGAGCAAAACCCACAGAGTGTTTTCTGTTAAGGTAACCAACCGAGATTCATTTGAAAAACGA  
       M  D  L  S  K  T  H  R  V  F  S  V  K  V  T  N  R  D  S  F  E  K  R   223 
 
771  ATCAATGGAGCTGAGATCCGAATTGGAGATTCCCTCGACAACAACGGCAACAACAATCCCAGGTGTGCTG  
      I  N  G  A  E  I  R  I  G  D  S  L  D  N  N  G  N  N  N  P  R  C  A    246 
 
841  TGATCACAAGCATCCCAGCAGGTGCTTCTACTGAATTCCAGTGTAACGGGATGGATGGCCGCTATGTTAA  
     V  I  T  S  I  P  A  G  A  S  T  E  F  Q  C  N  G  M  D  G  R  Y  V  N  270 
                                                                    V437 
911  CATTGTTATCCCTGGAAGAGAAGAGTACCTGACCCTGTGTGAGGTGGAGGTGTATGGCTCTGTCCTGGAT  
       I  V  I  P  G  R  E  E  Y  L  T  L  C  E  V  E  V  Y  G  S  V  L  D   293 
 
981  TAGGTGTCAGTACTAATACTGTTGAATGTACACAAACAAAACAAAATAGTAGATTAAGCTTTTTTGATTG  
      *   
 
1051 TTTCCATTCAAAATAAGACAGAGATGGTCTTATCCAATAAAATTACATCACG  
 
Figure 14. The complete cDNA and deduced protein sequence of MsxMcFBP32. 
The cleaved signal peptide is indicated by lowercase amino acids and is negatively enumerated.  Chemically 
sequenced peptides are underlined with a single line.  The in-frame stop codon is marked with an asterisk.  






































































































































































Expression analysis of FBP32 
Demonstrated by its quali- and quantitatively reproducible purification from blood, FBP32 
appears to be a constitutively expressed protein leading to relatively invariant levels in 
circulation (fig. 16).  However, the difficulties encountered while purifying FBP32 from the 
liver raised the possibility that, in analogy of mammalian APRs, the presence of lectin was 
correlated with inflammation brought on by either stress or disease.  The FBP32 cDNA gene 
sequence made available the probe necessary for testing the levels of lectin transcripts in liver 
after experimental inflammatory challenge induced by intramuscular injection of turpentine, a 
reagent commonly for this purpose [195].  After hybridization to liver RNA obtained at 
different times post-injection, the hybridization signal was normalized with the intensity of the 
constitutive 28S rRNA band stained with ethidium bromide (fig. 17).  Analysis of normalized 
band intensity indicates no difference in lectin transcript levels among treated fish and controls 
prior to 48 h post-injection, although levels increased approximately 2-fold at 72 h post-
injection in treated fish.  Similarly slow kinetics of expression of an APR (i.e. serum amyloid A) 
after injection with bacterial pathogen has been documented in salmonids [122].  However, the 
control fish demonstrated that FBP32 is normally expressed in the absence of inflammatory 
challenge.  Similar results were observed for plasma levels of the Japanese eel fucolectin [182].  
Only after challenging primary hepatocyte cultures with lipopolysaccharide did levels of 
transcript and protein increase.  Despite the presence of homologues of the mammalian acute 
phase reactants, such as pentraxins, it is possible that in poikilotherms the kinetics of systemic 
inflammatory responses is not as rapid as in mammals.  This is further supported by results 
demonstrating that CRP levels in X. laevis do not rise as expected after turpentine challenge 
[196].  In addition, development of an antibody response in teleosts is much slower and 
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extended relative to that in homeothermic animals, which may reflect a temperature 
dependence of these processes [112].  An important problem in studying the APR using non-
human models is that there is great interspecies variability in the changes of each APP [22].  
Moreover, the response even varies between closely related rodents such as rats and mice.  In 
other words, despite individual APRs being widely conserved, regulation of their expression is 
unique in each mammalian lineage and for that matter in vertebrates in general.  Therefore, it 
should not be surprising if the profile of APRs expressed in ray-finned fish, if such a response 
exists, differs even among the highly diverse teleostean families.  This initial assessment of 
FBP32 expression is only preliminary, but it appears that it does not respond like the typical 
mammalian acute phase reactants. 
In summary, a 32-kDa lectin from bass liver and blood showing specificity for Fuc was 
purified to homogeneity.  The deduced polypeptide sequence of FBP32 indicates it is not a 
member of the C-type family or any other lectin family described so far, and therefore 
represents a novel lectin within vertebrates.  The duplicated 140-peptide motif found in FBP32 
likely represents individual folding domains, which bind sugar, allowing the lectin to crosslink 
glycoconjugates.  Expression of FBP32 in the liver as a systemic response to experimental 
 
Figure 16. Immunoblot detection of MsaFBP32 during purification. 
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inflammatory challenge appears to be delayed relative to the local inflammatory response, 





Figure 17. Northern analysis of FBP32 in liver after turpentine challenge. 
 A. Hybridized blot (above) and EtBr-stained electrophoresis gel (below). B. Normalization of hybrid blot 
using ribosomal band intensity. 
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CHAPTER 3.  EMERGENCE OF A NOVEL LECTIN FAMILY 
The search for an MBP/selectin-like lectin from fish led to the isolation and characterization 
of a unique Fuc-binding lectin with characteristic tandem domains.  The lack of any similarity 
to motifs described for other lectins suggests that it may represent a novel animal lectin family 
still undescribed.  During the 1990’s, advances in technology led to an acceleration in the 
accumulation of DNA sequences deposited in gene databases.  The potential of genomics in 
explaining organismal complexity has led to an ever-expanding list of organisms being 
represented in the databases rather than just the conventional model organisms.  Meanwhile, 
refinement of computational tools for sequence comparison and improved accessibility allow 
exploiting this accumulating resource of DNA sequence.  The combination of these has not 
only led to an expansion in recognizable members of known protein families but also in 
identifying new families.  This in turn has allowed identification and assessment of the 
functional relevance of conserved sequence motifs or particular residues.  Accordingly, 
determining ancestry of the bass lectin may facilitate the identification of residues that are 
functionally relevant.  This chapter discusses the identification of bass lectin homologues 
present in disparate taxa, which illustrate a lectin family of great pliability yet surprising paucity 
in tetrapods. 
Materials and Methods 
Cloning FBP32 cDNA from parental species 
To clone the full-length cDNA of FBP32 from the hybrid bass parental species, RT-PCR was 
performed using liver cDNA from M. saxatilis and M. chrysops.  Liver total RNA was prepared, 
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as indicated in Chapter 2, and converted to cDNA by reverse transcription with the following 
modification from the procedure used in Chapter 2.  MCSRACEdT16VN, a lock-docking 
cDNA-synthesis primer  (5’-CCG CAT GCG GCC GCA GAT CTA GAT ATC GAT TTT 
TTT TTT TTT TTT VN-3’) [197], was substituted for the previously mentioned oligo(dT) 
primer.  This protocol modification allows using the MCSRACE primer (5’-CCG CAG ATC 
TAG ATA TCG A-3’) for 3’ RACE.  The primers used for RT-PCR were FBP1.F (5’-CTG 
GAC TCC AGG GAT AAA AGA TCT G-3’) and MCSRACE.  The primer FBP1.F was 
designed to anneal to the beginning of the MsxMc full-length cDNA, and therefore should 
amplify the full-length parental species cDNA when used in combination with MCSRACE.  
To ensure fidelity of the amplicons, Invitrogen’s eLONGase™ (San Diego, CA, USA), a 
proofreading polymerase mixture, was used for PCR.  The PCR reaction mix consisted of 1X 
eLONGase™ buffer A, 1X eLONGase buffer B, 0.2 mM dNTPs, 0.2 µM of each primer, 1 
µl of cDNA, and 1 µl of eLONGase polymerase mix in a 50 µl reaction volume.  The cycling 
parameters followed the touchdown PCR technique [198], where the annealing temperature is 
lowered successively at each cycle so as to increase specificity of the reaction.  Cycling 
parameters are: (1) 94 °C for 1 min; (2) 94 °C, 30 sec; (3) 60 °C, 30 sec minus 0.5 °C per cycle 
(4) 68 °C, 2 min (repeat steps 2 through 4 for 19 cycles); (5) 94 °C, 30 sec; (6) 50 °C, 30 sec; (7) 
68 °C, 2 min (repeat steps 5 through 7 for 19 cycles); (8) fill-in at 68 °C for 3 min.  Amplicons 
were ligated into a plasmid vector, and sequenced as described in Chapter 2. 
Gene database search for homologues 
To identify proteins with similarity to the FBPL motif described for MsxMcFBP32, a search of 
publicly available gene repository databases was undertaken.  The query sequence used for 
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searching was the deduced peptide sequence of the N-domain of MsxMcFBP32 from Asn5 to 
Val145.  Searches of protein database were performed with the BLASTP algorithm and of DNA 
databases with TBLASTN algorithm [199] residing on the web sites’ server 
(www.ncbi.nlm.nih.gov/BLAST/).  A search of dbEST [200] was performed with the 
TBLASTN algorithm.  Searches of the pufferfish genome of Fugu rubripes were performed at 
the Department of Energy’s Joint Genome Initiative (www.jgi.doe.gov) and for Tetraodon 
nigroviridis at the Genoscope (www.genoscope.cns.fr/externe/tetraodon/).  A search for the 
lectin domain in Urochordates was performed using the whole genome shotgun-sequencing 
traces stored at Ciona intestinalis web page (ghost.zool.kyoto-u.ac.jp/indexr1.html). 
Cloning and sequencing of Xenopus laevis FBPL ESTs 
Confirmation of the identity of the X. laevis liver EST (GenBank Accession BE508834) 
matching PXN1-XENLA was accomplished by 3’ RACE.  The primer XL1.F (5’- AAG GTC 
TTC TCA ATT GCG GTG A-3’) was used in amplifying the transcript from X. laevis liver 
total RNA that was reverse transcribed with the lock-docking primer as described above.  The 
PCR reaction mixture was: 1X Takara buffer, 2 mM dNTPs, 0.4 mM each primer, 1.25 U 
Takara rTaq polymerase (PanVera Corp., Madison, WI, USA) for a 50 µl final reaction 
volume.  The touch-down PCR cycling parameters were: (1) 94 °C for 3 min; (2) 94 °C , 30 
sec; (3) 65 °C, 30 sec minus 0.5 °C per cycle  (4) 72 °C , 3 min (repeat steps 2 through 4 for 19 
cycles); (5) 94 °C, 15 sec; (6) 55 °C, 15 sec; (7) 72 °C, 3 min (repeat steps 5 through 7 for 24 
cycles); (8) fill-in at 72 °C for 5 min. 
For 5’ RACE, Invitrogen’s GeneRacer kit (San Diego, CA, USA) was used according to the 
manufacturer’s instruction.  First, cDNA produced from liver total RNA was PCR amplified 
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using primer XL3.R (5’-TGC TCA AAA TCA CCA TTC CTC TC-3’) and the kit’s 5’ adapter 
primer.  The PCR reaction mixture was: 1X Takara buffer, 2 mM dNTPs, 0.2 mM each 
primer, 1.25 U Takara rTaq polymerase (PanVera Corp., Madison, WI, USA) for a 50 µl final 
reaction volume.  The cycling parameters were the same as for the 3’ RACE reaction.  A 
second amplification was performed using the nested XL4.R (5’-TTT CCA CTG TTA AGC 
CAA AGA CC-3’), the 5’ nested adapter primer, and 1 µl of the first amplification reaction as 
template.  The reaction mixture and cycling parameters remained the same as for the first 
amplification.  The amplicon was cloned prior to sequencing as described above. 
A full-length sequence of the revised sequence of Xla-PXN was PCR amplified with the 
primer XL7.F (5’-AGA GCT ACT GGG ACA TCC AGT CTA TG-3’) using X. laevis liver 
cDNA primed with the lock-docking primer.  The reaction mixture and cycling parameters 
were identical to that described above.  
Clones dc23g11 (#5593519) and dc10c11 (#5592223) from which the X. laevis liver EST 
(GenBank Accession BE507877) was obtained, were purchased from the American Type 
Culture Collection (Manassas, VA, USA).  After sequencing the insert ends to confirm their 
identity, both clone inserts were sequenced by using the transposon-mediated template 
generation system (TGS) (MJ Research, Waltham, MA, USA), a more rapid method than the 
directional deletion method.  
In parallel to sequencing the purchased clones, PCR amplification of the putative FBP-like 
contig was performed with X. laevis liver cDNA.  Amplification was performed using the lock-
docking primer and forward primer XL8.F (5’-GAA TGT TTG GCA GAG GAC TG-3’) 
directed to the foremost 5’ end of the EST contig.  The PCR reaction mixture was: 1X Takara 
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buffer, 2 mM dNTPs, 0.2 mM each primer, 1.25 U Takara ExTaq polymerase mix (PanVera 
Corp., Madison, WI, USA) for a 50 µl final reaction volume.  The polymerase mix used has 
proofreading capability.  The touch-down PCR cycling parameters were: (1) 94 °C for 2 min; 
(2) 94 °C , 30 sec; (3) 60 °C, 30 sec minus 0.5 °C per cycle  (4) 72 °C , 3 min (repeat steps 2 
through 4 for 19 cycles); (5) 94 °C, 15 sec; (6) 50 °C, 15 sec; (7) 72 °C, 3 min (repeat steps 5 
through 7 for 24 cycles); (8) fill-in at 72 °C for 5 min.  After cloning the resulting amplicon, the 
insert was sequenced by primer walking. 
Design of FBPL degenerate primers 
Deduced peptide sequences from the FBP32 homologues identified in the public databases 
were aligned using Block Maker (blocks.fhcrc.org/blocks/blockmkr/make_blocks.html).  
Specifically, the FBPL sequences included in the multiple alignment were the two tandem 
domains of MsaFBP32, the steelhead trout FBPL, completed after 3’ extension of the trout 
liver EST (GenBank Accession T23111), and the published frog liver PXN1_XENLA 
(GenBank Accession P49263).  The alignment produced as output was processed by the 
CODEHOP program [201] (blocks.fhcrc.org/blocks/codehop.html), using the default 
parameters, which searches for segments within the alignment without gaps (i.e. blocks) to 
which hybrid primers are designed to anneal to the reverse translated DNA.  Two forward and 
two reverse primers were selected from the program’s output.  These are DFBP1.F (5’-CCA 
CAC CGA GAA GCA GAT GVA YCC NTG GTG-3’), DFBP2.F (5’-AGA GAA TCA 
ACG GAG CCG ARA THM RNA T-3’), DFBP3.R (5’-AGT TTC CGA TGC GGA TCT 
CNR CNC CRT T-3’) and DFBP4.R (5’-CGG GGA TCA TGA CGG TCA CRT ANY KNC 
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C-3’).  The last letter in the primer’s name, F for forward and R for reverse, specifies its 
orientation. 
Detection of FBPLs by MOPAC 
PCR amplification of MsaFBP32 homologues from genomic DNA was performed with the 
following reaction mixture: 1X EnzOne 2000 buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.5 µM 
each primer, 1 µg genomic DNA and 2 U of EnzOne 2000 polymerase (ID Labs, London, 
Ontario, Canada).  Note the use of genomic DNA rather than cDNA.  Instead of cDNA, 
genomic DNA was used as a PCR template because it was the most readily available genetic 
material from non-conventional animal model species.  The same cycling conditions used for 
MOPAC of MsxMcFBP32 in chapter 2 are used. 
Sequencing of zebrafish FBPL ESTs 
Sex-specific primers Bre10.F (5’-CGG TTT GTT TCT GGC GAA G-3’) and Bre11.F (5’-
GCA AAC AGT CTC CTC TGT GTT C-3’) were designed for confirming by 3’ RACE the 
expression of an FBPL in gonads.  The head kidney library clone (IMAGE: 6960385) was 
purchased from Open Biosystems (Huntsville, AL, USA) and fully sequenced. 
Sequencing of steelhead trout FBPL EST 
From the Onchorhyncus mykiss liver EST sequence (GenBank Accession T2311) an upstream 
primer for 3’ RACE was designed, Om1.F (5’-AGA CAC AAC GTC CAG TTG ATA AAG 
TGC CTG AG-3’) for 3’ RACE.  Five µg of rainbow trout liver total RNA was reverse 
transcribed with the lock-docking primer as described above.  The PCR reaction mixture was 
as follows: 1X EnzOne 2000 buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.2 mM each primer, and 
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2 U EnzOne2000 polymerase (ID-Labs), for a final reaction volume of 50 µl.  The cycling 
parameters are: (1) 94 °C for 2 min; (2) 94 °C , 40 sec; (3) 45 °C, 1 min (4) 72 °C , 2 min 
(repeat steps 2 through 4 for 29 cycles); (5) fill-in at 72 °C for 5 min. 
For 5’ RACE, the cDNA was produced from steelhead trout liver total RNA using the 
Invitrogen GeneRacer kit according to the manufacturer’s instructions.  A gene specific 
primer, Omy7.R (5’-TGG ACC TCT ATT CCA CCG GAG AC-3’) is used in combination 
with the kit’s anchored primer to amplify the remaining 5’ end of the trout FBP-like transcript.  
As positive control, the 5’ end of β-actin transcript was amplified since it is typically an 
abundantly expressed gene.  The β-actin gene specific primer used is OmyACT2.R (5’-TAC 
AGG GAC AAC ACG GCC TGG ATG G-3’).  The PCR reaction mixture was: 1X Takara 
buffer, 2 mM dNTPs, 0.2 mM each primer, 1.25 U Takara rTaq polymerase (PanVera Corp., 
Madison, WI, USA) for a 50 µl final reaction volume.  The touch-down PCR cycling 
parameters were: (1) 94 °C for 2 min; (2) 94 °C , 30 sec; (3) 65 °C, 30 sec minus 0.5 °C per 
cycle  (4) 72 °C , 3 min (repeat steps 2 through 4 for 19 cycles); (5) 94 °C, 15 sec; (6) 55 °C, 15 
sec; (7) 72 °C, 3 min (repeat steps 5 through 7 for 24 cycles); (8) fill-in at 72 °C for 5 min. 
The full-length transcript of the above gene was PCR amplified using the primer Om11.F (5’-
TCT CCC ACA TGG TGT CCT GGA G-3’) in the equivalent of a 3’ RACE as described 
above. 
All of the amplicons were ligated to plasmid vector by T/A ligation as described above in 
preparation for sequencing. 
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Sequencing of fruit fly FBPL EST 
The plasmid clone, LP08801, whose 5’ EST (GenBank Accession AI295227) presented 
similarities to the bass lectin domain, was purchased from Research Genetics (Hunstville, AL, 
USA).  This clone’s provenance is from a larva, early pupal stage cDNA library prepared by 
the Berkeley D. melanogaster Genome Project.  Sequencing of the insert was performed by 
directional deletion method using an ExoIII/S1 Deletion kit (Fermentas; Hanover, MD, 
USA).  The plasmid (50 µg) was first linearized by digesting with the restriction enzyme BglII 
(25 U) (Promega) for 2 h at 37 °C, then 10 µg treated with Klenow fragment of E. coli 
polymerase I (New England Biolabs , Beverly, MA, USA) for 10 min at 37 °C to fill-in the 
ends, and phenol/chloroform purified to remove the enzymes.  To create an end digestible 
with ExoIII/S1 nuclease, the plasmid was digested with 10 U of EcoRI (Promega) for 1 h at  
37 °C.  Directional deletion with ExoIII/S1 nuclease mix was performed at 37 °C with aliquots 
containing 5 µg of plasmid sampled every minute.  The plasmid of each digest reaction was 
recircularized with T4 DNA ligase and transformed into chemically competent E. coli JM109.  
Selected plasmids were sequenced as already described using the T7 polymerase site adjacent 
to the insertion site of the plasmid vector, pOT2a (www.resgen.com/products/DEST.php3). 
To complete the sequence of the transcript of the cDNA sequenced from the LP08801 clone, 
a D. melanogaster bacteriophage cDNA library prepared from larvae was purchased (Stratagene, 
La Jolla, CA, USA).  A PCR amplification approach was taken using bacteriophage arm-
specific primers in combination with a gene-specific primer.  Plate lysates of bacteriophage 
were prepared by inoculating 1 ml (A600=2) of overnight cultured E. coli Y1090r- with 50,000 
bacteriophage.  After 15 min incubation at 37 °C, the transduced cells were mixed with 7 ml 
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soft agar and plated on 150 mm Luria-Bertani agar plates.  Twenty plates were prepared this 
way to obtain a library representation of 1,000,000 PFUs.  The bacterial lawn was lysed by 
incubating at 37 °C for 12 h, and the released bacteriophages were suspended in SM buffer.  A 
200 µl aliquot of the lysate was heated at 100 °C for 10 min to release the DNA.  
Confirmation of the presence in the lysates of bacteriophage clones that contain the LP08801 
insert was performed by PCR amplification.  Primers specific for LP08801 sequence, Dme5.F 
(5’-TCG TCT TCT CGA ATG CGA ATC TC-3’) and Dme2.R (5’-AAA GTT CAG CGG 
CTG GCG GTT GTA GAA-3’), were used to test the 20 lysates yielding a 674 bp amplicon 
when positive.  The PCR reaction mixture is 1X EnzOne2000 Buffer, 0.2 mM dNTPs, 1.5 
mM MgCl2, 0.2 mM of each primer, and 2 U EnzOne2000 polymerase (ID Labs) and 5 µl of 
boiled lysate for a final reaction volume of 50 µl.  The cycling parameters were: (1) 94 °C for 5 
min; (2) 94 °C , 30 sec; (3) 60 °C, 30 sec (4) 72 °C , 1 min (repeat steps 2 through 4 for 34 
cycles); (5) fill-in at 72 °C for 1 min.  The positive lysates were used for 5’ RACE.  The PCR 
reaction consisted of the primers Lgt11.F (5’-GAC TCC TGG AGC CCG-3’) and Lgt11.R (5’-
GGT AGC GAC CGG CGC-3’) specific for the bacteriophage arms and the nested gene-
specific primers Dme4.R (5’-TTT GCC AAA GTC CAG ACG CAC CAG-3’) and Dme6.R 
(5’-ACC AGC GCC ATC AGT GGA AAT C-3’).  The first PCR reaction mixture was: 1X 
EnzOne2000 Buffer, 0.2 mM dNTPs, 1.5 mM MgCl2, 0.2 mM of Lgt11.F or Lgt11.R primer, 
0.2 mM Dme4.R, and 2U EnzOne2000 polymerase (ID Labs), and 5 µl of boiled lysate for a 
final reaction volume of 50 µl.  The cycling parameters were: (1) 94 °C for 5 min; (2) 94 °C , 
30 sec; (3) 60 °C, 30 sec (4) 72 °C , 1 min (repeat steps 2 through 4 for 34 cycles); (5) fill-in at 
72 °C for 1 min.  The second nested PCR reaction mixture consisted of: 1X EnzOne2000 
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Buffer, 0.2 mM dNTPs, 1.5 mM MgCl2, 0.4 mM of Lgt11.F or Lgt11.R primer, 0.4 mM 
Dme6.R, and 1U EnzOne2000 polymerase (ID Labs), and 1 µl of 1/100 dilution of the first 
reaction for a final reaction volume of 25 µl.  The resulting amplicons were cloned and 
sequenced as described above. 
Analysis of expression of CG9095 during fruit fly development 
One µg each of poly (A)+ RNA from embryo, larval, and adult stages of D. melanogaster 
(Clontech Laboratories, Palo Alto, CA, USA) were reverse-transcribed with Thermoscript kit 
(Invitrogen) at 55 °C, as instructed by the manufacturer.  The PCR reaction mixture was: 1X 
EnzOne 2000 buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.4 µM each primer, 1 µl of cDNA, 1U 
EnzOne 2000 polymerase (ID Labs , London, Ontario, Canada) in a final volume of 25 µl.  
The cycling parameters were as follows: (1) 94 °C, 2 min; (2) 94 °C, 30 sec; (3) 60 °C, 30 sec; 
(5) 72 °C, 1 min (repeat steps 2 through 5 for 39 cycles).  The primers used were Dme5.F (5'-
TCG TCT TCT CGA ATG CGA ATC TC-3') and Dme2.R (5'-AAA GTT CAG CGG CTG 
GCG GTT GTA GAA-3').  Primers directed to a ubiquitous ribosomal protein (rp49) [202], 
rp49.F (5’-AAG ATC GTG AAG AAG CGC AC-3’) and rp49.R (5’-AAC TTC TTG AAT 
CCG GTG GG-3’), were used as controls of cDNA synthesis completion. 
Multiple alignment of peptide sequences 
An alignment of the deduced peptide sequences from the identified members of the FBPL 
family was produced with Clustal_X v.1.81 [203] using default settings.  The presentation of 
the alignments was prepared with GeneDoc v.2.6.002 [204].  Shading of similarities reflects 




Distance analysis of polypeptide sequences possessing an FBPL motif was performed using 
Neighbor-Joining analysis [206] as implemented in Clustal_X v.1.81.  Reliability of branching 
order was estimated using a bootstrap test [207]. 
Results and Discussion 
Meeting the parents 
Interest in identifying the parental origin(s) of the MsxMcFBP32 cDNA sequence in the 
hybrid bass led to the search for homologous sequences in the striped bass (M. saxatilis) and 
white bass (M. chrysops).  A DNA primer (FBP1.F) specific to the 5’ end of the MsxMcFBP32 
cDNA was used to amplify the full gene sequence from RNA isolated from liver in each 
species.  Both the striped bass (MsaFBP32) and the white bass (MchFBP32) yielded a 1,144 bp 
amplicon.  To ensure an amplicon with the highest fidelity to the cDNA, a proofreading DNA 
polymerase mixture was used in the PCR.  Increased accuracy of the cDNA sequence was 
further gained from multiple sequences: 10 clones were sequenced for MsaFBP32 and five 
clones for MchFBP32.  Comparison of the nucleotide sequence from both species presented 
few changes (12 positions) (fig. 18).  Mutations were either silent or resulted in conserved 
substitutions in the peptide sequence.  The encoded polypeptides were 293 residues long, as in 
the MsxMcFBP32 protein.  Surprisingly, the UTR segments of the cDNA, which are 
considered to diverge rapidly among species presumably due to diminished selective pressure, 
were almost identical.  The calculated biochemical properties for each species lectin were as 
follows: MsaFBP32 (Mr 32,393.1 Da, pI 6.16) and MchFBP32 (Mr 32,308 Da, pI 6.01).  The 
calculated mass for MsaFBP32 was closer to the mass estimated for the striped bass serum 
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lectin from mass spectrometry (32,388.2 Da) resolving the discrepancy previously mentioned 
for MsxMcFBP32.  The high nucleotide identity, even within non-coding regions, between the 
lectin homologues from parental species-specific lectin reflect the close relatedness between 
these sister taxa [135].  
>MsFBP CTGGACTCCA GGGATAAAAG ATCTGTTCTA ACCAGGAAGC AGGAATAATG AGGCACAGTG 
         G  L  Q   G  .  K   I  C  S  N   Q  E  A   G  I  M   R  H  S  V 
>McFBP CTGGACTCCA GGGATAAAAG ATCTGTTCTA ACCAGGAAGC AGGAATAATG AGGCACAGTG 
         G  L  Q   G  .  K   I  C  S  N   Q  E  A   G  I  M   R  H  S  V 
 #1    ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP TGGTATTTCT GTTGCTGCTC CTCTTAGGGG CGTGTTCAGC TTACAACTAT AAAAATGTGG 
         V  F  L   L  L  L   L  L  G  A   C  S  A   Y  N  Y   K  N  V  A 
>McFBP TGGTATTTCT GTTGCTGCTC CTCTTAGGGG CGTGTTCAGC TTACAACTAT AAAAATGTGG 
         V  F  L   L  L  L   L  L  G  A   C  S  A   Y  N  Y   K  N  V  A 
 #61   ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP CCTTGCGTGG AAAAGCGACT CAGTCGGCAC GTTATTTGCA CACACATGGA GCCGCCTACA 
         L  R  G   K  A  T   Q  S  A  R   Y  L  H   T  H  G   A  A  Y  N 
>McFBP CCTTGCGTGG AAAAGCGACT CAGTCGGCAC GTTATTTGCA CACACATGGA GCCGCCTTCA 
         L  R  G   K  A  T   Q  S  A  R   Y  L  H   T  H  G   A  A  F  N 
 #121  ---------- ---------- ---------- ---------- ---------- -------*-- 
 
>MsFBP ACGCCATTGA TGGAAACCGT AACTCTGACT TCGAAGCTGG ATCGTGCACC CACACTATTG 
         A  I  D   G  N  R   N  S  D  F   E  A  G   S  C  T   H  T  I  E 
>McFBP ACGCCATTGA TGGAAACCGT AACTCTGACT TCGAAGCTGG ATCATGCACC CACACTGTTG 
         A  I  D   G  N  R   N  S  D  F   E  A  G   S  C  T   H  T  V  E 
 #181  ---------- ---------- ---------- ---------- ---*------ ------*--- 
 
>MsFBP AACAGACCAA CCCCTGGTGG AGAGTGGACC TACTGGAGCC CTACATCGTC ACCTCCATCA 
         Q  T  N   P  W  W   R  V  D  L   L  E  P   Y  I  V   T  S  I  T 
>McFBP AACAGACCAA CCCCTGGTGG AGAGTGGACC TACTGGAGCC CTACATCGTC ACCTCCATCA 
         Q  T  N   P  W  W   R  V  D  L   L  E  P   Y  I  V   T  S  I  T 
 #241  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP CCATCACCAA CAGAGGAGAC TGCTGTCCAG AAAGGCTCAA CGGGGTGGAG ATTCACATCG 
         I  T  N   R  G  D   C  C  P  E   R  L  N   G  V  E   I  H  I  G 
>McFBP CCATCACCAA CAGAGGAGAC TGCTGTCCAG AAAGGCTCGA TGGAGCGGAG ATTCACATCG 
         I  T  N   R  G  D   C  C  P  E   R  L  D   G  A  E   I  H  I  G 
 #301  ---------- ---------- ---------- --------*- *--*-*---- ---------- 
 
>MsFBP GCAACTCTAT ACAAGAAAAT GGTGTTGCAA ACCCAAGGGT TGGTGTAATT TCTCATATCC 
         N  S  I   Q  E  N   G  V  A  N   P  R  V   G  V  I   S  H  I  P 
>McFBP GCAACTCTTT ACAAGAAAAT GGTGTTGCAA ACCCAAGGGT TGGTGTAATT TCTCATATCC 
         N  S  L   Q  E  N   G  V  A  N   P  R  V   G  V  I   S  H  I  P 
 #361  --------*- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP CTGCAGGGAT CTCACATACT ATCAGTTTCA CTGAACGTGT GGAGGGACGT TACGTGACTG 
         A  G  I   S  H  T   I  S  F  T   E  R  V   E  G  R   Y  V  T  V 
>McFBP CTGCAGGGAT CTCACATACT ATCAGTTTCA CTGAACGTGT GGAGGGACGT TACGTGACTG 
         A  G  I   S  H  T   I  S  F  T   E  R  V   E  G  R   Y  V  T  V 
 #421  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP TGCTTCTACC TGGTACAAAC AAGGTTCTTA CACTCTGTGA AGTGGAGGTT CATGGGTACC 
         L  L  P   G  T  N   K  V  L  T   L  C  E   V  E  V   H  G  Y  R 
>McFBP TGCTTCTACC TGGTACAAAC AAGGTTCTTA CACTCTGTGA AGTGGAGGTT CATGGGTACC 
         L  L  P   G  T  N   K  V  L  T   L  C  E   V  E  V   H  G  Y  R 




>MsFBP GAGCCCCAAC TGGAGAGAAC CTGGCCCTCC GAGGAAAAGC CACACAGTCT TCATTGTTTG 
         A  P  T   G  E  N   L  A  L  R   G  K  A   T  Q  S   S  L  F  E 
>McFBP GAGCCCCAAC TGGAGAGAAC CTGGCCCTCA AAGGAAAAGC CACACAGTCG TCATTGTTTG 
         A  P  T   G  E  N   L  A  L  K   G  K  A   T  Q  S   S  L  F  E 
 #541  ---------- ---------- ---------* *--------- ---------* ---------- 
 
>MsFBP AATCTGGTAT TGCATATAAT GCCATTGATG GGAATCAAGC CAACAATTGG GAAATGGCCT 
         S  G  I   A  Y  N   A  I  D  G   N  Q  A   N  N  W   E  M  A  S 
>McFBP AATCTGGTAT TGCATATAAT GCCATTGATG GGAATCAAGC CAACAATTGG GAAATGGCCT 
         S  G  I   A  Y  N   A  I  D  G   N  Q  A   N  N  W   E  M  A  S 
 #601  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP CCTGCACTCA CACAAAAAAC ACAATGAACC CCTGGTGGCG AATGGATCTG AGCAAAACCC 
         C  T  H   T  K  N   T  M  N  P   W  W  R   M  D  L   S  K  T  H 
>McFBP CCTGCACTCA CACAAAAAAC ACAATGAACC CCTGGTGGCG AATGGATCTG AGCAAAACCC 
         C  T  H   T  K  N   T  M  N  P   W  W  R   M  D  L   S  K  T  H 
 #661  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP ACAGAGTGTT TTCTGTTAAG GTAACCAACC GAGATTCATT TGAAAAACGA ATCAATGGAG 
         R  V  F   S  V  K   V  T  N  R   D  S  F   E  K  R   I  N  G  A 
>McFBP ACAGAGTGTT TTCTGTTAAG GTAACCAACC GAGATTCATT TGAAAAACGA ATCAATGGAG 
         R  V  F   S  V  K   V  T  N  R   D  S  F   E  K  R   I  N  G  A 
 #721  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP CTGAGATCCG AATTGGAGAT TCCCTCGACA ACAACGGCAA CAACAATCCC AGGTGTGCTG 
         E  I  R   I  G  D   S  L  D  N   N  G  N   N  N  P   R  C  A  V 
>McFBP CTGAGATCCG AATTGGAGAT TCCCTCGACA ACAACGGCAA CAACAATCCC AGGTGTGCTG 
         E  I  R   I  G  D   S  L  D  N   N  G  N   N  N  P   R  C  A  V 
 #781  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP TGATCACAAG CATCCCAGCA GGTGCTTCTA CTGAATTCCA GTGTAACGGG ATGGATGGCC 
         I  T  S   I  P  A   G  A  S  T   E  F  Q   C  N  G   M  D  G  R 
>McFBP TGATCACAAG CATCCCAGCA GGTGCTTCTA CTGAATTCCA GTGTAACGGG ATGGATGGTC 
         I  T  S   I  P  A   G  A  S  T   E  F  Q   C  N  G   M  D  G  R 
 #841  ---------- ---------- ---------- ---------- ---------- --------*- 
 
>MsFBP GCTATGTTAA CATTGTTATC CCTGGAAGAG AAGAGTACCT GACCCTGTGT GAGGTGGAGG 
         Y  V  N   I  V  I   P  G  R  E   E  Y  L   T  L  C   E  V  E  V 
>McFBP GCTATGTTAA CATTGTTATC CCTGGAAGAG AAGAGTACCT GACCCTGTGT GAGGTGGAGG 
         Y  V  N   I  V  I   P  G  R  E   E  Y  L   T  L  C   E  V  E  V 
 #901  ---------- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP TGTATGGCTC TGTCCTGGAT TAGGTGTCAG TACTAATACT GTTGAATGTA CACAAACAAA 
         Y  G  S   V  L  D   .  V  S  V   L  I  L   L  N  V   H  K  Q  N 
>McFBP TGTATGGCTC TGTCCTGGAT TAGGTGTCAG TACTAATACT GTTGAATGTA CGCAAACAAA 
         Y  G  S   V  L  D   .  V  S  V   L  I  L   L  N  V   R  K  Q  N 
 #961  ---------- ---------- ---------- ---------- ---------- -*-------- 
 
>MsFBP ACAAAATAGT AGATTAAGCT TTTTTGATTG TTTCCATTCA AAATAAGACA GAGATGGTCT 
         K  I  V   D  .  A   F  L  I  V   S  I  Q   N  K  T   E  M  V  L 
>McFBP ACAAAAAAGT AGATTAAGCT TTTTTGATTG TTTCCATTCA AAATAAGACA GAGATGGTCT 
         K  K  V   D  .  A   F  L  I  V   S  I  Q   N  K  T   E  M  V  L 
 #1021 ------*--- ---------- ---------- ---------- ---------- ---------- 
 
>MsFBP TATCCAATAA AATTACATCA CGAAAAAAAA AAAAAAAA:: ::::                  
         S  N  K   I  T  S   R  K  K  K   K  K  ?   ?                    
>McFBP TATCCAATAA AATTATATCA CGAAATGSAA AAAAAAAAAA AAAA                  
         S  N  K   I  I  S   R  N  ?  K   K  K  K   K                    
 #1081 ---------- -----*---- -----**+-- --------** **** 
Figure 18. Pairwise alignment of MsaFBP32 and MchFBP32 full-length cDNAs. 
Asterisks (*) in consensus line at the bottom indicate nucleotide differences, dashes (-) are identities, and 
colons (:) are gaps.  The deduced peptide sequence is presented below its corresponding cDNA.  
Nucleotide position numbering is listed in the left margin.  MsFBP32: striped bass lectin, McFBP32: white 
bass lectin  
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To confirm the length of the cDNA, a Northern analysis on liver RNA was performed.  A 
similar length transcript of the expected length (1.2 kb) (fig. 19) hybridized to the cDNA 
probe, although a larger but weaker hybridizing species was also observed above it.  The higher 
band hybridized more strongly appeared more brightly when hybridizing to poly(A)+-selected 
RNA, corroborating the faint band observed in the lane of total RNA.  This band possibly 
represents either an alternative transcript, or a different transcript sharing the FBPL motif.  
RNA extracted from various organs was also probed by Northern analysis to test if the lectin 
was expressed extrahepatically (fig. 20).  Only a faint band of corresponding size was observed 
from intestine, and a larger faint smear appeared for gill tissues.  Thus, it appears that the liver, 
the principal producer of blood proteins, is the major site of this lectin’s synthesis, although 
possibly not the only one.  That it is the only site is uncertain since only a sparse sampling of 
organs was tested. 
 
Figure 19. Northern analysis of striped bass liver RNA probed with FBP32 probe. 
Total, total RNA; poly(A), mRNA  
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A unique lectin family  
Comparison to previously described lectin sequence motifs [31, 32] did not reveal any 
similarity with the bass lectin polypeptide sequence.  Further, a search of motif databases 
including protein profiles [208] (www.expasy.ch/motifscan) produced no significant matches.  
Therefore, it appeared that the bass lectin was a unique lectin motif of yet unknown ancestry.  
Although no matches to lectins were identified, a stretch of N-terminus sequence from a single 
protein named PXN1-XENLA [209] shared significant similarity (E=8x10-26) to the bass lectin 
motif.  Surprisingly, PXN1-XENLA, which is described as a pentraxin-fusion protein cloned 
from the liver of the African clawed frog (X. laevis) consists of a fusion domain (i.e. FBP32-like 
domain (FBPL) linked to a pentraxin domain (fig. 21, Panel A) [25], an unrelated domain that 
also exhibits lectin activity [210].  PXN1-XENLA along with other discovered mosaic forms 
of pentraxins [211, 212] are referred to as “long pentraxins” [213], to distinguish them from 
the prototypic short forms lacking extensions.  Interestingly, these long pentraxin domain 
extensions do not share similarity to each other or to other known domains.  In the case of 
PTX3 from mouse [214], the extension stabilizes multimers through formation of disulfide 
bridges [215].  In contrast, for PXN1-XENLA the similarity between its fusion domain and 
 
Figure 20. Northern blot detection of tissue expression of MsaFBP32. 
In, intestine; Gl, gills; He, hear; SM, skeletal muscle; Li, liver. 
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FBPL suggests that it possesses fucose-binding activity (fig. 21, Panel B) rather than a 
structural role.  This hypothesis remains to be tested since no biochemical data is presently 
available. 
Revision of PXN1-XENLA  
The establishment of public repositories [200] for expressed sequence tags [216, 217] allows in-
depth screening of diverse cDNA libraries.  A search of the translated dbEST database in 
GenBank with the FBP motif produced a weak hit with a X. laevis liver EST (GenBank 
Accession BE508834).  Upon inspection, the sequence apparently encoded half of an FBPL 
domain connected to a second FBPL domain.  Due to the short sequence typical of ESTs, it 
was not possible to deduce the full polypeptide sequence.  Surprisingly, a nucleotide alignment 




Figure 21. Similarity of the Xenopus laevis pentraxin-fusion protein to the tandem domains of the bass 
lectin. 
A. Schematic domain organization of the two proteins (oval represents the pentraxin domain).  B. Multiple 
amino acid alignment of the MsxMcFBP32 tandem domains and the lectin–like domain of the pentraxin 
fusion protein (i.e. squares illustrated in the panel A). The alignment is marked every 10 residues with an 




(fig. 22. Panel A).  Inspection of the consensus segment indicated that the signal sequence 
reported for PXN1-XENLA was in fact the end of a FBP-domain.  The originally reported 
PXN1-XENLA cDNA failed to identify this upstream FBP-domain, and this may have been 
due to two reasons.  First, due to an erroneous nucleotide insertion and substitution, the 
reading frame was shifted and a stop codon was introduced upstream of the starting Met of 
the putative 5’UTR, respectively (fig. 22. Panel B).  Second, the report of the cloning of 
PXN1-XENLA cDNA [209] remarkably indicates that only 1,739 bp were sequenced from of 
a 9.5 kb insert of a bacteriophage cDNA clone (XL-PXN1), and erroneously concluded that 
the deduced polypeptide was complete.  To test whether the EST genuinely represented 
PXN1-XENLA, a 3’ RACE reaction was performed using a forward primer (XL1.F) 
complementary to the portion of the BE508834 not shared with L19881.  The amplicon had a 
length of 1,890 bp, which is the expected length of L19881 including the EST.  Finally, 





Figure 22. X. laevis liver EST matching the 5’ end of published PXN1-XENLA cDNA (L19881). 
A. Position of liver EST (GeneBank Accession BE508834) aligned consensus relative to the full cDNA of 
L19881.  Boxed segment of the upper arrow is the incomplete FBP domain, which overlaps with the 
signal sequence boxed in the lower published sequence.  B. The appearance of a signal sequence (circled 
Met) in the original sequence, L19881, coincides with a frameshift caused by an insertion (arrow) that 
disrupts the FBPL visible in the EST’s (IMAGE clone dc13f08.y1) translation.  Asterisks below the 
consensus sequence line mark nucleotide differences. 
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If the cDNA was 9.5 kb as originally reported, a substantial amount of sequence remained to 
be determined.  5’ RACE amplification produced an amplicon of 2.2 kb (fig. 23).  Surprisingly, 
upon sequencing the amplicon, it became apparent that five FBPLs preceded the pentraxin 
domain, and not just one FBPL as originally reported (See appendix). 
To confirm that this sequence represented an authentic transcript and not a chimera, an 
artifact frequently present in cDNA libraries, the full-length cDNA was amplified using a 
forward primer (XL7.F) complementary to the 5’ end of the 5’ RACE amplicon (fig. 24).  The 
amplicon produced was (3,840 bp) of the size expected from the contig assembled with the 5’ 
RACE amplicon and the 3’ RACE amplicon (Fig 25).  
 
Figure 23. 5’ RACE of XL-PXN1. 





Although the sequence has been extended to almost twice the length originally reported, it is 
still shorter than the 9.5 kb of the original cDNA clone.  The conciseness of the 5’UTR does 
support that the sequence is finished.  An attempt to extend the sequence searching dbEST 
identified several 5’ ESTs from X. laevis liver that matched the 5’ end of the revised XL-PXN1 
(fig. 26).  However, none of these sequences extended further upstream, which would support 
that the sequence was indeed complete.  Consensus found for liver ESTs to the internal 
sequence of Xla-PXN also lend further support to the veracity of the revised sequence.  In 
summary, the revised sequence (Xla-PXN) links five tandem FBPL domains to a pentraxin 
domain resulting in a much larger protein (120 kDa). 
 
Figure 24. PCR amplification of full length Xla-PXN. 
Lanes 1) 1 Kb marker, 2) 100 bp marker, 3) XL7.F/MCSRACE, 4) XL7.F/MCSRACE (negative control) 
 
Figure 25. Sequencing contig of full length Xla-PXN. 
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The march of FBPLs in tetrapods 
The search in dbEST identified several X. laevis liver ESTs encoding FBPLs that did not match 
Xla-PXN.  A preliminary contig was assembled from these sequences and was extended by 
searching for ESTs with nucleotide consensus.  This in silico-assembled cDNA apparently 
encoded a polypeptide with two tandemly arrayed FBPLs, similar to MsaFBP32 (fig. 27).  
A flaw observed in the sequence assembly is that the overlap of the 5’ EST (GenBank 
Accession BE509406) to the 3’ EST (GenBank Accession BE505397) was of only 25 
nucleotides, raising doubts about the authenticity of this contig.  To verify the sequence, the 
respective plasmid clones from which these EST had been sequenced were purchased from 
the ATCC.  Both clones were sequenced almost to completion using transposon-mediated 
gene walking but presented problems.  Surprisingly, the plasmid (IMAGE clone 3396692) that 
 
Figure 26. Support for completed ORF of Xla-PXN 
Independent ESTs from a X. laevis liver library Li1 match the 5’ end of Xla-PXN.  The top line is the 
complete CDS after extension by 5’ RACE.  The first five boxes of this line are the lectin domain and the 
sixth box is the pentraxin domain.  
 
Figure 27. In silico assembly X. laevis liver EST contig unique from Xl-PXN. 




produced EST BE509409 (fig. 28, Panel A) coded for three FBPLs instead of two but the 
ORF was truncated (i.e. start Met missing).  IMAGE clone 3397988, the source of EST 
507877, contained a composite transposon previously described in X. laevis [218], that 
interrupts the lectin ORF, as well as causing other interruptions illustrated in the 3rd reading 
frame (fig. 28, Panel B).  Such problems have become evident with the advent of high-
throughput sequencing of cDNA libraries [219, 220].  Analysis of human EST sequences 
indicated that formation of chimeras in cDNA clones might be as high as 11% [219].  What 
was clear is that this transcript encoded more than two FBPL domains, which are not joined to 





Figure 28. Partial sequencing path of purchased X. laevis liver cDNA clones. 
 A.  clone 3396692, B. clone 3397988 
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Finally, to obtain the authentic cDNA sequence, liver RNA was amplified by 3’ RACE with a 
primer complementary to the 5’EST (fig. 29).  The sequence of the 2.2 kb amplicon generated 
(fig. 30) contained a 1,826 bp ORF that encoded a 63.3 kDa polypeptide with four tandem 
FBPLs (XlaII-FBPL).  Inclusion of what is judged authentic 5’ end sequence from the 
chimeric clone (IMAGE clone 3397988) extends the sequence upstream to a final length of 
2,548 bp, without affecting the described ORF (See Appendix). 
 
This finding indicates that in X. laevis, like in bass, the liver is a site of synthesis of multiple 
FBP domain-containing proteins.  Differences in the number of FBP domains in both species 
suggest that they are unlikely to be orthologous.  Interestingly, the wide range in domain 
number presented by these sequences illustrates an apparent lack of structural restrictions for 
the formation of higher order arrangements. 
 
Figure 29. PCR amplification of full-length XlaII-FBPL. 
Lanes 1) 100 bp marker, 2) 1 kb marker, 3) XL8.F/MCSRACE, 4) XL8.F/MCSRACE (negative control). 
Gel: 1.2% agarose, 1X TAE 
 
Figure 30. Sequencing contig of the liver XlaII-FBPL containing four FBPL domains 
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A unique result from the dbEST search from X. laevis cDNA libraries is the detection of 
transcripts containing FBP-like domains expressed early in development (i.e. neurula stage 19-
23) which is the first evidence that FBPL play a role during development.  Because none of 
these sequences was verified by cloning, only those assemblies that contained multiple 
sequences providing added nucleotide coverage were included here.  Two distinct putative 
transcripts were assembled from embryonic stage libraries, constructed from different 
embryonic stages (i.e. neurula stage 13 through 48).  The first contig (fig. 31, 3rd reading frame) 
encodes what apparently is a single FBPL.  The second contig (fig. 32, 1st reading frame) also 
encodes for a single FBPL, but is different from the first. 
 
 
Figure 31. Multiple alignment of X. laevis neurula ESTs encoding single FBPL (XlaEST2) 
 
Figure 32. In silico assembled contig (Xla-neurula) from X. laevis embryos encoding a single FBPL. 




Both ORFs resulting from these assemblies appear complete, since they contain a starting Met 
followed by a signal peptide, as predicted by SignalP.  Expression of these transcripts 
correlates with presence of terminally-fucosylated, O-linked glycoconjugates on primordial 
germ cells (PGC) [221] so it is conceivable that these lectins may play a role in cell adhesion 
during PGC migration.  
The genetic tractability of the diploid Xenopus tropicalis has renewed interest in its potential as a 
model for studying late embryonic development [222].  This in turn has led to an increased 
effort to develop publicly accessible genomic tools.  The recently announced (genome.jgi-
psf.org/xenopus1/xenopus1.info.html) plan for sequencing genome of X. tropicalis will 
undoubtedly provide an invaluable resource for annotating the multiple genes that contain 
FBP-like domains.  Continuing the data mining approach, two homologues from X. tropicalis 
were identified from the dbEST.  Both assemblies originate from neurula-stage cDNA libraries 
again supporting the significance of FBPs in development.  The first assembly (fig. 33) resulted 
in a 1,115 bp cDNA encoding a 295 residue mature polypeptide, designated XtrII-FBPL 
(Appendix).  In contrast to the transcript present in X. laevis neurula, this ORF contained two 
FBPLs, which is the first example of a bass FBP32-like binary FBP identified in the tetrapod 
lineage.   
 
Figure 33. In silico assembled contig of XtrII-FBPL. 
(GenBank Accession AL660887, AL639100, AL646694, AL656280, AL657713 and AL636894). 
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The second assembled 1,638 bp cDNA (fig. 34) encodes a 432 residue protein containing three 
FBPLs, and was designated XtrIII-FBPL (see Appendix).   
The authenticity of both assemblies is supported by coverage from multiple sequences from 
independent clones.  Curiously, neither of these transcripts matches any of the X. laevis ESTs 
deposited so far, and it remains unclear if they are present in this species.  Although one 
assembly from X. laevis embryos encodes for three FBPLs, the limited coverage and quality of 
the sequence makes it premature to assign an ORF with certainty.   
The diverse FBPL gene repertoire uncovered in Xenopus spp. suggests this domain fulfills 
diverse roles.  The multiple-order concatenates of FBPLs and the pentraxin fusion-protein 
exemplifies the architectural diversification this domain has undergone.  If each domain 
presumably represents a binding site, concatenation could increase the lectin’s avidity through 
the cluster effect [223].  The diversity of expression sites also argues that FBPLs are not always 
destined for circulation; ESTs from kidney, heart, and spleen, which contrary to the liver, are 
not major producers of serum proteins, likely represent FBPLs performing more localized 
functions.  Completion of the sequence for these extrahepatically-expressed FBPL ESTs will 
tell if they also present unique domain architectures.  Members of the genus Xenopus are 
ancient frogs (Suborder Archaeobatrachia) that rarely leave water, however most living frog 
 
Figure 34. In silico assembled contig of XtrIII-FBPL. 
(GenBank Accession AL657179, AL662666, AL676555, AL655669 and AL6558391) 
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species are “modern” frogs (Suborder Neobatrachia) [224] and mainly inhabit land.  
Interestingly, some modern frogs have evolved direct development, whereby metamorphosis 
occurs within the egg enabling these species to bypass the need to deposit eggs in a body of 
water.  Admittedly, there is no evidence correlating the presence of FBPLs with a water-
dwelling lifestyle, but the extensive divergence observed in anurans should facilitate 
investigating this question.  Clearly, FBPLs have extensively diversified in the African-clawed 
frog, a descendant of the lobe-finned fish (Sarcopterygii), but its presently unknown if this 
reflects the case within the ray-finned fish.  As ray-finned fish frequently possess twice the 
number of genes present in mammals, evidently the result of a genome-scale duplication that 
occurred after the two lineages diverged [109], it is likely they have an even greater diversity of 
FBPLs. 
Diversity of FBPLs from ray-fined fish 
Undoubtedly, the increasing availability of EST and genomic databases for non-conventional 
model organisms greatly enhances the possibilities of success in the search of FBPL 
homologues.  However, to trace their ancestry confidently a greater taxonomic diversity is 
required.  Prior to the escalation in EST sequencing that facilitated the discoveries described 
above, the only homologue detected in GenBank was PXN1-XENLA.  The success of the 
MOPAC procedure with the bass FBP32 suggested that rapid identification of FBPLs could 
be accomplished by PCR.  A trout liver EST, the first FBPL identified in dbEST, (GenBank 
Accession T23111) provided additional sequence diversity in the multiple sequence alignment.  
The design of degenerate primers was facilitated by the CODEHOP program [201], which 
automates the process of identifying those blocks of conserved amino acids optimal for 
designing primers with limited degeneracy.  The alignment provided to the program included 
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both domains from the bass lectin, the single FBPL from the unrevised PXN1-XENLA and 
the single FBPL discovered after 3’ RACE of the trout EST.  From the high similarity blocks 
identified within the FBPL sequence alignment, CODEHOP returned a number of possible 
DNA primers in both orientations.  A selection of four primers, two forward and two reverse 
primers, was made after comparing each with the nucleotide alignment of the FBPL sequences 
to confirm complementarity (fig. 35).  
The first attempt at MOPAC using this primer set was performed with liver cDNA from 
zebrafish, channel catfish (Ictalurus punctatus), tilapia (Oreochromis mossambicus), and X. laevis, as a 
positive control.  Amplification with universal primers of β-actin served as a second positive 
control for reverse transcription.  Expected bands of 137 bp (DFBP1.F/DFBP3.R) and 265 
bp (DFBP1.F/DFBP4.R) were only observed in the X. laevis control (data not shown).  The 
catfish produced a strongly staining but larger than expected band (650 bp) that was cloned 
and sequenced.  The deduced polypeptide revealed it was unrelated to FBP.  The other species 
produced several weakly staining bands also greater in size than the expected, and sequencing 
was not pursued.  Since liver is not the sole site of FBPL synthesis, a second attempt was made 
using genomic DNA as template.  Only zebrafish genomic DNA was used at first including 
striped bass genomic DNA as positive control.  A band of the expected size (i.e. 137 bp) was 
produced from zebrafish (fig. 36) as well as for the striped bass (data not shown).  Sequencing 
this band confirmed that it was indeed a segment of a zebrafish FBPL gene.  
 
Figure 35. Design of degenerate DNA primers for MOPAC using CODEHOP. 
Number next to arrow follows designation in Methods and Materials.  Msa32N:MsaFBP32 N-FBPL; 
Msa32C: MsaFBP32 C-FBPL; Omy4: O. mykiss FBPL-4; XLPXN1: X. laevis XENLA-PXN. 
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The full-length sequence was obtained by 3’ RACE (fig. 37) and by 5’ RACE (fig. 38) using 
total RNA extracted from whole zebrafish.  The appearance of two bands from 5’ RACE 
resulted from the amplification of a 5’ end truncated form despite the specificity of the 
technique for amplifying only from full-length transcripts. 
 
 
Figure 36. PCR amplification from genomic DNA of a zebrafish FBPL homologue by MOPAC. 
Lanes 1) 100 bp marker, 2) primers DFBP1.F/DFBP3.R, 3) DFBP1.F/DFBP4.R, 4) DFBP1.F/DFBP3.R, 
5) DFBP2.F/DFBP3.R.  Gel: 1.2% agarose, 1X TAE 
 
Figure 37. Nested 3’ RACE of DreI-FBPL. 
Lanes 1) 100 bp marker, 2) Bre2.F/MCSRACE (neat), 3) Bre2.F/MCSRACE  (1/100), 4) 
Bre2.F/MCSRACE (negative control), 5) OmyACT.F/ MCSRACE (neat), 6) OmyACT.F/ MCSRACE 
(1/100), 7) OmyACT.F/ MCSRACE (negative control).  Gel: 1.2% agarose, 1X TAE 
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Like the bass lectin, the ORF for the zebrafish homologue (DreI-FBPL) encoded two FBPL 
domains (Appendix) to which the amplicon obtained by MOPAC mapped to the N-terminal 
domain (fig. 39).  
Unlike the bass lectin, however, DreI-FBPL is a longer polypeptide (345 a.a.) due to an 
extension of the COOH-terminal end.  Importantly, this segment displays two Cys in addition 
to the positions conserved in the other FBPLs, suggesting that unique disulfide bridges are 
likely established in this protein.  The universality of this degenerate primer set for amplifying 
FBPLs was not tested but the success in cloning DreI-FBPL suggests it may constitute a useful 
tool for identifying FBPLs in species for which gene libraries have not yet been developed.  
Cloning of novel gene through MOPAC is advantageous for its speed but it should not 
substitute for traditional gene library screening since it may miss divergent homologues.  This 
 
Figure 38. Nested 5’ RLM-RACE of DreI-FBPL. 
Lanes 1) 100 bp marker, 2) Inner/Bre4.R (nested PCR), 3) Inner/Bre4.R (primer negative control), 4) 
Outer/OmyACT4R (actin RACE control), 5) Outer/OmyACT4.R (primer negative control), 5) 
OmyACT1.F/OmyACT4.R (GSP positive control), 6) Bre3.F/ Bre6.R (GSP positive control).  Gel: 2 % 
agarose, 1X TAE 
 Figure 39. Completion of DreI-FBPL sequence. 




was apparent during screening of a bacteriophage genomic DNA library (Chp. 4) using the 
DreI-FBPL cDNA as a probe.  Upon sequencing, a positive clone for a second FBP-like gene 
was identified.  From the partial sequence of a genomic clone, λZf13, a complete FBPL was 
found which was similar but not identical in DNA sequence to the FBPLs of DreI-FBPL.  To 
obtain more sequence downstream, 3’ RACE was performed from whole body cDNA (fig. 
40).  Only after a “nested” PCR on the first amplification reaction did an amplicon become 
visible (fig. 40, lane 6). 
The deduced polypeptide of this partial cDNA (DreII-FBPL) contained a single FBPL along 
with an extension although slightly shorter than observed for DreI-FBPL (see Appendix).  
Attempts to complete the sequence by 5’ RACE were unsuccessful and no 5’ ESTs matched 
the partial cDNA of DreII-FBPL, and although it remains to be rigorously determined 
whether the full-length sequence only contains a single FBPL, this possibility is likely since the 
extensive upstream sequence (7 kb) in the genomic clone shows no evidence of other FBP 
domains. 
 
Figure 40. 3’ RACE with nested DNA primers of DreII-FBPL identified from λZf13. 
Lanes 1) 100 bp marker, 2) BreIIA.F/MCSRACE (primary PCR), 3) BreIIA.F/MCSRACE (primer 
negative control), 4) OmyACT1.F/MCSRACE (actin RACE control), 5) OmyACT1.F/ MCSRACE 
(primer negative control), 6) BreIIB.F/MCSRACE (nested PCR), 7) BreIIB.F/MCSRACE (primer 
negative control).  Gel: 1.2% agarose, 1X TAE 
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One interesting characteristic that has emerged from screening for FBPLs is the diversity in 
sites of expression.  This varied localization may drive the selection of the multiple FBPLs and 
points to a subfunctionalization towards tissue-specific operation.  The expression of an FBPL 
in the gonads rather than the liver of zebrafish are one such an example.  Two ESTs were 
initially recognized as containing an FBPL motif: one originated from an ovary cDNA library 
(GenBank Accession BI983962), and the other from a testis cDNA library (GenBank 
Accesion BQ074381).  Alignment of both sequences presented a long segment of consensus 
but the 5’ ends containing the 5’UTR differed.  Specifically, the testis EST 5’UTR was shorter 
than the ovary EST.  Two forward primers were designed as specific for each EST to confirm 
their uniqueness.  Using these primers in a 3’ RACE with whole-body cDNA from fish of 
both sexes produced several amplicons (fig. 41).  Unexpectedly, the testis-specific primer 
(Bre11.F) produced the longest amplicon.  After sequencing the longest amplicon generated by 
each primer it was confirmed that they were identical since the amplicon produced by the 
ovary-specific primer is nested in the larger testis-specific amplicon.  
 
Figure 41. PCR Amplification of DreIII-FBPL with gonadal EST-specific primers. 
Lanes 1) 100 bp marker, 2) Bre10.F/MCSRACE (primary PCR), 3) Bre10.F/MCSRACE (primer negative 




Alignment of the sequences revealed that the reported testis EST was shorter because of a 
deleted segment in the 5’ UTR.  Fortunately, the Bre11.F primer did not span the segment 
deleted, and was able to amplify the longer cDNA.  Analysis of the full cDNA sequence, 
(DreIII-FBPL) of this gene reveals two FBPLs in tandem like DreII-FBPL, but lacking the 
extension (See Appendix).  The absence of this characteristic makes it more alike to 
MsaFBP32 than to the other two zebrafish FBPLs.  That the above-mentioned transcripts are 
specific to one sex or the other appears doubtful, and is most likely that they present in both.  
The function(s) of this protein in gonadal physiology [225] is unknown, but it is conceivable 
that it plays a role in phagocytosis during follicular atresia [226] and spermatogenesis [227].  It 
is of note that a Fuc-binding lectin has been isolated from ova of the European sea bass 
(Dicentrarchus labrax) [228], a species closely related to American moronids [135], but it remains 
unknown if it represents an FBPL.  A fourth FBPL (DreIV-FBPL) was reconstructed (Table 
3) from an assembled whole genome shotgun contig (Ensembl NA11125), but to date no 
matching EST has been deposited demonstrating its expression.  Another FBPL apparently 
expressed outside the liver was detected in a head kidney-derived library (GenBank Accession 
CD758445).  Sequencing (DreV-FBPL) of the clone also revealed a tandem domain 
arrangement (See Appendix), with no extension.  The emerging scenario in zebrafish of 
multiple, binary domain-FBPLs limited in spatial expression diverge from the observations in 
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Fish can count 
From the deduced FBPLs found in Xenopus spp. it is clear that this domain is capable of 
forming tandem arrays of multiple FBP domains.  In teleost fish, however, none of the FBPLs 
detected exhibit more than two domains.  As previously mentioned, the in silico search initially 
detected an EST containing the 5’ end-sequenced liver cDNA clone from the steelhead trout, 
Oncorhynchus mykiss (GenBank Accession T23111).  The initial identification of this partial 
sequence as an FBPL was confirmed by 3’ RACE.  To complete the ORF, 5’ RACE was 
performed that resulted in the amplification of two closely sized bands greater than 1.5 kb (fig. 
42, lane 4).  Due to the closeness in size of the amplicons, they were TA-cloned without prior 
separation, and then individually identified during the colony selection process (fig. 43).  
Clones containing either a 1.9 kb or a 2.1 kb insert were selected for sequencing. 
 
 
Figure 42. 5’ RACE amplicons of trout FBPL from liver total RNA. 
Lanes 1) 100 bp marker, 2) GeneR5’/OmyACT2.R (primer negative control), 3) GeneR5’/Omy7.R 
(primer negative control), 4) GeneR5’/Omy7.R, 5) GeneR5’/OmyACT2.R (actin positive control). Gel: 
1.2% agarose, 1X TAE.  Two amplicons close in size are evident in lane 4.   
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Surprisingly, the longest 5’ RACE amplicon (2,960 bp), which extended the length of the initial 
EST, encoded an ORF (698 aa) with four tandem FBP domains, the first fish FBPL with 
greater than two domains (fig. 44).  
The sequences revealed that the shorter amplicon had a 118 bp deletion in the 5’UTR, just 
upstream of the start Met.  To examine the possibility that this deletion may be a product of 
the RACE methodology, a DNA primer, Om11.F, specific for the most 5’ end of the 5’ 
RACE amplicon was used in 3’ RACE (fig. 44).  A second primer, Om8.F, specific for the 
putative signal peptide, which is downstream from the deletion, was used as a secondary 
verification.  For the first primer, two amplicons were produced (fig. 45, lane 1); the first band 
was the expected 2.9 kb if no 5’UTR deletion was present but the second band of 1 kb was 
unexpected.  Sequencing of the smaller band indicates it is chimeric since it contained the 
 
Figure 43. Colony PCR of OmyFBPL4 5’ RACE subclones. 
Clones two (lane 2), four (lane 4), five (lane 5) and seven (lane 7) were sequenced. 
 
Figure 44. Contig of RACE amplicons for OmyFBPL4. 
The arrow labeled T23111 indicates position of EST.  First, short box at right indicates the signal peptide-
encoding segment.  Longer boxes illustrate the four FBPLs.  Annealing positions of DNA primers used in 
PCR amplification of full sequence are illustrated with short arrows. 
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5’UTR of OmyFBPL4, including the deletion observed in the 5’ RACE amplicon, fused to a 
microsatellite-like sequence in the 3’ half (GenBank Accession AY039629) [229] of the 
sequence (fig. 46).  Because microsatellites are presumably not transcribed, it is possible that 
contamination of the amplification reaction with genomic DNA generated this amplicon.  On 
the other hand, it may reflect the localization of the microsatellite within the trout FBPL gene 
leading to an aberrant transcript.  This alternative explanation is supported by the localization 
of the deletion in the smaller 5’ RACE amplicon being in the same location as the junction to 
the microsatellite.  The results from both 5’ RACE and full length PCR are inconclusive 
regarding the authenticity of the deleted 5’UTR segment.  The elucidation of the structure of 
this gene will shed light on the possibility of alternative splicing sites that may produce multiple 
gene products.  PCR amplification with the Om8.F primer produced a single 2.5 kb amplicon 




Figure 45. PCR amplification of full-length OmyFBPL4. 
Lanes 1) 100 bp marker, 2) Om11.F/MCSRACE, 3) Om11.F/MCSRACE (primer negative control), 
4) Om8.F/MCSRACE, 5) Om8.F/MCSRACE (primer negative control). Gel: 1.2% agarose, 1X TAE. 
Lane 2 uses an upstream primer specific for the most 5’ end of the largest band from the 5’ RACE.  
Lane 4 uses a primer specific to the segment missing in the lower band of the 5’ RACE. 
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The circulation of this lectin in blood has not been confirmed but the presence of a signal 
peptide suggests the liver secretes it.  Many other lectins have been described from blood of 
the steelhead trout [127, 129], including other unrelated lectins [192] possessing tandem 
domain arrangements.  Pentraxins have also been identified in trout, but do not appear as in X. 
laevis to be fused to an FBPL [122, 230].  From the domain architecture, it is possible that 
OmyFBPL4 is orthologous to the four domains of XlaII-FBPL. 
For some FBPLs identified from EST projects, the length and quality of sequence allowed for 
assembly of the complete ORFs.  Such is the case of a single domain-FBPL from a head-
kidney cDNA library of the common carp [231].  Interestingly, this library was produced from 
cultured head kidney cells treated with LPS and the lymphocyte mitogen concanavalin A, but 
the impact of these treatments is unknown since differential expression was not tested nor was 
the library subtracted [232].  Curiously, like zebrafish, this FBPL is expressed in the portion of 
kidney dedicated to hematopoiesis [233] but unlike zebrafish, it only possesses a single domain. 
The three-spined stickleback, Gasterosteus aculeatus, has become a popular model in the study of 
morphological evolution due to their rapid diversification [234].  Current efforts in studying 
the genetic basis for this phenomenon include establishing a genome-wide linkage map, which 
will permit correlating adaptive phenotypes to the responsible loci [235].  As part of this effort, 
an EST project was initiated for the production of genetic markers to enhance the resolution 
of the map (cegs.stanford.edu/index.jsp).  Among the latest deposited sequences in dbEST are 
 
Figure 46. Sequencing contig of 1 kb chimera. 
Box illustrates segment that matches the 5’UTR of OmyFBPL4. 
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two binary FBPLs, CDA91_B12 (GenBank Accession CD508500 and CD508499) and 
CDA35_C06 (GenBank Accession CD498736 and CD498735) resulting from this EST 
project.  Unfortunately, the libraries were generated from mixed tissues from both sexes, 
making it difficult to attribute the expression to a specific tissue or sex.  
One surprising result came from the purification and cloning of a Japanese eel lectin.  As 
discussed in Chapter 2, the NH2-terminal peptide sequence of the European eel lectin shares 
only a few residues with the bass FBP32, and thus they did not initially appear to be related.  
Searching for serum proteins regulated by changes in water osmolarity, Honda et al. followed a 
proteomic approach using 2-D electrophoresis to examine plasma of freshwater and saltwater-
adapted eels [182].  One particularly abundant protein was cloned from liver and gills that 
matched the N-terminal reported for the European eel agglutinin [168], which raises the 
possibility that it was a homologue of the previously characterized fucolectin from the 
European eel [236].  Although levels of the Japanese eel FBPL did not correlate with changes 
in water osmolarity, they appeared to increase upon challenge with bacterial LPS, supporting a 
role for these lectins in immunity.  As the carp head kidney FBPL, only a single FBP domain is 
present in this protein. 
The completion of the genome sequence for the tiger pufferfish, F. rubripes, represents a 
landmark in vertebrate and fish genomics [237], and its release provided the opportunity to 
search a fish genome for the full repertoire of FBPL genes.  Two scaffold assemblies (>100 
kb) from the 3rd assembly version by the U.S. Department of Energy’s Joint Genome Initiative 
were identified as containing FBPL domains (for details see Chp. 4).  Upon close inspection, 
each of the two scaffolds apparently encoded a binary FBPL like MsaFBP32.  Coincidentally, 
the draft genome of a different pufferfish species, the green-spotted pufferfish (T. nigroviridis) 
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had also been assembled, allowing comparison between the two species.  Similarly, the search 
of the green-spotted puffer genome identified two scaffolds containing binary FBPL.  In 
comparison to other fish, the pufferfish appears to possess a reduced FBPLs repertoire.  A 
recount of FBPLs uncovered in euteleosts includes singular, binary, and quaternary domain 
arrangements.  This diverse architecture present within these widely diverging fish taxa (i.e. 
elopomorphs, ostariophysii protacanthopterygians, and acanthopterygians) indicates great 
divergence of this lectin family along the teleost lineage (fig. 47). 
A comparison of these FBPL genes between the two pufferfish species results in clear pairing, 
which suggests they are orthologous.  Interestingly, there is no sign that a quaternary FBPL like 
that in trout, or a singular FBPL as in the eel and carp.  Pufferfish belong to the order 
Tetraodontiformes, the most derived group of teleosts [238], which are peculiar due to their 
apparent morphological simplification and genome compaction [239].  Therefore, it is appears 





Figure 47. Phylogeny of living fish [238]. 
An FBPL has been identified in the divisions shaded in gray.  Elopomorphs include eels, ostariophysi 
include zebrafish, protacanthopterygi includes trout and acanthopterygi include sticklebacks, bass and 
pufferfish.  (Adapted from [238]). 
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FBPLs of invertebrates  
Hitherto, only FBPLs from ectothermic vertebrates have been discussed, but their presence in 
invertebrates was confirmed.  During searches of dbEST a partial FBPL motif (GenBank 
Accession AI295227) was detected from the fruit fly, D. melanogaster.  The fruit fly has become 
an invaluable model in the study of innate immunity [240] by facilitating the discovery of the 
mammalian Toll pathway [241], and therefore revealing a novel family of receptors  involved 
in pathogen recognition [242].  Although TLRs of vertebrates apparently bind pathogen 
products directly in the fly, Toll interacts with intermediary hemolymph proteins activated by 
an unknown receptor [17].  The possibility that an FBPL could be this putative receptor was 
explored by completing the sequence of this interesting EST.  To confirm the presence of a 
full FBPL, the corresponding clone (BDGP/HHMI D. melanogaster EST project clone 
LP08801) was purchased.  Sequencing of the plasmid insert (3,201 bp) was completed by 
directional deletion constructs.  Although the FBPL domain was complete, no start Met was 
present.  To complete the ORF, a cDNA library was screened by PCR with a bacteriophage 
arm-complementary forward primer and an insert specific primer.  The resulting 361 bp 
amplicon included the start Met and a signal peptide predicted with high confidence (fig. 48).  
Further upstream sequence was added from four complementary ESTs extending the 5’ UTR, 
whereupon several stop codons appeared in frame with the ORF (fig. 49).  The completed 
polypeptide presented the most complex mosaic domain topology so far identified for FBPLs.  
From the N-terminus, the signal sequence was followed by complement control protein (CCP) 
domains, also known as sushi domains or short consensus repeats (SCR) [243], the FBPL 
domain, a C-type lectin-like domain (CTLD), 3 tandem CCPs, and a mucin-like segment [244] 
that probably is O-glycosylated.  Interestingly, past these domains is a segment rich in 
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hydrophilic residues predicted to form a transmembrane domain [245] (fig. 50).  Therefore, 
LP08801 likely encodes a type I transmembrane receptor with the mucin domain likely serving 
as a stem to elevate the distal receptor domains away from the cell surface.  Only recombinant 
expression of this protein will confirm its topology with certainty, but the above-mentioned 
domains are likely extracellular.  The designation given to this gene after annotation of the fruit 
fly genome [246] is CG9095.  
 
 
Figure 48. 5’ RACE of LP08801 from larval cDNA library lysates. 
Lanes 1) 100 bp marker, 2) lgt11.F/Dme6.R, 3) lgt11.R/Dme6.R, 4) Dme5.F/Dme2.R (positive control), 
5) lgt11.F/Dme6.R, 6) lgt11.R/Dme6.R, 7) Dme5.F/Dme2.R (positive control), 8) lgt11.F/Dme6.R, 9) 
lgt11.R/Dme6.R, 10) Dme5.F/Dme2.R(positive control), 11) lgt11.F/Dme6.R (negative control), 12) 
lgt11.R/Dme6.R (negative control), 13) Dme5.F/Dme2.R (negative control). Gel: 1.2% agarose, 1X TAE 
 
Figure 49. Sequencing contig of the full length D. melanogaster  CG9095. 




Expression of CG9095 in the larval stage of the fly was evident from the source of the EST 
but it remained uncertain if it is expressed during other stages of development.  Thus, the 
presence of CG9095 was tested by RT-PCR in embryos and adults.  Results indicate that 
CG9095 is expressed at all stages of fly development, but expression appears higher in the 
embryo (fig. 51).  The continued expression of CG9095 throughout the developmental stages 
suggests that it derives from a tissue that remains relatively unchanged during metamorphosis, 
but experimental localization remains to be performed. 
 
Figure 50. Goldman-Engelman-Steitz hydrophobicity plot of the mature CG9095. 
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Searching for proteins likely homologous to CG9095 it was found that the furrowed gene [247] 
shared similar features including the transmembrane domain.  Both proteins possess the 
CTLD followed by CCPs but in the case of furrowed there are ten CCPs, in contrast to the three 
CCPs observed in CG9095.  The initial description of furrowed cDNA did not include an 
upstream CCP and FBPL domain despite both being present in the sequenced locus.  It 
appears that these domains were missed because the authors relied on an incomplete 
composite transcript, built from overlapping truncated cDNA clones, to annotate the exon 
boundaries.  The confirmation of gene annotation of the fruit fly genome [82] through 
sequencing full cDNA clones has led to a revised furrowed cDNA (GenBank Accession 
BT003214) which encodes for the missing domains.  Curiously, a comparison of the LP08801 
cDNA sequence to the genome sequence revealed that the 3’ end of the cDNA insert 
contained a segment that mapped to a different chromosome (i.e. Ch 3) than the CDS (i.e. Ch 
X) suggesting that it is a cloning artifact.  The multiple encounters with artifactual sequences 
from EST clones during this project emphasize the necessity for verifying sequences prior to 
reaching any conclusions.  In summary, furrowed is a paralogue of the CG9095 sharing all 
domain types but differing only in the number of CCP domains downstream of the lectin 
 
Figure 51. RT-PCR amplification of CG9095 from fruit fly embryonic, larval and adult RNA. 
Lanes 1) 100 bp marker, 2) Dme5.F/Dme2.R, 3) rp49.F/rp49.R (RT positive control), 4) 
Dme5.F/Dme2.R, 5) rp49.F/rp49.R, 6) Dme5.F/Dme2.R, 7) rp49.F/rp49.R, 8) rp49.F/rp49.R (negative 
control), 9)Dme5.F/Dme2.R (negative control).  Gel: 1.2% agarose, 1.2X TAE 
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domains.  Both are genes are localized on the X chromosome (CG9095:13B1, furrowed: 11A2), 
suggesting that they arose through a duplication event.  In the fruit fly, these are the only 
examples of proteins with this domain architecture and the only FBP-like domains found in 
the genome.  The furrowed mutant was so named due to the crevices observed in the 
misdeveloped eyes of fruit flies with lesions to this gene.  This phenotype along with aberrant 
bristles led to the conclusion that the furrowed gene was involved in ontogeny of sensory 
organs.  More recent work detected strong expression of furrowed in primary pigment cells in 
the eye of adult fruit flies [248] demonstrating it is not restricted to developmental processes.  
Recently, peptidoglycan-binding receptors [249, 250] were identified in fruit fly as the missing 
pathogen receptor that activates the Toll pathway.  It has also been discovered that the 
specificity of the immune response correlates with the source of the peptidoglycans [251].  
Considering these developments, the homology of CG9095 with furrowed, and their similarity 
of expression suggests that CG9095 may rather play a role in development than in immunity.  
A unique feature of CG9095 is the presence of two different lectin domains with potential to 
bind Fuc.  The description of fucosylated glycoproteins in D. melanogaster [252] confirms the 
presence of available ligands for these receptors.  At this point in the studies, the binding site 
of FBPL was not known so it was not possible to predict lectin activity, but the residues of 
CTLDs that mediate binding have been identified [253].  It is possible to predict ligand-
specificity and likelihood of binding [254] based just on consensus to these residues [83].  The 
result of this approach is that CTLDs have apparently diverged into those that bind sugar and 
those that retain the lectin fold but are unlikely to bind carbohydrate.  An analysis of CTLDs 
present in D. melanogaster [84] indicated that the domain present in furrowed appears capable of 
binding carbohydrates while that of CG9095 does not.  Closer inspection of the CG9095 
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CTLD indicates that it has several changes to the Ca2+-binding residues that would preclude 
binding to carbohydrate (fig. 53).  Specifically, there is a deletion of the segment containing the 
canonical Q-P-D and E-P-N motifs which determines specificity for galactose and mannose, 
respectively [255].  As documented for other CTLDs [256], it is possible that CG9095 will bind 
to proteins instead of carbohydrates. 
The recent completion of the mosquito, Anopheles gambiae, genome [257] sequence allows its 
comparison to the fruit fly’s genome [258].  A query of the mosquito genome indicates that it 
possesses both a CG9095-like gene and furrowed-like gene (GenBank Accession 
AAAB01008846.and AAAB01008811, respectively) syntenic on chromosome X, which 
supports an orthologous relationship.  Despite an estimated 250 million years having passed 
since these groups diverged, the level of conservation between furrowed orthologues is higher 
(61% identity, 80% similarity) than the overall similarity reported (56%) between many fruit fly 
and the mosquito orthologues [258].  It would thus appear that these proteins are subject to 
stronger selective pressures.  The genome of the honeybee (www.ncbi.nlm.nih.gov/BLAST 
/Genome/Insects.html) also encodes homologues of these receptors suggesting these 
receptors are conserved throughout dipterans and hymenopterans.  Annotation of other insect 
 
Figure 52. Alignment of the segments from CG9095 and furrowed spanning the FBPL and CTLD from 
the Drosophila homologues. 
The dotted vertical line (|) marks the junction between the FBPLD and CTLD.  The dotted box demarks 
the position of the Man/Gal-determining residues in the CTLD.  The pound sign (#) indicates the CRD 
residues involved in binding Ca2+.  Black shading indicates identity.  Gray shading indicates similarity. The 
segments share 31% identity and 50% similarity (Blosum 62). 
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genomes [259] will help trace if this cell receptor is conserved throughout this class of 
arthropods or represents an innovation associated with the development of holometabolism.  
An FBPL from a chelicerate has already been described from the horseshoe crab, but is not 
orthologous to the insect receptor.  Tachylectin-4, an FBPL purified and cloned from 
hemocytes of the Japanese horseshoe crab (T. tridentatus) [181], contains only a single domain, 
but forms larger noncovalent assemblies (470-kDa) than the bass and eel FBPLs.  This lectin is 
one of many [63] characterized from secretory granules released from hemocytes upon 
stimulation with bacterial products.  The appearance of horseshoe crabs in the fossil record 
dates back to the Cambrian period [260] and indicates they have changed little since.  
Therefore, in later appearing dipterans, the FBPL domain appears to have been co-opted to 
serve what is likely a cellular adhesion role. 
The lack of any FBPL homologue in the genome of several nematodes screened [81, 261] 
contrasts with their presence in arthropods despite both being protostomes.  This inconsistent 
distribution of FBPLs among protostomes may be better understood in light of revision of the 
relationship between arthropods and nematodes as ecdysozoans [262] rather than related as 
descendant and ancestor, respectively.  This is part of a much broader reorganization of the 
metazoan evolutionary tree [263] which changes the perception of what were intermediary 
taxons into actually independently evolving branches.  It is most likely that FBPLs were lost 
from the nematode lineage but remained in arthropods.  The presence of FBPLs in other 
protostomes would support that the domain was present in the earliest ancestors of this group.  
Indeed, FBPLs are found are found in lophotrochozoans, the second major division of 
protostomes.  ESTs from a planarian (GenBank Accession BP188149) and a bivalve mollusk 
(GenBank Accession CD647591 and CD646763) convincingly reveal an FBPL motif.  In the 
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case of the oyster, the FBPL even appears to possess more than one domain.  Consequently, 
from these results the phylogeny of FBPLs more likely appears to be a radiating bush rather 
than a progression of branches representing stages of domain evolution.  Although the FBPL 
is perceivably ancient, it remains unknown if it was present prior to the emergence of Bilateria.  
The establishment of genomics projects in porifera and cnidarians (genome.wustl.edu/) should 
contribute to elucidate this question.  Various genome projects in early branching eukaryotes 
such as plants, protozoa, and fungi [264] have not yielded any FBPLs.  Apposite to this issue is 
a survey of protein domains in choanoflagellates [265], a group of unicellular and colonial 
flagellates which are considered an outgroup of animals.  In contrast to the C-type lectin 
domain being present, no FBPLs are detectable in the substantial number of ESTs sequenced 
suggesting that this domain appeared in animals.  The presence of the C-type domain in 
choanoflagellates is evidence of the early appearance of this domain and others prior to the 
development of multicellularity in metazoans yet after the appearance of opisthokonts (e.g. 
Fungi).  Interestingly, one ORF presents a C-type domain associated with three CCP domains 
similar to the arrangement described in D. melanogaster CG9095.  In summary, the sporadic 
distribution of FBPLs in prototostomes parallels that in deuterostomes pointing to a 
preponderance of gene loss during this family’s evolution.   
Paucity of FBPs in prokaryotes: vertical vs. horizontal transfer? 
Although the initial search of FBPLs only detected homologues in animals, the completion of 
Streptococcus pneumoniae genome [266] presented the first evidence of this domain’s presence in 
prokaryotes.  This important human pathogen has a special place in the history of molecular 
biology since it led to the discovery of DNA as the agent of heredity, facilitated by its ability 
for uptake of exogenous DNA [267].  Interest in the great diversity within prokaryotes and the 
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small size of genomes has resulted in the rapid completion of over 100 genomes [264].  Since 
the establishment of the Comprehensive Microbial Resource (CMR) [268], browsing the 
multitude of completed bacterial genomes is greatly facilitated.  Using this resource a search of 
all ORFs was undertaken to test if any bacteria contained an FBPL domain.  Surprisingly, an 
FBPL was detected only in the genome sequence (2.16 Mb) of the capsulated and virulent 
strain (TIGR4) of S. pneumoniae.  The ORF, designated SP2159 (GenBank Accession 
AAK76213), consists of a 579 residue NH2-terminal segment of no detectable homology 
followed by a triplet of FBPL domains.  In contrast to the eukaryotes, the FBPL domains of 
SP2159 are devoid of Cys, which suggests that this protein is localized intracellularly where the 
negative redox potential abrogates any structural stabilizing effect of cystines, but the presence 
of a confidently predicted signal sequence cleavage site (VKA31-D32N) suggests otherwise.  
Indeed, FucU along with RbsD are the first intracellular Fuc-binding protein described in 
bacteria [269].  Interestingly FucU shares homology to genes in vertebrates suggesting they 
bind sugar as well.  Since S. pneumoniae is a frequent cause of meningitis and pneumonia in 
humans, much attention is focused on searching for vaccine targets.  One strategy relies on 
prediction of surface proteins by scanning ORFs for export signals [270].  SP2159 was not 
among 69 proteins predicted to be present on the surface of S. pneumoniae [266] so it remains to 
be determined exactly where this protein localizes.  The location of SP2159, as is FucU, in the 
genome is within a regulon dedicated to Fuc catabolism [271].  S. pneumoniae is reported [272] 
to grow on diverse carbohydrates although not on fucose alone, yet analysis of the Fuc regulon 
promoter indicates that it is specifically activated by Fuc [273].  Therefore, it appears that the 
catabolism of Fuc solely cannot sustain growth due to requirement of an unknown product 
from glucose catabolism.  Tettelin et al. [266] suggest that the fucose regulon may be involved 
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in the uptake of N-acetylfucosamine or other fucose derivatives for the purpose of capsule 
synthesis since N-acetylfucosamine has been isolated from the capsule of S. pneumoniae, but this 
appears improbable, as no Fuc salvage pathway such as found in mammals has been described 
in bacteria [274].  The sequencing of the avirulent, uncapsulated strain R6 (2.03 Mb) [275] 
allows complete genome comparison to the virulent TIGR4 strain.  Indeed, the R6 strain also 
possesses an identical gene, spr1965 (GenBank Accession 15459666) suggesting this gene does 
not contribute to the differences in strain virulence. 
Genome comparisons among prokaryotes facilitate domain annotation by revealing 
unexpected homologies.  The release of the genome of the “flesh-eating” bacterium Clostridium 
perfringens (3.03 Mb) [276] revealed a putative protein, CPE0329 (trEBML Accession 
Q8XNK4), whose COOH-terminal contains a motif similar to the NH2-terminal segment of 
SP2159 (fig. 54, Panel A).  This shared domain stretches from Gln36 to Ile589 of the S. 
pneumoniae SP2159 protein, and shares 33% identical residues (fig. 54 Panel B).  No other 
protein in the current gene databases exhibits this motif, and its function in C. perfringens is 
unknown.  However, the presence of sugar catabolism genes surrounding CPE0329, like 
SP2159, suggests this novel domain also has a role in carbohydrate metabolism 
(www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl).  In a different species of clostridiae, a 
xylanase was described that contains triplicate family 6 carbohydrate-binding modules (CBM) 
[277] showing no sequence similarity to FBPLs.  However, the avidity effect produced by the 
multiplicity of CBMs in the xylanase serves as a paradigm for the analysis of SP2159. 
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As part of the U.S. Department of Energy’s Microbial Genome Program, an ever-growing 
number of bacterial genomes are rapidly being sequenced.  Many of the targeted bacteria are 
environmental isolates chosen for their unique physiological properties, which are expected to 
be useful in bioremediation, energy production, and other biotechnological purposes 
(www.science.doe.gov/ober/EPR/mig_cont.html).  Among these, several bacterial species 
were chosen for their ability to degrade cellulose and other relatively insoluble complex 
polysaccharides from vegetable sources.  One species in particular, Microbulbifer degradans [279], 
has the ability to grow on a wide variety of complex polysaccharides many which are relatively 
insoluble (i.e. agar, agarose, alginic acid, araban, carrageenan, carboxymethylcellulose, chitin, 
fucoidan, glycogen, laminaran, pectin, pullulan, sodium polygalacturonate, starch and xylan, 
but not cellulose) [280].  In the recent release of the draft assembly of M. degradans genome (6 
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       Figure 53. Schematic representation of domain organization by ProDom for S. pneumoniae SP2159 (above) 
and C. perfringens CPE0329 (below) proteins. 
A. The domain connected by dashed line (ProDom Accession PD493674) [278] is the novel motif shared 
by both proteins.  The FBPL domains are labeled CRD.  Ruler demarks residue number.  B. Peptide 
pairwise alignment of the novel domain demarked in the previous panel.  The black and gray shading 
indicates identity and similarity of residues, respectively.  
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presented a single FBPL domain.  It seems telling that the presence of FBPL domains in 
bacteria correlates with their broad ability to utilize diverse carbohydrates.  The only other 
detected domain on the polypeptide is that of FA58C coagulation factor domain (GenBank 
Accession smart00231) which is upstream from the FBPL domain.  Annotation of this domain 
states that it transferred from vertebrates to bacteria, but a more detailed examination reveals 
that the profile includes a fungal member, and therefore its presence in bacteria may truly 
reflect vertcal transmission.  In enzymes that target carbohydrates as substrates, such as 
glycooxidases and glycohydrolases, the apparent function of this domain [281, 282] is to bind 
and tether the carbohydrate substrate while the contiguous enzymatic domain exerts its 
particular activity.  However, no detectable enzymatic domains are present in ZP_00065873.1 
to support it being involved in degradation.  Admittedly, the putative polypeptide is longer 
than just the two identified domains, leaving the possibility that an unrecognized enzymatic 
domain is present, or that a portion of the peptide even associates with a catalytic domain.  
The presence of cell wall protuberances observed on M. degradans suggest that it produces 
anchored cellulolosome-like [283] complexes that facilitate the degradation of insoluble 
complex polysaccharides.  Hence, it is possible that the FBPL of ZP_00065873.1 functions in 
binding cellulosomes to insoluble carbohydrate substrate, such as the terminal fucosylated 
xyloglucans [284] present in plants, to facilitate degradation.  Remarkably, although the 
clostridial CPE0329 domain is not present in the M. degradans FBPL, Clostridium are also well 
known for forming cellulosomes [283]. 
Clearly, the presence of FBPLs in species within both Gram-positive, low G+C firmicutes (S. 
pneumoniae) and Gram-negative γ-proteobacteria (M. degradans), suggests that this domain either 
has undergone widespread loss or has been disparately transferred into bacteria in multiple 
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events.  In contrast to the FA58C domain, the noticeable absence of FBPLs in the genomes 
from the many bacteria and fungi sequenced suggests it indeed may have horizontally 
transferred directionally from bilaterians to S. pneumoniae and M. bulbifer.  The phenomenon of 
horizontal gene transfer (HGT) is generally accepted among Eubacteria and Archaeobacteria 
since it is supported by several examples from different gene families [285].  It is proposed that 
a lack of nucleus and their close association in communities produces the frequency of HGT 
amongst these cells.  For the scenario of bacteria-to-eukaryote HGT, the maintenance of a 
bacterial endosymbiont has allowed subsequent movement of organellar genes (i.e. chloroplast 
and mitochondria) to the nucleus [286].  Recent controversy arose when bacterial genes were 
stated to have directly transferred to vertebrates [287] since this requires the improbable events 
of transfer to germ cells and eventual gene-fixation.  This conclusion was promptly challenged 
with evidence of orthologues present in intermediate eukaryotes [288-290], in this case the 
slime mold.  Examples supporting animal-to-bacteria HGT are few [291-293] and the 
mechanism by which it occurs is unknown but this transfer direction seems plausible especially 
for pathogens, like S. pneumoniae, in close association with their hosts.  Presently, thorough 
phylogenetic analysis of SP2159’s ancestry is not possible since no orthologues have been 
identified even among other Streptococcaceae [294].  Moreover, the genomes of the beta-
hemolytic S. pyogenes [295], S. agalactiae [296], and S. mutans [297] do not present evidence of a 
Fuc regulon.  The absence of FBPLs in these species suggests that SP2159 maybe solely 
present in the non-beta-hemolytic viridans Streptococcus, S. mitis group or even constrained  to S. 
pneumoniae alone [298].  Since the S. mitis genome has been only partially sequenced, it is 
presently unknown if it shares the Fuc regulon of S. pneumoniae.  The inconsistent presence of 
the Fuc regulon in bacteria suggests that gene loss for the pathway [299] is the cause for the 
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restricted species distribution of FBPLs.  However, the identified Fuc regulons demonstrate a 
general distribution throughout many groups of bacteria (GenBank Accession COG4154 
(FucU); COG0738 (FucP); COG2407 (FucI) and the FBPL is absent in all.  Either this is the 
result of early gene loss prior to bacterial divergence, or the product of horizontal transfer as 
discussed above.   
FBPL motif and domain topology 
At the outset of this project, only one homologue (i.e. PXN1-XENLA) of the bass FBP32 was 
identified.  Presently, forty FBPLs have been identified by sequence similarity from the major 
branches of the tree of life, including deuterostomes, protostomes and bacteria with exception 
of fungi and plants (Table 5).  The motif shared by these proteins does not present similarity to 
any described lectin family, and therefore represents a novel lectin domain showing specificity 
for terminal Fuc.  As mentioned earlier, the variable number of repeats of FBPLs and 
formation of mosaic combinations suggests that this motif represents an independently folding 
structural domain (fig. 54) [106].  Currently, domain concatenations range from singular up to 
five domains and possibly reflect the selection of varying levels of valence to control affinity.  
These tandem arrangements and multiple copies of FBPLs are evidence of the recurring role 
gene duplication [105] has played in shaping FBPL diversity.  Several unique mosaic domain 
combinations [300] have been described from bacteria, fruit fly and frog, but none found so 
far in fish.  Signal peptides on most FBPL ORFs predict that these lectins primarily localize as 
extracellular proteins.  The structure, which the FBPL motif adopts, is unknown but it likely 
shares several common features observed in mosaic proteins [301].  Secondary structure within 
most domains of mosaic proteins consists of β-strands.  It is frequently observed that 
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duplicated domains frequently have NH2- and COOH-terminals entering and exiting, 
respectively, close in the structure [302] which would allow domains to extend from the 
polypeptide.  Undoubtedly, the elucidation of an FBPL structure will settle many questions 
regarding this domain.  It follows from this topological diversity that quaternary structure 
variation is bound to be high among these lectins.  For example, the presence of a pentraxin 




Table 5. Taxonomic distribution and properties of deduced polypeptides containing an FBPL 




pI Site Ref. 
Eubacteria  
γ-Proteobacteria M. degradans ZP000065873 1 790 85737.3 4.72   
Lactobacillales S. pneumoniae Spn AAK76213 3 1007 114309.6 5.69  [266] 
Eukaryota 
Platyhelminthes D. japonica Dja_BP188149 1 144 16615.6 6.30 head   
Mollusca 
Class Bivalvia 
C. virginica Cvi-gonad 3(?) I - - gonads  
Arthropoda 
Class Merostomatata 
T. tridentatus Tachylectin-4 1 232 26639.3 6.05 hemocyte 
granules 
[181] 
Class Insecta D. melanogaster CG9095 1 925 100949.8 8.01 all life 
stages 
 







 A. gambiae Aga_ebiT8141 1      
  Aga_ebiP5322 1      





Order Anguilliformes A. japonica AjaFTL-1 1 158 17034.1 5.54 liver  [182] 
  AjaFTL-2 1 158 17256.3 5.94 liver [182] 
  AjaFTL-3 1 158 17294.3 5.84 liver [182] 
  AjaFTL-4 1 156 16948.9 5.94 gills [182] 
  AjaFTL-5 1 158 16958.9 6.06 gills [182] 
  AjaFTL-6 1 154 17135.1 6.20 gills [182] 
  AjaFTL-7 1 158 17336.5 6.06 gills [182] 
Order Cypriniformes D. rerio DreI-FBPL 2 345 37652.8 6.13 adult   
  DreII-FBPL 1(?)  I  adult   
  DreIII-FBPL 2 288 30970.8 4.65 gonads  
  DreIV-FBPL 2 293 32093.8 5.83   
  DreV-FBPL 2 290 31122.9 6.38 a. kidney  
 C. carpio CaH170 1 139 15181.0 9.21 a. kidney [231] 
Order Salmoniformes O. mykiss OmyFBPL4 4 698 77288.0 5.19 liver  
Order Gasterosteiformes G. aculeatus Gac-CDA91-B12 2 292 31971.3 5.12 n/a  
  Gac-CDA35-C06 2 292 31793.2 5.83 n/a  
Order Perciformes M. saxatilis MsaFBP32 2 293 32393.1 6.16 liver  
  MsaFBPII 2 293 32304.1 5.74 liver  
 M. chrysops MchFBP32 2 293 32308.0 6.01 liver  
  MchFBPII 2 293 32174.9 6.00 liver  
Order Tetraodontiformes F. rubripes Fru_1786 2 291 32158.6 5.21 heart, 
gonads 
 
  Fru_5138 2 285 31382.4 8.49 n/a  
 T. nigroviridis Tni_794_4 2 287 31505.9 5.76 n/a  




Order Anura X. laevis Xla-PXN 5 1092 120426.2 5.14 liver  
  XlaII-FBPL 4 578 63255.0 5.29 liver  
  Xla-neurula 1 176 19336.9 7.74 embryo  
 X. tropicalis XtrII-FBPL 3 432 47365.3 5.98 embryo  
  XtrIII-FBPL 2 295 32764.5 5.21 embryo  








































































































The increased representation of diverse FBPLs permits a comprehensive examination of the 
profile of conserved residues that define the motif (fig. 55).  Among the most conserved 
residues are six Cys-containing positions present throughout the domains (i.e. MsaFBP32: 
Cys42, Cys74, Cys75, Cys97, Cys113, and Cys139).  Based on this conservation pattern and 
results from SDS-PAGE, these Cys likely form intradomain disulfide bridges.  Surprisingly, 
only binary FBPLs such as MsaFBP32 present a different combination of Cys conservation 
between domains.  Although disulfide bridges have not been mapped in MsaFBP32, the 
differential presence of Cys pairs between the NH2- and COOH-domains and the unique 
placement of contiguous Cys suggests likely bridging mates (i.e. Cys42-Cys139, Cys74-Cys75, 
and Cys97-Cys113).  The presence of non-conserved Cys residues in odd numbers as in 
tachylectin-4, DreI-FBPL, DreII-FBPL, Aja-FTL-2, -3, and -7 suggests the existence of other 
bridges, some that may be between subunits.  Several hydrophobic positions are also strongly 
conserved, underlining the critical structural role they likely play in folded protein.  The unique 
PWW motif, so useful during the design of MOPAC primers, does show some variation, 
which would hinder the design of universal primers for FBPLs.  Large gaps of variable width 
occur in areas showing low conservation in the alignment and likely correspond to loops, 
which are the most variable of secondary structures.  Although several positions exhibit a high 
frequency of certain amino acids, it is impossible to predict from the consensus which 
positions interact with Fuc. 
Prospects for tracing orthology between FBPLs are poor due to their inconsistent taxonomic 
distribution and differing topologies.  However, the comparison of domains may reveal 
relationships related to their expansion.  For this reason, an unrooted distance tree (fig. 56) was 
constructed from the alignment of all available FBPL domains.  The resulting multifurcating 
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tree did not confidently resolve into deep nested clades but did rather indicate close 
relationships among several domains.  One clade held all tandem domains from Xla-PXN 
suggesting they arose from internal domain duplications.  A second clade groups all other 
Xenopus spp. FBPLs, reiterating independence from Xla-PXN and the teleost FBPLs.  The 
orthology between the fruit fly and mosquito furrowed and CG9095 receptors supported by 
similarities in domain topology and chromosomal location is also sustained by their pairwise 
clustering.  Curiously, the oyster FBPL groups with prokaryote FBPLs, which is most likely 
due to long branch attraction between the most divergent sequences.  The exclusive clade 
containing the multiple copies of Japanese eel fucolectins strongly suggests their origins from 
duplications within the Anguilliformes lineage (i.e. eel).  Greater similarity between FTL-2 and 
FTL-3 and between FTL-1 and FTL-5 suggests these are the most recent duplications in the 
group.  The first pair is expressed in the liver like FTL-1 but FTL-5 was isolated from gills 
pointing to likely candidates for comparing fucolectin regulation.  The presence of multiple 
FBPL copies contradicts earlier protein family analysis suggesting that duplication did not 
contribute significantly to gene expansion in eels [305].  One conspicuous feature of this tree is 
the two sister clades showing the grouping of N-terminal and COOH-terminal domains of 
binary FBPLs from acanthopterygians (stickleback, bass and pufferfish).  However, the 
duplicate genes from each species tend to group together suggesting that independent 
duplication events have occurred along all three lineages.  Applying character-based methods 
may improve the resolution of this gene tree but the extensive gene duplication and gene loss 
likely confounds any attempt at recovering reconstructing ancestry of the FBP domain. 
 
 








































































































































































































































































































































































































 Figure 56. Analysis of genetic distance between FBPL domains. 
The phylogram was created from neighbor-joining analysis using Gonnet matrix as implemented in 
Clustal_X v.1.81.  Distances were corrected for multiple substitutions and gap positions were excluded.  




Phylogenetic analysis of binary FBPLs 
Sequence alignment of FBP domains indicated that many of the binary FBPLs discovered in 
teleosts were more closely related to each other, than to the rest of FBPLs.  To analyze this 
relationship further, an alignment of all binary FBPLs was produced using the deduced full-
peptide sequences that reflected the actual topological order of domains (fig. 57, Panel A).  
Examination of the domains indicates that even between binary FBPLs there is much variation 
especially in the segments permissible to gaps.  For example, the conserved pattern of 
putatively paired cysteines observed in the domains of bass FBPLs (i.e. Cys42-Cys139, Cys74-
Cys75, and Cys97-Cys113) varies for the other homologues.  The phylogram produced with 
these mature ORFs (fig. 57, Panel B) recovered the same clade seen for the COOH-terminal 
domains from bass, stickleback, pufferfish and one zebrafish FBPL.  Again, the higher 
similarity between paralogues of bass and stickleback suggests that they emerged 
independently in each species lineage.  The exception is the pufferfish, where greater similarity 
is observed between species indicating that duplication preceded their speciation.  A similar 
topology was observed for the bass duplicates in the previous domain tree.  The placement of 
DreIV, the gonadally expressed FBPL, as an outgroup to the bass, stickleback, and pufferfish 
clade suggests it is the ancestral form to the binary FBPLs present in the more derived fish.  
The interesting, albeit weak, association between DreI and XtrII suggests a possible link 
between the FBPLS of tetrapods and ray-finned fish.  In summary, binary FBPLs have 
diversified through lineage-dependent gene duplications and speciation events producing a 
combination of paralogous relationships unique to teleosts. 
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Unknown fate of FBPs during tetrapod evolution 
One remarkable feature of the FBPL family is its apparent absence in higher homeotherm 
vertebrates.  The presence of FBPLs in Xenopus spp. confirms that this protein family was 
firmly established into the tetrapod lineage, but it is presently unclear up to what stage of 
tetrapod evolution it persisted.  Currently, no FBPLs are detectable by sequence alignment in 
the finished human genome (www.ncbi.nlm.nih.gov/genome/guide/human/) or the draft 
mouse genome [306] and annotated cDNAs [307] (www.ncbi.nlm.nih.gov/genome/guide/ 
mouse/) raising the possibility that FBPLs have been lost in higher vertebrates.  For humans,  
more than 99% of the euchromatin (i.e. gene containing DNA) has been sequenced and 
assembled into an accurate finished sequence, so if any FBPLs were present they most likely 
would appear during a sequence similarity search. 
One of the factors correlated with  increased organismal complexity is the increased diversity 
of shuffled protein domains [308], so it is surprising to find that a protein family already 
established and highly diversified in the tetrapod lineage appears to have dissappeared from 
higher vertebrates.  Comparative genomic studies suggest that gene loss after duplication [309] 
is a frequent event even in vertebrates [310] but the loss of a protein family has not been 
documented.  The absence of FBPLs in these groups may not represent the situation for all 
mammalian taxa since recent evidence points to primates and rodents being more closely 
related than to other mammals (i.e. carnivore and ungulates) [311].  The rising availability of 
mammalian genomic resources [312], encouraged by the increased interest in comparative 
studies, eventually will permit addressing if other eutherians, marsupials and monotremes also 
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lack FBPLs.  Reptiles, as predecessors of mammals, are of interest for determining if FBPs 
persisted after the emergence of tetrapods on land. 
Unfortunately, reptiles as a group are currently unrepresented in genome studies 
(igweb.integratedgenomics.com/GOLD/) so the presence of FBPLs in this order is cannot be 
readily addressed.  Revisions in amniote phylogeny based on morphological and molecular 
characters places birds as a sister group of reptiles, although their affinity among reptile groups 
is still debated [313].  A query of an extensive chicken EST collection from various tissues 
[314] did not return any matches so it appears that FBPLs are also absent from birds and likely 
reptiles.  The production of publicly available BAC libraries from representatives of extant 
reptilian clades (i.e. a Testudine, Crodilian, Squamate and a Rhynchocephalian) is currently 
planned (www.nsf.gov/bio/pubs/awards/bachome.htm), which may enable a broader FBPL 
survey in reptiles.  The lack of results tentatively rules out the presence of FBPLs in land-
dwelling tetrapods, but the paucity of the FBPLs observed in invertebrates weakens this 
conclusion.  One explanation for not detecting FBPLs in the above mentioned taxa with the 
approaches selected, may be that they have been subject to rapid diversification in these 
groups, and have diverged beyond statistically significant recognition [315].  However, despite 
the extensive time (>500 Ma) passed since the protostome/deuterostome divergence [316], the 
FBPLs of ectothermic vertebrates and arthropods still share significant similarity.  Examining 
the ubiquity of FBPLs in extant amphibians, including “modern frogs” (Neobatrachia), and 
methodically examining their presence in reptiles (anapsids and diapsids) may help in 
addressing this apparent FBPL family extinction, but the unclear evolutionary path from 
amphibians to reptiles [317] may still confound any conclusion for higher vertebrates.  As for 
mammals, representation of vertebrate diversity in genomic databases will eventually grow 
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allowing a more thorough search for members of this lectin family.  There is the possibility 
that apparent lack of FBPLs is correlated with the appearance of homeothermy since 
immunocompetence of cold-blooded vertebrates has been related to body temperature [318].  
However, maybe a more dramatic evolutionary innovation that predates homeothermy, the 
development of the cleidoic egg, may be the demarcation between the vertebrate classes 
possessing or lacking FBPLs.  This characteristic is believed to have allowed cold-blooded 
amniotes to leave behind a water-dwelling lifestyle and colonize land since their eggs no longer 
required water for developing.  Again, a thorough survey of reptilian and amphibian orders for 
FBPLs is required to address this apparent lectin family extinction. 
The lack of correspondence among available vertebrate FBPLs confounds the identification of 
the ancestor gene that gave rise to this diversity.  Completion of an ascidian (urochordate) 
genome [319] and the advancement of an echinoderm genome [320] provided an opportunity 
for analyzing the complement of FBPLs in taxa representing early stages in the evolutionary 
path towards the emergence of vertebrates.  Both of these organisms are invertebrates, but like 
vertebrates, they are deuterostomes.  Specifically, echinoderms as well as hemichordates (e.g. 
acorn worm) represent the most primitive of extant deuterostomes, the non-chordates.  
Likewise, the urochordates are the most primitive of extant chordates [321].  A search of the 
ascidian genome or EST collections [322, 323] did not produce any significant matches to 
FBPLs.  Curiously, a plasmid clone (fig. 58, Panel A) produced for the genome-sequencing 
project (ghost.zool.kyoto-u.ac.jp/indexr1.html) exhibited a partial FBPL motif.  The strong 
similarity of this putative ORF to FBPs suggests that it is authentic (fig. 58, Panel B) but the 
absence of this sequence from the assembled genome raises doubts.  Annotation of this clone 
is woefully lacking but it apparently was among the Japanese-produced libraries that were not 
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included during the assembly of the C. intestinalis genome [319] (as described in the 
supplementary information).  Evidently, further work is required to confirm if this clone is 
truly part of the ascidian’s genome, so at present it appears that an FBPL is absent in the 
ascidian lineage.  This apparent complete loss of the family is intriguing in light of the 
expansion of immune-related genes detected in C. intestinalis, including genes encoding surface 
receptors with multiple C-type lectin motifs [85].  Ascidians appear to be particular among 
urochordates, which may help explain the loss of this family in C. intestinalis.  The notochord 
evident in the motile larval stage of ascidians unarguably places them morphologically among 
chordates, however upon morphing into an adult this structure disappears, as the individual 
becomes a sessile benthic inhabitant.  Larvaceans, suggested to be the earliest diverging 
urochordates [324], are pelagic and retain their notochord into adulthood; therefore, the 
primitive adult body plan of ascidians appears to be secondarily derived.  Despite being 
phylogenetically distant, one a deuterostome the other a protostome, C. intestinalis shares with 
C. elegans several embryonic characteristics such as rapid development, early fixation of cell fate 
and reduced embryo cell number [325].  Interestingly, these morphological similarities are 
paralleled by changes in their genomes.  In contrast to other metazoan genomes analyzed to 
date, both animals possess a reduced nuclear-genome size manifesting high rates of mutation 
including gene order rearrangements and apparetn gene loss (e.g. Hox genes).  Both these 
physiological and genome characteristics suggest that both taxons have regressed relative to 
their respective ancestors. 
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Although FBPLs appear to be absent from ascidians, there is evidence of their presence in an 
earlier diverging deuterostome, an echinoderm.  Specifically, the purple sea urchin 
(Strongylocentrotus purpuratus) possesses multiple FBPL ESTs expressed in larvae (GenBank 
Accession CD310754, CD289590, CD307188, and CD304127).  Similar to ascidians, 
echinoderms appear to have regressed to an ancestral state, in this case that of radial symmetry; 
nevertheless, they have retained the FBPL family.  The spotty distribution of FBPLs in 
deuterostomes resembles the scenario observed in protostomes suggesting a relaxation in 
selection that eventually leads to gene loss.  The expression of FBPLs during early sea urchin 
development, similarly as in Xenopus spp., suggests their ancestral role is in deuterostome 
A 
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BLAST 2 SEQUENCES RESULTS VERSION TBLASTN 2.2.3 [Apr-24-2002] 
Score = 63.2 bits (152), Expect = 9e-10 
Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 6/104 (5%) 
 Frame = +2 
 
Query: 1   NVALRGKATQSARYLHTHGAAYNAIDGNRNSDFEAGSCTHTIE-QTNPWWRVDLLEPYIV 59 
           N+A +GKATQS+  +   G    AIDGN+N  +  G  THT E + NPWW +DL +   + 
Sbjct: 557 NIARKGKATQSS--VGAGGVPERAIDGNKNPSYTRGGQTHTTEGKANPWWELDLGKAREI 730 
 
Query: 60  TSITITNRGDCCPERLNGVEIHIGNS-----IQENGVANPRVGV 98 
             + I NRGD    RL+   + + +S      ++ G+A P+  V 
Sbjct: 731 EKVAIWNRGDGLXGRLDDFTLTLLDSNRKAVFKKXGLAAPKSSV 862 
 
Score = 33.1 bits (74), Expect = 1.0 
Identities = 16/21 (76%), Positives = 16/21 (76%) 
 Frame = +2 
 
Query: 119 RYVTVLLPGTNKVLTLCEVEV 139 
           RYV V LPG NK LTL EVEV 
Sbjct: 479 RYVRVELPGKNKTLTLAEVEV 541 
Figure 58. Tentative identification of an FBPL sequence in the ascidian, C. intestinalis. 
A. Overlap of sequencing traces from both ends of the genomic DNA plasmid clone, GCiWno578_c20.  
Boxes indicate the FBPL motif presented in the lower panel.  Note that the motif corresponding to the 
COOH-terminal end of the FBPL domain is upstream of its amino terminal motif.  B. Blast2 pairwise 
alignment between the NH2-terminal FBPL of MsaFBP32 and the translated sequence of genomic clone 
in panel A.  In the intervening row, identical residues are indicated by letters and similarities by crosses.  
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development.  However, an argument against this hypothesis is that genes with function(s) in 
development typically are phylogenetically widespread due to their indispensable role.  In 
summary, an FBPL is absent from the assembled ascidian genome, but the tentative 
identification of a partial motif in an ascidian genomic DNA clone raises the possibility that 
the assembly is incomplete and that FBPLs indeed have not been lost from ascidians.  Further 
work is necessary to confirm if this is so.  Clearly, evidence from an echinoderm demonstrates 
the conservation of FBPLs in an early deuterostome, however completion of a 
cephalochordate’s genome, the sister clade of vertebrates [321], may provide a better 
representation of the FBPL gene complement just prior to the emergence of vertebrates. 
Displacement of FBPLs by C-type lectins? 
The shared ligand specificity of FBPLs with C-type lectins raises the possibility that 
intragenomic competition [302] may be responsible for disappearance of FBPLs.  In the 
extensive nematode genomes sampled, FBPLs are noticeably absent, but CTLDs have greatly 
diversified [83].  Indeed, CTLDs have proliferated more in nematodes than in the fruit fly [84], 
which still have an FBPL homologue.  This concept of domains competing arises from the 
observation that some proteins (e.g. protein kinases and PH domain family) in time come to 
dominate a particular function despite the initial availability of functionally similar but 
unrelated domains.  The hyperadaptability of these domains likely leads to establishing their 
dominance.  Comparison of CTLDs identified in genome sequences available hitherto 
indicates an independent expansion and diversification of CTLDs [81-83, 254, 326] within 
each bilaterian lineage.  Many of these domains are unlikely to bind carbohydrates since they 
are missing the canonical sugar-binding residues.  The most dramatic example is illustrated by 
the antifreeze proteins from arctic fish, such as the herring and sea raven, where CTLDs no 
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longer bind sugars but rather bind to and disrupt the growth of nascent ice crystals [327].  The 
ability of CTLDs to evolve diverse specificities beyond carbohydrates may have provided the 
advantages to replace functions performed by FBPLs in the mammalian and nematode 
genomes.  Alternate evidence for this non-orthologous gene displacement [328] is present in 
bacteria where eubacterial enzymes have been lost, but whose function has been replaced by 
unrelated archaeal functional analogs.  
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CHAPTER 4. GENETIC ANALYSIS OF FBPL FAMILY 
The previous chapter demonstrated that MsaFBP32 is but a single example of a diverse and 
taxonomically broadly distributed newly-identified lectin family..  This was facilitated by the 
increased interest in sampling active transcriptomes in lieu of sequencing lengthy eukaryotic 
genomes.  However, one disadvantage of focusing on cDNAs is that this approach fails to 
provide important information such as gene organization and context, which remain unknown 
since this information is lost upon transcription.  The earlier failure of confidently 
reconstructing the ancestry of FBPLs suggests that qualitative characters such as shared genetic 
context may be helpful in assigning orthologies within the family.  However, presently no 
studies have described the structure of the gene encoding any of the members of this lectin 
family.  Since none of the sequenced genomes available at the time presented evidence of an 
FBPL gene, no observations could be readily made about them.  This chapter presents the 
completion of the MsaFBP32 gene sequence and discovery of its nearby paralogue.  In 
addition, it describes the diversity of FBPLs present in the finished genome project from 
pufferfish and the ongoing project for the zebrafish.  
Materials and Methods 
Screening of striped bass genomic DNA bacteriophage library 
A striped bass  genomic DNA bacteriophage library, kindly provided by Dr. Yonathan Zohar 
(COMB), in 20 separate pools after a single amplification was screened by conventional DNA 
hybridizations methods.  The vector used for making the library was λFixII (Stratagene, La 
Jolla, CA, USA), and the strain used for initial transfection was XL1-Blue MRA (P2) 
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(Stratagene).  In preparation for plating plaques, the bacterial host, XL1-Blue MRA 
(Stratagene), was grown in Luria-Bertani broth/0.2% (w/v) maltose/10 mM MgSO4 to an 
OD600 of 1 at 37 °C shaking at 300 rpm, to an OD600 of 1.  The cells were pelleted at 1,000 x g 
for 5 min and suspended in sterile 10 mM MgSO4 to an OD600=0.5.  Of this cell suspension, 
600 µl was added to 12 ml polypropylene culture tubes (Fisher Scientific), and approximately 
40,000 PFU were added to each tube and mixed.  The transfection was incubated at 37 °C in a 
water bath for 20 min.  Seven ml of Top agarose (Luria-Bertani broth/0.4% (w/v) agarose) 
equilibrated at 49 °C were added to each tube, and the contents were plated promptly by 
swirling on 150 mm Petri plates containing Luria-Bertani agar equilibrated at 37 °C.  The plates 
were set on the bench for 15 min, and then transferred to a 37 °C incubator for lawn growth.  
After approximately 9 h the plaques had reached a diameter of approximately 1 mm  and the 
plates were removed from the incubator and chilled at 4 °C for 30 min to harden the agarose 
top layer in preparation for plaque lifting.  Positively charged nylon HyBond N+ membrane 
discs (132 mm) (Amersham Biosciences) were placed onto each plate and left for 1 min to 
adsorb the plaque DNA.  An 18-gauge hypodermic needle was used to poke orientation holes 
through each membrane into the agar below for later orientation of the autoradiograph to the 
plates.  The membranes were placed on sheets of Whatman 3MM filter paper (Fisher 
Scientific) wetted with 1.5 M NaCl, 0.5 M NaOH for 30 sec for bacteriophage lysis and 
denaturation of the double strand DNA, and then transferred to filter paper wetted with 0.5 M 
Tris-HCl (pH 7.4), 1.5 M NaCl for neutralization.  Subsequently, the membranes were 
transferred to a tray of 2X SSC (20X SSC: 3M NaCl, 0.3 M sodium citrate) to clear them of 
any debris from the plates.  The plaque lifts were dried and stored at room temperature 
between filter paper until hybridization. 
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Probe hybridization was performed using conventional methods as follows.  The 480 bp probe 
used to screen the library was derived from a cDNA cloned and spanned the second tandem 
domain of MsFBP32.  The probe template was generated by PCR amplification from a striped 
bass cDNA clone (pFBP6) clone with primers FBP469.F (5’-GTT ACG TGA CTG TGC 
TTC TAC CTG G-3’) and FBP949.R (5’-ACA GGG TCA GGT ACT CTT CTC TTC C-3’), 
followed by gel purification of the amplicon with Qiagen’s QIAquick Gel Extraction kit 
(Valencia, CA, USA).  The PCR reaction mix was composed of 1X EnzOne 2000 buffer, 1.5 
mM MgCl2, 0.2 mM dNTP, 0.5 mM of each primer, 10 ng pFBP6, 2.5 U EnzOne 2000 
polymerase (ID Labs), in a 100 µl final reaction volume within 500 µl PCR tube (Marsh).  The 
cycling parameters were: (1) 94 °C , 2 min: (2) 94 °C , 10 sec; (3) 50 °C , 30 sec; (4) 70 °C, 1 
min (repeat step 2 through 4 for 29 cycles); (5) 72 °C for 1 min.  The DNA was radioactively 
labeled by random hexamer primer as described in chapter 2.  The membranes were prepared 
by first wetting in 2X SSC and prehybrized in 80 ml of hybridization solution (hyb solution) in 
a round plastic storage container.  The labeled probe was added to the solution at a 
concentration of 1x106 CPM/ml and hybridization proceeded at 65 °C with rocking overnight 
in a forced air oven.  Probed membranes were washed twice in 200 ml of 2X SSC, 0.1% (w/v) 
SDS for 15 min at room temperature.  For increased stringency, the membranes were washed 
twice in 200 ml of 0.1X SSC, 0.1% (w/v) SDS at 65 °C for 15 minutes.  Washed membranes 
were blotted to remove excess liquid and wrapped in Saran wrap for exposure to XAR10 film 
(Eastman Kodak, Rochester, NY, USA) overnight at -80 °C with an intensifying screen.  The 




Phages that yielded a positive signal by autoradiography during the first screen were rescreened 
twice more by plating well separated plaques (approx. 100) on 100 mm LB Petri plates, and 
lifting to 82 mm Hybond N+ (Amersham Biosciences) membrane discs.  The membranes 
were treated as described above for bacteriophage lysis and hybridized to the same probe.  
Phages that hybridized positively throughout the three purification screens were analyzed by 
restriction enzyme fingerprinting.  Bacteriophage DNA was purified using Qiagen’s Lambda 
Midi Phage Kit, according to the manufacturer’s instructions.  Liquid lysates (50 ml) were 
prepared in NCZYM broth by combining phage and bacteria (1:200), and incubating at 37 °C 
for 8 h.  Approximately 5 µg of purified DNA was digested with 10 U of restriction enzyme at 
37 °C for 1 h.  The digested DNA was resolved on a 1% agarose, 1X TAE gel.  A 
representative bacteriophage was picked for each restriction pattern identified as unique.  Each 
of these clones was sequenced from both ends of the clone using T7 and T3 phage-
polymerase primers to test if they were contiguous. 
Southern blot analysis 
The digested bacteriophage DNA resolved by agarose slab electrophoresis performed above 
was transferred to BioRad ZetaProbe GT membrane. To fragment large DNA bands, the gel 
was soaked in 0.25 M HCl for 10 min.  Upward alkaline transfer using 0.4 M NaOH was 
performed according to the manufacturer’s instructions.  After overnight transfer, the 
membrane was washed in 2X SSC, and air-dried. 
PCR amplification of MsaFBP32 gene from λMs15 
A segment of the λMs15 bacteriophage clone was amplified by long-PCR.  In a final reaction 
volume of 25 µl, using buffer #3 from the Expand Long PCR polymerase mix (Roche 
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Molecular Biochemicals; Indianapolis, IN, USA), the largest amplicon obtained used FBP1.F 
(5’-CTG GAC TCC AGG GAT AAA AGA TCT G-3’) and HiT3 (5’-AAT TAA CCC TCA 
CTA AAG GG-3’) primers by the following cycling parameters: (1) 94 °C , 2 min: (2) 92 °C , 
10 sec; (3) 50 °C , 30 sec; (4) 70 °C, 12 min (repeat step 2 through 4 for 29 cycles); (5) 70 °C 
for 12 min.  The amplicon was subcloned into pCR2.1 vector using the Invitrogen’s TOPO 
TA and transformed into E. coli TOP10F’ host supplied with the kit. 
Deletional directional sequencing  
A CsCl-purified plasmid preparation [158] was used for preparing directional deletion 
constructs.  The procedure made use of the Fermentas ExoIII/S1 Deletion kit (Hanover, MD, 
USA).  Twenty µg of plasmid were digested overnight with 10 U of SacI (New England 
Biolabs) in 50 µl at 37 °C.  To produce a 5’ overhang sensitive to the nuclease cocktail, a 
sequential digest with 20 U SpeI was performed for 2 hrs at 37 °C.  The double-digested 
plasmid was purified by phenol/chloroform extraction and ethanol-precipitated in preparation 
of the nuclease treatment.  Directional deletion by nuclease digestion was done according to 
the kit manufacturer’s instructions. 
Bacteriophage clone shotgun sequencing 
To sequence the bacteriophage clone, the insert was randomly fragmented using partial 
digestion with Sau3AI, and subcloned by blunt end ligation into pBluescriptII plasmid [156].  
Random clones were then picked for sequencing until the complete sequence of the phage 
insert was obtained.  In detail, 10 µg of λMs15 clone DNA were digested with NotI to release 
the bacteriophage vector arms.  The insert DNA was gel purified on 0.7% low-melt 
agarose/1X TAE slab electrophoresed at 3 V/cm.  The insert DNA-containing band was cut 
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into small pieces, weighed and digested with Agarase (New England Biolabs) at 42 °C for 1 
hour.  The released DNA was ethanol-precipitated and suspended in TE (pH 8).  Purified 
DNA (5 µg) was diluted to 100 µl in 1X restriction buffer provided for the enzyme in 
preparation for random fragmentation.  Optimal fragments for cloning into a plasmid vector 
(i.e. 2-9 kb) were obtained by titering the restriction enzyme, Sau3AI (New England Biolabs), 
with equal amounts of insert DNA.  Specifically, 30 µl aliquots of DNA solution were 
dispensed into the first of five 1.5 ml microtubes.  The next three tubes held 20 µl and the fifth 
tube contained 10 µl of insert DNA.  All tubes were chilled on ice prior to adding the 
restriction enzyme.  Four units of restriction enzyme were added to the first tube followed by 
serially transferring 10 µl to the following tube, so that all tubes held 20 µl final volumes.  
Reactions were then incubated at 37 °C for 15 min on a heat block.  The digestions were 
stopped by placing tubes on ice and adding 2 µl of 0.5 M EDTA (pH 8.0), followed by heat-
killing the enzyme at 70 °C for 15 min.  After analysis of 1 µl aliquots from each digest on 
0.7% agarose/1X TAE those that presented the desired size range smear were pooled and 
phenol/chloroform-extracted, followed by ethanol precipitation. 
The ends of the digested bacteriophage insert were repaired using DNA polymerase and 
polynucleotide kinase.  The precipitated digested DNA was resuspended in 22 µl of TE (pH 
8.0).  The following was added in order: 3 µl 50 mM MgCl2, 3 µl 0.5 mM dNTP mixture and 2 
µl bacteriophage T4 DNA polymerase (5 U/µl) (New England Biolabs).  The reaction was 
incubated for 15 min at room temperature.  One µl of Klenow fragment E. coli polymerase I (5 
U/µl) (New England Biolabs) was added followed by 15 min more at room temperature.  The 
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volume was raised to a final 50 µl with water and phenol/chloroform extracted and ethanol 
precipitated.  The repaired fragment ends were phosphorylated in preparation for vector 
ligation by resuspending the DNA in 23 µl of water, and adding in order the following: 3 µl 
10X bacteriophage T4 polynucleotide kinase buffer, 20 mM ATP, and 1 µl bacteriophage T4 
polynucleotide kinase (1 U/µl).  The reaction was incubated at 37 °C for 30 min followed by 
heat-killing of the enzyme at 65 °C for 5 min.  The DNA was cleaned by phenol/chloroform 
extraction and ethanol-precipitated.  The end-repaired/phophorylated DNA was resuspended 
in 25 µl of TE (pH 8.0) in preparation for the insert-vector ligation step. 
In preparation for insert ligation, pBluescriptII SK+ (Stratagene) was digested with a 
restriction enzyme that produces blunt-ends receptive to the blunted DNA fragments.  Ten µg 
of plasmid were digested with 20 U of HincII (New England Biolabs) in a final reaction 
volume of 100 µl at 37 °C for 2 hours.  The fully digested plasmid was dephosphorylated to 
avoid religation by adding 10 µl of water to the digested plasmid (100 µl), 10 µl of 10X CIP 
buffer and 5 U of calf intestinal phosphatase (CIP) (1 U/µl) (New England Biolabs).  The 
reaction was left for 1 hr at 37 °C after which the enzyme was removed by phenol/chloroform 
extraction and ethanol precipitation.  Plasmid DNA was resuspended in TE (pH 8.0) at a final 
concentration of 100 ng/µl. 
For producing the shotgun library, ligation of the digested DNA to the plasmid vector was 
performed as follows.  The reaction consisted of the following reagents: 5 µl of 100 ng/µl 
plasmid, 0.167 pmole repaired DNA (approx. 0.1 pmole/µl), 5X blunt ligation buffer (200 
mM Tris-HCl (pH 7.5), 50 mM MgCl2, 50 mM DTT, 10 mM ATP, and 30% (w/v) PEG8000), 
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0.3 µl bacteriophage T4 DNA ligase (400 U/µl) (New England Biolabs) and water to a final 
volume of 20 µl.  Incubation was overnight at room temperature.  Transformation into 
chemically competent E. coli TOP10F’cells (Invitrogen) used 2 µl of the ligation reaction and 
50 µl cell aliquots.  The steps in transforming the cells after adding 250 µl of SOC broth (2% 
(w/v) tryptone, 0.5% (w/v) yeast extract, 0.05% (w/v) NaCl, 20 mM glucose) were 30 min on 
ice, 30 sec at 42 °C in water bath, 2 min on ice and 1 hr of recovery at 37 °C.  Cells were finally 
β-gal selected by plating on LB agar/100 µg/ml ampicillin/ 0.025 % (w/v) X-gal/ 0.05 % 
(w/v/) IPTG plates.  White colonies were picked and plasmids extracted by Wizard SV 
plasmid mini-preps (Promega) were sequenced using vector-based primer T7 (5-’TAA TAC 
GAC TCA CTA TAG GG-3’) and T3 (20-mer) (5’-AAT TAA CCC TCA CTA AAG GG-3’). 
Cloning of MsaFBPII cDNA from liver 
MsaFBPII was PCR-amplified from M. saxatilis liver cDNA with the following primers: 
BreIIA.F (5’-CGC TAA AGA GAA ACG CCT CT-3’) and BreIIC.R (5’-TCG GTC TGC 
GAC GCT GTT GTT AA-3’).  Transcript-s 3’and 5’ends of MsaFBPII were obtained by 
RACE with the following primers: MsfbpII3UTR.F (5’-CAG ACA ATA CCG CAT ATG 
TGC T-3’), MsfbpIIB.R (5’-TGA GCA CAT ATG CGG TAT TGT CTG-3’), and 
MsfbpIIA.R (5’-CAC ACG TGA TTG TTG CAC CTG AGA C-3’). 
PCR amplification of Mcfbp32 
To amplify the orthologous white bass gene, DNA isolated from red blood cells was used as 
template.  The primers used were FBP1.F forward primer (5’-CTG GAC TCC AGG GAT 
AAA AGA TCT G-3’) and FBP949.R reverse primer (5’-ACA GGG TCA GGT ACT CTT 
CTC TTC C-3’).  The PCR reaction mix consisted of 1X kit buffer 3, 0.2 mM dNTPs, 0.3 µM 
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each primer,  0.5 µg M. chrysops DNA, 0.75 µl Expand Long polymerase mix (Roche Molecular 
Biochemicals) in a 50 µl volume.  Cycling parameters were: (1) 94 °C, 2 min; (2) 94 °C, 10 sec; 
(3) 60 °C, 30 sec; (4)70 °C, 5 min (repeat step 1 through 3 for 29 cycles) (5) 70 °C for 7 min.  
The resulting amplicon was cloned directly from the PCR reaction using TOPO TA kit 
(Invitrogen).  The resulting clone (pMc.3) was sequenced by ExoIII/S1 directional deletion 
generated subclones as described below. 
Isolation of genomic DNA 
Fresh whole blood from white bass was collected using EDTA (pH 8.0) as anticoagulant (final 
concentration 10 mM) from caudal vein puncture of the white bass.  DNA was isolated from 
the nucleated red blood cells employing the GenomicPrep Blood DNA Isolation kit 
(Amersham Biosciences) based on high salt precipitation of protein. 
PCR amplification of FBP32 gene in hybrid bass 
Striped bass, hybrid bass, and white bass genomic DNA was isolated from blood as described 
above.  The striped bass intron-specific upstream primer was fbpI312.F (5’-GCA GTA TTA 
TTC AAC CCC CAG CTT C -3’).  The white bass intron-specific upstream primer was 
fbpII1464.F (5’-GAC AAA CCA TGC AGA AGT TAT TAG CC-3’).  Both primers were 
used in combination with the downstream primer FBP949.R (5’-ACA GGG TCA GGT ACT 
CTT CTC TTC C-3)’, which is not species-specific.  The PCR reaction mixture was 1X 
DyNAzyme EXT Optimized buffer, 0.36 mM dNTPs, 2 mM MgCl2, 1 µM each primer, 2 µg 
of genomic DNA, 1U of Finnzyme DyNAzyme EXT polymerase mix (MJ Research, 
Waltham, MA, USA).  The cycling parameters were: (1) 94 C, 10 sec; (2) 94 °C, 10 sec; (3) 60 
°C, 30 sec; (4)70 °C, 10 min (repeat step 1 through 3 for 29 cycles) (5) 70 °C for 7 min. 
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Screening of zebrafish genomic DNA bacteriophage library 
A λFIX II bacteriophage genomic library from the zebrafish, D. rerio, was purchased from 
Stratagene.  The probe used for screening the library was produced by PCR amplification from 
the pBre3’ RACE clone with the primers, Bre2.F (5’-CAT CAC TAA CAG ACT GGA CTG 
CTG C-3’) and MCSRACE.  The cycling parameters were: (1) 94 °C, 2 min; (2) 94 °C, 15 sec; 
(3) 60 °C, 15 sec; (4)72 °C, 1 min (repeat step 1 through 3 for 29 cycles) (5) 72 °C for 5 min.  
The PCR reaction mix was composed of 1X EnzOne 2000 buffer, 1.5 mM MgCl2, 0.2 mM 
dNTP, 0.5 mM of each primer, 10 ng pFBP6, 2.5 U EnzOne 2000 polymerase (ID Labs) in 
100 µl.  The library was screened following the procedures described for the screening of the 
striped bass genomic library.  After Southern analysis of the positive clones using the same 
probe used in screening the library, labeled bands were identified for subcloning.  For 
purification of bands for subcloning, the clone insert (10 µg) was released with 20 U of XhoI 
or XbaI (New England Biolabs) at 37 °C for 2 h in a 200 µl reaction volume.  The digested 
DNA was purified by phenol/chloroform extraction and ethanol precipitated.  To purify the 
desired bands, the digested DNA was separated on a 1% (w/v) agarose, 1X TAE slab gel and 
resolved bands were purified with Qiagen’s QIAquick gel extraction kit.  Each DNA 
restriction fragment (10 µl or 1/3 of volume eluted from column) was ligated to 100 ng of 
pBluescriptII SK+ that had previously been digested with XbaI or XhoI.  Ligation was 
mediated by T4 DNA ligase (Promega) at 16 °C overnight.  The ligated plasmids (1/2 of 
ligation reaction) were transformed into chemically competent E. coli DH5α.  Positive CFUs 
where identified by α-complementation and grown for miniprep plasmid isolation.  To 
confirm the ligation of the correct restriction fragment, the plasmids were digested with XbaI 
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or XhoI to release their insert.  Separation of the digested plasmid DNA by agarose slab 
electrophoresis allowed sizing the insert fragment with calibrated DNA markers.  Each 
plasmid was sequenced with the transposon-mediated Template Generation System (MJ 
Research).  
PCR amplification of cDNA encoded by λZf13 
Total RNA isolated from zebrafish whole bodies was used for cDNA synthesis as described in 
Chapter 2 for liver RNA isolation of liver RNA.  The nested upstream primer set used for 
amplification were BreIIA.F (5’-CGC TAA AGA GAA ACG CCT CT-3’) and BreIIB.F (5’-
AAA GAG CCG TCG ATG GTT C-3’).  These were used in combination with the 
downstream primer MCSRACE as described for 3’ RACE.  The PCR reaction mix was: 10X 
EnzOne 2000 buffer, 1.5 mM MgCl2, 0.4 mM each primer, 1 U of EnzOne 2000 polymerase 
(ID Labs; London, Ontario, Canada) and 1 µl of cDNA in a 50 µl final reaction volume.  The 
cycling parameters were: (1) 94 °C, 3 min; (2) 94 °C, 15 sec; (3) 65 °C, 15 sec minus 0.5 °C per 
cycle  (4) 72 °C, 3 min (repeat steps 2 through 4 for 19 cycles); (5) 94 °C, 15 sec; (6) 55 °C, 15 
sec; (7) 72 °C, 3 min (repeat steps 5 through 7 for 19 cycles); (8) fill-in at 72 °C for 5 min.  The 
first reaction used the primer combination BreIIA.F/MCSRACE, and the second nested 
reaction used BreIIB.F/MCSRACE with 1 µl of the first reaction as template. 
Genome sequence database searches 
Scaffolds resulting from whole genome shotgun assemblies were retrieved from Zv2 
(www.ensembl.org) for D. rerio, JGI v3.0 (genome.jgi-psf.org/fugu6/fugu6.home.html) for 
Fugu rubripes, and Genoscope assembly v6 (www.genoscope.cns.fr) for Tetraodon nigroviridis.  
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Global alignments and comparative search for regulatory regions 
Global DNA alignments and the search for conserved transcription factor binding motifs were 
performed using rVISTA [329]. 
Results and Discussion 
A domain divided 
In contrast to other fish genomes, the relatively small genome size of striped bass (825 Mb) 
[330] allows the use of conventional small insert bacteriophage libraries to screen for genes.  
Following high stringency washes and three rounds of screening, 16 positive plaques were 
isolated and analyzed by restriction digest.  Small-scale preparations of bacteriophage DNA 
were digested with two enzymes, EcoRI and SacI, both with unique cut sites present in the 
polylinker regions of the bacteriophage vector.  From the digest analysis, seven unique 
restriction patterns were identified that did not share bands, and possibly represented unique 
genes (fig. 59).  A representative of each banding pattern was chosen for further analysis 
(λMs2, 3, 4, 7, 8, 10 and 15).  The ends of the clone inserts were also sequenced to confirm 
their unique ends.  
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Subsequent attention was focused on one clone, λMs15, due to the stronger autoradiography 
signal it generated during Southern analysis of the restriction digest (fig. 60).  Initially, 
subcloning was perfomed by PCR using λMs15 as DNA template and a gene specific primer 
and λ arm primer.  The position of the putative MsaFBP32 gene was mapped with respect to 
the bacteriophage vector arms by PCR using exon specific primers and phage arm primers 
(bacteriophage RNA polymerase promoters T7 and T3).  After several trials with the primers 
initially used for amplifying the MsaFBP32 cDNA, the largest amplicon of approximately 4.5 
kb was obtained using the 5’UTR consensus primer, FBP1.F and the vector arm primer, HiT3.  
The amplicon was subcloned by TA cloning (pMs15s.1), and the insert was sequenced by 
ExoIII/S1 nuclease directional deletion sequencing (fig. 61).  
 
Figure 59. Restriction enzyme mapping of striped bass’ genomic DNA clones. 
Bands corresponding to λFIXII bacteriophage vector arms are labeled left (20.2 kb) and right (9.14 




The result was a sequencing contig path of 4.5 kb, which contains the full gene sequence of 
MsaFBP32 in addition to 847 bp downstream of the mRNA polyadenylation signal.  A 
comparison of the cDNA sequence with the genomic clone sequence revealed the exon 
organization.  The compact MsaFBP32s gene (3.5 kb) consists of six exons of which the last 
five encode the ORF.  In detail, the first exon delimits the 5’UTR and the second exon 
delimits the signal sequence plus the first three amino acids of the mature protein sequence.  In 
 
Figure 60. Autoradiogram of restriction analysis of λMs bacteriophage clones. 
Restriction enzymes: Sc, SacI and Sl, SalI. 
 
Figure 61. Sequencing contig path of directionally deleted subclones of pMs15s.1 
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contrast to the partitions evident in these exons, the 3’UTR is continuous with the last coding 
exon.  Interestingly, the tandem motifs are each encoded by two exons (N-FBPL: exon 3-4 
and C-FBPL: exon 5-6) with intron splice sites in identical positions within each motif.  The 
coding exon phases are exon 2 (2-1), exon 3 (1-2), exon 4 (2-1), exon 5 (1-2), exon 6 (2-
poly(A)+ signal).  A sequence similarity search with the full gene revealed the presence of a 
Tc1/mariner-like element (TLE) pseudogene in intron II.  It lays contiguous to exon 3 but its 
transcriptional direction is oriented opposite to that of the lectin.  Similar placement of such 
element within an intron has been described [331], although in this case the TLE is apparently 
non-functional.  The ORF is truncated and the inverted target repeats characteristic of the cut-
out, paste-in insertion mechanism of this transposon family (fig. 63) [332], are absent, which 
indicates this is a pseudogene from this transposon family. 
To enable comparison of gene structures between species, the white bass FBP32 gene was also 
amplified from genomic DNA using upstream and downstream the primers that anneal to the 
first exon and last exon, respectively.  After sequencing (fig. 64) it became apparent that intron 
II was substantially longer (2,037 bp) in this species.  In contrast to the striped bass gene (3 kb) 
(fig. 62, Panel A), MchFBP32 is larger (~5 kb) (fig. 62, Panel B).  The resulting amplicon was 
processed for sequencing identically as pMs15s.1 and the resulting clone named pMc.3.  As for 
the rest of the gene, the exon structure was identical, and all other introns presented similar 
sizes to the MsaFBP32 gene.  Fish intron size is much reduced in comparison to mammalian 
genes [333]; the compactness of the FBP32 gene follows this same trend.  Interestingly, the 
Tc1/mariner-like sequence is also present in the same orientation and position as in the striped 
bass gene, which suggests that it was present prior to divergence of the two species.  
Qualitative comparison of rare genetic events, like transposon insertions, are increasingly 
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useful in resolving patterns of divergence where quantitative comparison of genes has failed 
[311, 334, 335].  It is possible that tracing the presence of the TLE in binary FBPLs in other 
teleosts will help in identifying other genes orthologous to those in moronids.  The NH2-
terminal sequence of a fucolectin isolated from the serum of the European sea bass [336] is 
virtually identical to that of MsaFBP32 suggesting they are orthologous.  Detection of the TLE 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































To test if both parental genes are present in the hybrid produced from crossing striped bass 
and white bass, PCR amplification was performed with upstream species-specific primers.  
Both genes were amplified from hybrid DNA while the parental species only produced 
amplicons with their respective primers (fig. 65).  The outcomes for heterospecific 
hybridizations in fish are varied [337] sometimes excluding the male genetic contribution, but 
these results confirm that at least for this individual a hybrid genome was produced.  Due to 
the high identity between the two species’ gene products, it is difficult to determine by PCR if 
both genes are active in the hybrid, so the consequences that hybridization may have on 
expression of the parental lectins are presently unknown. 
 
Figure 64. Contig path of directionally-deleted pMc3. 
 
Figure 65. Detection in palmetto hybrid of both FBP32 genes from parental species. 
 Mch, M. chrysops; Msa, M. saxatilis; SSP, species-specific primers. 
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The initial use of PCR for the purpose of gene walking yielded 380 bp upstream from the 
putative transcription start site.  This region did not contain the prototypical TATA box or 
CAAT box common to many other genes [338].  The start site did show consensus though 
with the initiator (Inr) control motif (PyPyANT/A PyPy) that is present in some non-TATA 
containing promoter regions [338].  In order to investigate the presence of other possible 
regulatory motifs further upstream, additional sequence was sought.  The λMs15 clone was 
known to contain in its ~15 kb insert a substantial length sequence upstream to MsaFBP32 
gene (~11 kb).  The full bacteriophage insert sequence was obtained from randomly selected 
subclones of the Sau3AI partially digested insert DNA.  A combination of insert end 
sequences (i.e. shotgun sequencing) and transposon-mediated full subclone sequencing was 
used in building the sequence contig (fig. 66).  
1 15,0691,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000 11,000 12,000 13,000 14,000  
Figure 66. Sequencing contig of full λMs15 insert.  The lowest arrow is that of pMs15s.1 
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Surprisingly, upon analysis of the completed sequence it was apparent that a duplicate 
MsaFBP32 gene was present upstream from the original (fig. 67).  The putative product, 
hereon referred to as MsaFBPII, also contains a duplicate FBPLs and a similar gene structure.  
The 3’UTR appears to be longer, as predicted from the most proximal polyadenylation signal.  
To confirm that, like MsaFBP32, the MsaFBPII gene was expressed in liver, 3’ RACE was 
performed with an exon-specific primer.  A positive amplicon from liver RNA demonstrates 
that both genes are coexpressed but their relative abundance is presently unknown.  The full 
cDNA sequence was completed by 5’ RACE, allowing full annotation of the non-coding 
regions (fig. 68, Panel A).  Comparison of the deduced polypeptide sequence indicates that 
they share 40% identity (70% similarity) indicative of a marked divergence (fig. 68, Panel B).  
The greatest differences not surprisingly lay in the UTRs, which commonly evolve more 
rapidly than the coding sequence. 
 
The detection of a paralogous FBP sequence raised the possibility of family expansion within 
the bass genome.  Although other genomic clones have not been sequenced, the fact that they 
hybridized with the FBP cDNA probe suggests that they contain an FBP-like sequence.  One 
of these clones, λMs4, maps as contiguous to λMs15 (fig. 69), further supporting the 
 
Figure 67. Map of λMs15 indicating the position of FBP genes and the transposon-like elements within. 
RT, inactive retrotransposon-like sequence; TLE, inactive Tc1/mariner-like element 
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hypothesis that multiple tandem duplications have occurred for the FBP gene.  The presence 
of repeats resulting from transposition events as annotated, could be conducive to the unequal 






Figure 68. Comparison of MsaFBP cDNAs. 
A. Schematic of exon positions and domains.  Both drawings are at same scale.  SS, signal sequence; CRD, 
FBPL carbohydrate recognition domain.  B. Pairwise alignment of deduced polypeptide sequence.  
Identical residues are indicated with dots. 
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As previously discussed, the ability for multiple FBP motifs to concatenate and to shuffle 
suggests they represent a structural domain unit.  By resolving the gene structure, this issue can 
be better addressed.  The presence of phase 1 introns delimiting each FBP motif supports this 
hypothesis, based on the trend observed for other domains commonly found as concatenated 
or mosaic proteins many of which are blood proteins [339].  Rarely are these shuffled domains 
flanked by introns of other phases.  Conversely, the interruption of the FBP domain by a 
phase 2 intron may protect its integrity since splicing would require uncommon domains of 
that phase.  Although the presented data illustrates gene organization in only a single fish 
genus, it may reflect the prototypical form for this lectin family.  Further sequencing of FBP-
like genes will help establish if the features observed for MsaFBP32 and MsaFBPII are the 
norm, or if substantial differences remain to be described.  
With the increased sequence information available from sequencing the full genomic clone a 
search was performed for transcription factor-binding site motifs (TFBS) [340].  The close 
position of the two FBP genes helped to focus the search to the intergenic region.  The 
extensive matches to putative TFBSs were examined for other common core promoter sites 
(i.e. BRE, TATA Box, and DPE) but none was present.  Core promoter structure can be 
varied, and in the absence of experimental promoter mapping studies, it is presently impossible 
to confidently annotate the regions regulating FBP expression.  Eventually, with the 
 
Figure 69. Overlap of λMs bacteriophage clones. 
Exons of both MsaFBPII and MsaFBP32 genes along with the retroposon pseudogene are indicated 
above the full sequence of λMs15.  The overlapping end of λMs4 is shown by an arrow below λMs15. 
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development of recombinant promoter/reporter constructs, the putative sites identified may 
be confirmed as relevant. 
The completion of the fruit fly genome sequence [82] provided an opportunity to describe the 
gene structure for the sole FBP-containing receptors.  Surprisingly, the second exon of the 
FBPL of CG9095 was fused with the exon encoding the CTL along with the second CCP 
domain (exon 4) (fig. 70).  This is likely a derived state resulting from intron loss, since both 
CTLs [341] and CCPs [243] are typically flanked by phase 1 introns.  This evidence, along with 
the fact that only two FBP-like domains are present in the fruit fly, suggests that this domain is 
no longer available for protein innovation.  This likely occurred prior to the divergence of the 
fly from the mosquito, since both CG9095 and furrowed orthologues share this feature. 
Genomics of FBP in the zebrafish model 
As discussed in chapter 2, amplification of zebrafish DNA with FBP-targeted degenerate 
primers resulted in the cloning of a cDNA that exhibited tandem domains and an extension at 
the COOH-terminus.  Since this feature is unique to this protein, the gene structures 
determined for MsaFBP are of limited use.  Therefore, a λ genomic library from zebrafish was 
screened with a partial DreI-FBPL cDNA probe available at that stage of the studies.  Two 
promising clones were further characterized by the same procedure used for the striped bass, 
 
 
Figure 70. Scheme of the fruit fly CG9095 cDNA. 
The CDS is indicated by the filled rectangle.  Intron splice sites and exon number are marked above.  
Protein domains are labeled below: complement control protein (CCP), FBP-type lectin-like (FTL), C-
type lectin-like (CTL), transmembrane domain (TM). 
 
 162 
but were only partially sequenced.  One clone, λZf10, encoded from the C-FBPL downstream 
providing the exon structure of the COOH-terminal extension of interest (fig. 71).  Since 
introns are typically short in fish genes, the intron lengths leading to the extension exons were 
substantially longer than expected.  
A second clone, λZf13, also encoded a single FBPL but despite substantial upstream sequence 
obtained (8 kb); no additional FBP domain was detected (fig. 72, Panel A).  To help annotate 
the genomic sequence, RACE was performed with whole body cDNA in order to determine 
the complete transcript sequence.  A successful 3’ RACE indicated that following the FBPL 
there is a similar but unique extension, as observed in DreI-FBPL.  Unfortunately, the 5’ 
RACE did not succeed, and it remains to be determined whether this represents a single 
domain FBPL, as present in the Japanese eel.  The rapid progress of assembling the whole 
genome shotgun sequence of zebrafish allowed searching for matches to these incomplete 
genes.  No match is presently found for λZf10, but an extensive scaffold is available for λZf13 
(fig. 72, Panel B).  After comparing the protein sequence of the second homologue, DreII-
FBPL, to the translation of this scaffold it is evident that at least two other FBPLs are 
confidently identifiable (fig. 72, Panel C).  Closer upstream to the DreII-FBPL,  the second 
exon encoding an FBPL appears to be present, which suggests that it may not be a single 
FBPL except for the absence of the first exon of this putative FBPL.  Until a full transcript is 
 Figure 71. Cloning of DreI-FBPL gene. 
Contig illustrates partial sequencing of λZf10 genomic clone insert.  Boxes indicate exons confirmed by 
alignment to cDNA.  The third and fourth exons encode for the C-terminal extension while the last exon 
encodes the 3’UTR.  Leftmost arrow represents sequence obtained from the T7 end of cloning site. 
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obtained, the exact sequence of this protein will remain unclear.  It is evident from this 










Score =  105 bits (262), Expect = 4e-21Identities = 50/93 (53%), Positives = 65/93 (69%) Frame = +2 
 
     DreII: 1      NLALKRNASQSSSFGFWSAERAVDGSRTGPKLWSVCSSTANQSNPWWRVDLGDVYRVSRV 60 
                   NLA  +N  QSS++  W  E+A+D +         CSST  Q++PWWR+DLG +Y+VS V 
Ctg30073.1: 128039 NLATGKNVMQSSTYSSWIPEQAIDFNPGLSDPSIGCSSTNGQTDPWWRLDLGHIYQVSTV 128218 
 
     DreII: 61     IITNINNSVADRINGAQIHIGNSLENNGTNNPM 93 
                   ++TN  N   +RINGA+IHIGNSLENNG NNPM 
Ctg30073.1: 128219 VVTNRLNCCPERINGAEIHIGNSLENNGNNNPM 128317 
 
Score = 95.5 bits (236), Expect = 4e-18Identities = 48/86 (55%), Positives = 63/86 (72%) Frame = +1 
 
     DreII: 8     ASQSSSFGFWSAERAVDGSRTGPKLWSVCSSTANQSNPWWRVDLGDVYRVSRVIITNINN 67 
                  A+QSS+   WSA+RA+DG R   ++   CSST N+++PW RVDL   Y V+RV+ITN N  
Ctg30073.1: 45568 ATQSSTSKDWSADRAIDGDRGLQQINKGCSSTLNETSPWLRVDLLYFYAVNRVVITNRNV 45747 
 
     DreII: 68    SVADRINGAQIHIGNSLENNGTNNPM 93 
                  S A ++ G +IHIG+SLENNG NNPM 
 
Ctg30073.1: 45748 SNAIQMTGLEIHIGSSLENNGNNNPM 45825 
 
Score = 48.9 bits (115), Expect = 4e-04Identities = 24/48 (50%), Positives = 33/48 (68%) Frame = +3 
 
     DreII: 94     CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEGP 141 
                   CAV+S+IPAG + ++ C  M+GRYV + I   S +LTLC V V+V  P 
Ctg30073.1: 126207 CAVVSTIPAGQTFSYSCNGMQGRYVFVDINAPSSILTLCAVGVFVVFP 126350 
 
Score = 43.5 bits (101), Expect = 0.019Identities = 32/92 (34%), Positives = 44/92 (47%) Frame = +3 
 
     DreII: 1     NLALKRNASQSSSFGFWSAERAVDGSRTGPKLWSVCSSTANQSNPWWRVDLGDVYRVSRV 60 
                  N AL R A  +S  G   A  A+DG      L   C+ T  Q +PW R++L + YR++ V 
Ctg30073.1: 43455 NAALWRTAVLASQTGSSYARNALDG------LPQTCAQTTFQPDPWIRLNLLNEYRINVV 43616 
 
     DreII: 61    IITNINNSVADRINGAQIHIGNSLENNGTNNP 92 
                   + N  N     +NG    IGN   +   NNP 
Ctg30073.1: 43617 TMINSLNLGYVPLNGTTTRIGND-PSYAYNNP 43709 
 
Score = 42.4 bits (98), Expect = 0.042Identities = 27/81 (33%), Positives = 43/81 (52%), Gaps = 8/81 (9%) Frame = -1 
 
     DreII: 18    SAERAVDGSRTGPK--------LWSVCSSTANQSNPWWRVDLGDVYRVSRVIITNINNSV 69 
                  SA+  + GSRT P         L + C++T  ++ PW +VDL  VY+VS   +T   +   
Ctg30073.1: 62127 SAQSVLCGSRTTPMDGGKNFSTLSTTCAATTWENFPWLKVDLQAVYQVSTATVTYREDRF 61948 
 
     DreII: 70    ADRINGAQIHIGNSLENNGTN 90 
                   D+     ++ G+SLE +G N 
Ctg30073.1: 61947 PDKT--VTVNFGSSLEFDGYN 61891 
 
Score = 40.8 bits (94), Expect = 0.12Identities = 19/44 (43%), Positives = 25/44 (56%) Frame = +2 
 
     DreII: 94    CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVY 137 
                  C  I +     S  F C  M GRYV + +PG   +LTLCE+E+Y 
Ctg30073.1: 45059 CTKIPNASPVTSTNFSCGGMVGRYVFVHVPGYMAILTLCELEIY 45190 
 
Score = 36.6 bits (83), Expect = 2.3Identities = 18/42 (42%), Positives = 28/42 (65%) Frame = -1 
 
     DreII: 158   LSEVQFLTQLESALARRGLSDVTLHWTQLPKQMPEQVAPAQR 199 
                  ++E   L QL SAL  RG+S++TL WT+ P++  EQ A  ++ 
Ctg30073.1: 53613 MNEYLILFQLTSALTERGISNMTLSWTKTPEE-EEQTAEEEK 53491 
 
Score =  194 bits (492), Expect = 9e-48Identities = 93/93 (100%), Positives = 93/93 (100%) Frame = +3 
 
     DreII: 1     NLALKRNASQSSSFGFWSAERAVDGSRTGPKLWSVCSSTANQSNPWWRVDLGDVYRVSRV 60 
                  NLALKRNASQSSSFGFWSAERAVDGSRTGPKLWSVCSSTANQSNPWWRVDLGDVYRVSRV 
Ctg30073.2: 98070 NLALKRNASQSSSFGFWSAERAVDGSRTGPKLWSVCSSTANQSNPWWRVDLGDVYRVSRV 98249 
 
DreII: 61         IITNINNSVADRINGAQIHIGNSLENNGTNNPM 93 
                  IITNINNSVADRINGAQIHIGNSLENNGTNNPM 
Ctg30073.2: 98250 IITNINNSVADRINGAQIHIGNSLENNGTNNPM 98348 
 
Score = 99.4 bits (246), Expect = 3e-19Identities = 47/47 (100%), Positives = 47/47 (100%) Frame = +2 
 
     DreII: 94    CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEG 140 
                  CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEG 
Ctg30073.2: 99371 CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEG 99511 
 
Score = 99.4 bits (246), Expect = 3e-19Identities = 47/47 (100%), Positives = 47/47 (100%) Frame = +1 
 
     DreII: 94    CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEG 140 
                  CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEG 
Ctg30073.2: 85228 CAVISSIPAGVSATFLCCFMEGRYVSLFIPGDSKMLTLCEVEVYVEG 85368 
Figure 72. Cloning of DreII-FBPL gene, a second homologue from zebrafish. 
A. Subcloning of λZf13 genomic clone.  B. Schematic of alignment of λZf13 partial sequence (shorter 
arrow at top) to zebrafish whole-genome shotgun contig ctg30073.2 (second assembly release Zv2) and 
upstream scaffold partner, ctg30073.1.  Black boxes indicate segments encoding putative FBP-like exons.  
Numbering refers to nucleotide position.  C. TblastN search of ctg30073 scaffold illustrating FBP-like 
matches distributed upstream of the DreII-FBPL locus.  Note that the nucleotide numbering is 




A view of the whole fish 
Among vertebrates, the second full genome to be sequenced after that of humans is the 
Japanese or tiger pufferfish (F. rubripes) [237], a member of Tetraododontids which is the most 
derived group of teleosts.  Justification for sequencing this specie’s genome emphasized its 
small genome size (400 Mb), and its potential contribution as a “genomic model” in the 
annotation of human genes [342-344] by facilitating identification of exon boundaries and gene 
regulatory regions [345].  Genome compactness is attributed to the reduction in intergenic 
DNA and intron size evidenced when comparing homologous chromosomal segments 
between the pufferfish and human [310, 346-350].  It is not clear why pufferfish have shed so 
much of their intergenic regions but one explanation initially offered was that it may correlate 
with the derived simplification of their body plan [330], although recent studies disagree [239].  
A second genome-sequencing project for the freshwater spotted green pufferfish (T. 
nigroviridis), a smaller, more manageable species, was undertaken concurrently with the Japanese 
pufferfish [351-353].  It is estimated that both pufferfish species shared a common ancestor 
some 30 mya, as estimated from comparison of mitochondrial cytochrome b DNA sequences 
[351].  Although the genome has not been published, an initial sequence assembly is publicly 
available through the worldwide web. 
With access to the first two full genome assemblies from teleosts, a unique opportunity arose 
for exhaustively searching for the full set of FBPL homologues in these species.  After 
searching by TBLASTN the F. rubripes assembly (v2) stored at the U.S. Department of 
Energy’s Joint Genome Institute, two scaffolds numbered 1786 (52.6 kb) and 5138 (15.7 kb) 
(fig. 74, Panel A) were identified as containing FBPL-like domains.  A similar search was 
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performed for the T. nigroviridis genome (v6) which identified two more scaffolds, 794_4b (10.3 
kb) and 461_3b (43.7 kb).  All four scaffolds seemingly encode binary FBPLs similar to those 
of the striped bass and zebrafish.  All other arrangements including single, higher order or 
chimeric were not found in either pufferfish genome.  Neither genome had been annotated at 
that time.  Presently, only the F. rubripes genome has been processed through an automated 
annotation pipeline.  Therefore, each FBP gene was examined and gene structure was assigned 
manually following the features of MsaFBP structure.  It must be stated since it is not 
illustrated that many gaps of unknown length are present in each scaffold as they represent the 
early stages of assembly.  The identification of the coding exons was straightforward, since 
they exhibited two exons per FBPL, as previously described.  Annotating the 5’ UTR and the 
signal peptide of the gene was more difficult, since they apparently are always encoded by 
individual exons.  This hinders the identification of the transcriptions start site (TSS) 
notoriously difficult to predict automatically.  Fortunately, upon searching the dbEST with the 
deduced F. rubripes transcript from scaffold_1786, a matching 5’ EST was identified (GenBank 
Accession AL842404.1) (fig. 73, Panel A).  Interestingly, the provenance stated for this clone 
was from a heart cDNA library, a tissue previously unknown to express an FBP.  Alignment of 
the EST to the scaffold (fig. 73, Panel B) allowed demarcating with certainty the 5’UTR exon, 
the signal peptide exon and first exon of the mature protein (Table 6).  Unfortunately, the 3’ 
EST of this clone is unavailable for annotating the 3’ UTR, but the presence of a stop on the 
last coding exon prior to a splice donor consensus suggests that the CDS is complete.  One 
caveat about this 5’EST sequence is that it appears chimeric as judged by the 5’ end not being 
present in the extensive upstream sequence available in the scaffold; it does though match a 
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different scaffold.  No EST was detected for the FBP present on scaffold_5138, so its 5’UTR 
remains unidentified and only a tentative signal peptide exon was demarcated (Table 6). 
 
A 
AL842404.1 EST Fugu heart
Scaffold1786 @5/…
FS_CONTIG_794_4b
1 52,6578,000 16,000 24,000 32,000 40,000 48,00028,32018,800  
Scaffold5138 @5/27/02,5:47 PM
FS_CONTIG_461_3b
1 43,7057,000 14,000 21,000 28,000 35,00031,310  
B 
>AL842404    >#1>                                     GTTTGTATGC AATAGCTCAT AATAATTTCA 
>Fr_1786     #18781  tcacccacag tgttgaggaa ataacaatga ttgtgtaaca ccgaagatgg aactttgctc 
>Tn_794_4b   #663    aggaaataac aatgaccaaa ggtgattgtg taataatata gtgtaatcgc tgctctgatt 
                     ******** * ** *****   ********** *** ****** ********** ***** **** 
 
>AL842404    #31     AGGTGCATAG CAACATTTTT AAGCCTCTCA GCGTGTTCTT GCAGCAGGTG CCTCTTTTCT 
>Fr_1786     #18841  tctgattggc tcaatggtgg aagagggaga aatcatataa agagctcaat gttgtgctct 
>Tn_794_4b   #723    ggctcaactg tggaagaggg agaaaacatt agcccgacgc tgagaaggtg gatgtgtatt 
                     ********** **********  ********* ********** **  ****** ** * ****  
                            → 
>AL842404    #91     TTTTCTTTCT TCACTCATCA GATGTAAGCA GAGAATCAGG TTGGTGAGTT CAG------- 
>Fr_1786     #18901  tctcaggTCT TCACTCATCA GATGTAAGCA GAGAATCAGG TTGGTGAGTT CAGgtgaaga 
>Tn_794_4b   #783    tctcaggTCC ACCCTCATTA GATGCAAGTA GAGAATCAGG TTGGTGAGTT CAGgtgaaac 
                      * ****  * * *     *      *   *                                ** 
Figure 73. Identification of two pairs of orthologous FBP genes in pufferfish. 
A. Schematic alignment of orthologous scaffolds.  Small arrow represents F. rubripes heart 5’ EST.  Boxes 
indicate FBP exons.  See text for description scaffold provenance. Note the difference in lengths 
between the two species.  B. Mapping of the TSS by alignment of F. rubripes heart 5’ EST (AL842404) to 
the othologous pufferfish scaffolds, Fr_1786 and Tn_794_4b.  The first exon is indicated in uppercase 
nucleotides.  The predicted splice donor site (gt) is indicated in bold.  Dashes (-) represent gaps and 
asterisks (*) indicate dissimilarities.  Note. The 5’ half of the EST sequence (underlined) does not match  



























































































































































































































































































































































































































































































































































































































































































































Contrary to the case of the striped bass and zebrafish, the pufferfish possess only two copies 
of FBP genes, which tentatively appear not to be syntenic and distant from each other.  
Phylogenetic analysis using their peptide alignment, as shown in chapter 3, suggests that the 
genes in F. rubripes 1786 and T. nigroviridis 794_4b scaffolds are an orthologous pair, as are F. 
rubripes 5138 to T. nigroviridis 461_3b. 
Searching for the ON switch 
Annotation of regions regulating gene expression [354] still remains a difficult endeavor due to 
the complexity of assembling transcriptional machinery [355], the degeneracy of transcription 
factor-binding sites [356] and their sometimes distant placement [357].  One approach that has 
shown promise is comparison of homologous genes, which share similar expression patterns.  
The selective pressure on the non-coding DNA relevant to transcription is expected to be 
preserved despite divergence.  As discussed above, of the various core promoter motifs 
searched for around the TSS of the striped bass FBPs, only an Inr motif centered on the +1 
position of MsaFBP32 was detected.  Since both transcripts are coexpressed in liver, it is likely 
that their transcriptional control shares common features.  Alignment of upstream regions 
including the 5’UTR (2 kb) was performed to search for consensus segments still conserved 
after gene duplication, but did not present substantial consensus between these genes (fig. 74).  
It therefore appears that control elements either are outside this region or are highly 
degenerate and not detectable by means of consensus.  The paralogous relationship between 
these genes would suggest their regulatory regions might likely have diverged beyond 
recognition.   
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With greater number of genomes being completed, the study of genome evolution [328] seems 
more tractable, and has led to the development of publicly accessible tools for full genome 
comparisons [358].  Large-scale global alignments of widely diverging species have already 
produced promising results in finding potential gene regulatory regions [311].  In particular, 
teleosts which long ago diverged from tetrapods (450 mya) can be potentially useful for this 
approach [357, 359, 360].  Difficult phylogenies can also benefit from these alignments by 
identifying orthologues more confidently which share syntenic genes [361].  With the release of 
the F. rubripes assembly v.3, better quality scaffolds became available to implement this genome 
comparison approach.  Previous scaffolds were elongated substantially relative to v.2: 
scaffold_1786 and scaffold_5138 were replaced by scaffold_599 (126.5 kb) and scaffold_237 
(242 kb), respectively.  Changes in accuracy are reflected in the reduction in the size of one 
unexpectedly long intron likely misassembled from the fragmentary sequence produced by the 
shotgun approach. 
Using the rVISTA web site, the revised F. rubripes scaffolds were aligned to the unrevised 
Tetraodon scaffolds.  In addition, putative transcription binding sites shared between species 
 
Figure 74. Alignment (rVISTA) of first exon and region upstream for MsaFBPII and MsaFBP32. 
Histogram of percent identity (50-75%) vs. a 100 bp window moving along the alignment. 
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were screened.  The extensive consensus along the alignment of F. rubripes scaffold_237 and T. 
nigroviridis scaffold_461_3b strongly supports their orthology (fig. 75).  The localization of the 
FBP gene well within the extensive length of each scaffold was favorable for searching for 
regulatory regions.  Unfortunately, identification of the TSS for establishing where the genes 
begin has not been determined for these orthologues as mentioned above.  Therefore, the 
search for core promoter regions could not be done with confidence.  Still the alignment does 
illustrate consensus areas within both introns and flanking regions upstream and downstream 
that potentially regulate expression.  Curiously, the intron dividing the FBPLs shows low 
consensus between the species due to a gap present in the T. nigroviridis scaffold.  Since no 
further assembly releases have been made, it is presently unclear if it reflects a mutational event 
or is just a similar missassembly to that discussed for F. rubripes. 
Since the TSS of F. rubripes scaffold_599 was annotated with the help of an EST, it seemed a 
more promising source for describing the promoter regions.  Comparison of F. rubripes 
scaffold_599 and T. nigroviridis scaffold 794_4b also presented a high percentage of consensi 
along the alignment proving their orthology (fig. 76, Panel A).  Nevertheless, this alignment 
also failed to provide useful promoter sites due to the position of the FBP gene at the end of 
the short T. nigroviridis scaffold 794_4b.  The quality of the sequence at the end of scaffold 
 
Figure 75. Global alignment of F. rubripes scaffold_237 to T. nigroviridis scaffold 461_3b. 
Histogram of percent identity vs. a 100 bp window moving along the alignment.  Numbering refers to the 
longest scaffold (i.e. F. rubripes  scaffold_237).  Shading indicates ≥75% identity within the window.  Above 
the histogram, arrows indicate genes and boxes illustrate FBPLs. 
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794_4b is uncertain, although it is noteworthy that a rapid decline in sequence consensus 




         53210     53220     53230     53240     53250     53260 
seq1     aactgctgccatgaagctgcaggatgagatgctgttaacattttcttcttaatccgatga 
                                                                      
seq2     ------------------------------------------------------------ 
 
 
         53270     53280     53290     53300     53310 
seq1     tttgtgaaactaggttgtgtcacccacagtgttgaggaaataacaatgat---------- 
                                     |||||||||||||||||||||            
seq2     ----------------------------gtgttgaggaaataacaatgaccaaaggtgat 
                                      660       670       680 
 
         53320     53330     53340             53350     53360 
seq1     tgtgtaacaccgaagatggaactttgct--------ctctgatgggctcaatggtggaag 
         ||||||| |          |  |    |        ||||||| |||||||  ||||||| 
seq2     tgtgtaata----------atatagtgtaatcgctgctctgattggctcaactgtggaag 
        690                 700       710       720       730 
 
       53370     53380     53390                 53400     53410 →    
seq1     agggagaaatcatataaagagctcaatgttg-----t-------gctcttctcaggTCTT 
         ||||||||| |||      ||| | | | ||             |   ||||||||||   
seq2     agggagaaaacat-----tagcccgacgctgagaaggtggatgtgtatttctcaggTCCA 
        740       750            760       770       780       790 
 
         53420     53430     53440     53450     53460 
seq1     CACTCATCAGATGTAAGCAGAGAATCAGGTTGGTGAGTTCAGgtgaag------attgca 
         | ||||| ||||| ||| |||||||||||||||||||||||||||||       ||| |  
seq2     CCCTCATTAGATGCAAGTAGAGAATCAGGTTGGTGAGTTCAGgtgaaacgtctcatttct 
             800       810       820       830       840       850 
 
     53470     53480     53490 
seq1     ttcaagtgcattcaaacccttc-------------------------------------- 
         | ||      || ||    |||                                       
seq2     taca----gcttgaatttgttcgcgtggaaaaagttgactgcagctaaagtgtgtgataa 
                 860       870       880       890       900 
Figure 76. Global alignment of F. rubripes scaffold_599 to T. nigroviridis scaffold 794_4b. 
A. Histogram of percent identity vs. a 100 bp window moving along the alignment.  Numbering refers to 
the longest scaffold (Fugu_599).  Shading indicates ≥75% identity within the window.  Arrows indicate 
direction of gene transcription and boxes illustrate FBP exons.  B. Detailed view of alignment at the TSS 
(arrow).  The first exon is indicated in uppercase nucleotides.  The predicted splice donor site (GT) is 
indicated in bold.  Dashes  (-) represent gaps and vertical bars (|) indicate identities.  Seq1, F. rubripes 
scaffold_599; Seq2, T. nigroviridis scaffold_794_4b. 
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CHAPTER 5. STRUCTURAL ELUCIDATION OF AN FBPL 
Heretofore, because the three-dimensional (3-D) structure of this lectin family has not been 
resolved, it was not possible to explain how FBPLs specifically recognize Fuc.  Certainly, an 
alignment of the numerous FBPL family members facilitates gauging the permissibility of 
mutations within the primary structure.  However, it is impossible to discern ligand-binding 
residues within the consensus residues, which more likely represent structurally important 
positions.  For this reason, the process of mapping the FBPL binding site through a point-
mutational approach could be a prolonged and tedious process and in the end inefficient since 
the spatial relationship of the residues in question would remain unresolved.  Presently, X-ray 
crystallography and NMR spectroscopy remain the proven methods for macromolecular 
structure determination despite advances in de novo prediction [362].  Recent advances in 
protein in vitro expression, optimization in crystallization parameters, accelerated data collection 
with high energy synchrotron X-ray sources and computing capabilities have accelerated the 
speed with which new protein structures are presently being resolved [363].  Consequently, this 
has allowed much progress in understanding the structural diversity through which lectins 
recognize ligands [364-366].  Even a single resolved structure can greatly contribute to 
understanding the structure of other homologues [367].  This is because tertiary structure 
among homologues appears markedly conserved despite extensive mutational divergence from 
each other [368].  Based on this observation, large-scale efforts have been proposed to resolve 
representative structures for all protein sequence families not present in the structural database 
[369].  Thus, it was considered timely to attempt to resolve the first 3-D structure of an FBPL.  
In addition to MsaFBP32, the European eel (Anguilla anguilla) agglutinin (AAA) was included 
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in the crystallization trial because it was reasoned to be less flexible and therefore more 
amenable to forming a crystal since it lacks the spacer that separates the tandem domains 
present in MsaFBP32.  For this, collaboration was initiated with a highly qualified, experienced 
crystallography team at the Department of Biochemistry and Biophysics at the Johns Hopkins 
School of Medicine, led by Dr. L. M. Amzel.  In this chapter, the result of the elucidation of 
the structure for AAA bound with α-Fuc [370] will be discussed in an abridged form. 
Materials and Methods 
Repurification of AAA from a commercial preparation 
Ten milligrams A. anguilla agglutinin (AAA) were purchased from Sigma (St. Louis, MO, 
USA).  The lyophilized protein was first resuspended in 10 mM phosphate buffer (pH 7.2) and 
the soluble fraction was passed over a Fuc-Sepharose 6B matrix (1 ml) which was washed with 
50 ml (50 column volumes) of phosphate buffer.  The active lectin was eluted using 5 ml (5 
column volumes) of 200 mM Fuc in phosphate buffer.  Only half of the amount stated on the 
purchased vials (5 mg) was finally recovered after affinity chromatography.  The substantial 
losses may be attributed to the insoluble particulate observed after resuspension. 
Size exclusion chromatography 
The native molecular weight of AAA was estimated by size exclusion chromatography as 
described in chapter 2. 
Crystallization 
Crystallization of AAA was performed by the hanging drop method.  Briefly, the well from a 
24-well polystyrene plate was filled with 1 ml of reservoir solution and covered with a silanized 
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round converslip onto which a drop was spotted composed of equal volumes of AAA (10 
mg/ml protein, 5 mM Fuc, 10 mM NaCl, 10 mM Tris-HCl (pH 7.5), and 1 mM CaCl2) and 40-
50% (v/v) 2-methyl-2,5-pentanediol (MPD) at pH 7-9 reservoir solution.  Rhombohedral 
crystals of AAA grew to 0.3 mm in 72 h at 18 °C.  Crystal dimensions (a=65.5 Å, b=65.5 Å 
and c=245.1 Å) indicates it belongs to the R32 space group.  For the purpose of phase 
determination by isomorphous replacement, crystals were soaked overnight in reservoir 
solution containing 500 µM K2AuCl4. 
X-ray diffraction data collection 
Diffraction data was detected by a Rigaku Raxis IV++ image plate (Danvers, MA, USA) from 
cryomounted (100 K) crystals bombarded with radiation from a Rigaku RU-H3R rotating 
CuKα anode.  The resulting data was processed with Rigaku Crystal Clear software. 
Structure determination 
After detecting a single gold position from the Patterson difference map, refinement was 
initiated with MLPHARE from the CCP4 software suite [371].  Two additional gold positions 
were detected after the partial solution with the single site and were subsequently included in 
the refinement, which finally reached 1.9 Å.  The resulting high-resolution electron density 
map facilitated building a structural model in spite of not knowing the primary sequence.  The 
right-handedness consecutive β-chains indicated the enantiomer.  Residue position identity 
was tentatively assigned based on the primary sequences of the Japanese eel fucolectin and 
positions where the density data disagreed a new residues was assigned based on the density 
shape and the protein environment.  The coordinates and structure factors were deposited in 
the Protein Data Bank (PDB accession 1K12) (www.rcsb.org/pdb/). 
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Results and Discussion 
Crystallization of AAA 
The initial search for crystallizing conditions for AAA made use of 75 different solutions in a 
hanging drop format.  Surprisingly, in a period of 48 hours usable crystals were obtained from 
a protein concentration of 5 mg/ml with MPD as a precipitant.  The phase of the diffraction 
pattern was subsequently obtained from a gold-derived crystal.  Within each rhombohedral 
unit cell, there were 18 asymmetric units representing AAA monomers.  In an attempt to 
determine the character of the interaction of Fuc with AAA, the monosaccharide was included 
in the precipitating solutions in hopes it would co-crystallize with the protein.  Successfully, the 
refined electron density map revealed one monosaccharide per peptide subunit, which 
illustrated the fucose to be solely in the α anomeric configuration.  In total, the refined 
molecular model of AAA subunit includes 158 residues, 3 ligands (1 α-Fuc, 1 chlorine anion, 
and 1 cation (either Na+ or Ca2+), and 130 solvent molecules.  Moreover, the final refined map 
revealed weak indications of alternative amino acid residues at some positions, which suggest 
the minor presence of other isolectins in the crystal.  This observation suggested the presence 
of multiple isoforms in AAA, which may represent a situation analogous to that described for 
the agglutinin in the Japanese eel [182]. 
A novel lectin fold 
The AAA structural model (fig. 77) confirms that the FBPL motif represents a folding domain 
as previously supposed.  It is unique from the other lectin folds described so far [365, 366, 
372-374] and therefore, was named F-type lectin domain (FTLD) following the convention 
previously established in the literature.  Specifically, the fold is that of a β-barrel formed with a 
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jellyroll topology.  The barrel consists of eight antiparallel β-strands arranged into two β-sheets 
almost sandwiched together.  The first sheet consists of five β-strands (β2, β3, β10, β6 and β7) 
and the second sheet of three β-strands (β11, β5 and β8).  The bottom of the barrel is covered 
by two short β-strands (β4 and β9).  The NH2- and COOH- ends of the polypeptide form a 
two stranded β-sheet (β1 and β11), which enter and exit together from the closed end of the 
barrel structure, which may explain the domains tendency to concatenate.  The sugar-binding 
site is located at the concave end of the barrel and is surrounded by five loops, which connect 
the principal β-sheets.  Due to the sequence variability of homologous stretches evident in the 
sequence alignment these loops have been named CDR 1 through 5 in analogy to the 
complementarity-determining regions described for immunoglobulins.  Surprisingly, one of 
these loops (CDR4: Arg79-Ala90) possesses the particular contiguous cysteines conserved 
among eukaryotic FBPLs.  These reactive residues are exposed to the solvent and form a 
cystine, a feature that has not been described in other proteins, that closely interacts with the 
sugar ligand via a hydrophobic interaction.  As for the other cysteine residues present in the 
FBPL motif, they also form the predicted disulfide bridges, which appear to stabilize the fold.  
The cystine formed by Cys50-Cys146 is apparently essential, as judged by its preservation in all 
eukaryotic family members, for stabilizing a loop rich in short 310 helices and even participating 
(Cys146) in the coordination of the enveloped cation.  In contrast, the disulfide bridge formed 
by Cys108-Cys124, which brings together strands β7 and β8 from opposite sheets, appears 
dispensable in some FBPLs.  As mentioned above the ubiquity of cysteines in eukaryotic 
FBPLs markedly contrasts with their absence in prokaryotic FBPLs.  It appears that S. 
pneumoniae and M. degradans FBPLs either do not require disulfide bridges for stability or reside 
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intracellularly where the high redox potential makes bridging impossible, therefore releasing 
selection for these residues.  Intradomain interactions such as salt bridges also have a role in 
stabilizing the structure.  One specific salt bridge between Arg41 and Glu149 attaches the loop 
between η2 and η3 helices to the β11 strand.  A second salt bridge between Asp64 and 
Arg131 creates an intrasheet link.  The result of these features is a compact globular fold (43 Å 
l, 30 Å w) that is stabilized through disulfide bridges and metal coordination.  
Saccharide-binding site 
The eel fucolectin had a notable role more than 50 years ago demonstrating that 
carbohydrates, specifically Fuc, and not proteins were the epitopes of the ABO blood group 
 Figure 77. F-type lectin fold. 
Ribbon diagram with helices colored yellow and β-sheets colored red (three-strand sheet) and blue (five-
strand sheet).  The β-strands in green form a 2-strand sheet.  Bound α-Fuc is shown as a stick model above 
the lectin.  Calcium is shown at right as a silver sphere. 
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[183].  Therefore, it was of great interest to identify the mechanism by which AAA bound Fuc.  
Although determining the 3D-shape of a protein itself contributes a wealth of detail, localizing 
a superficial binding-site can be difficult if the ligand is not present in the resolved structure 
[178, 253].  By co-crystallizing AAA with Fuc, the saccharide-binding site was unambiguously 
identified to the concave end of the barrel.  As for other lectins a combination of molecular 
interactions explain the specificity demonstrated by AAA for Fuc.  The monosaccharide is 
bound by a positively charged, shallow depression (fig. 78, Panel A) resulting from the close 
placement of a trio of basic side chains which contribute to binding by forming hydrogen 
bonds.  However, no cations are directly involved in binding.  From the base of the CDR 4 
loop, two arginines (Arg79 and Arg86) donate hydrogens to the 3-, 4- hydroxyls, and the ring 
O5 positions (fig. 78, Panel B).  The axial 4-hydroxyl is the only moiety that exhibits 
cooperative hydrogen bonding, a characteristic of protein-saccharide interactions, as both 
Arg79 and Arg86 donate to this oxygen while the Nε2 of His52 accepts the hydroxyl 
hydrogen.  Arg86 has a prominent role in orientating the saccharide ring as it donates to the 
vicinal 3- and 4-hydroxyls, which are at optimal distances by being equatorial and axial, 
respectively.  The concentration of interactions at the 4-hydroxyl emphasizes the importance 
of the L- configuration of Fuc.  In contrast, its enantiomer, D-Fuc (i.e. deoxy Gal), prefentially 
adopts a 4C1 configuration, which would not present the preferred hydroxyl configuration.  The 
orientation of the 2-hydroxyl away from the protein surface makes it a good candidate for 
further glycosidic polymerization.  Specificity in lectins is frequently achieved through 
interactions with key features of the saccharide (i.e. hydroxyl disposition) that distinguish the 
favored ligand from the rest [50].  The disposition of the key feature is determined relative to 
common features (e.g. 3-hydroxyl and the ring oxygen) shared by all hexoses (i.e. Gal, Man and 
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Glc and their derivatives).  Similarly, AAA orients Fuc using the 3-hydroxyl and the ring 
oxygen to distinguish the axial disposition of the 4-hydroxyl.  This characteristic and the 
absence of a hydrogen acceptor in AAA for the 3-hydroxyl suggests that this moiety may also 
be suitable for glycoside extension, but steric hindrance may not allow this because of its 
proximity to the binding site.  The placement of these basic residues is optimized through a 
network of hydrogen bonds from other residues and water molecules surrounding the binding 
site.  Other interactions are also evident at the binding site such as van der Waals contacts 
between the ring C1 to C2 bond and the unusual cystine of CDR4.  This close distance 
between CDR4 and Fuc would lead to steric clash if the anomeric configuration were β, which 
explains the selectivity for the α anomer since the C1-hydroxyl faces away from the protein 
surface.  Contribution of the hydrophobic effect is evident in the nestling of deoxy C6 into a 
hydrophobic pocket where the Phe45 side chain lays, which explains the preference for Fuc 
over L-Gal.  However, like most lectins, specificity is not absolute and new interactions may 
sometimes even arise with unnatural ligands leading to higher affinity [375].  In the case of 
AAA, an inverted 3-O-methyl-D-Gal can partly mimic the configuration of groups in Fuc, 
which may explain why it is a good inhibitor [376].  In summary, binding of AAA is mediated 
by few residues exploiting the δ-guanido moiety of Arg to form a lattice of hydrogen bonds 


















































































































































































































As with MsaFBP32, AAA is present in circulation where it is more likely to encounter complex 
polysaccharides, such as oligosaccharides (i.e. blood group antigens) [377] or enterobacterial 
exopolysaccharides (i.e. colanic acid) [378] rather than free Fuc.  These larger ligands are likely 
to form additional interactions to those observed with the monosaccharide alone.  The identity 
of the natural ligand of AAA is presently unknown, but inhibition studies [379] with α-
fucosylated oligosaccharides supports that additional interactions occur with subterminal 
saccharides.  Reactivity of AAA to lactosamine-linked (α1-4) Fuc (type 1: H-antigen and 
Lewisa), but not to neo-lactosamine-linked (α1-3) Fuc (type 2: Lewisx) indicate the dramatic 
effect that just changes in linkage has on binding.  Therefore, in addition to the primary site, 
surrounding sub-sites likely influence the binding of larger oligo- or polysaccharides.  The 
interactions of AAA with fucosylated oligosaccharides, H-antigen type 1 and Lewisa, were 
confidently modeled using the solution conformation of these oligosaccharides derived from 
conformational studies.  The principal interactions are with polar residues from the rigid 
CDR1 loop, which rises above the binding shallow and with Tyr46 of CDR2.  Interestingly, 
the CDR1 loop is variable among the several cDNAs cloned from the Japanese eel suggesting 
that it may regulate specificity for certain glycoconjugates.  It is evident from the co-
crystallization data and the models that the selectivity of the principal binding site of AAA is 
for α-Fuc; moreover, the variable surrounding loops have the potential to regulate binding of 
native glycoconjugates.  The close interaction with the 3- and 4-hydroxyls, and C6 would 
preclude binding of substituted fucosyl-containing polysaccharides such as fucoidan [175] and 





A conspicuous feature revealed by the AAA 3-D structure is a metal nestled within the loop 
rich in short 310 helices (fig. 79).  The geometry of the heptacoordinated site is pentagonal 
bipyramidal mediated by oxygens contributed by both the peptide backbone and side chains.  
In detail, the first coordination shell ligands are mediated by the semicontinuous residues 
Asn35 (O), Asp38 (Oδ1), Asn40 (O), Ser49 (O, Oγ1), Cys146 (O), and Glu147 (Oε1).  
Despite only six residues being involved in coordination, heptacoordination is achieved by 
Ser49 performing as a bidentate ligand.  One shortcoming of crystallographic data with regard 
to studying metal-binding sites is that it permits establishing only indirectly a metal ligand’s 
identity.  Fortunately, features such as coordination geometry and ligand-metal distance, which 
correlate with specific metals, reduces the possible candidates.  Coordination distance is 
especially useful for identifying metals since it is rarely restrained during the structure 
refinement process producing accurate final measurements.  Both the coordination distance 
(2.4-2.6 Å) and geometry present in AAA are consistent with parameters observed during 
crystallographic analysis of Na+ or Ca2+ coordination by small molecules.  Selectivity for Ca2+ 
over other metals, including Na+, is achieved in proteins by coordination with neutral ligands 
[380] such as main-chain carbonyls and alcohol moieties.  A survey of structures of known 
calcium-binding proteins [381] indicates that oxygen, frequently from the peptide carbonyls, is 
always the ligand at these sites.  Comparison of coordination numbers points to seven as the 
norm but can vary from five to eight.  Since AAA shares all these features, Ca2+ is most likely 
the identity of the cation.  However, only chemical analysis of metal content of AAA can 
unequivocally identify the metal. 
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The principal role that calcium appears to play in AAA is structural stabilization.  In contrast 
to C-type lectins, none of the metal-coordinated residues interacts with the carbohydrate 
ligand, therefore supporting solely a structure role.  Intracellular levels of calcium are tightly 
regulated (100 nM) due to the importance of this cation as a secondary messenger in cellular 
signalling, but in the extracellular environment, a higher and relatively constant level (2.5 mM) 
is detected.  Therefore, calcium-binding by proteins in the extracellular space is more related to 
their stability rather than to signaling [381].  The high coordination number of Ca2+ makes it an 
ideal crosslinker for bringing together different parts of a polypeptide acting in essence similar 
to a disulfide bridge.  Previous studies of cation requirements in tachylectin-4 [181] and the 
Japanese eel fucolectin [182] suggest that calcium is involved in sugar binding.  In contrast, 
agglutination by MsaFBP32 was not significantly affected by chelating despite possessing 
similar residues at homologous positions.  Although the evidence from the AAA structure 
rules out any direct relationship between cation and saccharide, it is possible that the removal 
of calcium induces changes in the CDR1 and CDR2 loops, which lead to abrogation of 
 Figure 79. Heptacoordinated Ca2+-binding site of AAA. 
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binding.  An explanation for the discrepancy between the cation requirements of two fish 
FBPLs is that calcium removal may actually affect quaternary structure rather than tertiary 
structure.  Both tachylectin-4 and eel fucolectin form larger order assemblies, which may be 
susceptible to chelation resulting in their disassembly.  In contrast, the native monomers 
MsaFBP32 may remain active even after chelating since they possess two intramolecular FBPL 
domains, which could still allow agglutination.  Further studies should address this possibility. 
Quaternary structure of AAA 
Unlike NMR spectroscopy, protein X-ray crystallography relies on the ability of dissolved 
polypeptides to assume an abnormal crystalline state.  Inherent during the crystallization 
process is the constraint of molecular movement in the densely packed lattice.  However, 
crystals from macromolecules are typically less dense and much intermolecular space remains 
filled by solvent.  Consequently, the level of hydration of a crystallized protein is comparable 
to when it is dissolved.  Therefore, in the absence of any deformations associated with crystal 
contacts, the crystallographic structure confidently reflects the native shape of the protein 
under physiological conditions.  In the crystallographic model of AAA, the quaternary 
structure appeared as a homo-trimer of cyclic symmetry (i.e. C3 point group) (fig. 80, Panel A).  
Although the oligomer appears loosely associated, the large surface area (1,240 Å) buried at the 
subunit interface supports this being the native arrangement for the lectin.  Corroboration by 
SEC (fig. 80, Panel B) of the molecular mass estimated for the crystallized structure (51 kDa) 
also supports the accuracy of this subunit arrangement.  Surprisingly, this model contradicts 
the conclusion others have previously reached based on electrophoresis results 
notwithstanding similar results from SEC [168].  The quaternary structure of the eel agglutinin 
was concluded to be of a homo-tetramer [168, 182, 382, 383] formed by association of two 
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cystine-linked dimers.  Based on the AAA structure, the presence of an intermolecular cystine 
bond is unlikely since those present are internal except for that on CDR4, which is directly in 
contact with the saccharide.  An explanation for this SDS-PAGE band pattern is that the 
covalently linked bands are artifacts created during the electrophoresis process.  Similar results 
were observed when AAA was treated with an expired reducing SDS-PAGE sample solution 
(data not shown).  Cystine-forming positions are well conserved among eel fucolectins, 
however FTL-1, -3 and -7 (GenBank Accession BAB03524, BAB03525 and BAB03529) 
possess an odd half-Cys as their last residue, which possibly could form an intermolecular 
bond.  Nevertheless, AAA did not reveal a similar residue and so the contribution of this 
singular cysteine to quaternary structure of those isolectins remains presently unknown.  In 
recognition of the conflicting reports on the quaternary state of AAA there is the possibility 
that MsaFBP32 forms a trimer despite high confidence in the analytical analysis described in 
chapter 2.  Alignment of the MsaFBP32 peptide sequence to the AAA structure reveals that 
the chloride-coordinating Lys, which forms the trimer’s symmetry axis, is conserved.  This is 
relevant to the results from the cross-linking analysis since BS3 specifically reacts with primary 
amino moieties (i.e. NH2-terminal and lysine).  Therefore, if MsaFBP32 forms a trimer, at least 
two of these three proximal lysines could be cross-linked through the bifunctional reagent, 
forming dimers as the major species.  This was not the case, so the ladder observed by SDS-
PAGE must result from heterologous residues present on opposite sides of the monomer, 
which linked as they collided.  A similar analysis has not been performed on AAA to test if it 
behaves similarly, but the crystallographic structure of MsaFBP32 most likely will provide the 
most accurate answer to this question. 
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An interesting revelation by the AAA quaternary structure is its similarity to the symmetry 
present in lectins involved in surface recognition [51].  This association creates a planar array 
of binding sites at one end of the oligomer, which has consequences on surface selectivity and 
affinity.  For example, the spacing between the binding sites of MBPs (45-53 Å) is broader 
than between residues of an oligosaccharide on a glycoprotein [384] so it minimizes binding to 
self-glyconjugates.  Instead, the wide spacing appears to favor interaction with the arrays of 
saccharides typical of a pathogen’s surface.  However, the binding-sites on AAA are much 
closer (25 Å) suggesting that its target is most likely densely fucosylated.  The clustering of 
protomers also has the effect of compensating [385] for the weak affinity (mM) typically 
exhibited by individual binding sites of lectins.  Association in higher order multimers 
potentially multiplies individual site affinities.  The mechanism of agglutination (i.e. bridging) 
by AAA of RBCs remains unexplained by the redefined quaternary structure since binding 
sites are not opposed so as to link cells.  Maybe the coating of the cells with lectin diminishes 
the repulsion between the charged surfaces.  However, the internal dihedral point symmetry of 
the tandem domains in MsaFBP32 would produce such a bridge if it were to associate as a 
trimer.  Clearly, AAA exhibits many of the same topological properties as other lectin families, 
which contribute to efficient binding.   
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A structural view of the FBPL motif 
As discussed, the elucidation of the AAA 3-D structure provides valuable details explaining the 
basis of its biochemical properties and, possibly biological function(s).  Consequently, 
evolutionarily conserved variations in the FBPL motif can be analyzed in detail focusing on 
positions relevant for ligand binding, metal binding, or tertiary structure (fig. 81) and serve as a 
guide for future experimentation.  Evident from the alignment is an α-Fuc-binding motif 
(HX24RXDX4(R/K) shared by most domains including those from proteins present in 
prokaryotes, which suggests that most FBPL domains are specific for this saccharide.  
However, some domains deviate from this motif, suggesting alternate specificities or even lack 
of saccharide-binding activity.  An example is the fruit fly’s CG9095 where two residues of the 
sugar-binding triad are mutated to aliphatic residues unable to produce the H-bonds typical of 
the AAA binding site.  This reduces the likelihood that the domain binds sugar, coinciding 
with the observation previously discussed that CG9095’s C-lectin domain also is unlikely to 
 Figure 80. Quaternary structure of AAA. 
A. Ribbon diagram with helices colored magenta and β-strands colored yellow.  The single chlorine ion 
marking the three-fold axis of rotation is coordinated by a lysine (Lys16) from each subunit.  Bound fucose 
is shown as a stick model.  A white sphere illustrates the calcium.  B. Analysis of AAA size by SEC.  The 
lectin peak (green) elutes between that of BSA (67kDa) and ovalbumin (43 kDa) and consequently its 
estimated size is 53.3 kDa, representing the size of a trimer. 
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bind carbohydrate.  The case of both domains of the binary DreV appears to be extreme since 
a large deletion is present in the CDR4 loop, which would most likely abrogate α-Fuc-binding.  
Another interesting pattern is that most binary FBPLs (i.e. striped bass, zebrafish, pufferfish 
and stickleback) possess a unique combination of saccharide-binding motif and cystine bonds 
(NH2-term:  CXHX24RGDCCXERXX16XX22C) and (COOH-term: 
CXHX24RDXXXERCX16CX22C).  Specifically, one domain has lost the contiguous cystine 
that contacts the saccharide ring while it gained the nested cystine.  It is not clear what effect 
the loss of this cystine has on binding since the alkaline residue trio is conserved but the 
predominance of this character only among binary FBPLs suggests that it has some functional 
value.  Future recombinant expression of individual domains should allow biochemical 
confirmation of these possible alternate specificities.  
Analysis of the mutation effects on metal-binding residues is not as clear as for saccharides 
since most ligands are provided by main-chain carboxyls and their conservation probably 
relates more to their configuration in the folded protein.  However, differing degrees of 
conservation are evident for the three positions that interact through side-chains.  Serine 49 is 
of special interest, since as a bidentate ligand, it is central to the pentagonal bipyramidal 
coordination geometry.  In a few cases, this position is substituted with non-alcohol residues 
unable to produce the bidentate coordination (i.e. His, Asp, Pro, Gly, and Val).  In most others 
however, it is substituted by residues possessing oxygens (i.e. Asp, Gln, Glu, Thr and Tyr) that 
likely are still able to form coordination bonds.  In the former cases, there is the possibility that 
a water molecule may substitute in coordination or there is a reduction in coordination.  A 
coordination number of six produces an octahedral geometry, which for Ca2+ is permissible as 
exemplified by several solved protein structures [381].  Nevertheless, there appears to be a 
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strong selection for heptacoordination in FBPLs to stabilize the large helix-rich loop.  Similar 
support is given by the absolute conservation seen for Glu 147, which also provides a side-
chain ligand.   
As commonly observed in other proteins, sequence insertions or deletions (indels) are most 
permissible in loops where they have minimal effect on the core fold.  Such is the case for the 
F-type lectins where the CDRs are the sites for various indels.  Interestingly, the CDR1 loop, 
which appears to interact with saccharides subterminal to α-Fuc, shows great divergence 
suggesting that it might regulate binding to the wide diversity of glycoconjugates.  
Coincidentally, the intron that splits the exons coding for each domain of MsaFBP32 and 
others is localized (AAA: Glu 123-Cys 124) close to the long irregular turn at the lower side of 
the barrel which also presents length variability but it does not appear to be subject to 







































































































































































































































































































































































































































































































Structural analogy is widespread 
The lack of detectable similarity of F-type lectin motif to other protein families would suggest 
that this fold is unique.  To test this hypothesis, a structure-based comparison was made by 
means of the Dali database [386].  Surprisingly, at least seven other proteins with negligible 
sequence similarity shared the same jellyroll fold as the eel fucolectin (fig. 82).  The structural 
analogs are the C domains of human blood coagulation factor V (FA58C) and VIII (PDB 
1CZT) [387], the COOH-terminal domain of a bacterial sialidase (PDB 1EUT) [281], the 
NH2-terminal domain of a fungal galactose oxidase (PDB 1GOF) [282, 388], a subunit of the 
human APC10/DOC1 ubiquitin ligase (PDB 1XNA) [389], and the NH2-terminal domain of 
the XRCC1 single-strand DNA repair complex (PDB 1JHJ) [390].  Curiously, the FA58C 
domain of identical structure is present next to the FBPL domain in the M. bulbifer ORF 
previously described.  Evident from the sequence alignment derived from these superimposed 
structures is that although they only share marginal sequence similarity among themselves (fig. 
83, Panel A) they are still able to fold into virtually identical domains.  Clearly, the fold is better 
defined by a physicochemical profile rather than by the conventional similarity matrix typically 




Five distinct protein families (i.e. galactose binding, discoidin, AAA, XRCC1, and 
APC10/DOC) are represented by the structural alignment with AAA; nevertheless, their 
homology is questionable.  Surveys of sequenced genomes indicate that frequently protein 
families share common folds (superfolds) but that most folds are unique to a protein family 
[391].  As of the latest release of SCOP (v1.63) [392] a total 15 families including AAA have 
been assigned to the galactose-binding domain-like fold.  However, most of these structures 
are likely the result of convergence resulting from the limited number of favorable topological 
folds [393] since they only share the 5/3 β-sheet with AAA but not the exact jellyroll topology.  
The strongest evidence of ancestry comes from shared saccharide-binding residues in 
members of the galactose-binding family.  The secreted bacterial sialidase and fungal galactose 
 Figure 82. AAA shares structural similarity with diverse proteins. 
Green, AAA (PDB 1K12); Yellow, fungal galactose oxidase (PDB 1GOF); Gray, bacterial sialidase (PDB 
1EUT); Blue, C2 domain of coagulation factor V (PDB 1CZT); Red, anaphase-promoting complex (PDB 
1JHJ); Magenta, DNA single-strand break repair complex (PDB 1XNA). 
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oxidase possess similar enzymatic domains linked to the galactose-binding domain, but their 
positions on the polypeptide are different, which suggests they have emerged independently 
[394].  The lectin domain apparently serves to enhance the interaction of the catalytic domain 
with the substrate similar to the previously mentioned family 6 CBM from C. stercorarium, 
which coincidently also shares a jellyroll topology [395].  However, the interaction between the 
Gal crystallized with bacterial sialidase does not explain binding specificity since only the 
equatorial hydroxyl on C-3, commonly shared Glc and Man [50]; no saccharide heteroatom is 
evident in the galactose oxidase structure to facilitate corroboration of these findings.  
Other structural analogues may have originated from carbohydrate-binding domains but have 
evolved new specificities.  It also appears that all of these families share the placement of their 
binding-site among the loops at the opening of the -barrel.  The FA58C domain, present as a 
tandem repeat at the C-terminal of part of multi-domain circulating coagulation factors, is 
similar to the discoidin domain (DS) [396] named for a lectin from the slime mold [397, 398] 
for which the binding site has not been determined.  Interestingly, like the F-type domain, the 
FA58C domain is also frequently found as tandem replicates.  However, instead of binding 
saccharides, its CDRs are studded with hydrophobic residues that enable it to bind 
phospholipids present on the cell surface [399].  In contrast, the b1 domain of neuropilin-1 
receptor [400], a DS homologue, is devoid of the hydrophobic spikes and instead presents a 
polar cleft.  Another set of DS homologues, the discoidin domain receptors [401], which 
possess tyrosine kinase-signalling domains, are activated by binding to collagen [402].  It is 
evident from these examples that the animal DS domains have evolved to bind a diversity of 
ligands other than saccharides.  The remaining structural analogs, among the only jellyroll 
proteins placed cytoplasmically [389], do not appear either to bind glycoconjugates.  For 
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XRCC1, the binding site for single-strand DNA breaks was mapped to a groove at the top of 
the barrel, but does not appear to involve interactions with the glycoside backbone.  No 
binding activity has been attributed to APC10/DOC1 domain, however the variable loops 
suggest it has a putative ligand.  Curiously, the presence of a cation-binding loop is variable 
among these structural analogs since FA58C, APC10/DOC1, nor XRCC1 have a cation 



























































































































































































































































































































































In summary, resolving the AAA 3-D structure has substantially added to the understanding of 
both biochemical features and ancestry of FBPLS.  Clearly, the motif represents a structural 
domain unique among all other known animal lectin families.  This F-type lectin fold exhibits a 
compact jellyroll topology formed by two sandwiched β-sheets and is stabilized by cystines.  
Selectivity for the specific features of α-Fuc conformation is achieved mostly through 
hydrogen bonds provided by a highly conserved trio of basic residues, which center on the 
axial hydroxyl of C-4.  Further selectivity for fucosylated complex glycoconjugates is expected 
from sterically inevitable interactions with the extended variable loops surrounding the binding 
site and a unique cystine formed by contiguous residues.  Calcium is present in the lectin, but 
unlike the C-type domain, not as a saccharide-coordinating ligand but as a structural prosthetic 
group.  Mutability of the identified saccharide-binding motif in members of the family suggests 
that ligands other than to α-Fuc are likely.  Although the fold is unique among animal lectins, 
surprisingly four other widely distributed protein families with diverse functions share it.  
Microbial saccharide hydrolases still appear to apply the domain for binding carbohydrates.  
However, in metazoans these analogs apparently have diverged to bind anionic surface lipids 
or intracellular ligands such as DNA.  Clearly, in contrast to the FBPLs, the fold is present in 
higher vertebrates but the ancestry among the families is debatable since sequence similarities 
are negligible.  It is certain that this fold emerged early in life yet may have been adopted 
independently by each of these distinct protein families.  The current high priority placed on 
elucidation of representative protein 3-D structures should quickly provide a complete 
assessment of the diversity families adopting this fold.  
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CONCLUSIONS AND FUTURE DIRECTIONS 
As planned, the approach of using affinity chromatography for screening for saccharide-
binding proteins from blood or liver of the bass was effective in pointing to the presence of a 
fucose-binding lectin in circulation.  Biochemical characterization (i.e. SDS-PAGE, SEC, ESI-
MS and cross-linking) of this lectin indicates that it consists of a 32 kDa monomer (FBP32).  
Although similar in molecular size to the typical size expected for the reduced MBL monomer, 
FBP32 does not form a covalently-linked trimer or appear to assemble into higher order 
oligomers characteristic of collectins.  Cloning of the gene through PCR using peptide 
sequence-based primers and liver cDNA provided the initial gene sequence, which 
subsequently allowed deduction of the full polypeptide sequence.  Evident in the ORF is a 
tandemly duplicated motif (FBPL) that does not share sequence similarity to C-type lectins or 
any other lectin family motifs presently described.  Initial searches in the gene repositories for 
proteins homologous to FBP32 identified only one cDNA (XL-PXN1) isolated from the liver 
of the African clawed frog [209].  Interestingly, the sole FBPL motif present in this frog 
homologue was adjacent to a pentraxin domain.  The human CRP, which is a homomultimer 
of the pentraxin domain, is well described as positive acute phase protein meaning that it is 
greatly upregulated during inflammation.  Recent investigation links chronic inflammation to 
an increased risks of developing heart disease, so CRP has become a valuable measure for the 
prognosis of heart infarction [403].  Moreover, mammalian pentraxins are capable of pathogen 
recognition, mediated through lectin activity that leads to complement cascade fixation.  
Reports of polypeptides similar to FBP32, but consisting of a single FBPL, from the eel and 
the horseshoe crab provide evidence linking these lectins to pathogen recognition [181, 182].  
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This supports a role for this unique family of lectins as humoral factors of the innate immune 
system whose expression is potentially upregulated during inflammation.  Preliminary study of 
the effect of inflammatory challenge in the bass point to an increase in gene transcription, but 
no obvious increase of lectin levels in circulation was evident.  Current understanding of 
inflammation comes from studies in mice and humans but little is known of inflammatory 
processes in lower vertebrates.  Several cytokine homologues have been identified from 
teleosts that are known to mediate inflammation in mammals [404], but a readily detectable 
marker of inflammation, such as CRP in humans, has not been established for teleosts.  
Development of such a sensitive marker would facilitate determining how levels of FBPLs 
correlate to a developing inflammation.  Pentraxins, ficolin and collectins in addition to 
activating complement also serve as opsonins [405-407].  The receptors that have been 
implicated in recognition of particles coated with these proteins are the Fc receptor and the C1 
receptor [408].  There is no structural similarity apparent between the Fc region of 
immunoglobulins and pentraxins, yet opsonophagocytosis of pentraxins is convincingly 
mediated by Fc receptor.  Therefore, it is plausible that MsaFBP32 may also share a receptor 
with other opsonins.  Phagocytosis assays may provide an indication of this activity.  Clearly, 
further study of FBP32 as a potential opsonin is needed to unequivocally assign its function to 
innate immunity.  
The four diverse FBP homologues initially identified hinted that the domain could be shuffled 
as a unit to create diverse configurations.  To gauge the diversity of FBPLs and attempt to gain 
functional information through phylogenetic comparison, incomplete sequences (i.e. ESTs) 
showing similarity to the FBP domain were completed to deduce the full polypeptide 
sequence.  The rapid advance of genome sequencing also provided the opportunity for 
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enumerating the full set of FBPL genes present within a species.  Additional configurations 
were positively identified including tandem repeats of two to five FBPLs and a likely cell 
surface receptor with additional C-type lectin and sushi domains.  From this compilation, it 
became evident that FBPLs are present in select eubacteria, in both lophotrochozoan (i.e. 
mollusca and platyhelminthes) and ecdysozoan protostomes (i.e. merostomata and insecta), 
early deuterostomes (i.e. echinodermata) and the already mentioned lobe-finned fish lineage 
(i.e. X. laevis) and ray-finned fishes.  In contrast, as confidently supported by whole genomes 
sequenced in some cases for several congeners, this lectin family appears absent from fungi, 
nematodes, ascidians, and higher vertebrates (i.e. mammals and chicken) which suggest that it 
has been selectively lost independently several times even in relatively closely-related lineages.  
The paucity of bacteria possessing an FBPL also suggests that either many lineages also lost 
this domain, which is a parsimonious scenario in this kingdom, or that it may have been 
acquired through horizontal transfer from metazoans.  Lack of shared FBPL domain 
configuration among the phyla sampled makes tracing ancestry difficult for this lectin family 
except in euteleosts where the binary domain configuration is shared.  Nevertheless, even these 
FBPLs point to lineage-specific duplications within the diverse teleost orders represented so 
inter-taxon correspondence of genes is still not evident throughout the tree.  The mottled 
phylogenetic distribution of this lectin family, diverse temporospatial expression, and its varied 
domain architecture point to a functionally plastic protein, which has been tailored in each 
lineage and apparently sometimes has lost its fitness value.  The absence of FBPLs from higher 
vertebrates is an evolutionary quandary that eventually could be resolved through targeted 
sampling of taxons neighboring the Anura but the great extinction events of the past that 
claimed so many families of amphibians may have obscured any potential evidence forever.  
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With the accrual of genome sequences, further insight is possible into the evolution of FBPL 
genes and their transcriptional control.  The sequence of the duplicated striped bass FBPL 
genes illustrate the common exon/intron organization shared in this lectin family in addition 
to evidence of a localized gene expansion, a feature not present in the pufferfish FBPL loci.  
Each lectin domain is encoded by two exons and flanked by phase 1 introns, a characteristic 
apparently conducive to exon shuffling since it is shared with domains frequently present in 
tandem configurations within numerous blood proteins.  Regarding control of gene 
expression, computational analysis of the regions proximal to the putative transcription start 
sites detected an Inr motif in MsaFBP32 only, but no other motifs common to core promoters 
or involved in inflammation (i.e. NF-κB).  Both striped bass genes described are coexpressed 
in the liver so they likely share similar control elements.  Surely, the proximity between the 
striped bass genes should facilitate promoter mapping, but presently no immortalized cell 
cultures have been developed from the liver of this species, which hinders this approach.  
Long-distance alignment of the pufferfish orthologues detected conserved stretches of 
upstream non-coding DNA that may be involved in control of gene transcription.  The release 
of the zebrafish genome is drawing near, which should allow testing if these motifs are 
conserved in a more distant orthologue, therefore providing stronger evidence of their positive 
selection.  Considering the multiplicity of FBPLs and absence from higher vertebrates, 
thorough analysis of in vivo function would benefit greatly from development of gene 
“knockout” methods for lower vertebrates.  Developmental patterns of expression of FBPLs 
are presently unknown but “knockdown” methods, currently applicable only during early 
development, are an alternative approach for FBPLs that are developmentally regulated.  
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Recent developments in non-lethal screening for effects of knockdowns in adult mice [409] 
holds promise for studying FBPL function in adult fish.   
Resolution of the crystallographic structure of the eel agglutinin, a single-domain FBPL, greatly 
advances understanding this lectin family as it finally translates from motif into a unique spatial 
topology designated F-type fold.  In addition, co-crystallization of the lectin with α-Fuc 
provides structural evidence explaining the specificity exhibited by this lectin.  Specifically, a 
trio of well-conserved basic residues in a shallow pocket and a unique contiguous-residue 
cystine directly interact with the uniquely configured natural saccharide.  However, other 
interactions may also form with unrelated ligands, which mimic some of the characteristics of 
α-Fuc expanding the range of possible ligands.  The variability in the loops surrounding the 
binding pocket also suggest they could exert selectivity on ligand repertoire in analogy to the 
CDR loops of Igsf.  Another novel discovery obtained from the crystal structure is that the 
lectin associates into a previously unknown quaternary structure of three-fold cyclic symmetry 
very similar to that observed in collectins.  Surprisingly, topological comparison indicates that 
the fold is more widespread than indicated by sequence homology alone.  Structural analogs 
include vertebrate coagulation factors, eukaryotic DNA repair enzymes and cell cycle control 
proteins, and microbial hydrolytic enzymes demonstrating the emerging trend of topological 
redundancy between sequence-based families.  Presently, the crystallographic structure of 
MsFBP32 has also been resolved and illustrates the binding-sites of the tandem domains as 
being antipodal.  It also confidently demonstrates MsFBP32 as forming a trimeric quaternary 
arrangement like that observed for AAA, which disagrees with the results from SEC.  
Evidently, readily applicable biochemical methods are insufficient to accurately describe the 
physicochemical properties of FBPLs.  Comparison of FBPL homologues to the AAA 
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structure suggests most of them probably bind α-Fuc, but a few may have developed alternate 
specificities.  With the accumulated evidence in hand, it is now possible to address the 
contextual diversity of FBPLs with a view to identify their fucosylated ligands more effectively. 
The findings presented here open several distinct avenues for future studies.  The moronid 
bass are advantageous as accessible and copious sources for blood, but due to their lengthy 
reproductive cycle are not suitable as genetic models.  Several other teleosts have been 
proposed as suitable biological models but have generated limited interest in the general 
scientific community.  Currently, advances in biomedicine using zebrafish as in vivo models of 
vertebrate early development have broadened the tools available for studying gene function, 
but in vitro assays for studying cellular function still require further development.  In 
comparison to mammalian cells lines very few teleostean cell lines have been established and 
been made generally accessible.  Currently, immortal cell lines from trout liver (SOB-15) and 
zebrafish (ZFL) are available, but do not appear to express FBPL under normal culture 
conditions (data not shown).  Establishing conditions that induce FBPL expression in these 
cells would provide an important step for tracing the signaling network that regulates these 
genes and eventually correlating it with the physiological state of the organism.  Structural 
studies are greatly advanced with the two unique FBPLs crystallized but still many questions 
remain unanswered.  Formation of the trimer that is apparent for AAA by SEC but not for 
MsaFBP32 is still perplexing.  The ability of analytical ultracentrifugation to allow direct 
observation of sample aggregation states under equilibrium is the best candidate approach to 
address this question.  The role in binding of the contiguous-residue cystine present in some 
FBPLs, but not others should be further addressed to determine its contribution to ligand 
affinity.  This raises the issue that the kinetics and energetics of binding have yet to be 
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addressed.  Kinetic analysis of ligand binding using optical biosensors has become 
commonplace nowadays as the technology can accommodate diverse ligand-receptor species 
and has been applied to lectins.  Titration microcalorimetry should also provide useful 
information regarding the driving forces behind the observed binding selectivity.  Currently, 
attempts are being made to purify recombinant FBPLs from a bacterial host, but a refolding 
step will likely be require to obtain active lectin.  This is important given the fact that FBPLs 
come from smaller organisms that require special keeping.  Finally, the vagaries in inheritance 
of FBPLs should serve as a warning.  If conceited evolutionary suppositions aim our scientific 





A. MsaFBP32 cDNA 
         ATGTCTCAAAGAGGCTAGGTACAGTAACTCACTGGACTCCAGGGATAAAAGATCTGTTCTAACCAGGAAG 
       1 ---------+---------+---------+---------+---------+---------+---------+  
 
  
         CAGGAATAATGAGGCACAGTGTGGTATTTCTGTTGCTGCTCCTCTTAGGGGCGTGTTCAGCTTACAACTA 
      71 ---------+---------+---------+---------+---------+---------+---------+  
                 m  r  h  s  v  v  f  l  l  l  l  l  l  g  a  c  s  a  Y  N  Y    
 
 
         TAAAAATGTGGCCTTGCGTGGAAAAGCGACTCAGTCGGCACGTTATTTGCACACACATGGAGCCGCCTAC 
     141 ---------+---------+---------+---------+---------+---------+---------+  
          K  N  V  A  L  R  G  K  A  T  Q  S  A  R  Y  L  H  T  H  G  A  A  Y    
 
 
         AACGCCATTGATGGAAACCGTAACTCTGACTTCGAAGCTGGATCGTGCACCCACACTATTGAACAGACCA 
     211 ---------+---------+---------+---------+---------+---------+---------+  
         N  A  I  D  G  N  R  N  S  D  F  E  A  G  S  C  T  H  T  I  E  Q  T  N  
 
 
         ACCCCTGGTGGAGAGTGGACCTACTGGAGCCCTACATCGTCACCTCCATCACCATCACCAACAGAGGAGA 
     281 ---------+---------+---------+---------+---------+---------+---------+  
           P  W  W  R  V  D  L  L  E  P  Y  I  V  T  S  I  T  I  T  N  R  G  D   
  
         CTGCTGTCCAGAAAGGCTCAACGGGGTGGAGATTCACATCGGCAACTCTATACAAGAAAATGGTGTTGCA 
     351 ---------+---------+---------+---------+---------+---------+---------+  
          C  C  P  E  R  L  N  G  V  E  I  H  I  G  N  S  I  Q  E  N  G  V  A    
 
 
         AACCCAAGGGTTGGTGTAATTTCTCATATCCCTGCAGGGATCTCACATACTATCAGTTTCACTGAACGTG 
     421 ---------+---------+---------+---------+---------+---------+---------+  
         N  P  R  V  G  V  I  S  H  I  P  A  G  I  S  H  T  I  S  F  T  E  R  V  
 
 
         TGGAGGGACGTTACGTGACTGTGCTTCTACCTGGTACAAACAAGGTTCTTACACTCTGTGAAGTGGAGGT 
     491 ---------+---------+---------+---------+---------+---------+---------+  
           E  G  R  Y  V  T  V  L  L  P  G  T  N  K  V  L  T  L  C  E  V  E  V   
 
 
         TCATGGGTACCGAGCCCCAACTGGAGAGAACCTGGCCCTCCGAGGAAAAGCCACACAGTCTTCATTGTTT 
     561 ---------+---------+---------+---------+---------+---------+---------+  
          H  G  Y  R  A  P  T  G  E  N  L  A  L  R  G  K  A  T  Q  S  S  L  F    
 
 
         GAATCTGGTATTGCATATAATGCCATTGATGGGAATCAAGCCAACAATTGGGAAATGGCCTCCTGCACTC 
     631 ---------+---------+---------+---------+---------+---------+---------+  
         E  S  G  I  A  Y  N  A  I  D  G  N  Q  A  N  N  W  E  M  A  S  C  T  H  
 
 
         ACACAAAAAACACAATGAACCCCTGGTGGCGAATGGATCTGAGCAAAACCCACAGAGTGTTTTCTGTTAA 
     701 ---------+---------+---------+---------+---------+---------+---------+  





         GGTAACCAACCGAGATTCATTTGAAAAACGAATCAATGGAGCTGAGATCCGAATTGGAGATTCCCTCGAC 
     771 ---------+---------+---------+---------+---------+---------+---------+  
          V  T  N  R  D  S  F  E  K  R  I  N  G  A  E  I  R  I  G  D  S  L  D    
 
 
         AACAACGGCAACAACAATCCCAGGTGTGCTGTGATCACAAGCATCCCAGCAGGTGCTTCTACTGAATTCC 
     841 ---------+---------+---------+---------+---------+---------+---------+  
 
 
         N  N  G  N  N  N  P  R  C  A  V  I  T  S  I  P  A  G  A  S  T  E  F  Q  
 
 
         AGTGTAACGGGATGGATGGCCGCTATGTTAACATTGTTATCCCTGGAAGAGAAGAGTACCTGACCCTGTG 
     911 ---------+---------+---------+---------+---------+---------+---------+  
           C  N  G  M  D  G  R  Y  V  N  I  V  I  P  G  R  E  E  Y  L  T  L  C   
 
 
         TGAGGTGGAGGTGTATGGCTCTGTCCTGGATTAGGTGTCAGTACTAATACTGTTGAATGTACACAAACAA 
     981 ---------+---------+---------+---------+---------+---------+---------+  
          E  V  E  V  Y  G  S  V  L  D  *                                        
 
 
         AACAAAATAGTAGATTAAGCTTTTTTGATTGTTTCCATTCAAAATAAGACAGAGATGGTCTTATCCAATA 
    1051 ---------+---------+---------+---------+---------+---------+---------+  
                                                                                 
 
 
         AAATTACATCACGAAAAAAAAAAAAAAAA 
    1121 ---------+---------+--------- 1149  
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                 10                  30                  50                  70          
                  .         .         .         .         .         .         .          
         AGAGCTACTGGGACATCCAGTCTATGCAACAGAGCTCTCCAGTATGGCATCTTCCATATTTTGTATACTC          
                                                    M  A  S  S  I  F  C  I  L            
                           90                 110                 130                    
                  .         .         .         .         .         .         .          
         TTGTATTTAGGCATTATTTGTGGACAACACATTGGAGTTGATGCCTGGAGTCCTCCTAAAGATGGACCCT          
         L  Y  L  G  I  I  C  G  Q  H  I  G  V  D  A  W  S  P  P  K  D  G  P  Y          
                150                 170                 190                 210          
                  .         .         .         .         .         .         .          
         ATTTTAAGCCAGCCCCTAATGTGGCACTTGATGGAATTACTTCACAGTCCAGTACCATGGCCTATTATGG          
           F  K  P  A  P  N  V  A  L  D  G  I  T  S  Q  S  S  T  M  A  Y  Y  G           
                          230                 250                 270                    
                  .         .         .         .         .         .         .          
         AAACTCAAGACATGCCAACGATGGTTCTTTGGCCAACAACTATCTGAGATCTCAGTGCTCCTACACAAAA          
          N  S  R  H  A  N  D  G  S  L  A  N  N  Y  L  R  S  Q  C  S  Y  T  K            
                290                 310                 330                 350          
                  .         .         .         .         .         .         .          
         AAAGAAGCAGACCCTTGGTGGATGGTGGACCTACAGAAACCTTATCAAATTTTATCTGTGGCTGTCACCA          
         K  E  A  D  P  W  W  M  V  D  L  Q  K  P  Y  Q  I  L  S  V  A  V  T  N          
                          370                 390                 410                    
                  .         .         .         .         .         .         .          
         ACAGAGTGTTGGAATGCTGCAAAGAAAGGCTTTTTAATGCTGAAATCCACATTGGAAATGACCCTAAGCA          
           R  V  L  E  C  C  K  E  R  L  F  N  A  E  I  H  I  G  N  D  P  K  Q           
                430                 450                 470                 490          
                  .         .         .         .         .         .         .          
         AGGTGGAAAATTAAATCCCAGATGCGGTGTTATCTCATCTATAGAATCTGGGGAGACCCTTTCATTCTCA          
          G  G  K  L  N  P  R  C  G  V  I  S  S  I  E  S  G  E  T  L  S  F  S            
                          510                 530                 550                    
                  .         .         .         .         .         .         .          
         TGCCAAGGAATGGTTGGGCAGTATGTGACCATTACTTTACCAGGGAAGGAGGAGCATCTTATTCTGTGTG          
         C  Q  G  M  V  G  Q  Y  V  T  I  T  L  P  G  K  E  E  H  L  I  L  C  E          
                570                 590                 610                 630          
                  .         .         .         .         .         .         .          
         AAGTTCAAGTGTTTGGTCTGCCTGTCAGCAGTTCTGATGATGTTGAAGTGACGGCACCAAAATATCTGAC          
           V  Q  V  F  G  L  P  V  S  S  S  D  D  V  E  V  T  A  P  K  Y  L  T           
                          650                 670                 690                    
                  .         .         .         .         .         .         .          
         AACACCAAACGGAGCTCCAAACTTGGCTGTGAAAGGGATAGCCCAGCAATCCAGTCTCTACAACATGTAT          
          T  P  N  G  A  P  N  L  A  V  K  G  I  A  Q  Q  S  S  L  Y  N  M  Y            
                710                 730                 750                 770          
                  .         .         .         .         .         .         .          
         GGAGAACCAAAGAACGCCAATGATGGGTCTCTAGCCAGTAATTATTTCTTCCTTGAGTGTGCCAGCACTA          
         G  E  P  K  N  A  N  D  G  S  L  A  S  N  Y  F  F  L  E  C  A  S  T  S          
                          790                 810                 830                    
                  .         .         .         .         .         .         .          
         GTGAGCAGGAGGATCCCTGGTGGATGGTTGATCTCAAAGCAAGCCACAGAGTTTACACTGTAGCTGTGAC          
           E  Q  E  D  P  W  W  M  V  D  L  K  A  S  H  R  V  Y  T  V  A  V  T           
                850                 870                 890                 910          
                  .         .         .         .         .         .         .          
         CAACAGAGGTGACTGCTGTGCTGAGAAAATTAACAATGCTGAAATAAGAATCGGAGATTCCAACGATGCA          
          N  R  G  D  C  C  A  E  K  I  N  N  A  E  I  R  I  G  D  S  N  D  A            
                          930                 950                 970                    
                  .         .         .         .         .         .         .          
         GGAGGACAACAAAATCCAGTATGTGGCATTATCAAGTCAATGGCCAATGGGGAGACACTTTCCTTTGAGT          
         G  G  Q  Q  N  P  V  C  G  I  I  K  S  M  A  N  G  E  T  L  S  F  E  C          
                990                1010                1030                1050          
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                  .         .         .         .         .         .         .          
         GCAATGGCATGCAAGGTCAGTATGTGACTGTCTTTATCCCTGGAAATAAAACATCACTCACCATCTGTGA          
           N  G  M  Q  G  Q  Y  V  T  V  F  I  P  G  N  K  T  S  L  T  I  C  E           
                         1070                1090                1110                    
                  .         .         .         .         .         .         .          
         AGTGCAAGTGTTTGGCCTCTCTAGTGAAGCTCCTGATTATACTGGAATATATGTGGTTTCTAAAGATGAC          
          V  Q  V  F  G  L  S  S  E  A  P  D  Y  T  G  I  Y  V  V  S  K  D  D            
               1130                1150                1170                1190          
                  .         .         .         .         .         .         .          
         TCATTTCACCTGGCCGACATATTTATAAATTTTTTTGGTCTATGGAGCAGTGACCAAGAATACGATTATG          
         S  F  H  L  A  D  I  F  I  N  F  F  G  L  W  S  S  D  Q  E  Y  D  Y  D          
                         1210                1230                1250                    
                  .         .         .         .         .         .         .          
         ATTTACCTACAGTAGCTACACGAACTGATGAAAATCTTGCCTTCAGGGGAATCAGCTCCCAGTCCAGCAC          
           L  P  T  V  A  T  R  T  D  E  N  L  A  F  R  G  I  S  S  Q  S  S  T           
               1270                1290                1310                1330          
                  .         .         .         .         .         .         .          
         ATATGATAACCTTGGAAAGGCAGAAAATGCCATTGATGGTTCCACCAGTACAAAATATATGTCAACGCAC          
          Y  D  N  L  G  K  A  E  N  A  I  D  G  S  T  S  T  K  Y  M  S  T  H            
                         1350                1370                1390                    
                  .         .         .         .         .         .         .          
         TGTTCTCACACTGACCTAGACATAGAGCCATGGTGGAAGGTGGACCTTATCAATACCTATAATGTCACCG          
         C  S  H  T  D  L  D  I  E  P  W  W  K  V  D  L  I  N  T  Y  N  V  T  E          
               1410                1430                1450                1470          
                  .         .         .         .         .         .         .          
         AAGTACAAATAACTAACAGGGGCGACTGCTGTAACAATCGTATTAATGGTGCAGAAATTAGAATAGGCAC          
           V  Q  I  T  N  R  G  D  C  C  N  N  R  I  N  G  A  E  I  R  I  G  T           
                         1490                1510                1530                    
                  .         .         .         .         .         .         .          
         TGCTCCTGAAAAGGGTGGAACAAAAAATCCCAGATGTGCTAAAATTGCAACCATGGCCCTTGGAGAGTCA          
          A  P  E  K  G  G  T  K  N  P  R  C  A  K  I  A  T  M  A  L  G  E  S            
               1550                1570                1590                1610          
                  .         .         .         .         .         .         .          
         GCAACATTCAGCTGTGGAATGGTGGGGCGATATGTGACTGTTACAATACCAGGCAGAGCTGCCTATCTCA          
         A  T  F  S  C  G  M  V  G  R  Y  V  T  V  T  I  P  G  R  A  A  Y  L  T          
                         1630                1650                1670                    
                  .         .         .         .         .         .         .          
         CTCTCTGTGAAGTAAAGGCCTTCGGCCATGAAATTTCTGGAAACTACACTAATAATCCCAGTTCTCCTGA          
           L  C  E  V  K  A  F  G  H  E  I  S  G  N  Y  T  N  N  P  S  S  P  D           
               1690                1710                1730                1750          
                  .         .         .         .         .         .         .          
         TTCGGAGGAAATTGAAGAACAGCAAGCTGCCACTGAACTGAGAAATATTTTAAAGCACTCTGATGCCGCA          
          S  E  E  I  E  E  Q  Q  A  A  T  E  L  R  N  I  L  K  H  S  D  A  A            
                         1770                1790                1810                    
                  .         .         .         .         .         .         .          
         TCTAATGTAGCTCTGCATGGGGCTGCATATCAGTCCAGCACAGCTGGTGAAGCTAATGCAAAGAATGCTG          
         S  N  V  A  L  H  G  A  A  Y  Q  S  S  T  A  G  E  A  N  A  K  N  A  V          
               1830                1850                1870                1890          
                  .         .         .         .         .         .         .          
         TAGATGGCAAGCTACAGAATCAGAATCCAGCTAAACAATGTGCTCAAACAACAGTGGAAACTGATCCCTG          
           D  G  K  L  Q  N  Q  N  P  A  K  Q  C  A  Q  T  T  V  E  T  D  P  W           
                         1910                1930                1950                    
                  .         .         .         .         .         .         .          
         GTGGACAGTTGACTTAACATCAATCCATAAGGTCTTCTCAATTGCGGTGACAAACAGAGGAGACTGCTGC          
          W  T  V  D  L  T  S  I  H  K  V  F  S  I  A  V  T  N  R  G  D  C  C            
               1970                1990                2010                2030          
                  .         .         .         .         .         .         .          
         AGTGAAGGGCTTGATGGAGCAGAGATTCACTTAGGAGATTCAGCCTTCAGCTGGAAGAAGAACCCTGTGT          
         S  E  G  L  D  G  A  E  I  H  L  G  D  S  A  F  S  W  K  K  N  P  V  C          
                         2050                2070                2090                    
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                  .         .         .         .         .         .         .          
         GTGGAACTGTATCCAAAATTGGTCCTGGAGAAACATTTTCTTTTGAGTGCAATGGAATGGAAGGACGTTA          
           G  T  V  S  K  I  G  P  G  E  T  F  S  F  E  C  N  G  M  E  G  R  Y           
               2110                2130                2150                2170          
                  .         .         .         .         .         .         .          
         TGTAACCATTGTTCTACTAGGCAATGAAAAGTCTCTTACACTTTGTGAAGTACAGGTCTTTGGCTTAACA          
          V  T  I  V  L  L  G  N  E  K  S  L  T  L  C  E  V  Q  V  F  G  L  T            
                         2190                2210                2230                    
                  .         .         .         .         .         .         .          
         GTGGAAACACCAAATGGCGAGAGGAATGGTGATTTTGAGCAACAAAAAGAGAATCATGGAGCAAAGAATG          
         V  E  T  P  N  G  E  R  N  G  D  F  E  Q  Q  K  E  N  H  G  A  K  N  V          
               2250                2270                2290                2310          
                  .         .         .         .         .         .         .          
         TAGCTCCCCAAGGTATTCCTTATCAGTCAAGCTATTACGGCCAAAAGGAACAAGCCAAACGCGTTATTGA          
           A  P  Q  G  I  P  Y  Q  S  S  Y  Y  G  Q  K  E  Q  A  K  R  V  I  D           
                         2330                2350                2370                    
                  .         .         .         .         .         .         .          
         TGGATCTCTAGCAAGCAACTACATGGAAGGAGACTGCTGCCACACTGAGAAACAGATGCATCCTTGGTGG          
          G  S  L  A  S  N  Y  M  E  G  D  C  C  H  T  E  K  Q  M  H  P  W  W            
               2390                2410                2430                2450          
                  .         .         .         .         .         .         .          
         CAACTAGACATGAAATCCAAAATGCGTGTACATTCCGTGGCCATCACCAACCGAGGAGACTGCTGCCGGG          
         Q  L  D  M  K  S  K  M  R  V  H  S  V  A  I  T  N  R  G  D  C  C  R  E          
                         2470                2490                2510                    
                  .         .         .         .         .         .         .          
         AAAGAATCAATGGGGCTGAAATCCGCATTGGGAATTCTAAAAAAGAAGGGGGACTTAACAGTACCAGGTG          
           R  I  N  G  A  E  I  R  I  G  N  S  K  K  E  G  G  L  N  S  T  R  C           
               2530                2550                2570                2590          
                  .         .         .         .         .         .         .          
         TGGCGTTGTRTTCAAGATGAATTATGAGGAGACGTTATCCTTTAACTGCAAAGAGCTTGAGGGCCGATAT          
          G  V  V  F  K  M  N  Y  E  E  T  L  S  F  N  C  K  E  L  E  G  R  Y            
                         2610                2630                2650                    
                  .         .         .         .         .         .         .          
         GTCACTGTAACAATACCAGACAGAATGGAGTACCTAACACTGTGTGAAGTTCAGGTTTTTGCTGATCCAC          
         V  T  V  T  I  P  D  R  M  E  Y  L  T  L  C  E  V  Q  V  F  A  D  P  L          
               2670                2690                2710                2730          
                  .         .         .         .         .         .         .          
         TCGAAGTAGATGGAACGGAAGCATCGGATTCTTCAGAGTCTGTAGATGGAACAGAAGCACCAGCTTCTCC          
           E  V  D  G  T  E  A  S  D  S  S  E  S  V  D  G  T  E  A  P  A  S  P           
                         2750                2770                2790                    
                  .         .         .         .         .         .         .          
         AGAGTCTGATGTGGAACTACCAATTGCTTCTGGTATGAATGTGGATTTAACAAACAAATCTTTCATGTTC          
          E  S  D  V  E  L  P  I  A  S  G  M  N  V  D  L  T  N  K  S  F  M  F            
               2810                2830                2850                2870          
                  .         .         .         .         .         .         .          
         CCAAAAGAAAGTGACATCAACCATGTAAAGCTATTACCTGAAAAAGCAATGAGCCTCAAAGCCTTTACAC          
         P  K  E  S  D  I  N  H  V  K  L  L  P  E  K  A  M  S  L  K  A  F  T  L          
                         2890                2910                2930                    
                  .         .         .         .         .         .         .          
         TCTGCATGAAGGTGCTCTTGAATGTCCCTGAAAATCGAGAAACCATTTTATTTTCATACCGTACAATGTT          
           C  M  K  V  L  L  N  V  P  E  N  R  E  T  I  L  F  S  Y  R  T  M  F           
               2950                2970                2990                3010          
                  .         .         .         .         .         .         .          
         TTACGATGAGCTAAACCTTTGGATTGAGCGTGATGGTAGAATAGGCCTATACATGAGTGGAGATGGCATT          
          Y  D  E  L  N  L  W  I  E  R  D  G  R  I  G  L  Y  M  S  G  D  G  I            
                         3030                3050                3070                    
                  .         .         .         .         .         .         .          
         ATATTCCCGCGAATGAAATTTAAAAGTGAATGGAACCATCTCTGTTTGACTTGGGAGTCTAAGTACGGTC          
         I  F  P  R  M  K  F  K  S  E  W  N  H  L  C  L  T  W  E  S  K  Y  G  R          
               3090                3110                3130                3150          
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                  .         .         .         .         .         .         .          
         GCACAGAATTCTGGTTGAATGGCAGACGATCAGCTACAAAAGTGTATCACCAAAAGAACACTGTGCGTTC          
           T  E  F  W  L  N  G  R  R  S  A  T  K  V  Y  H  Q  K  N  T  V  R  S           
                         3170                3190                3210                    
                  .         .         .         .         .         .         .          
         AGGTGGAATCGTCTTGTTGGGTCAAGATCAAGATTCTTATGGGGGAGATTTTGATAAGACCCAAAGCTTT          
          G  G  I  V  L  L  G  Q  D  Q  D  S  Y  G  G  D  F  D  K  T  Q  S  F            
               3230                3250                3270                3290          
                  .         .         .         .         .         .         .          
         GTGGGACAAATCAAAGATCTTAAGATGTGGAACAAAGTCCTGCCCCTGAGGTCTCTCAAATCTTTGTTCA          
         V  G  Q  I  K  D  L  K  M  W  N  K  V  L  P  L  R  S  L  K  S  L  F  K          
                         3310                3330                3350                    
                  .         .         .         .         .         .         .          
         AGGGTAGAGAAATTGGAAATGGCAATATTTTTGATTGGAGTTCATTATCTTACTCAATGATAGGAAATGT          
           G  R  E  I  G  N  G  N  I  F  D  W  S  S  L  S  Y  S  M  I  G  N  V           
               3370                3390                3410                3430          
                  .         .         .         .         .         .         .          
         TGCAGAAGTCTAAAATGAAATCAGCTCAAGTTAGTAACACAATGGGCTCTTTCTCTGTGCAGTTCTTGAT          
          A  E  V  *                                       
                         3450                3470                3490                    
                  .         .         .         .         .         .         .          
         TAGTAACTAACAGTCAAACTATCACAGTCCAGAAGCTTACTCTGCGTCTATTCTGTAGAGCTGACAATTA          
                    
               3510                3530                3550                3570          
                  .         .         .         .         .         .         .          
         AAATAAAATCCATGGTACTCTTGTACGGCTTTGAGTGGCCATATATAGCTTTATATTGTGGTTGATATGT          
                       
                         3590                3610                3630                    
                  .         .         .         .         .         .         .          
         TATCACGCTGCATCTTGGGATATATTAGTTAAAGTTAAAAAGATGCTTGTATCTAATTTAGGGAAATAGA          
                       
               3650                3670                3690                3710          
                  .         .         .         .         .         .         .          
         GAACATGGTCAGTTGTCTGGTCAGATCCTGTGCTTGAAAACGGTTTAGGATTCTGGACTCTGTTTAAACT          
                  
                         3730                3750                3770                    
                  .         .         .         .         .         .         .          
         GATTTTACTTTATAACATATCCATTCTGATTGTAAAAATGAAAGTTAAATGTCAAACTACAATGTATTAA          
                       
               3790                3810                3830                   
                  .         .         .         .         .         .         
         AAAATAAAGATAATACAGTGATTTCAAAAAAAAAAAAAAAATCGATATCTAGATCTGCGG         
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                  10                  30                  50                  70          
                  .         .         .         .         .         .         .          
         GAATGTAGGTTGGCAGAGGACTGCCTGTACCCTACCTGATTGATCCCGATCCCCACACTGGCAACATCTG          
          N  V  G  W  Q  R  T  A  C  T  L  P  D  *  S  R  S  P  H  W  Q  H  L            
                           90                 110                 130                    
                  .         .         .         .         .         .         .          
         ACTTGTAAGAATTGATACACCTGTCTACTGATACCTTAAGGATCTGCCTGACTGTGATCATCGCTCTGTC          
         T  C  K  N  *  Y  T  C  L  L  I  P  *  G  S  A  *  L  *  S  S  L  C  P          
                150                 170                 190                 210          
                  .         .         .         .         .         .         .          
         CACCGTGATTCCATCTGCTGTATCCTACAAGTACTTGTCTCCATGTGTCTTAGCTGATCCATAGCAGTTG          
           P  *  F  H  L  L  Y  P  T  S  T  C  L  H  V  S  *  L  I  H  S  S  W           
                          230                 250                 270                    
                  .         .         .         .         .         .         .          
         GACAGAAATTGAATGCATCACCCAAGGAAGTGACTATCTCCCATAATCTCTGATGATGTGTCTTCTGCTA          
          T  E  I  E  C  I  T  Q  G  S  D  Y  L  P  *  S  L  M  M  C  L  L  L            
                290                 310                 330                 350          
                  .         .         .         .         .         .         .          
         CTCTTGGCTTTTGGAGCCATTGCCCAGGCTCAGAGATGTGATCCCCAGACAGAAGGGGTCAATGTTGCAA          
         L  L  A  F  G  A  I  A  Q  A  Q  R  C  D  P  Q  T  E  G  V  N  V  A  R          
                          370                 390                 410                    
                  .         .         .         .         .         .         .          
         GACTGGGAATTGCCAGCCAAAGCTCTACCTATGTCCATGATCCAATGCCTGGTCCTGAACGCGCTCTCGA          
           L  G  I  A  S  Q  S  S  T  Y  V  H  D  P  M  P  G  P  E  R  A  L  D           
                430                 450                 470                 490          
                  .         .         .         .         .         .         .          
         TGGAAATAACAAGGTCAATGCAATGATCCACCCCTGCTCCCACACCTACAATGACTTTGAGCCCTGGTGG          
          G  N  N  K  V  N  A  M  I  H  P  C  S  H  T  Y  N  D  F  E  P  W  W            
                          510                 530                 550                    
                  .         .         .         .         .         .         .          
         CGTGTGGACCTGAAAAAGACCTATGCAGTCAACTCTGTGGTCATAGTGAATAGGATGGACTGCTGCAGTG          
         R  V  D  L  K  K  T  Y  A  V  N  S  V  V  I  V  N  R  M  D  C  C  S  E          
                570                 590                 610                 630          
                  .         .         .         .         .         .         .          
         AGCGCCTTGAAGGGGCGCAGGTTCGTATTGGGAATTCTGCGGACAACAATAACCCAATTTGTGGCACCAT          
           R  L  E  G  A  Q  V  R  I  G  N  S  A  D  N  N  N  P  I  C  G  T  I           
                          650                 670                 690                    
                  .         .         .         .         .         .         .          
         CAGTGATGCCTCCCAAGCTACAATCACTCTGTTCTGCAATGGGATGGTGGGTCGGTACCTCAGTGTTGTT          
          S  D  A  S  Q  A  T  I  T  L  F  C  N  G  M  V  G  R  Y  L  S  V  V            
                710                 730                 750                 770          
                  .         .         .         .         .         .         .          
         ATTTCAGGACGACAGGAATTTCTCACGCTCTGTGAAGTGGAGGTTTATGGGCAAGAATCTGATGATAAAG          
         I  S  G  R  Q  E  F  L  T  L  C  E  V  E  V  Y  G  Q  E  S  D  D  K  D          
                          790                 810                 830                    
                  .         .         .         .         .         .         .          
         ATAATTTGGCGAGACTGGGAGATGCCACTCAGAGCTCAACTTACAGACCCGAGTACAACGCTGGTGCCGC          
           N  L  A  R  L  G  D  A  T  Q  S  S  T  Y  R  P  E  Y  N  A  G  A  A           
                850                 870                 890                 910          
                  .         .         .         .         .         .         .          
         TATTGATGGCAATAAGGTGACAAATATGATGTTGGGCTCATGTTCCCACACCAATAATGACAACCCGGCT          
          I  D  G  N  K  V  T  N  M  M  L  G  S  C  S  H  T  N  N  D  N  P  A            
                          930                 950                 970                    
                  .         .         .         .         .         .         .          
         TGGTGGCGGCTGGACCTAAAGAAAAGATACAAAGTGGACAAAGTGGTGATAGTGAACAGAGGAGACTGCT          
         W  W  R  L  D  L  K  K  R  Y  K  V  D  K  V  V  I  V  N  R  G  D  C  C          
                990                1010                1030                1050          
                  .         .         .         .         .         .         .          
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         GCGCTGAGAGACTGTTGGGAGCCCAGATTCATATTGGAAATTCAGCAAATAACAACAACCCAATATGCGG          
           A  E  R  L  L  G  A  Q  I  H  I  G  N  S  A  N  N  N  N  P  I  C  G           
                         1070                1090                1110                    
                  .         .         .         .         .         .         .          
         CGGCATAAACAGCGTCTCTGAGGCCACTATCACTCTGTCCTGTCATGGGATGGAGGGTCAGTATGTGAGT          
          G  I  N  S  V  S  E  A  T  I  T  L  S  C  H  G  M  E  G  Q  Y  V  S            
               1130                1150                1170                1190          
                  .         .         .         .         .         .         .          
         GTGGTCATTCCCGGGAGGGCAGAAAATCTCCAGCTCTGTGAAGTGGAGGTTTATGGGCAAGAAGTTAAAT          
         V  V  I  P  G  R  A  E  N  L  Q  L  C  E  V  E  V  Y  G  Q  E  V  K  C          
                         1210                1230                1250                    
                  .         .         .         .         .         .         .          
         GTGTTGCAGATAATTTGGCGAGACTGGGAGATGCCACTCAGAGCTCAACTTACAGACCCGAGTACAACGC          
           V  A  D  N  L  A  R  L  G  D  A  T  Q  S  S  T  Y  R  P  E  Y  N  A           
               1270                1290                1310                1330          
                  .         .         .         .         .         .         .          
         TGGTGCCGCTATTGATGGCAATAAGGGGACAAATATGATGTTGGGCTCATGTTCCCACACCAATAATGAC          
          G  A  A  I  D  G  N  K  G  T  N  M  M  L  G  S  C  S  H  T  N  N  D            
                         1350                1370                1390                    
                  .         .         .         .         .         .         .          
         AACCCGGCTTGGTGGCGGCTGGACCTAAAGAAAAGATACAAAGTGGACAAAGTGGTGATAGTGAACAGAG          
         N  P  A  W  W  R  L  D  L  K  K  R  Y  K  V  D  K  V  V  I  V  N  R  G          
               1410                1430                1450                1470          
                  .         .         .         .         .         .         .          
         GAGACTGCTGCGATGAGAGACTGTTGGGAGCCCAGATTCTTATTGGAAATTCAGCAAATAACAACAACCC          
           D  C  C  D  E  R  L  L  G  A  Q  I  L  I  G  N  S  A  N  N  N  N  P           
                         1490                1510                1530                    
                  .         .         .         .         .         .         .          
         AATATGCGGCGGCATAGACAGCGTCTCTGAGGCCACTATCACTCTGTCCTGTCATGGAATGGAGGGTCAG          
          I  C  G  G  I  D  S  V  S  E  A  T  I  T  L  S  C  H  G  M  E  G  Q            
               1550                1570                1590                1610          
                  .         .         .         .         .         .         .          
         TATGTGAGTGTGGTCATTCCCGGGAGGGCAGAAAATCTCCAGCTCTGTGAAGTGGAGGTTTATGGGCAAG          
         Y  V  S  V  V  I  P  G  R  A  E  N  L  Q  L  C  E  V  E  V  Y  G  Q  E          
                         1630                1650                1670                    
                  .         .         .         .         .         .         .          
         AAGTTAAAGCTATTACAGCAGTGAATGTGGCAAGATGGGAAGCGTCAGTCAGAGCTCCACTTATAGACCA          
           V  K  A  I  T  A  V  N  V  A  R  W  E  A  S  V  R  A  P  L  I  D  Q           
               1690                1710                1730                1750          
                  .         .         .         .         .         .         .          
         GAGTACAGCGCTGAAACAGCTATTGATGGTGATAAAGAGACAAATATCTTCATGCACCCGTGTGCCCACA          
          S  T  A  L  K  Q  L  L  M  V  I  K  R  Q  I  S  S  C  T  R  V  P  T            
                         1770                1790                1810                    
                  .         .         .         .         .         .         .          
         CTAATCCTGATAATCCTGCTTGGTGGCAACTGGACTTAAAGACTGCCTATATGATTGAGTCAGTGGTCAT          
         L  I  L  I  I  L  L  G  G  N  W  T  *  R  L  P  I  *  L  S  Q  W  S  *          
               1830                1850                1870                1890          
                  .         .         .         .         .         .         .          
         AGTGAACAGAGGAGACTGTTGCAGTGAGCGCCTGCTGGGAGCCCAGATCCGTGTTGGAAACTCACCATTT          
           *  T  E  E  T  V  A  V  S  A  C  W  E  P  R  S  V  L  E  T  H  H  F           
                         1910                1930                1950                    
                  .         .         .         .         .         .         .          
         CACAACAACCCTGTATGCGGCACCATCACCGACGTCTCTGAAACGACCATCACTCTGTCCTGTCACAAGA          
          T  T  T  L  Y  A  A  P  S  P  T  S  L  K  R  P  S  L  C  P  V  T  R            
               1970                1990                2010                2030          
                  .         .         .         .         .         .         .          
         TGGAGGGTCGCTATGTGAGTGTGGTGATTCCCGGGAGAGCGGAATATCTCCATATCTGTGAAGTGGAGGT          
         W  R  V  A  M  *  V  W  *  F  P  G  E  R  N  I  S  I  S  V  K  W  R  F          
                         2050                2070                2090                    
                  .         .         .         .         .         .         .          
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         TTATGGGGTGAAAATCTAAATATGATGCCCCACATGTTGGTTCAAGAATAGACATTTATTCATTTATTAG          
           M  G  *  K  S  K  Y  D  A  P  H  V  G  S  R  I  D  I  Y  S  F  I  R           
               2110                2130                2150                2170          
                  .         .         .         .         .         .         .          
         GCCGGGCATGGGTTATTGATTCAGTGTAAAATTGTGTTTAAGTTCGGTGCAATATTCTAGTCGTTTTCTG          
          P  G  M  G  Y  *  F  S  V  K  L  C  L  S  S  V  Q  Y  S  S  R  F  L            
                         2190                2210                2230                    
                  .         .         .         .         .         .         .          
         TTCATGACACTCAATATAAATAATCAATAAACTGAGATGTGAGAAAAAAAAAAAAAAAATCGATATCTAG          
         F  M  T  L  N  I  N  N  Q  *  T  E  M  *  E  K  K  K  K  N  R  Y  L  D          
               2250                  
                  .                  
         ATCTGCGGCCGCATGCGGA         




D. Xla-neurula cDNA 
                 10                  30                  50                  70          
                  .         .         .         .         .         .         .          
         GAGAAAGAAGTGCAACACTAACAAGACSRACKAAGGAGAAAGAAGTGCAACACTAACAAGACCAACTGAC          
          R  K  K  C  N  T  N  K  T  X  X  G  E  R  S  A  T  L  T  R  P  T  D            
                           90                 110                 130                    
                  .         .         .         .         .         .         .          
         AGGATGAAGTGCATTGTTCTCCTGCTGGTTTGCTTCTCTATCGGATGGGTTCACTCCAACCCCACAAAAA          
         R  M  K  C  I  V  L  L  L  V  C  F  S  I  G  W  V  H  S  N  P  T  K  K          
                150                 170                 190                 210          
                  .         .         .         .         .         .         .          
         AAGTTAACATTGCAAAATTTGGAGAAGCCTCACAGAGCTCAGATTACAGACCTGAGTACAATGCTGCTGC          
           V  N  I  A  K  F  G  E  A  S  Q  S  S  D  Y  R  P  E  Y  N  A  A  A           
                          230                 250                 270                    
                  .         .         .         .         .         .         .          
         TGCTATCGATGGTGATAGAGACTCAAATATGATGGCGGGTTCATGCTCCCTTACTGGTAACGACAAGCCA          
          A  I  D  G  D  R  D  S  N  M  M  A  G  S  C  S  L  T  G  N  D  K  P            
                290                 310                 330                 350          
                  .         .         .         .         .         .         .          
         TCTTGGTGGCAGTTGAACCTAAAGCACAGGTACAAAGTGGAGAAGGTGGTGATAGTGAACAGAGGAGACT          
         S  W  W  Q  L  N  L  K  H  R  Y  K  V  E  K  V  V  I  V  N  R  G  D  C          
                          370                 390                 410                    
                  .         .         .         .         .         .         .          
         GCTGCAGTGAGCGCCTTTTGGGAGCCCAGATCCGTGTTGGATTCACAGCCAATCTGAAGAACCCACTATG          
           C  S  E  R  L  L  G  A  Q  I  R  V  G  F  T  A  N  L  K  N  P  L  C           
                430                 450                 470                 490          
                  .         .         .         .         .         .         .          
         TGGCACCGTAACTGATGTCTCTGAAGAAACCATCACTCTGTCCTGTCACGGGATGGTGGGTCAGTACGTC          
          G  T  V  T  D  V  S  E  E  T  I  T  L  S  C  H  G  M  V  G  Q  Y  V            
                          510                 530                 550                    
                  .         .         .         .         .         .         .          
         ACTGTGTCTATTCCTGAACGTGAGGAATATCTCCAGCTCTGTGAAGTGGAGGTCTATGGGAACAAATACA          
         T  V  S  I  P  E  R  E  E  Y  L  Q  L  C  E  V  E  V  Y  G  N  K  Y  S          
                570                 590                 610                 630          
                  .         .         .         .         .         .         .          
         GCCCTGTTGTACCAGTCCATGAGGAATCGGAGGAAGATGTACTGCAAGACATAGGCAATTTATATAAACA          
           P  V  V  P  V  H  E  E  S  E  E  D  V  L  Q  D  I  G  N  L  Y  K  H           
                          650                 670                 690                    
                  .         .         .         .         .         .         .          
         TTAAAGAACACCTTGGTTTTAGGGATGTCGCGGACTGTTCGGCCGTGAACTAGTTTGCGCGAACATCGAC          
          *               
                710                 730                 750                 770          
                  .         .         .         .         .         .         .          
         TGTTCGCGTCCGCCGAATGTTCGCGAACGTCGCCTTAGCTGGCGCTTATTTTTGCCATTTCTCACCCAGA          
                    
                          790                 810                 830                    
                  .         .         .         .         .         .         .          
         CCAGCAGATACATGGCAGCCAATCAGGAAGCTCTCCCTCCTGGACCACCCCCACACCCCCTGGACCACTC          
                       
                850                 870                 890                 910          
                  .         .         .         .         .         .         .          
         CCCYTCCATATATAAACTGAAGCCCTGCWKYGTTTTTTCATTCTGCCTGTGTGTGCTTGGAAGAGCTAGT          
                       
                          930                 950                 970                    
                  .         .         .         .         .         .         .          
         GTAGGGAGAGAGCTGTTGAGTGATTTGAGGGACAGTTGATAGTAACTTTGCTGGCTAGTAATCTACTTGA          
                       
                990                1010                1030                1050          
                  .         .         .         .         .         .         .          
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         TACTGCTCTGTATTGTAGGGACAGAACTCTGCAGGGATTTGAGGGACAGTGAGTTTAGGTTAGTTAGCTT          
                       
                         1070                1090                1110                    
                  .         .         .         .         .         .         .          
         TGCTGGCTAGTAATCTACCTTCTACTGCAGTGCTCTGTATGTAGCTGCTGTGGGCACTGCTGCTGATCTC          
                       
               1130                1150                1170                1190          
                  .         .         .         .         .         .         .          
         TCATCTGCTGACTGCTGCCTGTAACCCAATAGTCCTTGTAAGGACTGCTTTTATTTTCTTTTTTGTTTTT          
                    
                         1210                1230                1250                    
                  .         .         .         .         .         .         .          
         TTACTTTGCTACTATAAGAGCCCAGTGCTATTAGTCTAGCTGTGTTGGGGAGTGGGACTGGTGTGCTGCT          
                             
               1270                1290                         
                  .         .         .         .               
         CCTCCTAGTAGNTCACCACTACCAGCACCAACCAGAGTCAAAATTG         
 
 217 
E. In silico XLEST2 cDNA 
                 10                  30                  50                  70          
                  .         .         .         .         .         .         .          
         AAGGATGAAGTGCATTGTGGTTCTGCTCGYWTTTGCAGCTGTTGGGTGGGCGCAGTTGTGCAACCCCCAG          
          R  M  K  C  I  V  V  L  L  X  F  A  A  V  G  W  A  Q  L  C  N  P  Q            
                           90                 110                 130                    
                  .         .         .         .         .         .         .          
         ATAGGAGGACAAAATTTGGCAAGATCAGGAGGAGTCAAGCAAAGCTCCACCTACGCTCCTCAGTACACTG          
         I  G  G  Q  N  L  A  R  S  G  G  V  K  Q  S  S  T  Y  A  P  Q  Y  T  V          
                150                 170                 190                 210          
                  .         .         .         .         .         .         .          
         TTGATAAAGCGATTGATGGCATAAAAAACACAAATACCTTTGTACAAGCATGCGCCATTACTGGATATGA          
           D  K  A  I  D  G  I  K  N  T  N  T  F  V  Q  A  C  A  I  T  G  Y  D           
                          230                 250                 270                    
                  .         .         .         .         .         .         .          
         CAAAAACGCTTGGTGGCAGGTGGACCTGAAGAATTCCTACAAAGTTGGTTCTGTGGTCATAGTGAACAGA          
          K  N  A  W  W  Q  V  D  L  K  N  S  Y  K  V  G  S  V  V  I  V  N  R            
                290                 310                 330                 350          
                  .         .         .         .         .         .         .          
         GGAGACTGTTGTGCCGATCGTCTGAAAGGAGCCCAGATCCGTGTTGGAAATTCAGCAGATAATAACAACC          
         G  D  C  C  A  D  R  L  K  G  A  Q  I  R  V  G  N  S  A  D  N  N  N  P          
                          370                 390                 410                    
                  .         .         .         .         .         .         .          
         CAGTATGCGCCACCGTCACTGATGTCTCTCAACTCACCATCAATATGTGCTGTAAGGGGATGGTGGGTCA          
           V  C  A  T  V  T  D  V  S  Q  L  T  I  N  M  C  C  K  G  M  V  G  Q           
                430                 450                 470                 490          
                  .         .         .         .         .         .         .          
         GTATGTGAGTGTGGTCATTCCTGGCCGCAATGAATATCTCCAGCTCTGTGAAGTTGAGGTTTATGGGGAG          
          Y  V  S  V  V  I  P  G  R  N  E  Y  L  Q  L  C  E  V  E  V  Y  G  E            
                          510                 530                 550                    
                  .         .         .         .         .         .         .          
         GAAAATAAACCTGAAGAAAAACCTGAAGAAAAACAACTTTGTTGGTAAAACCATGTTACATTCAGTCAGT          
         E  N  K  P  E  E  K  P  E  E  K  Q  L  C  W  *              
                570                 590                 610                 630          
                  .         .         .         .         .         .         .          
         GGCCTCAGCAGGTGAAGGCAAATCAAGCAAATCAAGCAGCAGATCTCCCATCATTGTCAGTGGTTGCTAC          
                       
                          650                 670                 690                    
                  .         .         .         .         .         .         .          
         ACTAGAACTTTCAAAACGTTCTTGGGGAATACAATGAGCAGCACTTCAACAAGAGTCCAGGCAAAGACCA          
                       
                710                 730                 750                 770          
                  .         .         .         .         .         .         .          
         ACATACCATCTCTAATGGATACTGTAGAGCAGGGGTAGCCACAAGTTATTGGATCCTGATCTAACAATCG          
                    
                          790                 810                 830                    
                  .         .         .         .         .         .         .          
         ATCTTAAGCTGAAGATCATGACAGCAAATGTTGTCCACAAACAGGTTAATTAGATCCACATTCTCACTGT          
                       
                850                 870                 890                 910          
                  .         .         .         .         .         .         .          
         TGAGATTCTTTCAATACTTTTTGGGTTTGTTCATTTAACCTTATCAATATGGGCTCATTGATCATTTGAA          
                     
                          930                 950                 970                    
                  .         .         .         .         .         .         .          
         CGGGTTTAAGCGCTGAAACCATATGGGACAAAACATTCCTTCGCTGAGGAACCATCGGTGGAGTATTTGT          
                    
                990                1010                1030                1050          
                  .         .         .         .         .         .         .          
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         GCCTGTGGTTTTAGTGGTGGAAGCTGTGAGCCTCACCTTGGGCTTGAGCAACTCCAGCACCTTGTGGCCT          
                       
                         1070                1090                1110                    
                  .         .         .         .         .         .         .          
         CCAGTGTATTCAATTAGTTGTGCTCTGTTGTACAACTGCAAAGCATTTCACATCCGGGCTCATAAATGGA          
                       
               1130                1150                1170                1190          
                  .         .         .         .         .         .         .          
         GGGTTTTGTGTTTGTTTTGTGTTGCCTGAGGCCACTGACAGAATGTGCAACTGTTCTTCTCTTTCATCCT          
                    
                         1210                1230                1250                    
                  .         .         .         .         .         .         .          
         CTCTCTCTTAATTGGTTTGGTGCAATTTTCTGTTTTTCGAGAATGTTTTTTATTTTATACAAGCAGCCAA          
                       
               1270                1290                           
                  .         .         .         .                 
         AATCAATAAATGAATATGATTGTGAWAAACAAAAAAAAAAAAAAAAAA         
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F. DreI-FBPL cDNA 
                  10                  30                  50                  70          
                  .         .         .         .         .         .         .          
         AACACATGTGAGTTGGGAGGAGAAAAACAAACACATGACATGGATGTAAAGTTAAGCTAATGTGTTTTTC          
                                                                                         
                           90                 110                 130                    
                  .         .         .         .         .         .         .          
         CTAAGAAACCCATTCACTCAAACATACCCTGATGAAAGCAGTCAGAAAGTGCTGGAAATGAACATGAGGC          
                                                                  M  N  M  R  L          
                150                 170                 190                 210          
                  .         .         .         .         .         .         .          
         TTTTTTACAGGAGTCTACCTCTCTTACTGGGGTTCTTATCAGTTCAGACGAGTGCGGCTGGCACAGAAGT          
           F  Y  R  S  L  P  L  L  L  G  F  L  S  V  Q  T  S  A  A  G  T  E  V           
                          230                 250                 270                    
                  .         .         .         .         .         .         .          
         GAACATAGCAGGATGGGGAACAGCCACCCAGTCGACAATATATATGGACGGGCTTCCTGTAAATGCTCTG          
          N  I  A  G  W  G  T  A  T  Q  S  T  I  Y  M  D  G  L  P  V  N  A  L            
                290                 310                 330                 350          
                  .         .         .         .         .         .         .          
         AATGGGATAAGCCCCCCCTGTACACACACTATAGTACAGACTCTGCCCTGGTGGAGACTAGACCTGCAGA          
         N  G  I  S  P  P  C  T  H  T  I  V  Q  T  L  P  W  W  R  L  D  L  Q  K          
                          370                 390                 410                    
                  .         .         .         .         .         .         .          
         AGAGCTACAGCGTGAACAGAGTCTCCATCACTAACAGACTGGACTGCTGCAGYGAGAGGATCAACGGTGC          
           S  Y  S  V  N  R  V  S  I  T  N  R  L  D  C  C  S  E  R  I  N  G  A           
                430                 450                 470                 490          
                  .         .         .         .         .         .         .          
         TGAGATTCGCATCGGAGACGTTCCTTCAGATGTGTTCAGCAACCCAGTATGTGCAGTAGTTTCTACCATT          
          E  I  R  I  G  D  V  P  S  D  V  F  S  N  P  V  C  A  V  V  S  T  I            
                          510                 530                 550                    
                  .         .         .         .         .         .         .          
         CCAGCAGGACAGACGTTCAGCTACTCGTGTAATGGGATGCAGGGACGTTACGTGTTTGTGGATATTAATG          
         P  A  G  Q  T  F  S  Y  S  C  N  G  M  Q  G  R  Y  V  F  V  D  I  N  A          
                570                 590                 610                 630          
                  .         .         .         .         .         .         .          
         CACCTTCAAGCATTCTTACTCTCTGTGCTGTAGGAGTCTTTGTGGTTTTTCCAGATAATTTGGCAACAGG          
           P  S  S  I  L  T  L  C  A  V  G  V  F  V  V  F  P  D  N  L  A  T  G           
                          650                 670                 690                    
                  .         .         .         .         .         .         .          
         TAAAAACGTGATGCAGTCATCAACCTACAGCTCCTGGATTCCTGAACAGGCCATTGATTTCAATCCAGGA          
          K  N  V  M  Q  S  S  T  Y  S  S  W  I  P  E  Q  A  I  D  F  N  P  G            
                710                 730                 750                 770          
                  .         .         .         .         .         .         .          
         TTATCAGATCCATCAATAGGGTGTTCCTCAACCAATAGTCAAACTGACCCATGGTGGAGGCTGGATCTGG          
         L  S  D  P  S  I  G  C  S  S  T  N  S  Q  T  D  P  W  W  R  L  D  L  G          
                          790                 810                 830                    
                  .         .         .         .         .         .         .          
         GCCACATTTACCAAGTGAGTACAGTAGTGGTCACTAACAGACTAAACTGCTGTCCAGAACGAATAAACGG          
           H  I  Y  Q  V  S  T  V  V  V  T  N  R  L  N  C  C  P  E  R  I  N  G           
                850                 870                 890                 910          
                  .         .         .         .         .         .         .          
         AGCCGAGATTCACATCGGAAACTCTTTGGAGAACAACGGCAACAACAATCCCATATGTGCTGTGATTTCC          
          A  E  I  H  I  G  N  S  L  E  N  N  G  N  N  N  P  I  C  A  V  I  S            
                          930                 950                 970                    
                  .         .         .         .         .         .         .          
         AGTATTCCTGCTGGAGTTTCTGCCACCTTCGCCTGTAACAATATGGAGGGTCGATATGTGAGTCTGTTGA          
         S  I  P  A  G  V  S  A  T  F  A  C  N  N  M  E  G  R  Y  V  S  L  L  I          
                990                1010                1030                1050          
                  .         .         .         .         .         .         .          
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         TTCGTGGAGACACAAAGTTTCTCACTCTGTGTGAAGTGGAGGTCTATGGACAAGGTCCATGTTTGAAGCA          
           R  G  D  T  K  F  L  T  L  C  E  V  E  V  Y  G  Q  G  P  C  L  K  Q           
                         1070                1090                1110                    
                  .         .         .         .         .         .         .          
         GTCATTGATGAAGCTGAAGCTCAACTCCAGCTTTAGTCTTTCTGAAGTTCGTCTCATGACACAGCTGGAA          
          S  L  M  K  L  K  L  N  S  S  F  S  L  S  E  V  R  L  M  T  Q  L  E            
               1130                1150                1170                1190          
                  .         .         .         .         .         .         .          
         TCTGCTCTGGCACAAAGAGGCTTTTCTGATGTCACGCTGCAATGGACACAACTGCCCAAACAGGAAGTGA          
         S  A  L  A  Q  R  G  F  S  D  V  T  L  Q  W  T  Q  L  P  K  Q  E  V  I          
                         1210                1230                1250                    
                  .         .         .         .         .         .         .          
         TACGGAAGAAAGTAGAGCAAGCTCACTGTGCTCAAACAAAGAGATGAAGGAAACGCTGAACTCTGGATCT          
           R  K  K  V  E  Q  A  H  C  A  Q  T  K  R  *                                   
               1270                1290                1310                1330          
                  .         .         .         .         .         .         .          
         GCTGTGATCTTCATTCACATGCAAAAAATACATTAAATACAAACACGTGACCAACTGGAGCGACACGATT          
                                                                                         
                         1350                1370                            
                  .         .         .         .         .                  
         CCGGAGAAACTGGGAATGAAATAAAAAAATCTGACAAAATGCCAAAAAAAAAAAAAAAA   
 
 221 
G. DreII-FBPL partial CDS 
        ATAATCTGGCGCTAAAGAGAAACGCCTCTCAGTCGTCCAGTTTTGGGTTTTGGTCTGCAG 
       1 ---------+---------+---------+---------+---------+---------+ 60 
           N  L  A  L  K  R  N  A  S  Q  S  S  S  F  G  F  W  S  A  E - 
  
         AAAGAGCCGTCGATGGTTCTCGAACTGGGCCAAAGTTATGGTCAGTGTGTTCGTCCACCG 
      61 ---------+---------+---------+---------+---------+---------+ 120 
           R  A  V  D  G  S  R  T  G  P  K  L  W  S  V  C  S  S  T  A - 
  
         CTAACCAAAGTAACCCGTGGTGGAGGGTGGATCTGGGGGACGTTTACCGCGTTAGCAGAG 
     121 ---------+---------+---------+---------+---------+---------+ 180 
           N  Q  S  N  P  W  W  R  V  D  L  G  D  V  Y  R  V  S  R  V - 
  
         TAATCATCACTAACATTAACAACAGCGTCGCAGACCGAATAAACGGAGCCCAGATTCACA 
     181 ---------+---------+---------+---------+---------+---------+ 240 
           I  I  T  N  I  N  N  S  V  A  D  R  I  N  G  A  Q  I  H  I - 
  
         TCGGAAACTCTCTGGAGAACAACGGCACCAACAATCCCATGTGTGCTGTGATTTCCAGTA 
     241 ---------+---------+---------+---------+---------+---------+ 300 
           G  N  S  L  E  N  N  G  T  N  N  P  M  C  A  V  I  S  S  I - 
  
         TTCCAGCTGGAGTTTCTGCAACCTTCCTCTGTTGTTTTATGGAGGGTCGATATGTGAGTC 
     301 ---------+---------+---------+---------+---------+---------+ 360 
           P  A  G  V  S  A  T  F  L  C  C  F  M  E  G  R  Y  V  S  L - 
  
         TGTTCATTCCCGGAGACTCAAAGATGCTYACTCTGTGTGAAGTGGAGGTGTATGTAGAAG 
     361 ---------+---------+---------+---------+---------+---------+ 420 
           F  I  P  G  D  S  K  M  L  T  L  C  E  V  E  V  Y  V  E  G - 
  
         GTCCGTGTTGGAAGCAGTCGTTGGTAAAACTGAAGCTCAACTCTAGCTTTAGTCTTTCTG 
     421 ---------+---------+---------+---------+---------+---------+ 480 
           P  C  W  K  Q  S  L  V  K  L  K  L  N  S  S  F  S  L  S  E - 
  
         AAGTGCAGTTCCTGACCCAGCTGGAATCTGCTCTGGCCCGAAGAGGACTTTCTGACGTGA 
     481 ---------+---------+---------+---------+---------+---------+ 540 
           V  Q  F  L  T  Q  L  E  S  A  L  A  R  R  G  L  S  D  V  T - 
  
         CGCTGCACTGGACGCAACTGCCCAAACAGATGCCAGAGCAAGTTGCGCCAGCTCAAAGAA 
     541 ---------+---------+---------+---------+---------+---------+ 600 
           L  H  W  T  Q  L  P  K  Q  M  P  E  Q  V  A  P  A  Q  R  K - 
  
         AGAAACGCTGAAAACTGAAACTCCCTGAGGATCAGCTTGGATTTTCTTCATCATTTAGTG 
     601 ---------+---------+---------+---------+---------+---------+ 660 
           K  R  *  
  
         CATTTATATTGCTTCAATATTTCTGTTTGTTTGAATGTAGATCAAATATTTAATGTGATT 
     661 ---------+---------+---------+---------+---------+---------+ 720 
 
         TTAATATTTACTGAATTTTATTGCTTTATCAGTTGTGCAGTTATCATTAATATTGTAAAT 
     721 ---------+---------+---------+---------+---------+---------+ 780 
 
         AAATACACCAAGTATTTAAGCAAAAAAAAAAAAAAAAA 
     781 ---------+---------+---------+-------- 
 
 222 
H. DreIII-FBPL CDS 
         ATGTTGTGGCTCGCTCTGCTCTTGGGGTTGTGTGTCACTGATGTGGCGCCGGCTAATCTG 
       1 ---------+---------+---------+---------+---------+---------+ 60 
         M  L  W  L  A  L  L  L  G  L  C  V  T  D  V  A  P  A  N  L   - 
  
         GCTCTGGGTGCCGCAGCGGTGCAGTCGTCCACTGGAGACCCCAATGGAAACGCTGAGCAC 
      61 ---------+---------+---------+---------+---------+---------+ 120 
         A  L  G  A  A  A  V  Q  S  S  T  G  D  P  N  G  N  A  E  H   - 
  
         GCAGTGGACGGAAACACAGAAGCAGACTACCGTAAGGGCTCCTGCACACACACCAGCCGT 
     121 ---------+---------+---------+---------+---------+---------+ 180 
         A  V  D  G  N  T  E  A  D  Y  R  K  G  S  C  T  H  T  S  R   - 
  
         GAGTTTAACCCCTGGTGGAGGGTGGATCTGGGTGGAGTGTCCAGCGTCAACAAAGTCACC 
     181 ---------+---------+---------+---------+---------+---------+ 240 
         E  F  N  P  W  W  R  V  D  L  G  G  V  S  S  V  N  K  V  T   - 
  
         ATCACCAACAGAGGAGACTGCTGTGAGGAGCGCATACGTGGAGCGCAGATCCGCATCGGG 
     241 ---------+---------+---------+---------+---------+---------+ 300 
         I  T  N  R  G  D  C  C  E  E  R  I  R  G  A  Q  I  R  I  G   - 
  
         GACAGCCTGGAGAACAACGGAAACAACAACCAGCTAGCTGCTACTCTTCTGGATGCTATT 
     301 ---------+---------+---------+---------+---------+---------+ 360 
         D  S  L  E  N  N  G  N  N  N  Q  L  A  A  T  L  L  D  A  I   - 
  
         AAAGGCTCTCAGACGTTCGAGTTTCAGCCGATTCAGGGCCGATACCTCAATGTTTTCCTG 
     361 ---------+---------+---------+---------+---------+---------+ 420 
         K  G  S  Q  T  F  E  F  Q  P  I  Q  G  R  Y  L  N  V  F  L   - 
  
         CCCGGGAATGATGAAACTCTGAGTCTGTGTGAAGTGGAGGTGTTTTCAGCAGGTCCATCA 
     421 ---------+---------+---------+---------+---------+---------+ 480 
         P  G  N  D  E  T  L  S  L  C  E  V  E  V  F  S  A  G  P  S   - 
  
         AAGAATATCGCCGCTGGAGCCGCCGCCGTTCAGTCCTCCACTTGGCCTCATGATGGTGAC 
     481 ---------+---------+---------+---------+---------+---------+ 540 
         K  N  I  A  A  G  A  A  A  V  Q  S  S  T  W  P  H  D  G  D   - 
  
         GCAGGGAATGCTGTGGATGGAAGCAGCGAGTCTGAGTATCAGGAGGGCTCCTGTTCACAC 
     541 ---------+---------+---------+---------+---------+---------+ 600 
         A  G  N  A  V  D  G  S  S  E  S  E  Y  Q  E  G  S  C  S  H   - 
  
         ACTCTGGGGGAAACCAACCCGTGGTGGAGGGTGGATCTAGGGAGAGTGTTCAGCATCCGC 
     601 ---------+---------+---------+---------+---------+---------+ 660 
         T  L  G  E  T  N  P  W  W  R  V  D  L  G  R  V  F  S  I  R   - 
  
         CGTGTCAGCATCACCAACAGAGGAGACTGCTGTGAGGAGAGGTTAAACGGAGCTGAGATC 
     661 ---------+---------+---------+---------+---------+---------+ 720 
         R  V  S  I  T  N  R  G  D  C  C  E  E  R  L  N  G  A  E  I   - 
  
         CGCATCGGGAACAGCCTGGAGAACAACGGAAACAGCAACCACCTAGTTGCGACTGTCGAG 
     721 ---------+---------+---------+---------+---------+---------+ 780 
         R  I  G  N  S  L  E  N  N  G  N  S  N  H  L  V  A  T  V  E   - 
  
         CACATTCCAGCTGGAAACACCGAGACGTTTGAGTTCCAGCCGGTTCAGGGCAGATTCCTC 
     781 ---------+---------+---------+---------+---------+---------+ 840 






         AACATTGTACTGCCTGGTGTAAACGTTTACCTCACTCTGTGTGAAGTGCAGGTGTTCACA 
     841 ---------+---------+---------+---------+---------+---------+ 900 
         N  I  V  L  P  G  V  N  V  Y  L  T  L  C  E  V  Q  V  F  T   - 
  
         GACTGA 
     901 ------ 906 
         D  *   - 
 
 224 
I. DreIV-FBPL in silico CDS 
         AAATCTGGCTTTAAGTGGCAGGGCCACACAATCAGACCTGTTGAAAAATCCATGGACAGG 
       1 ---------+---------+---------+---------+---------+---------+ 60 
          N  L  A  L  S  G  R  A  T  Q  S  D  L  L  K  N  P  W  T  G  - 
  
         AGAGGCCCTTGCCAGTAATGCTATTGATGGAAATCGTGACCCAGATTTTTACCATGGGTC 
      61 ---------+---------+---------+---------+---------+---------+ 120 
          E  A  L  A  S  N  A  I  D  G  N  R  D  P  D  F  Y  H  G  S  - 
  
         TTGTACTGCCACTGAAGTACAAGATGATCCGTGGTGGAGGTTAGATTTACTAGACACATA 
     121 ---------+---------+---------+---------+---------+---------+ 180 
          C  T  A  T  E  V  Q  D  D  P  W  W  R  L  D  L  L  D  T  Y  - 
  
         TGTGGTGAAATCCATAACAATAACAAACCGAAAAGACTGCTGTCCTGAAAGACTTGATGG 
     181 ---------+---------+---------+---------+---------+---------+ 240 
          V  V  K  S  I  T  I  T  N  R  K  D  C  C  P  E  R  L  D  G  - 
  
         AGCCGAGGTTCACATTGGCAACTCTCTGCTGAACAATGGCAACAGCAATCCACTGGCTGC 
     241 ---------+---------+---------+---------+---------+---------+ 300 
          A  E  V  H  I  G  N  S  L  L  N  N  G  N  S  N  P  L  A  A  - 
  
         AAAAATTTCCTCAATTCCAGCTGGAAGATCCCTCACTTTCAAATGGAAAAAAGGCATTTC 
     301 ---------+---------+---------+---------+---------+---------+ 360 
          K  I  S  S  I  P  A  G  R  S  L  T  F  K  W  K  K  G  I  S  - 
  
         AGGTCGTTACATCAATGTAATCCTTCGTGGCTCCAATCAAATTCTTACCCTCTGCGAGCT 
     361 ---------+---------+---------+---------+---------+---------+ 420 
          G  R  Y  I  N  V  I  L  R  G  S  N  Q  I  L  T  L  C  E  L  - 
  
         TGAAGTTTACGGTTATCCGGCTCCCAATGGTGAAAATGTAGCTTTAAGAGGCAAAGCTAC 
     421 ---------+---------+---------+---------+---------+---------+ 480 
          E  V  Y  G  Y  P  A  P  N  G  E  N  V  A  L  R  G  K  A  T  - 
  
         ACAGAGTTTTCTCTATGGAAATGGTTTTGCATCTAATGCAAATGATGGGAACAAAGATGG 
     481 ---------+---------+---------+---------+---------+---------+ 540 
          Q  S  F  L  Y  G  N  G  F  A  S  N  A  N  D  G  N  K  D  G  - 
  
         TGTTCACACTCATGGATCCTGCACACACACTCACAAAACCCTCAACCCCTGGTGGAGACT 
     541 ---------+---------+---------+---------+---------+---------+ 600 
          V  H  T  H  G  S  C  T  H  T  H  K  T  L  N  P  W  W  R  L  - 
  
         GGACCTGCTGAAAAGGCACAAAGTGTTTTCGGTGGTCATTACAAACACATTAGACAATCT 
     601 ---------+---------+---------+---------+---------+---------+ 660 
          D  L  L  K  R  H  K  V  F  S  V  V  I  T  N  T  L  D  N  L  - 
  
         TCCTGAAAGATTAAATGGTGCAGAAATACGAATTGGAGACAATCTGGACAACAATGGCAA 
     661 ---------+---------+---------+---------+---------+---------+ 720 
          P  E  R  L  N  G  A  E  I  R  I  G  D  N  L  D  N  N  G  N  - 
  
         TAATAATCCCAGATGTGCTACAATCGCTTCCATTCCTGCTGGTTTCTCCAGCTCTTTTGA 
     721 ---------+---------+---------+---------+---------+---------+ 780 
          N  N  P  R  C  A  T  I  A  S  I  P  A  G  F  S  S  S  F  D  - 
  
         CTGTGATGGGATGGAAGGACGTTACGTTAATGTTGTTATTCCAGGACGAGAAGAATATCT 
     781 ---------+---------+---------+---------+---------+---------+ 840 






         AACACTGTGTGAGGTTGAAGTTTACGGATCGCCACTGGACTGA 
     841 ---------+---------+---------+---------+--- 883 
          T  L  C  E  V  E  V  Y  G  S  P  L  D  *   - 
 
 226 
J. DreV-FBPL cDNA 
         GGGATCGACACCGCAGGATGACGGTGGTGATGCTGGCTGTGCTGCTGCTGCTGCTGGTGTGTGTGTGTGA 
       1 ---------+---------+---------+---------+---------+---------+---------+ 70 
                          M  T  V  V  M  L  A  V  L  L  L  L  L  V  C  V  C  D    
  
         CTCTACAGCCTTCAGACTCACAGGAAACATCGCTCTGAGAGCTGAAACCCATCAGTCCGCTGACCCGCTG 
      71 ---------+---------+---------+---------+---------+---------+---------+ 140 
          S  T  A  F  R  L  T  G  N  I  A  L  R  A  E  T  H  Q  S  A  D  P  L     
  
         AACGGAGACTCCGCATGGAGAGCAGTGGCTGGAGATGGAGATCGGTCCTGCAGCTCCATCAGCTCGAAGA 
     141 ---------+---------+---------+---------+---------+---------+---------+ 210 
         N  G  D  S  A  W  R  A  V  A  G  D  G  D  R  S  C  S  S  I  S  S  K  R   
  
         GAAGCCCCTGGTGGAGAGTTTCTCTAGCACAGACCTACAGAATCGCCAAAATCTCCATCAGCACCGGCAC 
     211 ---------+---------+---------+---------+---------+---------+---------+ 280 
           S  P  W  W  R  V  S  L  A  Q  T  Y  R  I  A  K  I  S  I  S  T  G  T    
  
         TGAGGGCATCAGCGGGGCCGAGATCCGCATTGGCAGCAGTCTGGAGGAGGACGGAAACCACAACCAGCTG 
     281 ---------+---------+---------+---------+---------+---------+---------+ 350 
          E  G  I  S  G  A  E  I  R  I  G  S  S  L  E  E  D  G  N  H  N  Q  L     
  
         GTGAGAGTGTTCTCTGTGCGGCCGGGGAAAGCTCAGGTGTTTAAGTTCAGGCCTGTGGAGGGACGCTTCA 
     351 ---------+---------+---------+---------+---------+---------+---------+ 420 
         V  R  V  F  S  V  R  P  G  K  A  Q  V  F  K  F  R  P  V  E  G  R  F  I   
  
         TCACTGTGATTTTACCAGGAGTGGACCGTGTGCTGAATCTGTGTGAGGTGGAGGTGTTCGCGCTCGCTGA 
     421 ---------+---------+---------+---------+---------+---------+---------+ 490 
          T  V  I  L  P  G  V  D  R  V  L  N  L  C  E  V  E  V  F  A  L  A  E    
  
         AGACTCTAACTCAGACTCAGAGCTGGTGAATGTGGCAGTATCGGGTCGAGCCACTCAGTCCAGCATGCGT 
     491 ---------+---------+---------+---------+---------+---------+---------+ 560 
          D  S  N  S  D  S  E  L  V  N  V  A  V  S  G  R  A  T  Q  S  S  M  R     
  
         CTGGGTTCTGCTGCGTGTCTCAGTCTGCCACAGAACGCCATCGACGGGAACCGGCAGTACGACCCGTCCC 
     561 ---------+---------+---------+---------+---------+---------+---------+ 630 
         L  G  S  A  A  C  L  S  L  P  Q  N  A  I  D  G  N  R  Q  Y  D  P  S  R   
  
         GCGGCTCATGTGCGCAGACAGACACCGAGAGCGCCCCCTGGTGGAGGCTGGACCTGCTGCGGACACACAC 
     631 ---------+---------+---------+---------+---------+---------+---------+ 700 
           G  S  C  A  Q  T  D  T  E  S  A  P  W  W  R  L  D  L  L  R  T  H  T    
  
         CATCACTGCAGTGGCTCTGACCCGCGGAGACCAGGACGTCAACGGCGCGAGGGTGACCATCGGGGACTCG 
     701 ---------+---------+---------+---------+---------+---------+---------+ 770 
          I  T  A  V  A  L  T  R  G  D  Q  D  V  N  G  A  R  V  T  I  G  D  S     
  
         CTGCAGGATGAGGGACGAGCAAACCCGCTGTGTGTGTCCGTGTCCTTCATCCCTGCTGGAGGCACAGGCT 
     771 ---------+---------+---------+---------+---------+---------+---------+ 840 
         L  Q  D  E  G  R  A  N  P  L  C  V  S  V  S  F  I  P  A  G  G  T  G  C   
  
         GCTTCAGGTGTGTTCCTGCTCTCCGGGGCCGATACGTGACTGTGGCTCTGGCTGGAGTAAACAGGACCCT 
     841 ---------+---------+---------+---------+---------+---------+---------+ 910 
           F  R  C  V  P  A  L  R  G  R  Y  V  T  V  A  L  A  G  V  N  R  T  L    
  
         GAGCCTGTGTGAGGTGGAGGTGTTCGGGGTGCCTGATCAATAACATCCAGACATCAGCAGCGCTCCATAT 
     911 ---------+---------+---------+---------+---------+---------+---------+ 980 
          S  L  C  E  V  E  V  F  G  V  P  D  Q  *                                
  
         TTACTGGCTCCTGTTTTCATTTCTGCTTGTGTTGCATTATGGGATCTTGATCTTTCTTCCAACAACTTTT 
     981 ---------+---------+---------+---------+---------+---------+---------+ 1050 
 
         AACCTTAAACAGTGTGTGAAAGTGTGTCCTGCACATGTGATAGTGTGCAGTGCTCTATTGTGTGTGTGTG 
    1051 ---------+---------+---------+---------+---------+---------+---------+ 1120 
  
         TTGTGTCATAGATATATACACTAGATATCGCATAGAGACCCTGAGTATTCGTCTATAGCGCCGCCACATT 




         GGTACAGTGCTCCCAGGACAAGTGTCATTCAATCGCACTAGTCAAGACAGTGTTATTACGTGAAGATGCG 
    1191 ---------+---------+---------+---------+---------+---------+---------+ 1260 
 
         GGACTTTAGCGCTGTCTATGAGTGTAGTAATGAGCAAACAAAGAAAACAAAGCACAAAGGCAGAACACTT 
    1261 ---------+---------+---------+---------+---------+---------+---------+ 1330 
 
         CATAGGTAATATTCAGTTTTTTCTGTTTTTGTATGTTCTGAACTCTTGTGCTAATCAGGTAACATTATTG 
    1331 ---------+---------+---------+---------+---------+---------+---------+ 1400 
 
         ATGATAACAGTCACTTACTGCATTCACCATACGGCAAAGCAGCTCCAACTCGCACTAAACACTCGACTAA 
    1401 ---------+---------+---------+---------+---------+---------+---------+ 1470 
 
         TGCTGGTTTTGTTGAATAAAATCAGCAAACAATGCAGGAGAAATATGACAACGAGATGCTGCGCTGCCAG 
    1471 ---------+---------+---------+---------+---------+---------+---------+ 1540 
 
         AAACTTGTATTATTGTCGGCTAACGTTAGTGAAAGAGTCGTTCGGGGGATTCATTCACAAGCGAGTCGCT 
    1541 ---------+---------+---------+---------+---------+---------+---------+ 1610 
 
         CCTCCGTCAGCATGAGCAGTGACAGCAGGAGAGGAGCTGTGTTTCAGGACATGATTAGATCACATTTAAC 
    1611 ---------+---------+---------+---------+---------+---------+---------+ 1680 
 
         AGGGAGGGTGAATAGTACATTTCTGTACACACAAACACAAGCTTTCTGTCAGGAATGCCCGTGCGGTCAC 
    1681 ---------+---------+---------+---------+---------+---------+---------+ 1750 
 
         TGATCCATTAATGTAGAAAAGTGATGTAAAACTATAATTTTCTTAATTAGAAAAAAAAATTATATACTAA 
    1751 ---------+---------+---------+---------+---------+---------+---------+ 1820 
 
         CCTTCAGGAAAACTCCCGATCATAGATATATGTGTATATGTGTATATCTCTGGCTTTGCATGGCCACAGT 
    1821 ---------+---------+---------+---------+---------+---------+---------+ 1890 
 
         CCTCCACTGTACCTTGGTCCTGCATTCATTTCAAAGGAGCGCTACCCTGTAGCAGGATGGCGGCGCTATT 
    1891 ---------+---------+---------+---------+---------+---------+---------+ 1960 
 
         GACGCATTCCGTCCAATAGACAATAACAGGCCAGGCGACATCTAGTGTATATATCTATGGTGTTGTGTAT 
    1961 ---------+---------+---------+---------+---------+---------+---------+ 2030 
 
         TACGCTACAGAAGCCTCGTGGTAAACTGCAGCACATTCACTGATACTCTACACACTCATTCCTCTGCAGA 
    2031 ---------+---------+---------+---------+---------+---------+---------+ 2100 
 
         TGATCTCTTATATTATTTTAAACTGCTAGAAGTCTCTCTGGTAAACTGTAGAGTTGACTTTACAACATCA 
    2101 ---------+---------+---------+---------+---------+---------+---------+ 2170 
 
         GCAGTGGACAGAGCAGATCAACATCCCATAATGCACTTCACCATCATAAATAAACACTTGACTAAATATG 
    2171 ---------+---------+---------+---------+---------+---------+---------+ 2240 
 
         GACTAAATATGTGCTGTTTAACAGTGAACAAACACAAATAACAGCGACGCTATTGACATTATTATAATAA 
    2241 ---------+---------+---------+---------+---------+---------+---------+ 2310 
 
         ACAGCAAAAGCAGTCGCTCTGCAGACCTGAAGAGGTCCATGACCACATGACCAGCAGAACAACATCATGA 
    2311 ---------+---------+---------+---------+---------+---------+---------+ 2380 
 
         GAGGGAAGATCAGTTCACATCATCCCTGACCCAGACCTCCAATCATCAGTGGAAGAGAACGAGAGCTGAG 
    2381 ---------+---------+---------+---------+---------+---------+---------+ 2450 
 
         GCCTGGAGACAGAGATGTTCAATCTGTTCCACAACAGCTGTTTAACTGAGAGATCCACTTTACTTCTCAA 
    2451 ---------+---------+---------+---------+---------+---------+---------+ 2520 
 
         TATATTACTTTAATAGCTGATTTATTGTGTCTGTCCTAACCCTGTGTGTGTGTGTGTGTGTGTGTGTGTG 
    2521 ---------+---------+---------+---------+---------+---------+---------+ 2590 
 
         TGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG 




K. Omy-FBPL4 cDNA 
                 10                  30                  50                  70          
                  .         .         .         .         .         .         .          
         TCTCCCACATGGTGTCCTGGAGCCTGTTACAGTTTACGGCTTCCCCCAGATTACCGTGTTAACTCCTCGC          
                                                                                         
                           90                 110                 130                    
                  .         .         .         .         .         .         .          
         TCCATGTGTCTCTCCTCAGGCAGGTGGTAGCTGGTCCACTCCAGGAGTCTGAGGTGTGGGAAGTTCCTCC          
                                                                                         
                150                 170                 190                 210          
                  .         .         .         .         .         .         .          
         ACCCCCTTAGGACATCGAGGGGGCCACCGGCGTATGCAGTCCGATCCATACTGGACTTGACGTGTCAGGC          
                                                                                         
                          230                 250                 270                    
                  .         .         .         .         .         .         .          
         GAGGGGCTTTCAGTACCTCGTGGAGTGGGAGCGTGTAAGGTCCGGAGGAGAGATGCTGGGTGAGACAGCA          
                                                                                         
                290                 310                 330                 350          
                  .         .         .         .         .         .         .          
         CAACCCCTGTCCCAGCCTCGGACGCATCCACCTCAACTATGAACGCTAAAGAGGGATCAGGATGAGCCAG          
                                                                                         
                          370                 390                 410                    
                  .         .         .         .         .         .         .          
         CACGGGAGCCGAGCAAGATGAAAGACGTAATTATACTCTCCCTGCTGGGGATTCTGGGAATGGGAAGGTG          
                          M  K  D  V  I  I  L  S  L  L  G  I  L  G  M  G  R  C           
                430                 450                 470                 490          
                  .         .         .         .         .         .         .          
         CTCTAAAGATGAATTAGTGAATGTAGCTCTGAGGGGCAAAGCAGCCCAATCATCCACATCCTATGGAGGC          
          S  K  D  E  L  V  N  V  A  L  R  G  K  A  A  Q  S  S  T  S  Y  G  G            
                          510                 530                 550                    
                  .         .         .         .         .         .         .          
         ACTGCAAAAAGAGCCATTGATGGAATATGGAACCCGACTTACGAATATCTCTCCTGCAGCCACACTTCGG          
         T  A  K  R  A  I  D  G  I  W  N  P  T  Y  E  Y  L  S  C  S  H  T  S  G          
                570                 590                 610                 630          
                  .         .         .         .         .         .         .          
         GAGAGACCAGCCCCTGGTGGAGGGTGGACCTGCTGGAGACCTACCAAGTCACCTCCGTCACCATCACCAA          
           E  T  S  P  W  W  R  V  D  L  L  E  T  Y  Q  V  T  S  V  T  I  T  N           
                          650                 670                 690                    
                  .         .         .         .         .         .         .          
         CAGAGATACTTTAGCAGAGAGGATCAACGGGGCTGAGATCCGCATTGGAAACTCCCTGGAGAACGATGGC          
          R  D  T  L  A  E  R  I  N  G  A  E  I  R  I  G  N  S  L  E  N  D  G            
                710                 730                 750                 770          
                  .         .         .         .         .         .         .          
         AACAGTAACCCCAGGTGTGCGTTGATATCCTCCATCCCCGCAGGGGGCTCCACCACATTTCAATGCCACG          
         N  S  N  P  R  C  A  L  I  S  S  I  P  A  G  G  S  T  T  F  Q  C  H  G          
                          790                 810                 830                    
                  .         .         .         .         .         .         .          
         GGATGCGGGGGCAATACGTCAATGTGTTCCTCAGAGGATACATGCAATATCTGACCCTGTGTGAGGTGGA          
           M  R  G  Q  Y  V  N  V  F  L  R  G  Y  M  Q  Y  L  T  L  C  E  V  E           
                850                 870                 890                 910          
                  .         .         .         .         .         .         .          
         GGTGAATGCTCATCCTGCTCCTATTGAAATGGGACCAACTCAAGCTTCAGAACTCAACTTAATTGTTCCT          
          V  N  A  H  P  A  P  I  E  M  G  P  T  Q  A  S  E  L  N  L  I  V  P            
                          930                 950                 970                    
                  .         .         .         .         .         .         .          
         GTTACAGACAATGTTGCCTTAAAGAAAACGACTCGCCAATCCTCCCAGTACTCCCACATGGGGGGCTCTA          
         V  T  D  N  V  A  L  K  K  T  T  R  Q  S  S  Q  Y  S  H  M  G  G  S  N          
                990                1010                1030                1050          
                  .         .         .         .         .         .         .          
 
 229 
         ACAATGCCGTGGATGGAAGACGCCTCTCCATGTACAAAGACAAATCATGCAGCCGCACCAAGTCCCAAGT          
           N  A  V  D  G  R  R  L  S  M  Y  K  D  K  S  C  S  R  T  K  S  Q  V           
                         1070                1090                1110                    
                  .         .         .         .         .         .         .          
         CAACCCATGGTGGAGGGTGGACTTGCAGCGAGCGTACAACGTCACCTCCATAACAGTCACAAACATTGAA          
          N  P  W  W  R  V  D  L  Q  R  A  Y  N  V  T  S  I  T  V  T  N  I  E            
               1130                1150                1170                1190          
                  .         .         .         .         .         .         .          
         GACGTTGATCCAGAGATGATCGATGGTGCTGAAATCCACATTGGAAACTCGCTGCAGAATAATGGCAACA          
         D  V  D  P  E  M  I  D  G  A  E  I  H  I  G  N  S  L  Q  N  N  G  N  N          
                         1210                1230                1250                    
                  .         .         .         .         .         .         .          
         ACAATCCATTGTGCGCTGTGATCTCCTCATATCCCGCGTGGGAGGTCATGACCTTTCAGTGCAGTGGGAT          
           N  P  L  C  A  V  I  S  S  Y  P  A  W  E  V  M  T  F  Q  C  S  G  I           
               1270                1290                1310                1330          
                  .         .         .         .         .         .         .          
         CGAGGGTCGCTATGTGAACGTTTTCTTGCCGGGCTGCAATAAACACCTGTCACTGTGTGAGGTGGAGGTG          
          E  G  R  Y  V  N  V  F  L  P  G  C  N  K  H  L  S  L  C  E  V  E  V            
                         1350                1370                1390                    
                  .         .         .         .         .         .         .          
         AATGTGGGTAGCCGTCCTGGTGAGGAGCAGACATTATATGATATGGACGAACATCTTTCCTCTGACAGGA          
         N  V  G  S  R  P  G  E  E  Q  T  L  Y  D  M  D  E  H  L  S  S  D  R  R          
               1410                1430                1450                1470          
                  .         .         .         .         .         .         .          
         GGGTGCAAGATATGAAGAGAGGGCAAGACATTCTATGCCCAGACCATAAGACTCGATATGAGAATGCAGC          
           V  Q  D  M  K  R  G  Q  D  I  L  C  P  D  H  K  T  R  Y  E  N  A  A           
                         1490                1510                1530                    
                  .         .         .         .         .         .         .          
         CACTGGCGGGATAGCCAATCAGTCGTCGCAGTGGGACATGTTTGGAGATGCCAACAATGCCATTGACCTG          
          T  G  G  I  A  N  Q  S  S  Q  W  D  M  F  G  D  A  N  N  A  I  D  L            
               1550                1570                1590                1610          
                  .         .         .         .         .         .         .          
         AGCTGGAGCAACCGGTATCTGGAGGGGTCCTGCAGCCACACGAAAGCAGAGGTCGACCCCTGGTGGCGGG          
         S  W  S  N  R  Y  L  E  G  S  C  S  H  T  K  A  E  V  D  P  W  W  R  V          
                         1630                1650                1670                    
                  .         .         .         .         .         .         .          
         TGGACCTGAGCAAGACCCACAACGTCACCTACGTCACCATTACCAACAGAGGGGACTGCTGCTCAGACAG          
           D  L  S  K  T  H  N  V  T  Y  V  T  I  T  N  R  G  D  C  C  S  D  R           
               1690                1710                1730                1750          
                  .         .         .         .         .         .         .          
         GATCAGTGGAGCAGAGATCCACGTTGGGGACTCACTGTTCAACAACGGCAATAGCAACCCACTGTGTGCC          
          I  S  G  A  E  I  H  V  G  D  S  L  F  N  N  G  N  S  N  P  L  C  A            
                         1770                1790                1810                    
                  .         .         .         .         .         .         .          
         AGGATTCCATACATCCCTGCTGGGCAAAGCAGGACATTTCCGTGCGGTGGGATATCGGGGCGCTATGTCA          
         R  I  P  Y  I  P  A  G  Q  S  R  T  F  P  C  G  G  I  S  G  R  Y  V  N          
               1830                1850                1870                1890          
                  .         .         .         .         .         .         .          
         ACATTCTCCTCCCAGGAAAAGAGAAGTACTTGACTTTGTGTGAGGTGGAAGTGCAAGCAAGCACCTTTCA          
           I  L  L  P  G  K  E  K  Y  L  T  L  C  E  V  E  V  Q  A  S  T  F  Q           
                         1910                1930                1950                    
                  .         .         .         .         .         .         .          
         GGCAGGCCTGCCTTCAACTGCCCACAAGACAGCTGTTACAGCTCCAAACCGAAACCTGGCCTGGTTGTGG          
          A  G  L  P  S  T  A  H  K  T  A  V  T  A  P  N  R  N  L  A  W  L  W            
               1970                1990                2010                2030          
                  .         .         .         .         .         .         .          
         GATCTTCTGATACCCCTCGGAAGAACTGCTATTCGGAAAGAAGAGACCTATAATCAAAACAGTACAGAAG          
         D  L  L  I  P  L  G  R  T  A  I  R  K  E  E  T  Y  N  Q  N  S  T  E  E          
                         2050                2070                2090                    
                  .         .         .         .         .         .         .          
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         AAGAGACATTTGATCATGACAAAATATCATTTGAGACACAACGTCCAGTTGATAAAGTGCCTGAGAATTT          
           E  T  F  D  H  D  K  I  S  F  E  T  Q  R  P  V  D  K  V  P  E  N  L           
               2110                2130                2150                2170          
                  .         .         .         .         .         .         .          
         AGTCTCCGGTGGAATAGAGGTCCATTCCTCCCAGTATGACAGCCACGGTGCTGCCAGCAATGCCACCGAC          
          V  S  G  G  I  E  V  H  S  S  Q  Y  D  S  H  G  A  A  S  N  A  T  D            
                         2190                2210                2230                    
                  .         .         .         .         .         .         .          
         AGGAAGCGTAACCCACTGTACCATGCTGGCTCCTGCAGCCACACGGAGGCAGAGACCAACCCCTGGTGGA          
         R  K  R  N  P  L  Y  H  A  G  S  C  S  H  T  E  A  E  T  N  P  W  W  R          
               2250                2270                2290                2310          
                  .         .         .         .         .         .         .          
         GAGTGGACCTTTTGGACACATACCAAGTCACCTTTGTCACCATCACCAACAGAGGGGACTGCTGTCTCCA          
           V  D  L  L  D  T  Y  Q  V  T  F  V  T  I  T  N  R  G  D  C  C  L  H           
                         2330                2350                2370                    
                  .         .         .         .         .         .         .          
         CAAGATCAACGGAGCTGAGATCCGCATTGGAAACTCCCTGGAGAACAACGGCACGACCAATCCACTGTGT          
          K  I  N  G  A  E  I  R  I  G  N  S  L  E  N  N  G  T  T  N  P  L  C            
               2390                2410                2430                2450          
                  .         .         .         .         .         .         .          
         GCTGTGATCTCCGAGATGAGAGAAGGGCAGCCAATGGATATTCCATGTAACATGGAGGGACACTATGTCA          
         A  V  I  S  E  M  R  E  G  Q  P  M  D  I  P  C  N  M  E  G  H  Y  V  T          
                         2470                2490                2510                    
                  .         .         .         .         .         .         .          
         CTATCGTTCTCCCAGGCAGAGAGAAGTACCTGGCACTGTGCGAGGTAGAGGTGTATGGGGGAAAGTGATG          
           I  V  L  P  G  R  E  K  Y  L  A  L  C  E  V  E  V  Y  G  G  K  *              
               2530                2550                2570                2590          
                  .         .         .         .         .         .         .          
         ACMCTAACCAATCTGAAATGACTCCTTTTACAGGAAAGTTCCAAATAAGGCCAACATAGTTACCATCTAA          
                     
                         2610                2630                2650                    
                  .         .         .         .         .         .         .          
         CTACAGAATCACTTACTATTTTGAGAAGTGTGGAGAAAGTCACTCAGTATTTCTTGTCATACCCAGTGGG          
                    
               2670                2690                2710                2730          
                  .         .         .         .         .         .         .          
         ATCTCAAATAGTTCTTTGTTGAAGGCGGACGGCGTATTTTAGCCAAATTATAAACAGTCACATTTGTATT          
                       
                         2750                2770                2790          
                  .         .         .         .         .         .          




L. CG9095 cDNA 
The cleaved signal peptide is indicated by lowercase amino acids and are negatively enumerated.  
The protein motifs are indicated as follows: CCP are underlined; FBPL is bold; CTL is boxed and 
the transmembrane helix is dotted underlined.  The in-frame stop codon is marked with an 
asterisks.  The polyadenylation motif is double underlined. 
 
      1  GGACAGGAGCCGTGAGCGAGACAGCAACAATGCACCGCACGCAGCCGTCGCTGCCGCTGC    
                                      m  h  r  t  q  p  s  l  p  l  p   -19 
                                                                               
     61  CTCTGCCGCTGCTGGCGTTGGCGTTGGCGTTGGCTTCGGCGCTGGCTTTTGCGCAGGCGC    
           l  p  l  l  a  l  a  l  a  l  a  s  a  l  a  f  a  q  a  Q   1 
                                                                               
    121  AGAATATAGATGCCGGTTGCAGTTTCCCGGGATCGCCGGCGCACAGCAGCGTCGTCTTCT    
           N  I  D  A  G  C  S  F  P  G  S  P  A  H  S  S  V  V  F  S   21 
                                                                               
    181  CGAATGCGAATCTCACCCAGGGCACGGTGGCCTCCTACAGCTGCGAGCGGGGATTCGAGC    
           N  A  N  L  T  Q  G  T  V  A  S  Y  S  C  E  R  G  F  E  L   41 
                                                                               
    241  TTCTGGGACCGGCGCGGCGTGTCTGCGACAAGGGGCAATGGGTGCCCGAGGGCATTCCGT    
           L  G  P  A  R  R  V  C  D  K  G  Q  W  V  P  E  G  I  P  F   61 
                                                                               
    301  TCTGCGTTTTGAACGTTGCCGCTGGCAAGGCGCCCATGCAGATTTCCACTGATGGCGCTG    
           C  V  L  N  V  A  A  G  K  A  P  M  Q  I  S  T  D  G  A  G   81 
                                                                               
    361  GTGCTCCACAAAAGGCCATCGATGGCTCCACATCCGCCTTCTTCACACCGGAGACCTGCT    
           A  P  Q  K  A  I  D  G  S  T  S  A  F  F  T  P  E  T  C  S   101 
                                                                               
    421  CGCTGACGAAGGCGGAGCGATCGCCCTGGTGGTATGTGAATCTCCTGGAACCCTACATGG    
           L  T  K  A  E  R  S  P  W  W  Y  V  N  L  L  E  P  Y  M  V   121 
                                                                               
    481  TGCAACTGGTGCGTCTGGACTTTGGCAAATCCTGTTGCGGCAATAAGCCCGCCACAATTG    
           Q  L  V  R  L  D  F  G  K  S  C  C  G  N  K  P  A  T  I  V   141 
                                                                               
    541  TAGTGCGAGTGGGCAACAACCGACCGGACTTGGGCACAAATCCGATCTGCAACCGCTTCA    
           V  R  V  G  N  N  R  P  D  L  G  T  N  P  I  C  N  R  F  T   161 
                                                                               
    601  CGGGCCTCCTGGAGGCCGGACAGCCGCTCTTCCTGCCCTGCAATCCCCCGATGCCGGGAG    
           G  L  L  E  A  G  Q  P  L  F  L  P  C  N  P  P  M  P  G  A   181 
                                                                               
    661  CCTTCGTGAGTGTCCACCTGGAGAATAGCACACCCAATCCGCTGTCCATTTGCGAGGCGT    
           F  V  S  V  H  L  E  N  S  T  P  N  P  L  S  I  C  E  A  F   201 
                                                                               
    721  TCGTCTACACGGACCAAGCGCTGCCCATCGAGCGGTGTCCCACCTTCCGCGATCAGCCGC    
           V  Y  T  D  Q  A  L  P  I  E  R  C  P  T  F  R  D  Q  P  P   221 
                                                                               
    781  CTGGAGCTCTGGCCTCGTACAATGGCAAGTGCTACATCTTCTACAACCGCCAGCCGCTGA    
           G  A  L  A  S  Y  N  G  K  C  Y  I  F  Y  N  R  Q  P  L  N   241 
                                                                               
    841  ACTTTTTGGACGCACTGTCCTTCTGTCGATCCCGTGGCGGTACGCTGATCAGTGAGAGCA    
           F  L  D  A  L  S  F  C  R  S  R  G  G  T  L  I  S  E  S  N   261 
                                                                               
    901  ATCCGGCGCTGCAGGGATTCATCAGTTGGGAGCTGTGGCGGCGTCATCGCAGTGACGTCA    
           P  A  L  Q  G  F  I  S  W  E  L  W  R  R  H  R  S  D  V  S   281 
                                                                               
    961  GTTCGCAGTACTGGATGGGAGCGGTACGTGATGGCAGCGATCGCAGCAGCTGGAAATGGG    
           S  Q  Y  W  M  G  A  V  R  D  G  S  D  R  S  S  W  K  W  V   301 
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   1021  TGAACGGTGACGAGCTGACCGTCTCCTTCTGGAGTCATCCCGGCGGCGATGAGGATTGTG    
           N  G  D  E  L  T  V  S  F  W  S  H  P  G  G  D  E  D  C  A   321 
                                                                               
   1081  CCCGATTTGATGGCTCCAAGGGCTGGCTCTGGAGCGATACCAACTGCAACACGCTGCTGA    
           R  F  D  G  S  K  G  W  L  W  S  D  T  N  C  N  T  L  L  N   341 
                                                                               
   1141  ACTTCATCTGTCAGCACCAACCGAAGACCTGTGGCCGACCGGAGCAACCGCCCAATTCCA    
           F  I  C  Q  H  Q  P  K  T  C  G  R  P  E  Q  P  P  N  S  T   361 
                                                                               
   1201  CGATGGTAGCCCTGAACGGATTCGAGGTTGGCGCCCAGATCAAGTACAGCTGCGATGCCA    
           M  V  A  L  N  G  F  E  V  G  A  Q  I  K  Y  S  C  D  A  N   381 
                                                                               
   1261  ATCACCTGCTGGTGGGTCCCGCCACGAGGACCTGCCTGGAGACTGGATTCTACAATGAGT    
           H  L  L  V  G  P  A  T  R  T  C  L  E  T  G  F  Y  N  E  F   401 
                                                                               
   1321  TCCCGCCAGTGTGCAAGTACATCGAGTGTGGTCTGCCGGCCAGCATTGCCCATGGTTCCT    
           P  P  V  C  K  Y  I  E  C  G  L  P  A  S  I  A  H  G  S  Y   421 
                                                                               
   1381  ACGCCCTGCTCAACAACACGGTTGGCTACTTGAGCCTGGTGAAGTATTCGTGCGAGGAGG    
           A  L  L  N  N  T  V  G  Y  L  S  L  V  K  Y  S  C  E  E  G   441 
                                                                               
   1441  GTTACGAGATGATAGGACGAGCTTTGCTCACCTGCGACTTTGATGAGCGCTGGAATGGAC    
           Y  E  M  I  G  R  A  L  L  T  C  D  F  D  E  R  W  N  G  P   461 
                                                                               
   1501  CTCCACCACGTTGTGAGATTGTGGAGTGCGACACTCTGCCCGGCAACTACTACAGCACCA    
           P  P  R  C  E  I  V  E  C  D  T  L  P  G  N  Y  Y  S  T  I   481 
                                                                               
   1561  TTATCAACGCTCCCAATGGCACATACTACGGCTCCAAGGCGGAGATCAGTTGTCCACCCG    
           I  N  A  P  N  G  T  Y  Y  G  S  K  A  E  I  S  C  P  P  G   501 
                                                                               
   1621  GATACCGCATGGAAGGACCTCGAGTGCTTACCTGCCTGGCCAGTGGTCAATGGAGCAGTG    
           Y  R  M  E  G  P  R  V  L  T  C  L  A  S  G  Q  W  S  S  A   521 
                                                                               
   1681  CCCTGCCGCGTTGCATCAAACTGGAACCGTCCACTCAGCCCACTGCCGCGTCCACCATTC    
           L  P  R  C  I  K  L  E  P  S  T  Q  P  T  A  A  S  T  I  P   541 
                                                                               
   1741  CCGTGCCCTCGTCGGTGGCCACGCCACCACCGTTCCGCCCCAAGGTGGTCAGCTCGACCA    
           V  P  S  S  V  A  T  P  P  P  F  R  P  K  V  V  S  S  T  T   561 
                                                                               
   1801  CCAGCCGCACCCCCTACCGCCCAGCAGTATCCACGGCGAGCAGCGGCATTGGCGGCAGCT    
           S  R  T  P  Y  R  P  A  V  S  T  A  S  S  G  I  G  G  S  S   581 
                                                                               
   1861  CCACCAGCACAGTGGGCACGTATCCCAGTCTCAGCCCCACGCAGGTGGAGATCAATGGCG    
           T  S  T  V  G  T  Y  P  S  L  S  P  T  Q  V  E  I  N  G  E   601 
                                                                               
   1921  AATCTGAATCCGAAGAGGAAATCAATGTGCCTCCAGTGCCTGGCACCGTTCGCGAGGAGT    
           S  E  S  E  E  E  I  N  V  P  P  V  P  G  T  V  R  E  E  F   621 
                                                                               
   1981  TCCCACCACGACGCACAGTTCGTCCAGTGCTCATACCGAAGAAGCCGAACAGCACACCGG    
           P  P  R  R  T  V  R  P  V  L  I  P  K  K  P  N  S  T  P  A   641 
                                                                               
   2041  CTGCCCTGCCGCCCACCACCCATCAGGTGCCACCGCAACCACCGTCCACCTACGCACCCA    
           A  L  P  P  T  T  H  Q  V  P  P  Q  P  P  S  T  Y  A  P  T   661 
                                                                               
   2101  CACCACCGCGCAGCTCGCGACCAAGTGGTGCTCCGAATAGCGCCGGCGAAGTGGAGACAA    
           P  P  R  S  S  R  P  S  G  A  P  N  S  A  G  E  V  E  T  T   681 
                                                                               
   2161  CCACGCGGAATACACAGCAGATCATCGCCAATTCGCATCCGCAAGACAACGAGATCCCCG    
           T  R  N  T  Q  Q  I  I  A  N  S  H  P  Q  D  N  E  I  P  D   701 
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   2221  ACAGTGTCAACATCCAGCAGAACCAGTCGCCCAATGTCAACGTGCCCTTCGCCGTCGATA    
           S  V  N  I  Q  Q  N  Q  S  P  N  V  N  V  P  F  A  V  D  N   721 
                                                                               
   2281  ATCCCGACCGCAAGGAGACCAAGGAGGCCAAACTTAATCTGGGCGCCATCGTTGCTCTGG    
           P  D  R  K  E  T  K  E  A  K  L  N  L  G  A  I  V  A  L  G   741 
                                                                               
   2341  GCGCTTTTGGTGGTTTCGTCTTCCTGGCCGCCGTCATCACAACGATCGTGATCCTTGTGC    
           A  F  G  G  F  V  F  L  A  A  V  I  T  T  I  V  I  L  V  R   761 
                                                                               
   2401  GAAGAAACCGAACCACACAACACTATCGCCATCGCGCCTCGCCCGACTGCAACACTGTGG    
           R  N  R  T  T  Q  H  Y  R  H  R  A  S  P  D  C  N  T  V  A   781 
                                                                               
   2461  CCAGCTTCGATAGCTCCACCTCCGGATCCCGCAATGGACTCAACAGGTACTACCGCCAAG    
           S  F  D  S  S  T  S  G  S  R  N  G  L  N  R  Y  Y  R  Q  A   801 
                                                                               
   2521  CCTGGGAGAACCTGCACGAGTCCGCCTCGAAGAACAGCTCACACAACGCCCTCCGCCGCA    
           W  E  N  L  H  E  S  A  S  K  N  S  S  H  N  A  L  R  R  K   821 
                                                                               
   2581  AGGAGACCCTCGATCCACCGAGCATGACCCGTTCCCGGGACAATCTGCGCGACAATATGC    
           E  T  L  D  P  P  S  M  T  R  S  R  D  N  L  R  D  N  M  Q   841 
                                                                               
   2641  AGCGATCCCGCGAAAATCTCGACAGATGCGGCAGGGACAACTACGGCATGCGGGATGACT    
           R  S  R  E  N  L  D  R  C  G  R  D  N  Y  G  M  R  D  D  S   861 
                                                                               
   2701  CCGAGATGGTGGTGTCCTCGGTGGTGTCGGATGTGTGCCTGAAGGGCGAGAAGAAGCGCC    
           E  M  V  V  S  S  V  V  S  D  V  C  L  K  G  E  K  K  R  H   881 
                                                                               
   2761  ATCACCATCATCACCACAAGAGCAGCTCCCGCAACGGCGACTACCGCGATCGGGATCACT    
           H  H  H  H  H  K  S  S  S  R  N  G  D  Y  R  D  R  D  H  S   901 
                                                                               
   2821  CCTCCGGCAGACGCGAGCACCACCGACATAGTGGTGGTGGTGGTGGCGGCGGAGGCGGTG    
           S  G  R  R  E  H  H  R  H  S  G  G  G  G  G  G  G  G  G  G   921 
                                                                               
   2881  GTGGCGGCCACTATTGACCAACCATGGTCATCACCATCAATGTGGAGCGGCAGTAGCCAA    
           G  G  H  Y  *                                                926 
                                                                               
   2941  ACGAACGATAGTGGCCAGCAGCAGTCGGCGTAGAGATCGGATTCGGATTCGGACTTGGAT    
                                                                               
   3001  TTGGATTTTGATTTGGACTCGGGTTTTTGGTTTTGGATTTGGATTCAGATTCGAAAATCG    
                                                                               
   3061  CGATCTGAGAACTGCAATGCGAGCGCAACAACGAAACGTTTTTTGTTTAATTTTAGCATC    
                                                                               
   3121  AGTTTTTTTTCGCGCATTAGTTATGTAAGCCACAGATGGAGAAAAAAGGGGTTCGGAAAA    
                                                                               
   3181  TGTAAGGAGAAAACTTTTCTGTTTATAGTGAAAAAAAAAAAAAAAAAACTCGTATTAGGC    
                                                                               
   3241  CAGCCTATCCAACCCATTGCTCTGTGTCTAACACCAGGCTCTGTAAAATATTCGATCCTA    
                                                                               
   3301  AGATTTACCTTAATGTATATTTAGTGACTTTCTTAGACCCGATCCCTTTTCGACTTTCCC    
                                                                               
   3361  CTCTTTCACCCAGTTTAGATCCCTCGCTTCTATGGTTATAGGTCGTCAGTTTTCATTTAA    
                                                                               
   3421  AGTTTCTGTACAAACAATATCTTTCTCAATGTAAACACACAAAAACTCGTATAATTAGAG    
                                                                               
   3481  TACACCTAAACTTAATTTATGGTAATAAACGTTGATATTCAAAACCCAAAAAAAAAAAAA    
                                                                               
   3541  AAAAAAA   
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M. Pairwise alignment of MsaFBP32 and MchFBP32 genes. 
Exons are in uppercase. Introns are in lowercase.  The Tc1/mariner-like element (TLE) is in 
lowercase and underlined. 
 
>Msfbp         CTGAACTCCA GGGTTAAAAG ATCTGTTCTA ACCAGGAAGC AGGgtaagca 
>Mcfbp         CTGAACTCCA GGGTTAAAAG ATCTGTTCTA ACCAGGAAGC AGGgtaagca 
 #1            ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ctttagttat ttcatcaatg catctcgtat tttacaaatt gttgtcattt 
>Mcfbp         ctttagttat ttcatcaatg catctcgtat tttacaaatt gttgtcattt 
 #51           ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         tgcatcttta tttatttatt atttatattt gtatagcacc aaatgataac 
>Mcfbp         tgcatcttta tttatttatt atttatattt gtata::::: :::::::::: 
 #101          ...................................................... 
               ---------- ---------- ---------- -----***** ********** 
 
>Msfbp         agatgagcta aaacgagtgt ttctcggggt ccattggtgc tatataaata 
>Mcfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
 #151          ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         atccacaaca aagaaaagaa atgcaaca:: ::gtcattct gcactacaaa 
>Mcfbp         :::::::::: ::gaaaagaa atgcaacaaa ccgtcattct gcactacaaa 
 #201          ...................................................... 
               ********** **-------- --------** **-------- ---------- 
 
>Msfbp         cattaaaagc tggagtaaca ggaatgcgtt gtgcacatga atataagatt 
>Mcfbp         cattaaaagc tggagtaaca ggaatgcgtt gtgcacatga atataagatt 
 #251          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         tatgataatt atgctgtaca gatatgttag tgaagaacta tgaatcgata 
>Mcfbp         tatgataatt atgctgtaca gatatgttag tgaagaacta tgaatcgata 
 #301          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         acaaaaatac aacctaatga tatacattta caaaaatact tatatcctat 
>Mcfbp         acaaaaatac aacctaatga tatacattta caaaaatact tatatcctat 
 #351          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         aattcgtgtc ctctaaaatg tccaatagtt agtcccatgt tccccatact 
>Mcfbp         aattcgtgtc ctctaaaatg tccaatagtt agtcccatgt tccccatact 
 #401          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         cttgttttcc tcccctttac ccctaatatc tacatttcaa gcaacattat 
>Mcfbp         c::gttttcc tcccctttac ccctaatatc tacatttcaa gcaacattat 
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 #451          ...................................................... 
               -**------- ---------- ---------- ---------- ---------- 
 
>Msfbp         tttattatta tttttctaaa ttaaaaaaac tacttcaaaa tcattttgat 
>Mcfbp         tttattatta tttttctaaa ttaaaaaaac tacttcaaaa tcattttgat 
 #501          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         agagcagctt ctataaagat agctactggc cgaggggaaa aaagttaaga 
>Mcfbp         agagcagctt ctataaagat agctactggc cgagaggaaa aaagttaaga 
 #551          ...................................................... 
               ---------- ---------- ---------- ----*----- ---------- 
 
>Msfbp         ggacggcaga ggaacctaag aagagacatc agaaaagact acgtctcgtg 
>Mcfbp         ggacaacaga ggaacctaag aagagacaga aga:::gact acctctcgtg 
 #601          ...................................................... 
               ----**---- ---------- --------** ---***---- --*------- 
 
>Msfbp         ctggttttta gttgttggta agagccgtgt gaaagaatag atcgtttcat 
>Mcfbp         ctggttttta gttgttggta agagctgtgt gaaagaatag attgtttcat 
 #651          ...................................................... 
               ---------- ---------- -----*---- ---------- --*------- 
 
>Msfbp         tcgtacttgc agcaaagtgt tgcagtaaac tttaagagca gatcaaaaat 
>Mcfbp         tcgtacttgc agcaaagtgt tgcagtaaac tttaagagca gatcaaagat 
 #701          ...................................................... 
               ---------- ---------- ---------- ---------- -------*-- 
 
>Msfbp         gatcacatga tcaatcacat gttcaaagca gggatagcca atcagagact 
>Mcfbp         gatcacatga tcaattacat gttcaaagca aggatagcca atcagagact 
 #751          ...................................................... 
               ---------- -----*---- ---------- *--------- ---------- 
 
>Msfbp         taaccagcct cttttcgatt gttcattctt cttccttctc tttttgtttg 
>Mcfbp         taaccagcct cttttcgatt gttcattctt cttccttctc tttttgtttg 
 #801          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         cagttagtct tcattcaaga taattgcgac aaagtcatgt catcttcttc 
>Mcfbp         cagctagtct tcattcaaga taattgcgac aaagtcatgt catcttcttc 
 #851          ...................................................... 
               ---*------ ---------- ---------- ---------- ---------- 
 
>Msfbp         ttgaagactt tcatcagtca aaatgtactt ggagatgcca tttggagctt 
>Mcfbp         ttgaagactt tcatcagtca aaatgtactt ggagatgcca tttggagctt 
 #901          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         taatgctttt aacaattctc tctcttgtct ttctcaacca gAATAATGAG 
>Mcfbp         taatgctttt aacaattctc tctcttgtct ttctcaacca gAATAATGAG 
 #951          ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         GCACAGTGTG GTATTTCTGT TGCTGCTCCT CTTAGGGGCG TGTTCAGCTT 
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>Mcfbp         GCACAGTGTG GTATTTCTGT TGCTGCTCCT CTTAGGGGCG TGTTCAGCTT 
 #1001         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ACAACTATAg taagtataat gtaaaaaata tcctgtattt acagttgcaa 
>Mcfbp         ACAACTATAg taagtataat gcagaaaata tcctgtattt acagttgcaa 
 #1051         ...................................................... 
               ---------- ---------- -*-*------ ---------- ---------- 
 
>Msfbp         tcagaaat:: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         tcagaaatta aagctgcaag cagcgttggg cgggacctcg ccctccacgc 
 #1101         ...................................................... 
               --------** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         aactcggggc gtgctgcggc cgcgccacgt gccgttgtaa cacttgcgta 
 #1151         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ccacaacatg aaagtttcac gcaaatcaga tcaaagtcgc tatgcagtgc 
 #1201         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ttacttcctg ttgccagtag gtggcgctat cactaaatct gaatattgtc 
 #1251         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         atgtagacgt gttcagggca ggactgttat caaacatgtg acgtttcatt 
 #1301         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         gagattggac catgtacacg gaagttgtga ggacgtactg aagataggac 
 #1351         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         tactatctgt tttatggcca atcggtggaa ttcgacacat tgtcccgggc 
 #1401         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         acgcggttaa acgtacagtc acaaatagca caactgttga tcaccagtgt 
 #1451         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         gtctggattg cagtgatgga atttgaagtc aatctgacaa tatctgtagg 
 #1501         ...................................................... 




>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         aggagttcat taaaacagaa gcccataata gacagaaatg gcatcacagt 
 #1551         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ttgagattcg attcaacctg gccaactttg acggcacgcc acagacacgc 
 #1601         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ccttcaacgt acatacacaa atagcacaac tttttatcag caccattttt 
 #1651         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         tggctgtact gaccaatttt gaagcagatc taataaattg cctaggagga 
 #1701         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         gttcgttcaa atagaaggcg aaaaattaca gaaaatgacc aaaaaagaca 
 #1751         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         aaacggccga ctttgatgcc acgccacgga cacgcccttc aacgtacatg 
 #1801         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         cacaaatagc acaactttta atcagcacca ttttttgact gtactgacca 
 #1851         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         atattgaagc agatccgatg aattccctag gaggagttcg tccaaataca 
 #1901         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         acgcgaaaat ttcaccgaaa gtgaatgaaa atcaaaatgg cggacttccc 
 #1951         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         gtggggtttg gggtatgggt ccaagaggct tttttgtacg tcttggtgag 
 #2001         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ttacacgtgc ctaccgagtt tcgtacatat cggtgaaacg tggcgccggg 
 #2051         ...................................................... 




>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         gctgtttttt tttgttatcc tgcagggggc gctacaaacc cgacaaacct 
 #2101         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ccacttcctg ttttgaccaa aatgtacagg aagttttaat tgttttatgt 
 #2151         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         tttttgccag ggcggtcccc aggtgctgcg ggaagaattt cgtgcaaatc 
 #2201         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ggacaaagcc tgtaggagaa acatgaaaaa gtagtttgag gacatttcgt 
 #2251         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         gctctaacgg aaaaacattc taggcggaag tgggcgtggc ctatatgggg 
 #2301         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         agattcagct ccattcaccg aacatgttat atatatatat gatataaggt 
 #2351         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ttttgtatgt gcgacaaacc atgcagaagt tattagccta aacgcgtttt 
 #2401         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ttatgatagt agcgccacct agtggcaaat ccgaaagcaa cacaaagart 
 #2451         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         atcaaatttt tcaccaggcc tgaccacttt gccaaataaa attgagtttt 
 #2501         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         cgtatatgtt caggggggca aaaatgcagt cgaagtcgct aaaaataata 
 #2551         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
>Mcfbp         ataggtaaga agaagaaaca tagcagtttc aatagggacc tccagcgatc 
 #2601         ...................................................... 
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               ********** ********** ********** ********** ********** 
 
>Msfbp         :::::::::: ::::::::aa tcaaccccct cacctcagaa aacattatag 
>Mcfbp         gctggctcag tccctaataa tcaaccccct cacctcagaa aacattatag 
 #2651         ...................................................... 
               ********** ********-- ---------- ---------- ---------- 
 
>Msfbp         tgacaataaa tgacaaaaaa cctcattaaa caa::::::: :::::::tat 
>Mcfbp         tgacaataaa tgacaaaaaa cctcattaaa caacaaaaaa tatttgatat 
 #2701         ...................................................... 
               ---------- ---------- ---------- ---******* *******--- 
 
>Msfbp         atttgataca tatgatttat tttgacaaca gaagttgact taactttgaa 
>Mcfbp         atatga:::: :::::tttat tttgacaaca gaagttgact taactttgaa 
 #2751         ...................................................... 
               --*---**** *****----- ---------- ---------- ---------- 
 
>Msfbp         gttcaaatga aagctgtaac tcttttaaca cgtgcagtat tattcaaccc 
>Mcfbp         gttcaaatga aaactgtaac tctt:::::: :::::::::: :::::::::: 
 #2801         ...................................................... 
               ---------- --*------- ----****** ********** ********** 
 
>Msfbp         ccagcttcag tactttgtag cgcatcccaa cgtctaacaa acgttttttg 
>Mcfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
 #2851         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         gttctttcac ctctcgatca caatcttttc ccattgttca cgtgcaaaag 
>Mcfbp         :::::::::: :::::::::: :::::::::: :::::::::: :::::::::: 
 #2901         ...................................................... 
               ********** ********** ********** ********** ********** 
 
>Msfbp         tctctatctc agtgatgttt gatggcttcc gtgctgcctt ctttaaattc 
>Mcfbp         :::::::::: :::::::::: :::::::::: ::aagttctt cttt:::::: 
 #2951         ...................................................... 
               ********** ********** ********** *******--- ----****** 
 
>Msfbp         caccaaagtt aaatctagtg actgaacagg ccacttcagg atgttccagg 
>Mcfbp         :::::::::t aaatctggtg actgaacagg ccactccagg atgttccagg 
 #3001         ...................................................... 
               *********- ------*--- ---------- -----*---- ---------- 
 
>Msfbp         atctttttct caaccaagct ttggttgact tggagatgtg cttgggatca 
>Mcfbp         atctttttct caaccaagct ttggttgact tggagatgtg cttgggatca 
 #3051         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ttgtcttgct ggaaagtcca ttgatcacta aggtttaata tgttaacaga 
>Mcfbp         ttgtcttgct ggaaagtcca ttgatcacta aggtttaata tgttaacaga 
 #3101         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         aggcatcacg ttactcttta aaatggcctg gtatttctgg gaatccatga 
>Mcfbp         aggcatcacg ttcctcttta caatggcctg gtatttctgg gaatccatga 
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 #3151         ...................................................... 
               ---------- --*------- *--------- ---------- ---------- 
 
>Msfbp         tgccaggtac acgatcaaaa ttcacaaaca gtctattatt atatctttta 
>Mcfbp         tgccaggtac acgatcaaaa ttcacaaaca gtctattatt atatctttta 
 #3201         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         tatcgatatc aactgtgtcc ttcatagAAA ATGTGGCCTT GCGTGGAAAA 
>Mcfbp         tatcgatatc aactgtgtcc ttcatagAAA ATGTGGCCTT GCGTGGAAAA 
 #3251         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         GCGACTCAGT CGGCACGTTA TTTGCACACA CATGGAGCCG CCTACAACGC 
>Mcfbp         GTGACTCAGT CGGCACGTTA TTTGCACACA CATGGAGCCG CCTTCAACGC 
 #3301         ...................................................... 
               -*-------- ---------- ---------- ---------- ---*------ 
 
>Msfbp         CATTGATGGA AACCGTAACT CTGACTTCGA AGCTGGATCG TGCACCCACA 
>Mcfbp         CATTGATGGA AACCGTAACT CTGACTTCGA AGCTGGATCA TGCACCCACA 
 #3351         ...................................................... 
               ---------- ---------- ---------- ---------* ---------- 
 
>Msfbp         CTATTGAACA GACCAACCCC TGGTGGAGAG TGGACCTACT GGAGCCCTAC 
>Mcfbp         CTGTTGAACA GACCAACCCC TGGTGGAGAG TGGACCTACT GGAGCCCTAC 
 #3401         ...................................................... 
               --*------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ATCGTCACCT CCATCACCAT CACCAACAGA GGAGACTGCT GTCCAGAAAG 
>Mcfbp         ATCGTCACCT CCATCACCAT CACCAACAGA GGAGACTGCT GTCCAGAAAG 
 #3451         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         GCTCAACGGG GTGGAGATTC ACATCGGCAA CTCTATACAA GAAAATGGTG 
>Mcfbp         GCTCGATGGA GCGGAGATTC ACATCGGCAA CTCTTTACAA GAAAATGGTG 
 #3501         ...................................................... 
               ----*-*--* -*-------- ---------- ----*----- ---------- 
 
>Msfbp         TTGCAAACCC AAGgtgagtg catattaaca gttataagtg aaaacagtga 
>Mcfbp         TTGCAAACCC AAGgtgagtg catattaaca gttataagtg aaaacagtga 
 #3551         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         cagctagacc cacaattctg ttcaatgttc attacatttt acctttacct 
>Mcfbp         tagctagacc cacaattctg ttcaatgtta attacatttt acctttacct 
 #3601         ...................................................... 
               *--------- ---------- ---------* ---------- ---------- 
 
>Msfbp         ttaacctcag tccagtcagt gcagtcacaa cagacctgtt tcctaaccat 
>Mcfbp         ttaacctcag tccagtcagt gcagtcacaa cagacctgtt tcctaaccat 
 #3651         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         gacactacgt agatgaacat cattaatgtg ctgctttctc tcttcttgtg 
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>Mcfbp         gacactatgt agatgaacat cattaatgtg ctgctttctc tcttcttgtg 
 #3701         ...................................................... 
               -------*-- ---------- ---------- ---------- ---------- 
 
>Msfbp         tctcttttag GGTTGGTGTA ATTTCTCATA TCCCTGCAGG GATCTCACAT 
>Mcfbp         tctcttttag GGTTGGTGTA ATTTCTCATA TCCCTGCAGG GATCTCACAT 
 #3751         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ACTATCAGTT TCACTGAACG TGTGGAGGGA CGTTACGTGA CTGTGCTTCT 
>Mcfbp         ACTATCAGTT TCACTGAACG TGTGGAGGGA CGTTACGTGA CTGTGCTTCT 
 #3801         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ACCTGGTACA AACAAGGTTC TTACACTCTG TGAAGTGGAG GTTCATGGGT 
>Mcfbp         ACCTGGTACA AACAAGGTTC TTACACTCTG TGAAGTGGAG GTTCATGGGT 
 #3851         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ACCGAGCCCC AACTGgtgag aatttgagtc ataccatatt gtatatttgc 
>Mcfbp         ACCGAGCCCC AACTGgtgag aatttgagtc ataccatatt gcatatttgc 
 #3901         ...................................................... 
               ---------- ---------- ---------- ---------- -*-------- 
 
>Msfbp         aatttaggta attctaatta tatcagtagc taaataatac agagatcaga 
>Mcfbp         aatgaaggta attctactta tatcagtagc taaataatac agagatcaga 
 #3951         ...................................................... 
               ---**----- ------*--- ---------- ---------- ---------- 
 
>Msfbp         ggttatccag cctgcaggtc ccacaagaac cacagcagat ttcagtgacg 
>Mcfbp         ggttatccag cctgcaggtc ccacaagaac cacagcagat ttcagtgacg 
 #4001         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         gttgcccaac tcgcccaaaa tgattcttac tttgatcaca atttgatcca 
>Mcfbp         gttgcccaac tcgcccaaaa tgattcttac tttgatcaca atttgatcca 
 #4051         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ttccgtccca taacattttg aaaatctaga agagctgcat gctactaatc 
>Mcfbp         ttccgtccca taacattttg aaaatctaga agagctgcat gctactaatc 
 #4101         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ttggacgtct ttgatattta gctggactct :::::::::: :::::::::: 
>Mcfbp         ttggacgtct ttgatattta gctggactct ggtgtgcatt ctctacgggc 
 #4151         ...................................................... 
               ---------- ---------- ---------- ********** ********** 
 
>Msfbp         :::::::::: cagaggcttt ttgtttgaac atagtattca gttctcttta 
>Mcfbp         ccaaaaagat cagaggcttt ttgtttgaac atagtattca gttctcttta 
 #4201         ...................................................... 




>Msfbp         acgtgcctta gctggtagga aaacaagggt gataaatact gtccacagtg 
>Mcfbp         acgtgcctta gctggtagga aaacaagggt gatgaatact gtccacagtg 
 #4251         ...................................................... 
               ---------- ---------- ---------- ---*------ ---------- 
 
>Msfbp         ttaaattatt agagacaagc tcattgtatg agtgctgtag catggccccg 
>Mcfbp         ttaaattatt agagacaagc tcattgtatg agtgctgtag catggcccag 
 #4301         ...................................................... 
               ---------- ---------- ---------- ---------- --------*- 
 
>Msfbp         atgtaagtgt ttaattaatc taaacatcta tttgccacag tggcaaggcc 
>Mcfbp         atgtaagtga ttaattaatc taaacatata tttgccacag tggcaaggcc 
 #4351         ...................................................... 
               ---------* ---------- -------*-- ---------- ---------- 
 
>Msfbp         ttatactaat aaacctgtta ttagtataaa caagcaacaa caaggtaaat 
>Mcfbp         t::::::::: ::::::gtta ttagtataaa cacgcaa::a caaggaaaat 
 #4401         ...................................................... 
               -********* ******---- ---------- --*----**- -----*---- 
 
>Msfbp         tcaaagtgct cagtcgtgaa agcagaattg ctcttccata aagcgtgggg 
>Mcfbp         tcaaagtgct cagtcgtgaa agcagaattg ctcttccata aagcgtgggg 
 #4451         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         cttgccagag acagattaca aacagtctag atgcagcaga gaacattaaa 
>Mcfbp         cttgccagag acagattaca aacagtctag atgcagcaga gaacattaaa 
 #4501         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         caccaaaaac aacaaacaaa acctcaatat cagcgctgag accatatttt 
>Mcfbp         caccaaaaac aacaaacaaa acctcaatat cggcgctgag accatatgtt 
 #4551         ...................................................... 
               ---------- ---------- ---------- -*-------- -------*-- 
 
>Msfbp         tgttgcagGA GAGAACCTGG CCCTCAAAGG AAAAGCCACA CGGTCGTCAT 
>Mcfbp         tgttgcagGA GAGAACCTGG CCCTCAAAGG AAAAGCCACA CAGTCGTCAT 
 #4601         ...................................................... 
               ---------- ---------- ---------- ---------- -*-------- 
 
>Msfbp         TGTTTGAATC TGGTATTGCA TATAATGCCA TTGATGGGAA TCAAGCCAAC 
>Mcfbp         TGTTTGAATC TGGTATTGCA TATAATGCCA TTGATGGGAA TCAAGCCAAC 
 #4651         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         AATTGGGAAA TGGCCTCCTG CACTCACACA AAAAACACAA TGAACCCCTG 
>Mcfbp         AATTGGGAAA TGGCCTCCTG CACTCACACA AAAAACACAA TGAACCCCTG 
 #4701         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         GTGGCGAATG GATCTGAGCA AAACCCACAG AGTGTTTTCT GTTAAGGTAA 
>Mcfbp         GTGGCGAATG GATCTGAGCA AAACCCACAG AGTGTTTTCT GTTAAGGTAA 
 #4751         ...................................................... 




>Msfbp         CCAACCGAGA TTCATTTGAA AAACGAATCA ATGGAGCTGA GATCCGAATT 
>Mcfbp         CCAACCGAGA TTCATTTGAA AAACGAATCA ATGGAGCTGA GATCCGAATT 
 #4801         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         GGAGATTCCC TCGACAACAA CGGCAACAAC AATCCCAGgt agtttactga 
>Mcfbp         GGAGATTCCC TCGACAACAA CGGCAACAAC AATCCCAGgt agtttactga 
 #4851         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ctgttaatta attgcaatac caatataatt aaatataaat gtggtaactt 
>Mcfbp         ctgttaatta attgcaatac caatataatt aaatataaat gtggtaactt 
 #4901         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         tttttacatt atcgccataa tgaagtgatt tcttcttctt ctaccagGTG 
>Mcfbp         tttttacatt atcgccataa tgaagtgatt tcttcttctt ctaccagGTG 
 #4951         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         TGCTGTGATC ACAAGCATCC CAGCAGGTGC TTCTACTGAA TTCCAGTGTA 
>Mcfbp         TGCTGTGATC ACAAGCATCC CAGCAGGTGC TTCTACTGAA TTCCAGTGTA 
 #5001         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         ACGGGATGGA TGGCCGCTAT GTTAACATTG TTATCCCTGG AAGAGAAGAG 
>Mcfbp         ACGGGATGGA TGGTCGCTAT GTTAACATTG TTATCCCTGG AAGAGAAGAG 
 #5051         ...................................................... 
               ---------- ---*------ ---------- ---------- ---------- 
 
>Msfbp         TACCTGACCC TGTGTGAGGT GGAGGTGTAT GGCTCTGTCC TGGATTAGGT 
>Mcfbp         TACCTGACCC TGT                                         
 #5101         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         GTCAGTACTA ATACTGTTGA ATGTACACAA ACAAAACAAA ATAGTAGATT 
 #5151         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         AAGCTTTTTT GATTGTTTCC ATTCAAAATA AGACAGAGAT GGTCTTATCC 
 #5201         ...................................................... 
               ---------- ---------- ---------- ---------- ---------- 
 
>Msfbp         AATAAAA                                                
 #5251         ...................................................... 
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